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The United Kingdom Focal Point on Drugs 
 
The United Kingdom (UK) Focal Point on Drugs is based at the Department of Health 
and the North West Public Health Observatory at the Centre for Public Health, 
Liverpool John Moores University.  It is the national partner of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and provides 
comprehensive information to the Centre on the drug situation in England, Northern 
Ireland, Scotland and Wales.   
 
The Focal Point works closely with the Home Office, other Government Departments 
and the devolved administrations.  In addition to this annual report, it collates an 
extensive range of data in the form of standard tables and responses to structured 
questionnaires, which are submitted regularly to the EMCDDA.  It also contributes to 
other elements of the EMCDDA’s work such as the development and implementation 
of its five key epidemiological indicators, the Exchange on Drug Demand Reduction 
Action (EDDRA) and the implementation of the Council Decision on New 
Psychoactive Substances. 
 
Further information about the United Kingdom Focal Point, including previous annual 
reports and data submitted to the EMCDDA, can be found on the Focal Point website 
at www.ukfocalpoint.org.uk  
 
The EMCDDA's website is www.emcdda.europa.eu 
 
The Head of the United Kingdom Focal Point on Drugs is Alan Lodwick at the 
Department of Health (alan.lodwick@dh.gsi.gov.uk).  
 
 
The structure and content of this report 
 
The structure and content of this annual report are pre-determined by the EMCDDA 
to facilitate comparison with similar reports produced by the other European Focal 
Points.  Ten chapters cover the same subjects each year, and three further chapters, 
giving in-depth information on selected issues, change from year to year.  
 
Each of the first ten chapters begins with an Overview.  This sets the context for the 
remainder of the chapter, describing the main features of the topic under 
consideration within the United Kingdom.  This may include information about the 
main legislative and organisational frameworks, sources of data and definitions used, 
the broad picture shown by the data and recent trends. 
 
The remainder of each chapter is concerned with New Developments and Trends 
that have not been included in previous annual reports. Generally, this covers 
developments that have occurred in the second half of 2006 or the first half of 2007. 
Relevant data that have become available during this period will also be discussed 
although these will often refer to earlier time periods. 
 
This report, and the reports from the other European countries, will be used in the 
compilation of the EMCDDA’s annual report of the drug situation in the European 
Union and Norway to be published in 2008. 
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The United Kingdom and its constituent countries 
 
 
The United Kingdom population was estimated to be 60.6 million in the middle of 
2006 (ONS et al. 2007): 83.8 per cent (50.8 million) live in England, 8.4 per cent (5.1 
million) in Scotland, 4.9 per cent (3.0 million) in Wales and 2.9 per cent (1.7 million) 
in Northern Ireland.   
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SUMMARY 
Main findings 
1. National policies and context 
A new combined Northern Ireland alcohol and drug strategy was launched in October 
2007.  In both England and Wales there are to be new strategies in 2008.  A 
consultation on the strategy for England ended in October 2007.  This has been 
accompanied by a number of reports/critiques on current strategy. 
 
New agreements for reducing the harm caused by drugs (and alcohol) were set in 
October 2007 placing responsibility on a number of government departments to meet 
targets set by Government.  Indicator measures which will drive action are: the 
percentage change in the number of drug users recorded as being in effective 
treatment; the rate of drug-related offending; and the percentage of the public who 
perceive drug use or dealing to be a problem in their area.  
 
Methamphetamine has been reclassified as a Class A drug.  The Advisory Council 
on the Misuse of Drugs has been asked by Government to undertake a further review 
of cannabis looking specifically at the potential mental health effects.   
 
There have been two Departmental changes which have implications for drug 
strategy and policy.  One affects all of the United Kingdom where a new Ministry of 
Justice has assumed some of the functions formerly undertaken by the Home Office.  
In England, two new departments have been created: the Department for Children, 
Schools and Families and the Department for Innovation, Universities and Skills, the 
first of which assumed many of the responsibilities of the former Department for 
Education and Skills and takes lead responsibility for prevention and work with 
vulnerable young people. 
 
The Serious Crime Bill 2006-07 will introduce Serious Crime Prevention Orders, 
imposing restrictions on the activities of those involved in serious crime, and will have 
implications for drug trafficking.  
 
There are proposals to expand the range of controlled drugs that can be prescribed 
independently by Nurse Independent Prescribers and to enable Pharmacist 
Independent Prescribers to prescribe some controlled drugs.  Suboxone 
(buprenorphine/naloxone) has been licensed for use in the United Kingdom.  
2. Drug use in the population 
Latest survey data on drug use amongst adults in England and Wales (2006/07) 
show that the fall in recent prevalence of drug use, first seen in 2004/05, has 
continued.  This is mainly accounted for by a fall in cannabis use.  Similar trends are 
seen in Northern Ireland.  In Scotland, changes in the methodology of the 2006 
survey mean that it is not possible to make any meaningful comparisons with 
previous surveys.   
 
While prevalence amongst young people (aged 16 to 24) continues to be much 
higher than amongst the adult population as a whole, similar trends to those found in 
the wider group can be seen, with declining overall drug use and cannabis use.  Use 
of cocaine, however have continued to increase.   
 
Amongst school children prevalence also continues to fall.  The decrease is mainly 
attributable to a fall in the two most common drugs, cannabis, and, amongst this 
group, volatile substances.  Cocaine use appears to be stable.   
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The first survey of primary school children’s knowledge and use of drugs was carried 
out in Northern Ireland in 2006.  Most had heard of drugs, most commonly cannabis 
and cocaine, but a very small proportion had been offered them, and it was extremely 
rare for them to have tried them. 
 
The results of drug testing amongst servicemen/women are reported for the first time 
in the United Kingdom Focal Point report.  Prevalence is low compared to the general 
population.  Cannabis and ecstasy were the next most commonly detected drugs.   
3. Prevention 
A review of the evidence of the effectiveness of prevention programmes found that 
school-based drug prevention is effective, especially amongst low risk groups, and 
that programmes based on life skills show the most consistent effect.  Parent 
education shows some evidence of effectiveness.  The evidence for other universal 
interventions; primary school based drug prevention, peer education, family 
interventions, and mass media was less clear.  
 
In Northern Ireland, a website for professionals involved in drugs prevention work 
was launched.  A bilingual (Welsh and English) 24 hour helpline was launched in 
Wales. 
 
A considerable amount of work in the field of drug, alcohol and tobacco education in 
schools has been undertaken in Scotland in the last year.   
 
There has been a high focus on vulnerable young people.  The National Institute for 
Health and Clinical Excellence has produced public health guidance on community-
based interventions to reduce substance misuse among vulnerable and 
disadvantaged children and young people.  Toolkits for developing local profiles of 
drug use among vulnerable young people and for evaluating the effectiveness of 
interventions have been developed.  The Advisory Council on the Misuse of Drugs 
has reported on the implementation of its recommendations on the children of drug 
using parents.  There is now work underway to address the needs of children in the 
care of the Local Authority, in both England and in Scotland, including drug use. 
4. Problem drug use   
There are new estimates of problem drug use in England: 
• 327,466 opiate and/or crack users 9.88 per 1,000 population); 
• 281,320 opiate users (8.48 per 1,000 population);  
• 192,999 crack users (5.70 per 1,000 population); and  
• 137,141 injecting users (4.04 per 1,000 population). 
 
Based on most recent research it is estimated that there are about 400,000 problem 
drug users and 164,000 injecting drug users in the United Kingdom.  
 
In 2005/6, 128,446 presentations to treatment services were recorded through the 
Treatment Demand Indicator, this is an increase of nine per cent from the previous 
year (117,781).  49 per cent concerned drug users who sought treatment for the first 
time ever.  Opiates remain the most reported primary drug, and cannabis the second 
most reported.   
 
Among those who had not previously presented to treatment there is a slightly 
different pattern, with opiates accounting for a slightly lower proportion and cannabis 
accounting for a quarter of all presentations.  The latter have increased both amongst 
all presentations and first treatment over the last three years.   
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A representative survey of arrestees found that 28 per cent had taken either heroin, 
crack, and/or cocaine in the last month.  While it is difficult to draw firm conclusions 
cocaine users appear to be less lightly to be dependent on the drug, to use less 
frequently, than users of heroin or crack.  Cocaine users were also less likely to use 
either heroin or crack. 
 
Based on the monitoring of all those in treatment and estimates of problem drug it is 
estimated that the treatment engagement rate in 2005/6 was approximately 42 per 
cent.  
5. Treatment 
There has been a continued process of improving the quality of treatment provision in 
the United Kingdom.  Clinical guidelines have been revised.  In England, there have 
been further reviews of the quality of treatment services through the Healthcare 
Commission and the National Treatment Agency, additional guidelines on aspects of 
treatment from the National Institute for Health and Clinical Excellence: on 
buprenorphine and methadone for the management of opioid dependence; on 
naltrexone for the management of opioid dependence; psychosocial interventions; 
and on opioid detoxification.  There is revised guidance on good practice in care 
planning.  A Treatment Outcomes Profile has been developed in England to monitor 
the outcomes of treatment. 
 
The Scottish Government launched a wide ranging review of methadone 
programmes, concluding that methadone should continue to be the mainstay of the 
treatment system.   
 
The results of evaluations of pilot psychostimulant services in Scotland and in 
England have been published; neither were able to verify their effectiveness. 
6. Health correlates and consequences 
The most recently published data show that in 2005 there was a total of 1,827 drug-
related death in the United Kingdom, a majority relating to opiate use.  There were 45 
deaths associated with Volatile Substance Abuse in 2005 (47 in 2004), this is the 
lowest figure since 1981.   
 
The overall prevalence of HIV among injecting drug users (IDUs) in 2006 was similar 
to that seen in recent years, but remains higher than that seen in the late 1990s, with 
an overall prevalence of 1.3 per cent in England, Wales and Northern Ireland.  In 
Scotland, prevalence was 0.79 per cent.  The annual number of HIV diagnoses 
among IDUs in recent years has been low and relatively stable, an average of 140 
reports during the period 1998 to 2006.  However, the prevalence of hepatitis C 
infection among IDUs remains high overall. In 2005 and 2006 overall hepatitis C 
prevalence in England was 43 per cent.  Prevalence in Wales was 18 per cent and in 
Northern Ireland, 29 per cent.  Prevalence is not available for Scotland, but the 
incidence of hepatitis C among IDUs in many parts of Scotland remains high, in the 
range of 12 to 29 per cent.  Overall, about one in five IDUs have had hepatitis B 
infection. 
7. Responses to health correlates and consequences 
In England, the Department of Health has updated its action plan on reducing drug-
related harm.  For drug-related death there are plans for a health promotion 
campaign, which will be targeted at risk groups such as homeless drug users, 
speedballers, and new injectors.  Also included, is guidance on hepatitis C, the 
provision of needle exchange services and testing and treatment for blood-borne 
virus infections in prisons and the community.   
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The Scottish Government published a Hepatitis C Action Plan for Scotland in 2006.  
One aim is to improve the accessibility and effectiveness of needle exchange and 
other harm reduction services at a local level.  In 2007, the Scottish Prison Service 
began piloting an in-prison needle exchange scheme.  There are also plans to 
provide injecting paraphernalia to all prisoners leaving prison with an identified need 
by mid-2008.  
 
Hepatitis B vaccine uptake has continued to increase, with up to 2/3 thirds now in 
England, Wales and Northern Ireland and it is expected to plateau at 80 per cent.  
 
The Department of Health published new guidance on dual diagnosis in mental 
health inpatient and day hospital settings.   
 
In England, updated guidelines on the management of pregnant drug misusers and 
neonatal care are in consultation.  A new assessment tool to identify the prevalence 
of neonatal abstinence syndrome and delayed visual maturation in infants born to 
drug misusing parents has been launched in Scotland.  
8. Social correlates and consequences 
Offences under the Misuse of Drugs Act 1971 recorded by the police show that of a 
total of 5,428,300 recorded in England and Wales in 2006/07 194,300 (4%) were 
drug crimes.  This is an increase of nine per cent from the previous year (178,500).  
This is largely attributable to increases in the recording of possession of cannabis 
offences. 
 
The first representative survey of drugs and crime amongst arrestees in England and 
Wales covers the period 1st October 2003 to 30th September 2004.  The survey 
found that 57 per cent of arrestees had taken one or more drugs in the last month: 46 
per cent reported taking cannabis in the last month; 18 per cent heroin; 15 per cent 
crack; and 10 per cent cocaine (powder).  Results from the Offending, Crime and 
Justice Surveys of 2004 and 2005 reported significantly higher drug use amongst 
delinquent groups and youth offenders.   
 
The economic and social costs of Class A drug use in England are estimated to have 
been around €22.3 billion in 2003/04.  This equates to €63,940 per year per 
problematic drug user.  The Scottish Government has commissioned research to 
produce an initial estimate of the economic and social costs associated with illicit 
drug use 
9. Responses to social correlates and consequences 
In England and Wales, Clinical Management of Drug Dependence in the Adult Prison 
Setting sets out how clinical services should develop during the next two years so as 
to be consistent with services in the community. 
 
There has been a increase in the number of drug using offenders entering treatment 
through the Drug Interventions Programme.  
 
Drug testing on arrest is being piloted for a 2 year period in Scotland.  
 
Peer led support is now seen as part of the aftercare package of support for 
prisoners.   
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10. Drug Markets  
There were 189,032 seizures of drugs in the United Kingdom in 2005, a 42 per cent 
increase from the previous year.  Increases are reported for all drugs, the largest 
being for herbal cannabis (74.2%), cannabis plants (44.6%), and cocaine (51.5%).  
There was a decrease in the quantity of seizures for a number of drugs including 
herbal cannabis, cannabis resin, cocaine, crack and heroin.  The quantity of cannabis 
plants seized increased substantially, as did LSD and amphetamines. 
 
The average price of amphetamines, crack, ecstasy and heroin fell in 2006, whilst 
cocaine and cannabis prices remained stable.  The potency of cannabis resin and 
herbal cannabis fell.  Purity of ecstasy, cocaine and crack dropped considerably in 
2006 while there was a small drop in the mean purity of brown heroin.  
 
New research suggests that the estimated the size of the illicit drug market in the 
United Kingdom was €7.7 billion (£5.3b) in 2003/04, with a wide margin of error of 
€5.8 billion (£4.0b) to € 9.6 billion (£6.6b). 
Most relevant developments and trends 
Relevant trends: epidemiological indicators 
In terms of epidemiological indicators the most relevant developments and trends 
are: 
 
The continued fall in prevalence of drug use in the general population, including 
prevalence of cannabis.  However, cocaine use has continued to increase.  
 
The publication of problem drug use estimates for England. 
 
The Treatment Demand Indicator shows the continued increase in presentations to 
treatment across the United Kingdom.  This reflects a continued expansion in 
treatment availability.  It is of note that while there has been a relative increase in 
opiate presentations, as a proportion of treatment demand presentations, opiates 
continue to fall.  Cannabis presentations continue to rise, accounting for 25 per cent 
of all first ever treatment demands.  
 
In 2005 drug-related deaths in the United Kingdom rose for the second year, after a 
previous fall.  Deaths associated with volatile substances fell to their lowest figure 
since 1981.   
 
The overall prevalence of HIV among injecting drug users (IDUs) remains stable, as 
does the prevalence of hepatitis C infection, though it remains high (43% in England).  
Overall, about one in five IDUs have had hepatitis B infection.   
Relevant developments in policy and practice 
Drug strategies have been, or are being, revised throughout the United Kingdom.  A 
combined Northern Ireland alcohol and drug strategy was launched in October 2006. 
In England, the process of developing a new drug strategy is underway.  This is also 
the case in Wales where there has been a broader substance misuse strategy 
incorporating alcohol, drug misuse and prescribed drugs since 2000.  
 
A Stocktake Review of Alcohol and Drug Action Teams in Scotland concluded that a 
partnership model was necessary to tackle substance misuse at a local level and that 
ADATs had made a positive difference. 
 
All parts of the United Kingdom are actively pursuing improvements in the quality of 
drug treatment.  Important developments include the revision of clinical guidelines for 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 14
the treatment of drug misuse, and in England an action plan on drug-related harms in 
England and a strategy for hepatitis C in Scotland.  Also, technological appraisals 
and clinical guidelines on aspects of drug treatment from the National Institute of 
Health and Clinical Excellence.  All of these will have implications for improvements 
at the local level in treatment provision and on reducing drug-related harms.  With 
respect to the latter there should also be major improvements in the provision of 
syringe exchange services. 
 
In Scotland, a review of the place of methadone in drug treatment, found it to be the 
most appropriate treatment for heroin addiction; but it was noted that it should be 
seen as the minimum treatment, not the only treatment received.  In addition, a 
review of residential detoxification and rehabilitation services in Scotland was carried 
out to develop a comprehensive picture of the current position and help inform future 
policy and funding decisions. 
 
In England, new Public Service Agreements indicators will govern action in the field 
of drug misuse.  These are: the percentage change in the number of drug users 
recorded as being in effective treatment; the rate of drug related offending; and the 
percentage of the public who perceive drug use or dealing to be a problem in their 
area. 
 
Throughout the United Kingdom there has been increased action in the area of 
vulnerable young people seen as being at high risk of drug misuse. 
 
The work around accessing drug misusers into treatment through the criminal justice 
system continues.  
Consistency between indicators 
Opiates  
Evidence from research into problem drug use shows that opiates continue to be the 
main problem drug in the United Kingdom.  In England, latest estimates suggesting 
261,320 users.  The proportion presenting to treatment services with opiates as main 
drug has fallen, however actual numbers have increased, and the TDI continues to 
identify opiate use as accounting for the majority of presentations to services, around 
65 per cent (77,580 in the United Kingdom).  Most deaths continue to be associated 
with opiates (chiefly heroin and morphine), with 1,046 mentions on death certificates 
in 2005.  Data on seizures for 2005 showed a 20 per cent increase  from the previous 
year, although there was a fall in the quantity seized.  The purity of heroin fell, though 
not by much and there has been no clear long-term trend since at least 1984.  Price 
has fallen slightly. 
Cocaine powder 
Use of cocaine powder has continued to rise within the general population and is the 
second most used drug after cannabis.  In England and Wales, data from the 
2006/07 population-based surveys estimated there to be 828,000 recent and 396,000 
current users of powder cocaine.  No estimate could be given for problem cocaine 
users through research into estimating the number of PDUs for England.  The TDI, to 
some extent, reflects trends (where data is available) seen in other indicators, with 
cocaine presentations continuing to rise, though they still only represent 6 per cent of 
presentations and 9 per cent of first ever presentations.  There was also a 15 per 
cent increase in mentions of cocaine on death certificates (221) in 2005.  Data on 
seizures for 2005 showed a 52 per cent increased from the previous year, although 
there was a fall in the quantity seized.  The price of cocaine is stable.  Purity of 
cocaine dropped considerably in 2006.  
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Crack 
Crack use has been identified as problematic in the United Kingdom, estimates for 
2004/05 suggesting that there were 192,999 problem crack users in England.  
Presentations to treatment where crack is the primary drug have continued to rise, 
though they still only represent 6 per cent of all presentations and 7 per cent of first 
ever presentations.  Data on seizures for 2005 showed a 31 per cent increase in the 
number seized since the previous year, although there was a fall in the quantity 
seized.  Price has remained stable.  Purity of crack dropped considerably in 2006. 
Cannabis  
Cannabis remains by far the most used drug in the general population in England 
and Wales, but use has declined significantly since 1998.  The decline is seen 
particularly amongst 16 to 24 year olds though prevalence remains higher.  Recent 
use of cannabis is also declining amongst school children.  In contrast treatment 
presentations for cannabis have risen as a proportion of presentations over time, 
reported as the primary drug in about 16 per cent of all presentations making it the 
next most common drug after heroin and 25 per cent for first ever treatment 
presentations.  Data on seizures for 2005 showed a substantial increase in the 
number of seizures, with a 74 per cent increase for herbal cannabis, a 13 per cent 
increase for cannabis resin and a 45 per cent increase for plants, although there was 
a fall in the quantity of seizures of cannabis resin and herbal cannabis.  Price has 
remained stable.  Potency of cannabis resin and herbal cannabis fell  
Ecstasy  
Ecstasy remains the third most used drug in the general population, higher amongst 
young aged 16 to 24 (5%) though recent data shows no significant change from the 
previous year.  In terms of treatment demand, numbers are very low (600 in the UK).  
There were, however, 114 ecstasy-related deaths in 2005, an increase of 15 per cent 
since 2004.  Data on seizures for 2005 showed a very small increase in the number 
seized from the previous year, although there was a fall in the quantity seized.  Price 
has fallen. 
Amphetamines  
In the general population recent and current use of amphetamines remains low in the 
general population.  In 2005/06 there were 1,812 presentations to treatment, 4 per 
cent of all presentations.  However, data on seizures for 2005 showed a 19 per cent 
increase from the previous year, and a 58 per cent increase in the quantity seized 
although there was a fall in the quantity seized.  Price has fallen. 
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PART A: NEW DEVELOPMENTS AND TRENDS 
National policy and context  
1.1 Overview 
The Misuse of Drugs Act 1971 divides controlled drugs into three classes (A, B and 
C).  Drugs are placed in these three classes to reflect their relative harms and 
maximum criminal penalties for possession, supply and production are set 
accordingly.  In January 2004 cannabis was reclassified from Class B to Class C; in 
January 2006 ketamine was brought under the control of the 1971 Act as a Class C 
drug and in January 2007 methamphetamine was reclassified from Class B to Class 
A.  The Drugs Act 2005 amended sections of the Misuse of Drugs Act 1971 and the 
Police and Criminal Evidence Act 1984, strengthening police powers in relation to 
drug use. 
 
A United Kingdom Drug Strategy was launched in 1998 (UKADCU 1998) setting four 
principal aims: preventing drug use amongst young people; safeguarding 
communities; providing treatment; and reducing availability, to be achieved through 
education, prevention programmes, expanded treatment, legal sanctions and the 
expansion of legal opportunities.  The strategy was updated in 2002 with an 
increased emphasis on Class A drugs and problem drug users (DSD 2002).  
Government targets for the strategy are detailed in Public Service Agreements 
(PSAs). New agreements for reducing the harm caused by drugs (and alcohol) were 
set in October 2007 placing responsibility on a number of Government departments 
to meet the targets set.  Each of the devolved administrations1 (Northern Ireland, 
Scotland and Wales) has its own strategy, tailored to its individual circumstances 
(Scottish Office 1999; National Assembly for Wales 2000; DHSSPSNI 2006).  The 
Scottish Government2 is currently looking towards consensus across the drugs field 
(amongst service users, their families and local communities and the political 
community) regarding a long-term drugs strategy.  In Northern Ireland a New 
Strategic Direction for Alcohol and Drugs was launched in October 2006 (DHSSPSNI 
2006).  In Wales a new substance misuse strategy will be published in May 2008.  A 
three month consultation on the development of the new United Kingdom Drug 
Strategy closed in October 2007. The consultation proposed that the primary focus of 
the new strategy should be to: reduce the harms caused to the development and 
well-being of young people and families; bring the full force of law enforcement to 
bear on drug dealers at all levels; reduce the harms drugs cause to the health and 
well being of individuals and families; reduce the impact of drugs on local 
communities and reduce drug-related crime and associated anti-social behaviour. 
 
In all four administrations, delivery is through local multi-agency partnerships.3  In 
Scotland a stock-taking exercise of Alcohol and Drug Action Teams was recently 
undertaken and, as part of the process of developing consensus around a long-term 
drugs strategy, the Scottish Government are currently working to ensure that the right 
                                                
1 Devolution is the delegation of power from the UK Parliament to the Scottish Parliament and 
Welsh and Northern Irish Assemblies in specific policy areas. 
2 The Scottish Government was referred to as the Scottish Executive between 1999 and May 
2007. 
3 In England they are known as Drug Action Teams, or if they also take responsibly for 
alcohol, Drug and Alcohol Action Teams (referred to collectively here as DAATs.  In Northern 
Ireland Drug and Alcohol Coordination Teams (DACTs), in Scotland Alcohol and Drug Action 
Teams (ADATs) and in Wales, Community Safety Partnerships. 
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local delivery structures are in place with associated accountability mechanisms.  In 
2007 a number of functions of the Home Office became the responsibility of a new 
Ministry of Justice; overall responsibility for the delivery of the United Kingdom Drug 
Strategy remains with the Home Office.  
1. 2 Legal Framework  
1.2.1 Laws, regulations, directives or guidelines 
The Serious Crime Bill 
The Serious Crime Bill 2006-07 is currently before Parliament.  It will introduce 
Serious Crime Prevention Orders, through which the courts will be able to impose 
restrictions on the activities of those involved in serious crime, and will lead to 
improvements to the law on encouraging and assisting crime, with implications for 
trafficking of drugs.4  
Changes to the way the Home Office licences controlled drugs  
Changes to the way the Home Office licences controlled drugs took effect from 1st 
December 2006 (Home Office 2006a).  Under the new system, the issue of licences 
will continue to be based on the activity undertaken but will now provide coverage by 
schedule as opposed to individual drugs within a particular schedule.  This will mean, 
for example, that a company currently licensed for morphine (a Schedule 2 drug) will 
also be licensed for other drug within the same Schedule.  This will provide greater 
flexibility for companies and a resultant saving of time and costs by removing the 
need to apply to the Home Office for any variations to the licence.  Also, licences will 
no longer be valid for periods of up to a year but will be open-ended.  Licences will 
need to be returned, as before, if a company either ceases to trade or stops holding 
all drugs within a particular schedule.  Companies are required to submit an annual 
statement of compliance. 
Licensing of buprenorphine/naloxone  
Suboxone, a combination of buprenorphine and naloxone has been licensed for use 
in the United Kingdom since December 2006. It has been introduced to discourage 
the injecting of buprenorphine, by means of the naloxone component which 
precipitates withdrawal effects.5  
Reclassification of methamphetamine  
On 18th January 2007, methamphetamine became a Class A drug (HMSO 2007). 
Review of cannabis classification  
The Government has announced another review of cannabis classification by the 
Advisory Council on the Misuse of Drugs (ACMD) reporting to the Government in 
Spring 2008.  The Advisory Council will specifically look at the potential mental health 
effects of cannabis use and the availability of stronger strains.6 
 
A consultation document was issued, by the Home Office, on the proposals to 
expand the range of controlled drugs that can be prescribed independently by Nurse 
Independent Prescribers and to enable Pharmacist Independent Prescribers to 
independently prescribe controlled drugs. It also asked for views on whether Nurse 
and Pharmacist Independent Prescribers should be allowed to prescribe specific 
Schedule 2 drugs to addicts for the management of their addiction (Home Office 
2007a). The consultation was open for 12 weeks, and closed on 15 June 2007.  
                                                
4 See: http://www.publications.parliament.uk/pa/pabills/200607/serious_crime.htm  
5 For more information see: http://www.smmgp.org.uk/html/newsletters/net017.php#Suboxone 
6 For more information see: http://www.downingstreetsays.org/archives/004476.html 
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Nurse Independent Prescribers (formerly known as Extended Formulary Nurse 
Prescribing) are currently able to prescribe 12 Controlled Drugs7 independently, 
including diamorphine and morphine, solely for specified medical conditions.  The 
Advisory Council on the Misuse of Drugs will provide its final recommendation later 
this year and in light of responses to the consultation and subject to Ministerial 
agreement, change to the legislation will follow.8 
Changes to the Misuse of Drugs Regulations 20019  
A consultation document was issued on a range of proposed changes to the 2001 
Regulations.  The consultation ran for eight weeks and closed on the 6th July 2007.  
Many of the proposals had already been the subject of informal consultation with key 
stakeholders, enabling legislative change to follow on 26 July (The Misuse of Drugs 
and Misuse of Drugs (Safe Custody) (Amendment) Regulations 2007 Statutory 
Instrument 2007 No. 2154)10.  The implementation of the changes is staggered over 
a period of time to allow the sector to make preparatory steps to ensure compliance 
at the date it comes into force. 
 
The changes continue to strengthen the regulatory and governance arrangements by 
which the handling of controlled drugs are managed by healthcare professionals, 
following the findings of The Shipman Inquiry.11.  They also reflect the need to 
recognise and to give authority to possess and supply controlled drugs to new health 
professionals, albeit ones that are regulated, highly trained and are subject to 
Standard Operating Procedures within their organisations, in this case Operating 
Department Practitioners.  Changes have also been made to the form in which the 
Controlled Drugs Register– where all transactions for Schedule 2 controlled drugs 
must be recorded by a pharmacist – is kept.12 
                                                
7 Nurse Independent Prescribers are able to prescribe independently the following list of 
Controlled Drugs for the medical conditions indicated: buprenorphine (palliative care); 
chlordiazepoxide hydrochloride (treatment of withdrawal of alcohol); diamorphine 
hydrochloride (palliative care); diazepam (palliative care, treatment of withdrawal of alcohol, 
tonic-clonic seizures); fentanyl (palliative care); iorazepam (palliative care, tonic-clonic 
seizures); midazolam (palliative care, tonic-clonic seizures); morphine hydrochloride 
(palliative care, pain relief in respect of suspected myocardial infarction or for relief of acute or 
severe pain after trauma, including in either case post-operative pain relief); morphine 
sulphate (palliative care, pain relief in respect of suspected myocardial infarction or for relief 
of acute or severe pain after trauma, including in either case post-operative pain relief); and 
oxycodone hydrochloride (palliative care). 
8 For more information see: http://www.homeoffice.gov.uk/documants/cons-2007-indpres 
9 See http://www.homeoffice.gov.uk/documents/misuse-drug-regulations.pdf 
10 See http://www.uk-legislation.hmso.gov.uk/si/si2007/20072154.htm  
11 See: http://www.the-shipman-inquiry.org.uk/home.asp  
12 The main changes made to the 2001 Regulations by SI 2007 No. 2154 are as follows : (1) 
Re-scheduling of Midazolam from Schedule 4 to Schedule 3 (from 1 January 2008); (2) 
Introduction of new requirements for requisitions for human use used for the supply of 
Schedule 1-3 controlled drugs in the community (from 1 January 2008) ; (3) Authority to the 
Accountable Officer (introduced in the Health Act 2006) to authorise persons able to witness 
the destruction of controlled drugs (from 16 August 2007) ; (4) Authority to Operating 
Department Practitioners to possess and supply controlled drugs in certain settings (ward, 
theatre or other department) (from 16 August 2007); and (5) Removal of the requirement to 
maintain a Controlled Drugs Register in the prescribed form set out in Schedule 6 of the 2001 
Regulations, replaced with a requirement to record designated fields of information in a 
Controlled Drug Register (from 1 February 2008). 
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Warning over benzylpiperazine  
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a 
warning over the recreational use of benzylpiperazine (BZP).13  BZP acts as a 
stimulant.  Potential health risks are reported as vomiting, dizziness and allergic 
reactions. 
1.2.2 Laws’ implementation 
Guidance for police on cannabis possession 
Guidance on how the police should deal with simple cannabis possession, produced 
by the Association of Chief Police Officers (ACPO), has been revised following 
changes to police powers of arrest as a result of the Serious and Organised Crime 
and Police Act 2005.  Previous guidance advised officers to issue street warnings for 
most possession offences, arresting only in aggravating circumstances.  New 
guidance recognises that different communities have different crime problems and 
therefore leaves provision for local police commanders to arrest rather than issue a 
cannabis warning if this was a proportionate response within their community (ACPO 
2006a). 
1.3 Institutional framework, strategies and policies 
1.3.1 Coordination arrangements 
Redefined Home Office and new Ministry of Justice  
In May 2007 a number of the functions of the Home Office, which is responsible for 
the United Kingdom Drug Strategy, were transferred to a new government 
department, the Ministry of Justice14.  The Home Office remains responsible for: 
counter-terrorism; drugs; crime; anti-social behaviour; securing borders; legal 
migrants and visitors; identity and citizenship; and for ‘security, justice and respect 
that enable people to prosper in a free and tolerant society’.15  The core components 
of the Ministry of Justice (MoJ) are the criminal justice services, including criminal law 
and sentencing, courts, prison and probation services (under the umbrella of the 
National Offender Management Service). 
Department for Children, Schools and Families 
From June 2007 a new Department for Children, Schools and Families (DCSF) 
became responsible for policy relating to children and young people, and 
coordinating and leading work across Government on youth and family policy.  It 
takes on many of the functions of the former Department for Education and Skills 
(DfES) including the Every Child Matters programme and drug education in 
schools.16 
1.3.2 National plan and/or strategies 
The Northern Ireland alcohol and drug strategy, New Strategic Direction for Alcohol 
and Drugs 2006-2011 (DHSSPSNI 2006) was officially launched in October 2006. 
 
The current United Kingdom Drug Strategy covers a ten year period from 1998 and 
therefore, a new strategy will be introduced from 2008.  As result of this, there have 
                                                
13 See: 
http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSecondary=true&ssDo
cName=CON2030603&ssTargetNodeId=389   
14 For more information see:  
http://www.homeoffice.gov.uk/about-us/organisation/home-office-reform/ 
15 See: http://www.justice.gov.uk/  
16 See: http://www.number-10.gov.uk/output/Page1488.asp  
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been a number of commentaries and reports, particularly from civil society, as to 
what might be expected within a new strategy.  In addition, in 2007 there have been 
a number of position papers and critiques of current drug policy; notably the Royal 
Society for the Encouragement of Arts, Manufactures and Commerce’s (RSA) (2007) 
report on current policy, and a report from the newly established UK Drug Policy 
Commission (see below). 
Consultation document: Drug Strategy 
A consultation document, Drugs: Our Community,Your Say outlined proposals for a 
new Drug Strategy, to be implemented from April 2008 (HM Government 2007a).17  
The consultation ran from July to October 2007.  An alcohol strategy was launched in 
June 200718 and, also, a new crime strategy (launched in July 2007).19  In addition, a 
smoke-free law came into force in July 2007, making it an offence to smoke in 
enclosed public places. 
 
It is proposed that the aim of the new Drug Strategy is to make further progress on: 
• reducing the harms drugs cause to the development and well-being of young 
people and families; 
• bringing the full force of law enforcement to bear on dealers at all levels;  
• reducing the harms drugs cause to the health and well-being of individuals and 
families; and  
• reducing the impact of drugs on local communities, reducing drug-related crime 
and associated anti-social behaviour. 
 
The consultation document sets out the current approach and progress to date within 
five main themes: young people; education and families; public information 
campaigns; drug treatment, social care and support for drug-users in re-establishing 
their lives; protecting the community from drug-related crime and re-offending; and 
drug enforcement and supply activity.  It asked focused questions within each theme 
to gather views and provide ideas to develop the next drug strategy. 
New crime strategy  
A new crime strategy has also been published (Home Office 2007b).  It suggests that 
the use of drugs and alcohol continue to be among the biggest causes of crime and 
put some people at greater risk of offending, and of being a victim of crime.  
Reference is made to the drug strategy consultation document in addressing drug-
related crime and the importance of tackling drug misuse as a key driver of crime and 
offending.  
                                                
17 It is noted that the formulation and delivery of the drug strategy reflects the devolution of 
powers to the Assemblies in Wales and Northern Ireland and the Parliament in Scotland.  The 
United Kingdom is responsible for setting the overall strategy and for delivery in the devolved 
administrations only for the areas where it has reserved power. Each devolved administration 
exercises its delegated powers to shape the strategy to address local circumstances.  The 
areas of reserved power include policing and the criminal justice system (including all areas of 
offender management) within Wales.  The work of the Serious Organised Crime Agency 
(SOCA) and HM Revenue and Customs in addressing drug supply covers the whole of the 
United Kingdom. 
18 See:  
http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Alcoholmisuse/index.h
tm 
19 See: http://www.policyhub.gov.uk/news_item/crime_strategy_07.asp 
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1.3.3 Implementation of policies and strategies 
Public Service Agreements on drug misuse  
New agreements for reducing the harm caused by drugs (and alcohol) were set in 
October 2007 placing responsibility on a number of Government departments to 
meet the targets set (HM Government 2007b).  The Government’s delivery strategy 
for reducing drug harms can be divided into four main strands: 
1. Disrupt the supply of illegal drugs. 
2. Intervene early to prevent and reduce the harms caused by substance misuse, 
particularly amongst the most at risk young people and families. 
3. Provide effective treatment, social care and support to improve the health and 
well-being of young people and adults who are already using drugs in harmful 
ways and to help them re-establish themselves in the community. 
4. Tackle crime and anti-social behaviour associated with drug misuse and reduce 
the harms caused by drugs to the community and use the criminal justice system 
to help offenders engage with treatment services. 
 
The indicators that will measure progress against the new PSA are: 
• the percentage change in the number of drug users recorded as being in effective 
treatment. 
• The rate of drug related offending. 
• The percentage of the public who perceive drug use or dealing to be a problem in 
their area. 
 
In addition, the new PSA Delivery Agreement is closely linked to several other PSAs 
which are crucial to reducing the harms caused by drugs. These are: 
• The DCSF PSA to Increase the number of children and young people on the path 
to success; 
• The Ministry of Justice PSA Make Communities Safer which deals with the level 
of serious acquisitive crime and re-offending; 
• The Ministry of Justice PSA Deliver a more effective, transparent and responsive 
Criminal Justice System for victims and the public and particularly in relation to 
the recovery of criminal assets. 
Key Performance Indicators for substance misuse treatment services in Wales 
Key Performance Indicators for substance misuse treatment services in Wales are 
now published (for more information see Chapter 5.2.2).  
1.3.4 Evaluation of policies and strategies 
The Impact of UK drug strategy  
In the last year there have been a large number of publications and statements about 
the United Kingdom Drug Strategy, anticipating the launch of the new drug strategy 
in 2008.  Three major reports which consider the impact of the previous strategy are 
described in more detail below.  Other notable reports include an examination of drug 
policies and their links with other policy areas such as prevention, health, the law and 
the criminal justice system by Hughes et al. (2006) and an examination of the 
criminalisation of drug policy by Duke (2006).  More specifically, Roberts et al. (2006) 
consider the measurement of drug-related harm and Newcombe (2006) considers 
both the latter and Public Service Agreement (PSA) targets.  In addition, the London 
Drug Policy Forum has also produced a strategy (LDPF 2007). 
Independent report on drug misuse by Royal Society for the Encouragement of Arts, 
Manufactures and Commerce Independent review of drug policy 
An independent report on drug misuse by the Royal Society for the Encouragement 
of Arts, Manufactures and Commerce (RSA) (2007) argues that: illegal drugs are by 
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no means always harmful any more than alcohol use is always harmful.  It also 
argues that the implementation of policy is weighted towards the criminal justice 
system, and that current policy neglects other approaches such as those centred on 
individual health, public health, families, education, housing, social care and so forth.  
It concludes that policy should in future be pragmatic, directed at reducing harm 
rather than moralistic and with its means well adapted to its ends.   
 
The RSA report recommends that: 
• The “lead department should be the Department of Communities and Local 
Government.” (p.15) 
• “the Misuse of Drugs Act 1971 and the subsequent legislation associated with it 
be repealed and be replaced by a comprehensive Misuse of Substances Act. The 
new Misuse of Substances Act should acknowledge that, whether we like it or 
not, drugs are and will remain a fact of life.  On that basis, the aim of the law 
should be to reduce the amounts of harms caused to individuals, their friends and 
family, their children and their communities.” (p.15)  
•  “serious consideration should be given to making local Drug Action Teams 
statutory bodies and to giving them enhanced status, authority and 
responsibilities. The lead role within them should probably be given to local 
authorities” (p.15) 
• “DATs should be disentangled from Crime and Disorder Reduction Partnerships 
and represented on Local Strategic Partnerships in their own right.” (P.20) 
An Analysis of UK Drug Policy 
In a review commissioned for the independent UK Drug Policy Commission 
(UKDPC)20, Reuter and Stevens (2007) suggest that harm reduction measures 
appear to have had a major impact on the HIV epidemic among injecting drug users, 
but have not prevented the rise of other blood-borne viruses such as hepatitis C.  
They also note the success in increasing the number of dependent drug users 
entering treatment will have led to substantial reductions in drug use, crime and 
health problems at the individual level, with positive benefits for drug users, families 
and potential victims of crime.  However, they suggest that it is unlikely that these 
benefits will have been translated into a substantial impact on overall levels of 
dependent drug use and crime at the national level.  With respect to prevention, they 
report that there is little to suggest that drug education and prevention have had any 
significant impact on drug use, and despite substantial increases in drug seizures 
and tougher sentences for drug offenders, the prices of drugs have decreased and 
there is no indication that tougher enforcement has succeeded in making drugs less 
accessible.  Further, they argue that drug policy has limited ability to influence 
national trends in drug use and drug dependence and therefore, it is not appropriate 
to judge the performance of a country’s drug policy by the levels of drug use in that 
country.   
The impact of policies and strategies in the last ten years 
In a report looking at the impact of crime reduction policies and strategies since 
1997, Enver et al. (2007) reviewed drug misuse.  The authors argue that despite 
apparent progress against a number of targets including: numbers in treatment; 
targets on drugs and young people; and reducing health harms, there is a degree of 
                                                
20 The UK Drug Policy Commission was established in 2007.  Its objectives are to: provide 
independent and objective analysis of drug policy in the UK; improve political, media and 
public understanding of the implications of the evidence base for drug policy; and improve 
political, media and public understanding of the options for drug policy.  The Commission is 
supported by a charity, the Esmée Fairbairn Foundation for its support. For more information 
see: http://www.ukdpc.org.uk/index.shtml    
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disconnection between policies and targets and what might actually be happening in 
terms of real levels of drug use, availability and associated harms, for example where 
the number of arrests for young people using cannabis contribute to police targets on 
drug arrests. 
Policing cannabis as a Class C drug 
A research report on policing cannabis as a Class C drug considered the impact of 
the reclassification of cannabis (May et al. 2007).21  The rationale for street warnings 
was that they would be both a proportionate response and a time-saving one, leaving 
the police more time to deal with serious offences.  The study largely replicated an 
earlier study which examined the policing of cannabis as a Class B drug (May et al. 
2002).  The researchers concluded that the reclassification has had a smaller impact 
than advocates hoped or opponents feared; and that the use of street warnings is 
now an established police practice and one that appears to be working well, but that 
it is essential that police policies and procedures for dealing with cannabis offences 
are routinely monitored and exposed to some independent scrutiny. 
A rational scale for assessing drug harms 
Nutt et al. (2007) set out the feasibility of the use of a nine-category matrix of harm, 
with an expert delphic procedure, to assess the medical and social harms of a range 
of illicit drugs in an evidence-based fashion, as an alternative to the current drug 
classification system.22  The ranking produced by this assessment of harm differed 
from that of the current regulatory system.  It was found that, apart from heroin and 
cocaine (the two substances with the highest harm ratings) there was a poor 
                                                
21 This study, conducted in four areas of England, revisited the four sites within the two police 
forces where the first study was conducted. Work in the case study areas involved 
observational work with operational police officers; interviews with 150 police officers; 
analysis of custody records and street warning data during the period May 2004 to April 2005; 
and interviews with 61 young people. An internet survey of 749 respondents was also 
conducted. Fieldwork data was supplemented by published statistics and all fieldwork was 
carried out during 2005. The study included an internet survey and a survey of young people. 
Neither sample was representative of the overall population, but they provide some indication 
of knowledge and attitudes. 
22 The matrix designed included all nine parameters of risk, created by dividing each of the 
three major categories of harm into three subgroups, as described above. Participants were 
asked to score each substance for each of these nine parameters, using a four-point scale, 
with 0 being no risk, 1 some, 2 moderate, and 3 extreme risk.  An overall harm rating was 
obtained by taking the mean of all nine scores. The scoring procedure was piloted by 
members of the panel of the Independent Inquiry into the Misuse of Drugs Act.   Once refined 
through this piloting, an assessment questionnaire was developed with guidance notes.  Two 
independent groups of experts were asked to do the ratings, firstly the national group of 
consultant psychiatrists who were on the Royal College of Psychiatrists’ register as specialists 
in addiction (replies were received and analysed from 29 of the 77 registered doctors) who 
were asked to assess heroin, cocaine, alcohol, barbiturates, amphetamine, methadone, 
benzodiazepines, solvents, buprenorphine, tobacco, ecstasy, cannabis, LSD, and steroids. 
Secondly, a group of experts with a wider spread of expertise in many areas of addiction, 
ranging from chemistry, pharmacology, and forensic science, through psychiatry and other 
medical specialties, including epidemiology, as well as the legal and police services. This 
second set of assessments was done in a series of meetings run along Delphic principles, a 
new approach that is being used widely to optimise knowledge in areas where issues and 
effects are very broad and not amenable to precise measurements or experimental testing, 
and which is becoming the standard method by which to develop consensus in medical 
matters.  
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correlation between a drug’s classification23 under the Misuse of Drugs Act and its 
harm as assessed by the matrix.  
The reclassification of cannabis: a post-structuralist analysis 
Acevedo (2007) undertook a post-structuralist analysis of the reclassification of 
cannabis in the United Kingdom (2004–2005) suggesting that the political decision 
regarding cannabis reclassification can be understood as part of the redefinition of 
the ‘cannabis problem’ and hence, the creation of a new type of ‘cannabis user’.  
1.4 Budget and public expenditure 
1.4.1 In law enforcement, social and health care, research, international actions, 
coordination, national strategies 
Expenditure figures for 2005/06 are the subject of a selected issue this year and are 
presented in detail in Chapter 11. These have been assembled on a different basis to 
the figures quoted in previous Focal Point reports and should not therefore be 
compared.  
 
In Northern Ireland expenditure on drugs for 2007/08 is €11.44 million, a rise of 18 
per cent from 2005/06.  In Wales, for 2007/08 there will be a 32 per cent increase in 
spending from the previous year.  The allocation to Community Safety Partnerships 
has increased from €2.9 million to €32.3 million over the past four years. 
1.4.2 Funding arrangements 
NO NEW INFORMATION AVAILABLE 
1.5 Social and cultural context 
1.5.1 Public opinions of drug issues 
The 2006 Scottish Crime and Victimisation Survey (see Chapter 2) found that 76 per 
cent of respondents rated drug use as a "big problem", the same figure as in 2004. 
This is again a higher proportion than for any other social issue, with alcohol abuse 
and crime being rated a big problem by 65 per cent and 56 per cent of respondents 
respectively.  
1.5.2 Initiatives in parliament and civil society 
A number of consultation exercises have been undertaken. There have been a 
number of reports on current drug strategy and suggestions and recommendations 
have been made as to the new strategy (see section 1.3.2).  Major reports have been 
referred to in sections 1.3.2 and 1.3.4.  All guidance from National Treatment Agency 
(the NTA) is published in draft to allow comments from civil society. 
 
The main opposition party’s Social Justice Policy Group24 has published its report, 
Breakthrough Britain: Ending the costs of social breakdown (Social Justice Policy 
Group 2007).  The report defined five key ‘paths to poverty’: family breakdown; 
serious personal debt; drug and alcohol addiction; failed education; and 
worklessness and dependency, with the suggestion that they are all inter-connected.  
They propose policy reforms in the areas of treatment, harm prevention and child 
protection.  Among these proposals are: more support for abstinence treatment; 
                                                
23 The current classification of an illicit drug is nominally based on an assessment of risk to 
users and society, advice on which is provided to the Government by the independent 
Advisory Council on the Misuse of Drugs. 
24 The leader of the Conservative opposition party in the UK commissioned The Social Justice 
Policy Group to establish the causes of poverty and inform their future policies.   
UNITED KINGDOM FOCAL POINT REPORT 2007 
 25
dedicated drugs courts; raising treatment threshold and provision requirements; the 
reclassification of cannabis from Class C to B as part of a national action plan to 
discourage cannabis use; and the suggestion that government should tender for well 
designed, systematic, experimental trials of drug testing amongst school children, to 
be conducted in different parts of the country and across different school settings.   
 
With respect to harm reduction, they argue that the best way to reduce harm is to 
prevent it in the first place through policies aimed at an overall reduction in 
consumption of both alcohol and drugs, proposing a renewed commitment to the 
control of the supply of drugs. 
1.5.3 Mass Media Campaigns 
See Chapter 3. 
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2. Drug use in the population 
2.1 Overview  
Estimates of the prevalence of drug use in the general population in England and 
Wales are provided by the British Crime Survey.25  Similar surveys are undertaken in 
Scotland26 and Northern Ireland.27 Combining data from these surveys in 2005, it was 
estimated that just over a third of the adult population in the United Kingdom aged 
between 16 and 64 had used an illicit drug in their lifetime.  In England & Wales, for 
which the most complete time series data are available, prevalence of recent (last 
year) use had been fairly stable at around 12 per cent from 1998 to 2003 but has 
subsequently fallen to 10 per cent. 
 
Young adults under 35 are significantly more likely to use drugs, and amongst those 
who are under 25 years old, recent (last year) and current (last month) prevalence is 
higher still. In England and Wales, amongst these young adults, there has 
nevertheless been a steady decline in the recent use of any drug since 1998. 
 
Amongst the school age population, surveys of drug use prevalence have been 
undertaken in each of the four administrations of the United Kingdom.28  In England, 
for which the longest time series are available, drug use increased between 1998 
and 2003, but has fallen since then. 
 
Males are more likely to report recent and current drug use than females but the 
difference varies according to age, tending to be more pronounced in the older age 
groups.   
 
Cannabis continues to be the most commonly used drug across all age groups, with 
prevalence rates close to those for use of any drug.  Use of other drugs is 
considerably lower.  Since the late 1990s the British Crime Survey shows that use of 
cocaine increased substantially and it is now the second most used drug amongst 
adults.  However, there has been a corresponding decline in use of amphetamines, 
previously the second most used drug.  
                                                
25 The British Crime Survey (BCS) is a crime and victimisation survey which gathers 
information about experience of crime, and is designed to provide a complementary measure 
of crime to police recorded crime statistics.  It also asks respondents about their use of drugs.  
In 2002 it became a continuous survey.  
26 The Scottish Crime and Victimisation Survey (SCVS, previously the Scottish Crime Survey) 
Is similar in scope and aims to the BCS. Surveys were carried out, as part of the British Crime 
Survey (BCS) in 1982 and 1988, as the independent Scottish Crime Survey in 1993, 1996, 
2000, 2003 and as the SCVS in 2004 and 2006. 
27 The Northern Ireland Crime Survey is also similar to the BCS. Surveys were carried out in 
1994/95, 1998, 2001 and 2003/4 and the survey has been continuous since January 2005..  
In addition, a Drug Prevalence Survey, based on the EMCDDA model questionnaire, was 
carried out in 2002/03 and a second such survey has been undertaken in 2007. 
28 Amongst the school age population, the main sources of information on drug use 
prevalence are surveys undertaken in schools.  In England, a survey of the prevalence of 
smoking, drinking and drug use amongst young people (11 to 15 year old school children), 
has been undertaken annually since 1998.  The Young Person’s Behaviour and Attitudes 
Survey was undertaken in Northern Ireland in 2000 for the first time, and repeated in 2003.  It 
will be run again in 2007.  In Scotland, the Scottish Schools Adolescent Lifestyle and 
Substance Use Survey (SALSUS) is undertaken every two years.  The Health Behaviour in 
School Age Children Survey (HBSC) provides data from Wales and is undertaken every four 
years with a two-year interim survey.  The most recent survey, was conducted in 2006. 
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2.2 Drug use in the general population 
Since submission of the 2006 United Kingdom Focal Point report, results have been 
published from the 2006/07 British Crime Survey (BCS), covering England and 
Wales, the 2006 Scottish Crime and Victimisation Survey and the 2005 Northern 
Ireland Crime Survey.   
2.2.1 England and Wales: the British Crime Survey 
The latest findings from the British Crime Survey29 show that ten per cent of 16 to 59 
year olds had used drugs in the last year (Table 2.1).  Cannabis was the most 
commonly used drug for all recall periods.  For last year and last month use, it was 
followed by cocaine powder, ecstasy and amphetamines in that order.  For lifetime 
use amphetamines and poppers30 were the second and third most commonly used 
drugs.  The only statistically significant change between 2005/6 and 2006/7 was a 
decline in magic mushroom use from 1.0 per cent to 0.6 per cent.  
Table 2.1: Percentage of 16-59 year olds reporting having used drugs in lifetime, last year 
and last month, England and Wales, 20006/07 
Drug Lifetime use Last Year use Last Month use  Male Female Total Male Female Total Male Female Total 
Any drug 41.9 29.3 35.5 13.2 6.9 10.0 8.2 3.8 5.9 
Amphetamines 14.8 9.1 11.9 1.8 0.8 1.3 0.7 0.3 0.5 
Cannabis 36.3 24.2 30.1 11.1 5.5 8.2 6.8 2.9 4.8 
Cocaine powder 10.0 5.1 7.5 3.6 1.6 2.6 1.8 0.7 1.2 
Crack 1.3 0.7 1.0 0.3 0.1 0.2 0.2 0.0 0.1 
Ecstasy 9.8 4.8 7.3 2.6 1.0 1.8 1.2 0.4 0.8 
LSD 7.8 3.0 5.4 0.4 0.1 0.2 0.2 0.0 0.1 
Magic mushrooms 10.4 4.0 7.1 1.0 0.3 0.6 0.3 0.0 0.1 
Opiates 1.1 0.5 0.8 0.3 0.1 0.2 0.2 0.0 0.1 
Base  13,334 15,675 28,975 13,253 15,599 28,975 13,235 15,582 28,784 
Source: Murphy and Roe 2007 
 
Changes in last year prevalence since 1996 are shown in Figure 2.1.  This shows a 
steady decline in overall drug use, and cannabis use, since 2003 and also, the 
increase in cocaine use and corresponding decrease in amphetamine use since 
1996. 
                                                
29 29,144 respondents completed the drugs module of the 2006/07 BCS and an extra 2,717 
16 to 24 year olds were also interviewed as part of the 2006/07 BCS youth boost. 
30 Information on poppers (alkyl nitrites) is not asked for in the EMCDDA standard tables and 
has therefore been excluded from table 2.1. However, it is of note that ‘poppers’ has the third 
highest lifetime prevalence of drugs reported in the BCS (9.1%). Last year and last month 
prevalence were 1.4% and 0.5% respectively. 
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Figure 2.1: Percentage of 16 to 59 year olds reporting having used drugs in the last year in 
England and Wales, 1996 to 2006/07 
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Note that the first three time intervals in this graph are greater than a year 
Source: Nicholas et al. 2007 
2.2.2 The Scottish Crime and Victimisation Survey 2006 
Findings from the 2006 Scottish Crime and Victimisation Survey (SCVS) show that: 
• 36.6 per cent of 16 to 59 year olds have ever used drugs; 
• 12.6 per cent have used drugs in the last year; and 
• 8 per cent have used drugs in the last month. 
 
Cannabis is the most commonly used drug across all recall periods followed by 
cocaine for recent and current use.  However, for lifetime use, amphetamines, 
ecstasy and amyl nitrate (poppers) (not a drug reported on to the EMCDDA) are 
more common than cocaine (Table 2.2). 
Table 2.2: Percentage of 16-59 year olds reporting having used drugs in lifetime, last year 
and last month, Scotland, 2006 
Drug Lifetime use Last Year use Last Month use  Male Female Total Male Female Total Male Female Total
Any drug 42.5 30.9 36.6 16.2 9.1 12.6 10.4 5.6 8.0
Amphetamines 17.1 11.3 14.1 2.8 1.6 2.2 1.3 0.6 0.9
Cannabis 38.9 27.2 32.9 14.0 8.0 11.0 9.2 4.4 6.8
Cocaine powder 12.5 5.4 8.9 5.2 2.3 3.7 2.2 1.3 1.7
Crack 1.6 0.5 1.0 0.6 * 0.4 * * *
Ecstasy 13.5 6.5 9.9 4.6 1.9 3.2 2.2 1.0 1.6
LSD 11.0 4.6 7.7 1.1 0.1 0.6 0.5 0.1 0.2
Magic mushrooms 10.2 4.4 7.2 1.2 0.6 0.9 0.5 0.2 0.3
Opiates 1.9 0.6 1.3 0.9 0.2 0.6 0.8 0.2 0.5
Base 1,436 1,722 3,158 1,436 1,722 3,158 1,436 1,722 3,158 
* Less than 0.1% 
Source: Standard table prepared for United Kingdom Focal Point from SCVS data; 
Brown and Bolling 2007 
Men are significantly more likely to have used drugs than women with current and 
recent use almost double that of women.  
 
% 
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Changes in the methodology of the 2006 SCVS from paper completion to CAPI 
appear to have an impact on reported drug use so it is not possible to make any 
meaningful comparisons with previous sweeps of the survey.   
 
However, the new methodology is now similar to that of the BCS allowing 
comparison between the two surveys and showing reported drug use to be higher in 
Scotland than in England and Wales for all recall periods and for both men and 
women. (although this is without consideration of confidence intervals31). 
Frequency of use 
Almost half (47%) of those reporting current drug use in Scotland used drugs at least 
once a week with 21 per cent reporting use every day or almost every day.32  Men 
were more likely than women to have taken drugs on at least a weekly basis in the 
last month (53% and 37% respectively).  
2.2.3 The Northern Ireland Crime Survey 2005 
Table 2.3 shows prevalence figures for last year use from the three most recent 
Northern Ireland Crime Surveys.  Prevalence is generally lower than in England and 
Wales but shows similar patterns and trends with overall rates having fallen over the 
period covered by the surveys.  Cannabis is the most commonly used drug followed 
by ecstasy.  Prevalence has also fallen for both of these drugs.  Use of cocaine 
powder increased between 2001 and 2005, although rates are lower than in England 
and Wales. 
Table 2.3: Percentage of 16 to 59 year olds reporting having used drugs in the last year,  
Northern Ireland, 2001 to 2005 
Drug 2001 2003/4 2005
Any drug 11.0 9.7 8.2
Amphetamines 1.2 0.9 1.0
Cannabis 7.3 6.4 5.8
Cocaine powder 0.5 1.1 1.0
Crack 0 0 *
Ecstasy 3.0 1.9 1.6
LSD 0.5 0 0.2
Magic Mushrooms 0.5 0.2 0.2
Base 2,037 2,121 2,381
                                        * Less than 0.1% 
Source: McMullan and Ruddy 2006 
 
As elsewhere in the UK, men are more likely than women to have used illicit drugs.  
Interestingly, the overall fall in prevalence of last year use between 2003/4 and 2005 
is entirely accounted for by a considerable drop in the rate for women (from 8.1% to 
4.5%).  Prevalence amongst men actually rose slightly (from 11.5% to 12.4%).   
2.2.4 Drug prevalence survey – Northern Ireland 
Two bulletins containing further analysis of the 2002/03 Drug Prevalence Survey 
have been published. Bulletin 5: Polydrug Use, found that polydrug use involving 
illegal substances (alcohol, tobacco, any illegal drug) is low at around two per cent 
(NACD & DAIRU/DHSSPS 2007a). Bulletin 6: Sedatives, tranquilisers or anti-
depressants, reported higher prevalence rates of use of these drugs amongst women 
                                                
31 Although using comparable methodologies, design effects and confidence intervals on the 
surveys vary.   
32 Since only a small number of respondents (n=279) reported last month drug use, a limited 
amount of sub-group analysis is possible. 
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across all recall periods and found that older respondents were more likely to have 
ever used than younger respondents (NACD & DAIRU/DHSSPS 2007b). 
2.2.5 Study of factors contributing to frequency of cannabis use in England 
In a study of 60 cannabis users in England33, Terry et al. (2007) found that external 
constraints were important factors in the reduction and increase of cannabis use.  
The most stated factor for increases in use was increased use by others (79%), 
followed by a change in circumstances, which provided more opportunities to use the 
drug (36%).  Those who attempted to reduce their frequency of use commonly cited 
changed circumstances (55%) or negative effects of the drug (31%) as a factor.  
Periods of abstinence were best explained by a change in circumstances (73%) or 
concerns about the health consequences of use (31%). 
2.3 Drug use amongst young adults 
2.3.1 England and Wales: the British Crime Survey 
Findings from the 2006/07 British Crime Survey show that 24.1 per cent of 16 to 24 
year olds had used drugs in the last year (Table 2.4).  Cannabis was the most 
commonly used drug followed by cocaine powder and ecstasy.  The only statistically 
significant change between 2005/6 and 2006/7 was a decline in magic mushroom 
use (3.0% in 2005/06).  
 
Table 2.4: Percentage of 16-24 year olds reporting having used drugs in lifetime, last year 
and last month, England and Wales, 2006/07 
Drug Lifetime use Last Year use Last Month use  Male Female Total Male Female Total Male Female Total
Any drug 49.3 40.1 44.7 29.5 18.8 24.1 18.6 10.0 14.3
Amphetamines 12.9 9.4 11.2 4.8 2.2 3.5 1.6 0.7 1.2
Cannabis 44.1 34.8 39.5 26.2 15.7 20.9 16.1 7.8 12.0
Cocaine powder 13.0 8.8 10.9 7.5 4.6 6.0 4.1 2.2 3.1
Crack 1.6 1.1 1.4 0.6 0.1 0.4 . . 0.3
Ecstasy 13.1 7.6 10.3 6.5 3.1 4.8 3.6 1.4 2.5
LSD 4.6 1.8 3.2 1.4 0.2 0.8 . . 0.3
Magic mushrooms 10.2 3.8 7.0 2.6 0.9 1.8 0.7 0.1 0.4
Opiates 0.9 0.5 0.7 . . 0.2 . . 0.2
Base 2,725 3,030 5,749 2,704 3,005 5,706 2,693 2,997 5,687 
‘.’ Indicates that although the unweighted base under analysis was more than 50 there were 
insufficient drug users in the sample to enable robust drug group analysis.  
Source: Murphy and Roe 2007  
 
Changes in last year prevalence since 1996 are shown in Figure 2.2. Prevalence of 
use of any drug, and of cannabis, has fallen steadily from a peak in 1998.  An 
increase in cocaine use, particularly between 1996 and 2000, has been accompanied 
by a decrease in use of amphetamines. 
                                                
33 60 individuals were identified from a previous survey of 190 cannabis users recruited using 
snowball sampling across England. Structured interviews lasting approximately 90 minutes 
were conducted over a period of 16 months.  
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Figure 2.2: Percentage of 16 to 24 year olds reporting having used drugs in the last year, 
England and Wales, 1996 to 2006/07 
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Note that the first three time intervals in this graph are greater than a year 
Source: Nicholas et al. 2007 
Frequency of Use 
Frequent use (defined as use of any drug more than once a month in the past year) 
among 16 to 24 year olds, has decreased considerably since 2003/04 (Table 2.5).  
Questions on frequency of use in the BCS have been completed, by 16 to 24 year 
olds only, since 2002/03. 
Table 2.5: Frequent use: percentage of 16 to 24 year olds (all respondents) who have used 
any drug more than once a month in the past year, England and Wales, 2002/03 to 2006/07 
 Year 
 2002/03 2003/04 2004/05 2005/06 2006/07 
Frequent use (%) 11.6 12.4 10.3 9.5 8.3* 
Base 3,311 5,234 6,070 5,768 5,577 
*Statistically significant change 2002/03 to 2006/07 
Source: Murphy and Roe 2007 
2.3.2 The Scottish Crime and Victimisation Survey 2006 
Fifty-four per cent of young adults aged 16 to 34 reported lifetime use of any drug 
with half reporting lifetime use of cannabis (49.6%).  This is slightly higher than 
lifetime use amongst 16 to 24 year olds (52.9% and 48.9% respectively). 
 
For recent drug use the 16 to 24 year old age group has a higher prevalence than the 
16 to 34 age group, 31 per cent compared to 23.7 per cent.  This is mostly accounted 
for by lower drug use amongst females aged 25 to 34; 29 per cent of females aged 
16 to 24 reported recent drug use compared to eight per cent aged 25 to 34.  Table 
2.6 shows that at age 16 to 19 there is little difference between males and females in 
the reporting of any drug use34 but by age 30 to 34 males are four times more likely 
to report drug use than females. 
                                                
34 Although the prevalence for females appears higher, this is not a significant difference due 
to small base sizes. 
% 
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Table 2.6: Percentage of respondents reporting last year use of drugs by age and gender, 
Scotland, 2006 
Drug 16-19 20-24 25-29 30-34 
 Male Female Male Female Male Female Male Female
Any drug 33.1 36.1 32.3 24.2 33.2 11.9 20.6 5.2 
Amphetamines 6.4 6.1 4.9 5.3 5.9 3.2 1.4 0.6 
Cannabis 29.8 33.0 26.8 20.9 27.0 9.4 19.5 4.3 
Cocaine powder 10.6 10.2 14.5 8.2 12.8 3.1 4.8 0.9 
Crack - 1.4 1.3 - 0.7 0.6 1.3 * 
Ecstasy 11.0 10.3 11.4 4.8 11.4 3.8 4.2 0.6 
LSD 5.0 - 2.7 * 1.1 0.7 * - 
Magic mushrooms 1.4 2.6 3.7 2.1 1.5 1.2 1.8 - 
Base 78 79 125 144 136 195 149 209 
– indicates no responses; * signifies less than 0.1% 
Source: Standard table prepared for United Kingdom Focal Point based on SCVS data;  
Brown and Bolling 2007 
 
As with adults, drug use is higher in Scotland than in England and Wales for the 16 to 
24 age group.  Last year use of any drug was reported by 31.0 per cent in Scotland 
compared with 24.1 per cent in the 2006/07 BCS.  There were similar differences for 
each individual drug.  
2.3.3 The Northern Ireland Crime Survey 2005 
As elsewhere in the United Kingdom, last year prevalence is about two to three times 
higher for 16 to 24 year olds than for the adult population as a whole, both for use of 
any drug and for most individual drugs.  The decline in last year use reported in the 
three recent surveys for this age group appears to have been particularly marked, the 
prevalence falling from 28.1 per cent in 2001 to 24.0 per cent in 2003/4 and 18.8 per 
cent in 2005.  
2.4 Drug use in the school and youth population 
In the last year new data have become available from surveys of secondary 
schoolchildren in England and Scotland.  Results of a survey of primary school 
children in Northern Ireland have also been published.  Section 2.6 discusses drug 
use amongst specific groups in the school age population. 
2.4.1 England 
The latest survey of smoking, drinking and drug use in England was undertaken in 
2006 (Fuller 2007).  Key findings are that: 
• 17 per cent of 11 to 15 year olds had taken drugs in the last year and nine per 
cent had taken drugs in the last month; 
• last year drug use increased with age from six per cent of 11 year olds to 29 per 
cent  of 15 year olds; and 
• the prevalence of last year drug use was similar for boys and girls  but boys were 
more likely to be current drug users than girls.  
 
Table 2.7 shows prevalence figures by drug.  Cannabis was the most commonly 
reported drug for all recall periods followed by volatile substances and poppers35. 
Boys were more likely than girls to have used cannabis but girls were more likely to 
have used volatile substances and poppers. 
                                                
35 Poppers are not reported in EMCDDA standard tables. Lifetime, last year and last month 
prevalence were 6.2%, 4.2% and 1.8% respectively. 
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Table 2.7: Percentage of pupils reporting use of individual drugs in the last month, in the last 
year and in lifetime, by gender, England, 2006  
Drug Lifetime use Last Year use Last Month use  Male Female Total Male Female Total Male Female Total
Any drug 24.4 23.7 24.0 16.8 16.3 16.5 10.2 8.5 9.3
Amphetamines 1.6 1.3 1.5 1.4 1.0 1.2 0.7 0.3 0.5
Cannabis 13.8 11.6 12.7 10.8 9.4 10.1 6.5 4.8 5.6
Cocaine 1.9 1.9 1.9 1.6 1.6 1.6 0.9 0.6 0.8
Crack 1.1 1.2 1.2 0.8 0.8 0.8 0.4 0.2 0.3
Ecstasy 1.9 2.0 1.9 1.5 1.7 1.6 0.8 0.7 0.7
LSD 1.2 0.9 1.0 0.9 0.6 0.7 0.5 0.3 0.4
Magic mushrooms 2.7 1.5 2.1 1.9 0.9 1.4 0.8 0.3 0.5
Opiates 1.1 1.0 1.0 0.7 0.6 0.7 0.4 0.2 0.3
Volatile 
substances* 10.0 12.2 11.1 4.6 5.6 5.1 2.3 2.3 2.3
Base 3,994 4,138 8,132 3,994 4,138 8,132 3,994 4,138 8,132
*includes glues, gas, aerosols and solvents 
Source: Fuller 2007 
 
Last year prevalence amongst all school children has fallen considerably from 20.4 
per cent in 2001 to 16.5 per cent in 2006.  Last month prevalence has followed a 
similar pattern falling from 12 per cent in 2001 to 9 per cent in 2006 (Figure 2.3). 
Figure 2.3: Drug use amongst school children in England, 2001 to 2006 
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Source: Fuller 2007 
 
The decrease in last year drug use is mainly attributable to a fall in the two most 
common drugs, cannabis and volatile substances.  Magic mushroom use has also 
decreased since 2003 but there has been an increase since 2001 in the use of 
cocaine (1.2% to 1.6%).  However, the apparent sharp rise between 2004 and 2005 
did not continue in 2006 when prevalence fell (Table 2.8).  Recent use of other drugs 
has remained broadly stable. 
% 
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Table 2.8: Percentage of pupils reporting use of individual drugs in the last year, England, 
2001 to 2006 
Drug 2001 2002 2003 2004 2005 2006 
Any Drug 20.4 19.7 21.0 17.6 19.1 16.5 
Amphetamines 1.1 1.2 1.2 1.3 1.2 1.2 
Cannabis  13.4 13.2 13.3 11.3 11.7 10.1 
Cocaine 1.2 1.3 1.3 1.4 1.9 1.6 
Crack 1.1 1.0 1.2 1.1 1.0 0.8 
Ecstasy 1.6 1.5 1.4 1.4 1.5 1.6 
LSD 0.7 0.7 0.6 0.7 0.6 0.7 
Magic Mushrooms 2.1 1.5 2.1 2.0 1.8 1.4 
Opiates 0.8 0.8 0.9 0.7 0.9 0.7 
Volatile substances*  7.1 6.3 7.6 5.6 6.7 5.1 
Base  9,357 9,830 10,371 9,666 9,174 8,132 
Source: Fuller 2007 
 
The decline in recent use between 2005 and 2006 was seen across all ages covered 
by the survey. 
Frequency of Use 
The proportion of school children in England who report using drugs at least once a 
month declined from six per cent in 2005 to four per cent in 2006, far below 2003 
levels (Table 2.9).  This is largely due to a fall in frequent use amongst the older age 
groups, with the lowest age group reporting a stable level of frequent use.  There is 
no difference between girls and boys overall. 
Table 2.9: Frequency of use: Percentage of pupils who usually take drugs at least once a 
month by age, England, 2003 to 2006 
Age 2003 2004 2005 2006 
11 to 12 years 1 1 1 1 
13 years 5 4 3 2 
14 years 10 7 8 5 
15 years 15 11 13 8 
Total 7 5 6 4 
Bases     
11 to 12 years 3796 3617 3225 2876 
13 years 2087 1931 1841 1618 
14 years 1945 1870 1831 1584 
15 years 2205 2079 1887 1871 
Total 10033 9497 8784 7949 
Source: Fuller (2007) 
2.4.2 Scotland 
The Scottish Schools Adolescent Lifestyle and Substance Use Survey36 (SALSUS) 
was last carried out in 2006 and published in 2007.  The key findings showed that: 
• around a quarter of all 15 year olds (23%) and seven per cent of 13 year olds had 
used drugs recently; 
• cannabis was the most commonly used drug for both age groups and across all 
recall periods; and   
                                                
36 SALSUS is a biennial survey carried out by schools across Scotland. The achieved sample 
in 2006 was 23,017 pupils in school years S(2) and S(4). The majority of pupils in S(2) were 
13 years old (72%)  but also included 12 year olds (27%) and 14 year olds (2%). The majority 
of pupils in S(4) were 15 years old (71%) but also included 14 year olds (28%) and 16 year 
olds (1%). 
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• boys were slightly more likely to have used drugs than girls in both age groups 
and across all recall periods. 
 
Cannabis use accounts for most of the reports of lifetime drug use amongst 13 year 
olds (5.5%) and 15 year olds (24.5%).  Boys, however, are more likely to have tried 
cannabis than girls at both ages (Table 2.10).  The second most commonly used 
drug at age 13 is volatile substances (2.6%) but, by age 15, it is replaced by 
stimulant drugs, poppers (8%), ecstasy (5.4%) and cocaine (4.8%).  At this age, girls 
are less likely to have used cocaine and amphetamines than boys, but report similar 
levels of ecstasy use. 
Table 2.10: Percentage of pupils reporting lifetime use of individual drugs individual drugs by 
age and gender, Scotland, 2006.  
Drug 13 years 15 years 
 Male Female Total Male Female Total
Any Drug 9.0 7.7 8.5 28.6 26.2 27.4
Amphetamines 1.2 0.7 1.0 4.1 2.8 3.4
Cannabis 6.6 4.4 5.6 26.3 22.8 24.6
Cocaine 1.4 1.4 1.5 5.6 4.0 4.8
Crack 1.2 0.9 1.1 1.7 1.1 1.5
Ecstasy 1.2 1.1 1.3 5.5 5.3 5.4
LSD 0.9 0.8 0.9 2.6 1.5 2.1
Magic mushrooms 1.2 0.9 1.1 3.9 1.9 3.0
Opiates 0.8 0.5 0.7 1.1 0.7 0.9
Volatile substances 2.6 2.5 2.7 4.5 4.8 4.7
Base 5,473 5,564 11,037 6,034 5,946 11,980
Source: Standard table prepared for United Kingdom Focal Point based on SALSUS data 
 
There were large decreases in prevalence between 2004 and 2006 with any drug 
use falling from 11 per cent to 6 per cent.  However, caution must be exercised when 
comparing 2006 data, since changes to the fieldwork period may have influenced the 
findings.37 
Frequency of Use 
Results from SALSUS 2006 show that the majority of boys (83%) and girls (84%) had 
never taken drugs.  The next most common reported frequency was having only 
taken drugs once (7%), with a further three per cent reporting that they used to take 
drugs but do not anymore.  There is little gender difference at both ages, although 15 
year old boys are more likely to report drug use at least once a week or most days 
than 15 year old girls (Table 2.11). 
Table 2.11: Frequency of use by school children in Scotland, 2006, as a percentage 
Frequency Gender 
 Boys Girls 
Never taken drugs 83 84 
Only taken drugs once 7 7 
Used to take drugs but not now 3 3 
A few times a year 3 2 
Once or twice a month 2 2 
At least once a week 1 1 
Most days 2 1 
Base 11,507 11,510 
                                                
37 The change in the fieldwork period should be taken into account when comparing results 
with 2002 and 2004. The 2006 survey was carried out in the Autumn term while the previous 
two surveys were conducted in the Spring term. This has resulted in a lower age profile for 
2006 survey participants. As age has been identified as a key factor influencing the 
prevalence of drug use, caution should be taken when interpreting trends.  
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Source: ISD Scotland 2007 
 
Pupils reporting drug use most days were much more likely to say they had ever felt 
they needed help because of using drugs, 12 per cent compared to two per cent  of 
those who had tried drugs once, four per cent of those who used drugs once or twice 
a month and seven per cent of those who used at least once a week. 
2.4.3 Wales 
In Wales, the Health Behaviour in School Children (HBSC) survey is supplemented 
by questions relevant to the situation in Wales, and unlike the basic HBSC survey all 
questions are asked of all age groups in school.  A survey was carried out in 2004 
and a further survey began in 2006.  No results relating to drug use are available at 
the time of writing.  
2.4.4 Northern Ireland 
The latest published survey of school children in Northern Ireland 
(DAIRU/DHSSPSNI 2004) is for 2003 and has been referred to in previous United 
Kingdom Focal Point reports.  A school survey was carried out in 2007 and will be 
reported on in 2008. 
Survey of Primary school children in Northern Ireland 
The first ever survey of primary school children’s knowledge and use of drugs was 
carried out in Northern Ireland in 2006 (DAIRU/DHSSPS 2007a).  In a representative 
sample of 3,734 primary school children aged between 8 and 11, the survey found 
that: 
• eighty-one per cent had heard of drugs before the survey, most commonly 
cannabis (77%) and cocaine (71%); 
• the majority had heard about them from the news 
• awareness increased with year group  except for LSD; and  
• boys were more familiar with drug names than girls. 
 
Five per cent of those who had heard of drugs had been offered them, more than a 
quarter (26%) of these had been offered them by an adult they did not know.  Less 
than two per cent of all primary school children surveyed reported they had tried 
drugs.  The drugs most commonly tried by pupils were cannabis (31%) and solvents 
(27%).  Eleven pupils (0.3%) reported current use. 
Frequency of Cannabis Use among 14/15 year olds in Northern Ireland 
In a survey of 3,919 year 11 pupils (aged 14 to 15) in Northern Ireland38, 36.8 per 
cent had used cannabis in the last year or in their lifetime (McCrystal et al. 2007a).  
Of these, 10 per cent (142) were daily cannabis users accounting for four per cent of 
the sample. 70.3 per cent of daily cannabis users were male and two-thirds (67%) 
belonged to the lowest socio-economic groups.  Daily cannabis users reported high 
lifetime use of both legal and illegal substances and high frequency of drug use; 
almost half reported weekly ecstasy use compared to 2.5 per cent of low frequency 
users and 0.04 per cent of non-users.  They accounted for almost all use of cocaine 
and heroin in the sample.  Daily cannabis users also reported high levels of 
delinquency, antisocial behaviour and truancy. 
                                                
38 The survey examined the drug using behaviours of 3919 year 11 pupils (aged 14 to 15 
years old) attending 40 schools in three towns in Northern Ireland; Belfast, Ballymena and 
Downpatrick. All were participating in the fourth stage of the Belfast Youth Development 
Study (BYDS). Data were collected via a self-completion questionnaire by researchers with 
the assistance of school teachers. 
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2.5 Drug use among specific groups in the adult population 
2.5.1 Armed Forces39 
Compulsory drug testing in the Armed Forces was introduced by the Armed Forces 
Act 1996. Around 85 per cent of servicemen and women are tested annually (House 
of Commons Written Answers for 10 May 2006).  The rate of positive tests increased 
in 2004 and again in 2005, falling in 2006. The proportion testing positive for Class A 
drugs increased considerably in 2005 (Table 2.12).  In 2006, 55.5 per cent of positive 
tests contained traces of cocaine; 45.4 per cent for cocaine alone. Cannabis and 
ecstasy were the next most commonly detected drugs, 33.5 per cent testing positive 
for cannabis (28% cannabis alone) and 18.1 per cent testing positive for ecstasy 
(10% ecstasy alone).  Detection rates for other drugs were less than five per cent. 
Table 2.12: Drug tests and outcomes amongst Armed Forces personnel, 2000-2006 
Year No. tested 
No. 
Positive 
% 
Positive 
No. 
Class 
A 
Class A as 
% of 
positives 
2000 107,142 760 0.71 323 42.5 
2001 96,504 705 0.73 344 48.8 
2002 89,585 567 0.63 255 45.0 
2003 95,376 594 0.62 282 47.5 
2004 88,747 705 0.79 273 38.7 
2005 91,711 863 0.94 535 62.0 
2006 129,888 844 0.65 480 56.9 
Source : MOD 2006; House of Lords Written Answers Tuesday 17 April 2007 
 
The Army has the highest rate of positive tests (0.74%) of all three services; Royal 
Navy (0.46%) and the Royal Air Force (0.14%).  Junior ranks are responsible for 
almost all positive tests with, on average, one officer/cadet testing positive per year.  
Of the 844 military personnel who tested positive in 2006, 783 (92.7%) have been 
discharged (House of Lords Written Answers, Wednesday 25 April 2007).  
2.5.2 Minorities 
See Section 2.6.2 for schoolchildren from ethnic minorities 
2.5.3 Sex workers 
Jeal and Salisbury (2007) surveyed 71 sex parlour workers about their health needs 
and service use and compared the results to their previous findings for street sex 
workers.40  The study highlighted differences in the drug use characteristics of street 
workers and parlour workers.  Ninety-six per cent of street workers had used drugs 
every day in the last 30 days compared to 23 per cent of parlour workers.  Eighty-
seven per cent of street workers reported crack use and 85 per cent heroin use 
compared to seven per cent and six per cent respectively of parlour workers.  
 
A report by Terrence Higgins Trust (2006), which questioned 37 sex workers in an 
English city, found similar differences between street-based and indoor sex workers.  
All street workers used drugs, with three quarters using heroin or crack while only 30 
                                                
39 EMCDDA reporting guidelines ask for information on conscripts. There is, however, no 
conscription (compulsory military service) in the United Kingdom. 
40 The study used an interviewer-administered questionnaire based on the same 
questionnaire used for the health needs assessment of street workers three years previously 
(Jeal and Salisbury 2004). Participants were female sex workers, whose current main city of 
work was Bristol and who worked in massage parlours 
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per cent of indoor workers used drugs, mostly recreational drugs such as ecstasy or 
cocaine. 
2.5.4 Gay men 
Findings from the United Kingdom Gay Men’s Survey 200541 show widespread 
recent drug use (Hickson et al. 2007).  Amyl nitrite was the most commonly used 
substance in the last year (39.4%), followed by cannabis (27.7%).  The majority of 
users were poly drug users (Table 2.13).  Factors associated with higher current drug 
use included living in London, being aged 20 to 39 years old, mixed ethnicity and 
being HIV positive.  Ethnicity, post 16 education, annual income and current religious 
practice affected which drug was used. 
Table 2.13: Last year use of individual drugs amongst gay men in the United Kingdom, 2005 
Drug Last year 
use (%)
Amphetamines 7.2
Amyl nitrite/poppers 39.4
Benzodiazipines 4.1
Cannabis 27.7
Cocaine (powder) 16.8
Crack  1.4
Crystal Meth 2.8
Ecstasy 18.5
GHB 3.6
Heroin  1.0
Ketamine  9.1
LSD 2.8
Methamphetamine 2.8
Viagra 17.4
Source: Hickson et al. (2007) 
2.6 Drug use amongst specific groups in the school age population 
2.6.1 Truants and excludees 
In the English Schools survey for 2006, 19 per cent of pupils reported past truancy 
and 12 per cent reported having been excluded from school.42  Those who had 
truanted or been excluded from school were more likely to report frequent drug use 
(11%) than those who hadn’t (1%) although there had been a decrease from 2005 
(17%).  Truants and excludees were also much more likely to report Class A drug 
use, 14 per cent compared to one per cent. 
 
The SALSUS Schools Survey in Scotland found that current drug users were around 
three times more likely to report truancy in the past year than those who had never 
used drugs and were more likely to be frequent truants, 24 per cent of 13 year old 
current users had truanted more than ten times compared to two per cent of those 
who had never used drugs.  
                                                
41 The Gay Men’s Sex Survey 2005 is an annual survey carried out by Sigma Research in 
partnership with 107 health promotion agencies across the United Kingdom. It uses a self-
completion questionnaire distributed in booklet form by a range of Gay and HIV health 
promotion agencies. The survey is also available for completion online and heavily promoted 
by Gay commercial websites.  The final sample included 16,426 men aged 14 years and over 
living in the UK who either had sex with a man in the last year and/or who expected or were 
not sure if they would do so in the future. 
42 Recorded levels of truancy and exclusion should be viewed with caution as they are based 
on self-reported data. In addition, regular truants and those excluded from school during the 
fieldwork period were almost certainly under-represented in the sample. 
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2.6.2 Ethnic minority school children 
Jayakody et al. (2006) looked at ethnicity and drug use amongst 2,723 year 7 (11 to 
12 years) and year 9 (13 to14 years) school children in East London.  When adjusted 
for socio-economic status, sex, year group and years lived in United Kingdom, Black 
Caribbean, Mixed ethnicity and White British children reported higher levels of 
cannabis use.  Bangladeshi, Indian and Pakistani children were less likely to have 
used cannabis but more likely to have used volatile substances than other pupils. 
Around half of year 9 Bangladeshi pupils had tried paan43 in their lifetime.  Only two 
per cent of pupils had ever used class A drugs or amphetamines. The study found 
large differences between ethnicities commonly grouped together as ‘black’ (Table 
2.14). 
Table 2.14: Percentage of year 9 pupils (aged 13 to 14) reporting lifetime use of cannabis and 
volatile substances, by ethnicity and sex 
Ethnicity Cannabis Volatile substance Class A or amphetamines 
 Boys Girls Boys Girls Boys Girls
White British 18.3 15.9 1.6 2.6 2.6 2.0
White other 9.5 12.4 0 3.0 3.0 0
Bangladeshi 12.1 4.5 2.2 5.7 3.7 1.2
Pakistani 8.0 2.3 4.5 6.2 0 2.0
Asian Indian 3.6 3.1 4.9 2.2 4.6 0
Black Carib’n 24.6 25.4 0 0 4.7 0
Black African 3.7 10.1 1.5 3.6 0 2.4
Black British 19.5 17.0 0 3.0 0 0
Mixed ethnicity 30.0 17.4 0 2.0 7.1 6.1
Other ethnicity 13.7 21.3 0 0 3.9 4.4
Total 13.5 10.9 1.9 3.4 3.1 1.6
Base 651 723 649 720 650 720
Source: Jayakody et al. 2006 
2.6.3 Income and drug use 
Analysis of the Belfast Youth Development Study44 showed that higher income 
amongst year 10 (aged 13/14 years old) pupils was positively associated with levels 
of lifetime use for both licit and illicit drugs (McCrystal et al. 2007b).  Two-thirds of 
those who received a weekly income of more than £60 (€86.74)45 had used cannabis 
and more than one-third (36%) had used ecstasy compared with one-third and six 
per cent respectively of all study participants.  Pupils who received no money were 
much less likely to have taken drugs, around 12 per cent had used cannabis and one 
per cent had used ecstasy. 
2.6.4 Schoolchildren with a moderate learning disability attending special schools 
Findings from 4 years of the Belfast Youth Development Study (BYDS) suggest that 
young people attending special schools are at a lower level of risk to drug use than 
those attending mainstream school (McCrystal et al. 2007c).  Among a cohort of 
young people with a statement of special education needs attending a special school, 
cannabis use was the only illicit drug reported.  Thirteen per cent of year 12 pupils 
attending the special school had tried cannabis compared to 47 per cent attending 
                                                
43 Paan is the nut of the Piper betel.  It is commonly chewed for a period of about 20 minutes 
after which the fibrous residue is often spat out.  The International Agency for Research on 
Cancer (IARC) suggest the betel nut is human carcinogen. People chewing tobacco in paan 
are over five times more likely to be at risk of oral cancer. 
44 Analysis based on 4,524 questionnaire responses from year 10 (13/14 years old) pupils in 
three secondary schools in Northern Ireland. 
45 Bank of England annual spot exchange rate 2003/04. 
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mainstream schools.  The findings should be treated with caution as the sample size 
for special schools was much lower than the sample size for the mainstream schools. 
2.6.5 Looked after children 
The Department for Education and Skills (DfES) started collecting information on the 
number of looked after children identified as having a substance misuse problem in 
2006.  Of the 44,200 children looked after for at least 12 months, 2,300 (5.1%) were 
identified as having a substance misuse problem in the year to 30 September 2006 
(DfES 2007a).  
2.7 Relationship with other indicators and trends in a wider context 
Consistency between indicators is discussed in the introductory section of this report 
and the relationship between general prevalence data, treatment demand data and 
problem drug use estimates is discussed in Section 4.5.1.  
 
There appears to be no research that sheds light on the reasons for the recent 
declines in reported cannabis use, particularly among young people, and which are 
reflected in overall prevalence trends.  
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3. Prevention 
3.1 Overview  
Prevention of young people’s drug use is a key element of drug strategies in the 
United Kingdom.  In England, particular focus has been on a reduction of use of all 
Class A drugs, and the frequent use of any illicit drug particularly amongst vulnerable 
young people.  Consultation on a new drug strategy, mostly relating to England (HM 
Government 2007a)46 designates better education and intervention for young people 
and families (especially those most at risk) and better public information about drugs 
as priority areas.   
 
Universal drug prevention initiatives are an important area of policy in the field of 
prevention.  Communication programmes such as FRANK47 in England and Know 
the Score48 in Scotland provide information and advice to young people and their 
families.  In Northern Ireland, the Health Promotion Agency develop public 
information campaigns for various target groups and settings49 and in Wales, a Drug 
and Alcohol Helpline, Dan 24/750 was launched in 2006.  Throughout most of the 
United Kingdom drug prevention is part of the national curriculum and most schools 
have a drug education policy and guidelines around dealing with drug incidents.  
Guidance on drug education recommends an approach that includes all psychoactive 
substances, including alcohol and tobacco, and places drugs education within the 
wider health and social education agenda. 
 
More recently, drug prevention has become embedded in policy for children and 
young people aimed at enabling them to reach their full potential.  In England the 
relevant programme is called Every Child Matters: Change for Children51 and is 
described in Every child matters: change for children, young people and drugs (DfES, 
Home Office and DH 2005).  There are similar documents in Scotland, Getting it 
Right for Every Child52 and Delivering a Healthy Future An Action Framework for 
Children and Young People’s Health in Scotland53; and in Wales in Children and 
Young People: Rights to Action (2004).54  In Northern Ireland the latest drug strategy, 
New Strategic Direction for Alcohol and Drugs (2006-2011), identifies that at risk and 
vulnerable young people require specific targeting and Our Children and Young 
People – Our Pledge: A 10 year strategy for children and young people in Northern 
Ireland, 2006-201655 sets a framework for addressing the needs of young people;  
 
In England action on young people and drugs is covered within DCSF’s Public 
Service Agreement on increasing the number of children and young people on the 
path to success. 
                                                
46 The areas of reserved power include policing and the criminal justice system (including all 
areas of offender management) within Wales.  The work of the Serious Organised Crime 
Agency (SOCA) and HM Revenue and Customs in addressing drug supply covers the whole 
of the United Kingdom. 
47 See: http://www.talktofrank.com  
48 See: http://www.knowthescore.info/  
49 See: http://www.healthpromotionagency.org.uk/work/drugs/publications.htm  
50 See: http://www.askdan.org.uk/ 
51 See: http://www.everychildmatters.gov.uk/aims/ 
52 See: http://childpolicyinfo.childreninscotland.org.uk/index/news-app?story=4989 
53 See: http://www.scotland.gov.uk/Publications/2007/02/14154246/12  
54 See: http://www.learning.wales.gov.uk/pdfs/children-and-young-people-e.pdf 
55 See: http://www.allchildrenni.gov.uk/tenyearstrategychildren1-2.pdf 
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In England, the High Focus Area (HFA) initiative56 supports progress on 
implementing Every Child Matters: Change for Children – Young People and Drugs.  
It aims to make an early and sustained impact on the drugs PSA target and develop 
better ways to capture learning from local areas to better understand ‘what works’ in 
interventions to prevent drug misuse and improve outcomes for young people..  
Interventions focus on looking to address a range of potential harms, including drug 
use, by children themselves and by their families, which are viewed as putting 
children at risk.  In England and in Wales, all local areas are expected to produce 
Children’s and Young People’s Plans for all local services for children and young 
people, including prevention and treatment. In both countries, a Common 
Assessment Framework (CAF) has been developed to help practitioners working with 
young people to determine their needs, including drug issues.  All local areas are 
expected to have in place universal targeted and specialist support for young people 
around drug issues.  In Scotland, an Integrated Children's Services Planning 
framework57 requires the development of a single plan agreed with all relevant 
agencies to deliver integrated services for all children and young people, including 
those who are vulnerable and at risk. 
 
Current policy acknowledges that some groups of young people are more vulnerable 
to developing substance misuse problems than their peers and suggests more needs 
to be done for these young people.  This is particularly highlighted in the consultation 
document on the Government’s new drug strategy. 
 
Communities are provided with assistance through a range of initiatives to build the 
capacity to resist drugs, as well as being expected to have in place a range of 
prevention initiatives.  Also, there are specific interventions targeting young people in 
deprived communities, for example, Positive Futures (PF), a sports-based social 
inclusion programme in England aimed at marginalised 10 to 19 year olds, with 
projects in some of the most deprived areas in the country, as identified by the Index 
of Multiple Deprivation.58  Other projects to prevent drug harm and to ensure that all 
children and young people are able to reach their potential are running in ‘High Focus 
Areas59’ in England  which have high levels of crime and deprivation and/ or where 
drug misuse problems tend to be most prevalent.  In Scotland, a number of projects 
are funded by the Scottish Government in partnership with Lloyds TSB Partnership 
Drugs Initiative (PDI), targeting children with, or at risk of, problem drug misuse, as 
well as those affected by familial drug use. 
3.2 Universal prevention  
Universal prevention targets the entire population, regardless of individual levels of 
risk, at national, local community, school, or neighbourhood level with programmes, 
initiatives and messages aimed at preventing or delaying illicit drug use. 
                                                
56 See: http://www.homeoffice.gov.uk/drugs/drugs-misuse/preventing-drug-misuse/ 
57 See: 
http://www.scotland.gov.uk/Topics/Government/DataStandardsAndeCare/ChildrenandFamilie
s/IAF 
58 For more information see:  
http://www.communities.gov.uk/publications/communities/englishindices  
59 The High Focus Area (HFA) Initiative was launched in England in April 2005 as part of a 
joint strategy between the Home Office, the Department for Education and Skills and the 
Department of Health, in 30 local authority areas to support faster and sustained progress in 
implementation of universal, targeted and specialist services as set out in strategic guidance 
Every Child Matters: Young People and Drugs, and to learn from their experience.  The areas 
were selected on the basis of local need and levels of current service provision, including 
deprived/high crime areas where drug misuse problems are prevalent.   
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3.2.1 National drug strategy  
With respect to universal prevention, the consultation document on the United 
Kingdom Government’s new drug strategy states that the evidence suggests the 
importance of the role played by schools in drug prevention (HM Government 2007a) 
(see Chapter 1.3.2 for more information on this consultation document).  
3.2.2 Universal prevention campaigns  
In 2005/06 the FRANK website received 5.7 million hits from over 2 million visitors 
and the telephone helpline received approximately 1,350 calls per day; it is 
accessible in 120 languages.  In 2006 its national television and radio advertising 
campaign had a particular focus on cannabis, including a ‘Brain Warehouse’ 
campaign.  A future campaign focusing on cocaine is planned (Home Office 2007c). 
 
In Northern Ireland, the Health Promotion Agency has developed a new website, 
DrugsAlcohol.Info, for professionals involved in drugs prevention work.60 
 
In Scotland in 2006, the Know the Score website averaged over 14,000 visits per 
month and over the year received almost one million page hits from 171,000 visitors, 
with the pages on cannabis, cocaine and the drugs A - Z guide being the most 
popular.  The Scottish Government published a qualitative post-campaign evaluation 
of the 2006 ‘Know the Score’ anti-heroin media campaign (Scottish Executive 
2007a), which reported high levels of campaign awareness.  The evaluation focused 
on the impact it had on attitudes towards heroin use, and not on actual use of heroin.  
In 2007 the Scottish Government published a quantitative post-campaign evaluation 
of phase 3 of the ‘Know the Score’ anti-cocaine campaign.  (Scottish Executive 
2007b). The research focused on a primary audience of 16 to 26 year olds61.  In 
general, the results were similar to those for earlier phases of the campaign, 58 per 
cent reported that the campaign had not altered their likelihood of taking cocaine.   
 
The All Wales Drug and Alcohol Helpline, Dan 24/7, was officially launched in 
September 2006.62  The helpline offers a bilingual service throughout Wales and is 
available 24 hours. 
3.2.3 School  
See above with respect to the Government’s consultation on a new drug strategy.  
An evaluation of Blueprint 
The final evaluation report of Blueprint is due to be published in the autumn of 
2007.63  
                                                
60 See: http://www.drugsalcohol.info/Home.aspx  
61 A total of 443 interviews were conducted over the period 19th to 22nd December 2006 with 
a sample of young people aged between 16 and 26, who go out socialising once a week or 
more often and do not hold an anti-drugs attitude. Respondents were recruited on the street 
and invited into a central location. The interviews were carried out using a self completion 
multimedia CAPI (Computer Assisted Personal Interviewing) machine. Interviews were 
conducted in Dundee, East Kilbride, Edinburgh, Falkirk and Glasgow. This was the fourth 
wave of quantitative research have been conducted to evaluate the campaign. This wave 
evaluated the third phase of the campaign. For the purposes of analysis, respondents were 
split into one of the following four exposure groups based on the level of risk of encountering 
cocaine: Cocaine users, high cocaine exposure (but do not take cocaine), high other drug 
exposure (but not exposed to cocaine) and low risk (the remainder) 
http://www.scotland.gov.uk/Publications/2007/08/03121046/0  
62 For more information see: 
http://new.wales.gov.uk/news/archivepress/socialpress/socialpress2006/1085839/?lang=en 
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Drug, alcohol and tobacco education in schools in Scotland 
An evaluation of the effectiveness of drug education in Scottish secondary schools 
(Stead et al. 2007)64 reported that the vast majority of schools in Scotland provided 
drug education.  It was suggested that while there is much good practice more can 
be done to enhance effectiveness, particularly through clearer guidance on evidence-
based methods and approaches; continuity and progression; further training and 
support to boost teachers’ knowledge, skills and confidence; and more attention to 
resources.  Consideration will now be given by the Scottish Government, in 
conjunction with key stakeholders, to the implications of the research for policy and 
practice in the delivery of drugs education in Scottish schools.   
 
In Glasgow, three schools piloted a consultancy service programme in 2004/05 to 
improve their curricular provision on drug and alcohol issues, in line with national 
best practice guidelines and Glasgow’s health curriculum guidance.  An evaluation65 
of this found that teachers and pupils felt that the project has led to recognisable 
improvements in the way staff and pupils experience drug and alcohol lessons 
(Fitzgerald 2006).  The programme was extended to all other mainstream schools in 
Glasgow City in the 2005/06 academic year.  
 
Primary schools in Scotland have been participating in a number of events, called 
Choices for Life, designed to promote healthy lifestyles and provide drug, alcohol, 
tobacco and mental health awareness.  An evaluation suggested that they were 
successful in entertaining and stimulating pupils and in making them think about the 
issues relating to drugs, alcohol, tobacco and mental health; and in reinforcing; 
children’s existing negative attitudes about drugs.  However, it was not possible to 
measure the impact on their behaviour (Menzies and Myant 2006). 
 
The Schools (Health Promotion and Nutrition) (Scotland) Act 2007 places a duty on 
Scottish Ministers and local authorities to endeavour to ensure that all schools are 
health promoting.  Guidance will be issued to local authorities on health promotion 
and this will include drugs/alcohol and tobacco education.  
All Wales Schools Programme 
A formative evaluation of the All Wales Police Schools Liaison programme was 
carried out by the University of Wales (Tregida et al. 2005)66 focusing on processes 
                                                                                                                                         
63 Blueprint is a five-year research programme that evaluates the effectiveness of drug 
prevention initiatives in schools and community settings. It involves 29 secondary schools in 
four LEA areas; 23 are adopting the Blueprint multi-component drugs education programme, 
while six continue with their existing drug education programme to act as a comparison 
sample. 
64 The research consisted of a literature review, a survey of schools, classroom observations 
and qualitative research with young people and was commissioned in response to the School 
Drug Safety Team's recommendation for research into the outcomes and process of 
educating young people on drug related issues. 
65 The evaluation was conducted between November 2005 and February 2006. The study 
had four elements: semi-structured interviews with a lead teacher; a survey of a sample of 
teachers delivering drug and alcohol education in the 12 schools; 10 focus groups with pupils; 
and a validation workshop with eight representatives from six of the 12 schools to present and 
discuss the findings and agree recommendations arising from the evaluation. 
66 The evaluation incorporated a mapping exercise; programme observation in schools and 
focus groups with young people; and stakeholder interviews. The mapping exercise was to 
consider matters of coverage and ‘penetration’.  While the Programme in Gwent was already 
well established, the Programme elsewhere in Wales had largely been operational only since 
the autumn of 2004 i.e. for just one school year at the time of evaluation in 2005. The aim was 
to establish how many schools had been ‘reached’ in that short time. For the observation in 
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rather than the actual outcomes in terms of whether the initiative reduces drug use.  
It was reported that whilst there had been good progress in implementing the 
programme nationally, it was noted that it was still at a relatively early stage of 
development and in future, needed to be more flexible in order to address any 
particular local issues for schools.  The main consideration of future evaluations will 
be the effects of the programme on pupil’s values, attitudes and behaviour.  A 
second external evaluation is being undertaken, and is due to be presented to the 
Welsh Assembly Government by December 2007. 
Random Drug Testing in Schools  
In England, the Department for Children Schools and Families (DCSF) is aware of 
three maintained67 schools which have tested pupils for drugs68.  There are no plans 
to introduce random and compulsory drug tests for all school children.  
3.2.4 Evidence review of drug prevention 
In the Annual Review of Drug Prevention69 Sumnall et al. (2006a) built on the findings 
of three previous National Collaborating Centre on Drugs Prevention (NCCDP) 
briefing papers: one on vulnerable young people (Edmonds et al. 2005); one on a 
tiered approach to prevention and treatment (Burrell et al. 2006); and one on 
universal prevention (Jones et al. 2006).  Evidence was graded in terms of the 
following four star ratings: 
 
Rating  Basis for evidence 
* based on experience of best practice by health professionals and expert 
groups; 
** only one medium quality study from the United Kingdom, two or more 
studies with inconsistent findings or studies of medium quality70 outside the 
United Kingdom; 
                                                                                                                                         
Schools/Focus Groups the evaluation focussed on secondary schools. Where possible, 
schools were visited when elements of the Programme were ‘in action’, but all visits to 
schools incorporated interviews with school staff, the relevant police Schools Liaison Officer 
(SLO), and pupils who had experienced the Programme. Stakeholder interviews were 
conducted after an analysis of documents relating to the Programme, active participation in 
schools, and observation of external events and in-school Programme delivery. This 
approach permitted a grounded inquiry into a range of issues on which stakeholders were 
encouraged to convey their perspectives. Interviews were conducted with a variety of 
stakeholders related to the Programme e.g. personal, health and social education (PHSE) co-
ordinators and behaviour improvement officers in schools, substance misuse education 
workers, youth workers. The evaluation explored their awareness and understanding of the 
Programme and the contribution they believed it made. This methodology provided the data 
and basis for the subsequent analysis.  
67 In the United Kingdom, a state school that has voluntarily withdrawn itself from local 
authority support (an action called opting out), and instead is maintained directly by central 
government. The schools are managed by their own boards of governors. 
68See: 
http://www.publications.parliament.uk/pa/cm200607/cmhansrd/cm070122/text/70122w0008.ht
m 
69 In this review, drug prevention is defined as those interventions that prevent the onset, 
delay initiation, promote cessation and reduce the harms associate with drug use. 
70 Medium quality findings were defined as being based upon well conducted, non-
randomised intervention studies (controlled non-randomised trial, controlled before-and-after, 
interrupted time series), comparative cohort and correlation studies with a low to medium risk 
of confounding, bias or chance. Good quality findings were defined as being based upon well-
conducted meta-analyses, systematic reviews of randomised controlled trials (RCTs), or 
RCTs with a low to medium risk of bias. Findings that did not fall under these criteria were 
either excluded or only included as contextual information. 
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*** one good quality study or consistent findings in two or more studies of 
medium quality or two or more good quality studies from outside the UK; 
**** consistent findings in two or more studies of good quality carried out within 
the UK and applicable to the target population.  
 
An additional criterion was used to signify which prevention approaches warrant 
further research.  Evidence was rated for school based prevention programmes, 
family based universal prevention programmes, community-based universal 
prevention programmes and generic universal prevention programmes.  This was 
also applied to generic interventions for vulnerable or at-risk young people, peer-led 
education, specialised and alternative education provision, interventions for cared-for 
youth, family based interventions, interventions for young offenders and interventions 
for young people in BME (black and minority ethnic) communities. 
 
Key findings: 
• School-based drug prevention, for which the evidence was given a 3* rating is 
shown to be effective, but most especially amongst low risk groups.  Programmes 
based in life skills show the most consistent effect.  Parent education, also given 
a 3* rating shows some evidence of effectiveness; 
• the evidence grading for other universal interventions; primary school based drug 
prevention, peer education, family interventions, and mass media, was given a 2* 
rating; and 
• it was suggested that community-based drug preventions warrant further 
research.  
 
This review also refers to the economics of drug prevention, with a description of the 
four main types of economic analysis (described here as cost-effectiveness analysis, 
cost-utility analysis, cost-benefit analysis and cost-minimisation analysis).  It is 
suggested that economic evaluation offers the opportunity to inform planners and 
prioritise finite resources.  The key issues are introduced and discussed in a further 
report by Fordham et al. (2007).  
3.2.5 Reviews of policy on prevention 
In the independent review, Drugs – facing facts (RSA 2007) (see Chapter 1.3.2) it is 
proposed that school drugs policy should be shifted, and concentrated earlier, in 
primary school and that prevention should also focus on the period immediately after 
leaving school.  It is suggested that in the early years the first interventions in school 
may not tackle drugs issues directly, but instead aim at giving children the support, 
skills and strength that they might require in order to deal with problems they may 
encounter in the future.  This report also argues that Government should 
acknowledge that there is no way of preventing all people from using all drugs.  
Further, it is suggested in their consideration of the three main drug prevention 
strategies in the United Kingdom (mass media campaigns; drug education in schools; 
and efforts to raise awareness and change attitudes towards drug taking amongst 
vulnerable and disadvantaged young people) that there are two main limits to the 
likely return on investment in all three of these strategies.  The first is that research 
evidence suggests that prevention rarely leads to reduced drug use, and secondly, 
that even if it does reduce some drug use, this is unlikely to lead to major reductions 
in drug problems. 
3.2.6 Funding 
The Young People’s Substance Misuse Partnership Grant for England will total €81 
million in 2007/08.  This cross departmental grant is managed by the Home Office 
and is for the delivery of a range of local universal, targeted and specialist substance 
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misuse interventions for children and young people in line with strategic guidance 
issued in March 2005 to local Directors of Children’s Services and Drug Action 
Teams, Every Child Matters: Change for Children Young People and Drugs. 
3.2.7 Family  
Parenting programmes  
In a systematic review of parenting programmes for preventing use of drugs (as well 
as tobacco and alcohol) Petrie et al. (2007)71 concluded that parenting programmes 
can be effective in reducing or preventing substance use.  The most effective were 
those that shared an emphasis on active parental involvement and on developing 
skills in social competence, self-regulation and parenting. 
3.2.8 Community 
Final report on Positive Futures 
The final case study research report draws out the key themes about both the 
contribution of Positive Futures and the lessons which will help to establish a 
benchmark for sport and activity based social inclusion programmes in the future 
(Crabbe et al. 2006).  While there is a high level of confidence by agencies working 
with the programme of its effect in reducing drug use, there has been no evaluation 
of its actual impact in terms of reducing drug use. 
Community - level prevention in colleges  
Let’s Talk About Drugs investigated the feasibility of a community-level drug 
intervention based upon the principles of motivational interviewing within a further 
education college.  It aimed to create an environment that would stimulate interest in 
and awareness of drug use issues (as well as those around alcohol and tobacco 
consumption) with a harm reduction orientation.  A pilot study was carried out with 
college students and found some qualitative evidence of attitudinal and 
environmental benefit to suggest that an intervention of greater duration may have 
the capacity to produce a greater impact (Newbery et al. 2006). 
Prevention in coastal and ex-mining areas 
Mentor UK (2007)72 published the final report from its coastal and ex-mining areas 
pilot project for drug misuse prevention initiatives for young people.  They researched 
and developed 12 pilot projects in order to address the issues of isolation, parenting 
and alcohol and drug misuse; and to support and engage young people and local 
agencies to develop and implement local projects to address those needs.  This 
report describes their experiences and suggests how others working in those 
communities can learn from them.  Amongst its recommendations, Mentor UK call on 
Drug Action Teams in these areas to regularly undertake an audit of local community 
organisations and create work-plans to engage and involve them in drug prevention.  
This project had not been externally evaluated for its effectiveness at the time of 
writing.  
3.3 Selective prevention  
Selective prevention initiatives target subsets of the total population that are deemed 
to be at greater risk for substance misuse such as truants or young offenders. 
                                                
71 The search looked at Cochrane Central Register of Controlled Trials, specialised Register 
of Cochrane Drugs and Alcohol Group, Pub Med, psych INFO, CINALH and SIGLE. Two 
reviewers independently screened studies, extracted data and assessed study quality. 
Twenty studies met the inclusion criteria. 
72 http://www.mentorfoundation.org/uploads/UK_CEMA_Report.pdf 
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3.3.1 Recreational settings  
Northern Ireland Safer clubbing campaign 2005 – 2007 
The Health Protection Agency in Northern Ireland have re-issued a series of posters 
from the 2005 safer clubbing campaign that are displayed in the toilet areas of a 
range of pubs and clubs throughout Northern Ireland targeted at 18 to 30 year olds.73 
3.3.2 At risk groups  
Drug strategy consultation  
The United Kingdom Government’s new drug strategy consultation states that more 
can be done to reach out more effectively to the most vulnerable and the most at risk 
young people, suggesting that there is solid evidence showing that some groups of 
young people are more vulnerable to developing substance misuse problems than 
their peers.  These groups include young offenders, looked-after children, young 
homeless people, children who truant or are excluded from school, young people 
who have been sexually exploited or who work in the sex industry and children 
whose parents misuse drugs or alcohol. (HM Government 2007a). 
Identifying and exploring young people’s experiences of risk, protective factors and 
resilience to drug use 
A report from the Home Office (2007d) summarises and pulls together findings from 
two linked studies commissioned to explore methods of identifying groups and 
individuals ‘at risk’.  Firstly, a literature review was carried out of studies that have 
explored predictive factors of drug use and common factors arising from these 
studies were identified (Frischer et al. 2007).  Following on from this, a further study 
explored young people’s resilience to drug use.  There were two stages to this 
research: the first was a multivariate analysis of the 2003 Offending, Crime and 
Justice Survey (OCJS) data; the second stage was a qualitative study of the views 
and experiences of a sample of these young people, exploring the nature of their 
resilience to drug use (Dillon et al. 2007).  
 
The literature review found that the most extensive and consistent evidence relates 
to young people’s interaction with their families and the key predictors of drug use 
are parental discipline, family cohesion, and parental monitoring.  Further, some 
aspects of family structure such as large family size and low parental age are linked 
to adolescent drug use.  There is also consistent evidence linking peer drug use and 
drug availability to adolescent drug use. 
 
There is also evidence in the literature  that the number of risk factors that a person 
is exposed to is a predictor of drug use, regardless of what those particular risk 
factors are: the more risk factors there are, the greater the likelihood of drug use.  
 
The evidence indicates that risk and protective factors are context dependent and 
influence people for a variety of reasons.  Some, such as gender and ethnicity, are 
fixed and cannot be changed.  Others, such as parental discipline can be altered.  
Within these limits, improving the general social environment of children and 
supporting parents appear to be the most effective strategies for primary prevention 
of drug use.  Evidence from studies of such interventions for parental monitoring and 
enhancement of social attachments and skills indicate that risk factors and resilience 
can be successfully altered.  Studies exploring this type of intervention show promise 
but such interventions have been rarely implemented, or evaluated, within the United 
Kingdom. 
                                                
73 See: http://www.healthpromotionagency.org.uk/Resources  
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Guidance on vulnerable and disadvantaged children and young people 
The National Institute for Health and Clinical Excellence (NICE)74 has produced 
public health guidance on community-based interventions to reduce substance 
misuse among vulnerable and disadvantaged children and young people.  It calls for 
anyone who works with young people to identify those who are vulnerable to drug 
problems and intervene at the earliest opportunity.  It gives advice on stepping in and 
helping young people access the right support and services and outlines effective 
individual, family and group-based support, which can improve motivation, family 
interaction and parenting skills (NICE 2007a).  
Update of The National Service Framework for Children, Young People,and 
Maternity Services 
The National Service Framework for Children, Young People, and Maternity Services 
(Department of Health 2004a) is to be updated. 
Toolkit for developing local profiles of drug use among vulnerable young people  
A powerpoint toolkit has been developed to provide guidance and advice for 
practitioners and managers to help identify and deal with drug use in their area.  This 
provides national data on drug use among vulnerable young people, showing the 
prevalence of use among different groups.  It also explains how this data can provide 
a picture of probable need in an area if local data is not available (Home Office, DfES 
and TDA 2007). 
Evaluation toolkit 
The National Collaborating Centre for Drug Prevention (NCCDP) has developed a 
toolkit for practitioners to enable them to self-evaluate their drug prevention services. 
It has been designed to contain all the tools required by practitioners, managers and 
researchers to evaluate services that either they or others provide. The toolkit is 
currently being piloted by a number of services and an online version will be 
developed in the future. 
Children’s Charities Working Together on Drug Prevention Project  
The Children’s Charities Working Together on Drug Prevention Project brings 
together five national children’s charities to work together on substance misuse: the 
National Children’s Bureau (NCB)75, Barnardo's76, the National Society for the 
Prevention of Cruelty to Children (NSPCC)77, NCH78, and The Children’s Society.79  
The project’s aims are as follows: to develop the capacity of children’s charities to 
deliver drug prevention support to those working with vulnerable children and young 
people; increase the influence and inter-agency working between national children’s 
charities, Drug Action Teams (DATs) and children and young people’s substance 
misuse services; increase access to, and communication between, charities and 
mainstream children’s services for children and young people with substance misuse 
issues.  The project is being evaluated by Mentor UK.  Expected outcomes from the 
project include a greater recognition of the contribution the children’s voluntary sector 
makes to the substance misuse agenda and that mainstream services have 
increased capacity to address substance misuse effectively.  
                                                
74 See: http://guidance.nice.org.uk/PHI4/guidance/pdf/English/download.dspx 
75 For more information see: www.ncb.org.uk 
76 For more information see: www.barnardos.org.uk 
77 For more information see: www.nspcc.org.uk  
78 Previously known as National Children’s Home.  For more information see: 
http://www.nch.org.uk/ 
79 For more information see: www.childrenssociety.org.uk/  
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FRANK (High Focus Areas) 
As part of its extra focus on vulnerable young people, FRANK increased its presence 
in the 30 High Focus Areas across England through street marketing activity and 
advertising.  Adverts at bus stops and bus panels were used to extend the ‘Brain 
Warehouse’ theme used in the TV and radio adverts about cannabis.  Also, in the 
autumn of 2006 FRANK launched its FRANK Lights up After Dark Campaign.  The 
pack was intended to support High Focus Areas and other organisations to run their 
own FRANK Activity in the autumn/winter.  It contains information on wider FRANK 
activity, as well as tips and advice for running peer-to-peer street marketing events.80  
 
An evaluation of prevention initiatives in High Focus Areas is being carried out by the 
National Collaborating Centre for Drug Prevention (NCCDP). 
Know the Score  
In Scotland, ‘Know the Score’ has run national campaigns which have involved 
penetrating more difficult-to-reach areas, both socially and geographically.  These 
have utilised local radio campaigns, billboards and bus shelters and have been 
supported by editorials in local and national media.  In 2006/7 ‘Know the Score’ has 
piloted dedicated anti-cocaine awareness weekends in collaboration with local 
licensed venues across Scotland, utilising pub staff to help put the messages across.  
This campaign was also supported locally by the Association of Chief Police Officers  
Scotland (ACPOS), local voluntary groups, and Scotland’s Alcohol and Drug Action 
Teams (ADATs). 
Children of drug using parents  
The Advisory Council on the Misuse of Drugs has published a report which discusses 
the extent to which the 48 recommendations made in its 2003 report (ACMD 2003) 
have been implemented.  It describes policy changes that have taken place since 
then, and also points to areas where work is still required (ACMD 2007a).  It 
suggests that a key aspect of the initial report was the need for more integrated 
working between a range of services to identify and meet the needs of the children of 
drug using parents.  It points to major programmes in the United Kingdom which seek 
to ensure all children are able to reach their potential (see Chapter 12).  The Scottish 
strategy highlights the importance of safeguarding the welfare of the children of 
problem drug users and includes a specific performance target in relation to reducing 
the harm to this group of children.  The new Northern Ireland strategy includes 
specific targets in relation to the implementation of Hidden Harm and the Welsh 
strategy highlights the importance of developing support for children of substance 
misusing parents, with the aim of "safeguarding their welfare".  In England some 
progress is highlighted in embedding action to address the harm caused to children 
by parental drug misuse, including the requirement for new statutory Local 
Safeguarding Children Boards to develop specific arrangements and protocols to 
respond to parental substance misuse.  It is noted that Northern Ireland is only 
recently working towards implementing the Hidden Harm agenda. 
 
In Wales there are two specific initiatives to support the children of substance 
misusing parents: 
• Option 2 is a family intervention service that is prompted by a crisis that could 
result in children having to be taken into care. The aim of the service is to 
develop and encourage new behaviours within the family so that they can move 
beyond the crisis; and 
• an Early Parental Intervention Service Programme is being developed and 
piloted. The focus of the service is families where an adult’s substance misuse 
                                                
80 See: http://www.homeoffice.gov.uk/materials/401478?view=Standard 
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has been identified as having an impact on their parenting capacity. The aim is to 
deliver early preventative services in order to prevent a crisis that could result in 
children being taken into care. 
Family Drug and Alcohol Court 
A Family Drug and Alcohol Court is to be piloted from January 2008, its aim is to 
improve the engagement of adults in treatment services and increase their capacity 
to provide stable care for their children.  The model will test out provision of intensive 
assessment, support, intervention and care plan coordination for families affected by 
parental substance misuse, whose children are in care proceedings. The pilot, which 
will be carried out in the Westminster, Islington and Camden areas of London, is to 
be evaluated.81  
Children in the care of the local authority 
In England, the Department for Children, Schools and Families sets out the steps the 
Department will take, together with local delivery partners, to improve outcomes for 
children and young people in care.  Specific proposals are set out on including early 
identification of substance misuse issues within routine health assessments in the 
Green Paper Care Matters: Time for Change (DfES 2007b) (see Chapter 12). 
 
In Scotland, a Ministerial Working Group, which ran from November 2005 to June 
2006, considered what was required to improve educational and other outcomes for 
looked after children and care leavers.  As a result, a report entitled Looked After 
Children and Young People: We Can and Must Do Better (Scottish Executive 2007c) 
raised many important issues and contains 19 action points across its five themes: 
working together; becoming effective lifelong learners; developing into successful 
and responsible adults; being emotionally, mentally and physically healthy and 
feeling safe and nurtured in a home setting.  The action points and tasks contained in 
the report are not the responsibility of any one organisation or area; rather the 
document reflects the importance of partnership working.  The need for positive 
Corporate Parenting is also highlighted throughout the report.  An Implementation 
Board has been established (consisting of senior officials from within and outside of 
the Scottish Government) to oversee the implementation of the report, with a 
structure of eight working groups to take forward the specific tasks and actions. 
3.3.3 At risk families 
The are already a number of generic early interventions for families and/or children, 
including those families where parental substance misuse is seen as placing children 
at risk.  Increasingly, services are being developed to provide support to prevent 
children being taken from families where substance misuse has been identified as a 
problem. 
 
The Department of Health in England has commissioned research to conduct an 
evaluation of the Families First Project, running in Middlesbrough from April 2006 to 
November 2008.82  This is a multi-disciplinary service, incorporating adult and 
children’s services, offering a comprehensive assessment, holistic intervention and 
family support package to families with problematic drug and/or alcohol use where 
there is a likelihood of children being removed from the family by the Local Authority.  
The support provided aims to reduce many of the ‘risk factors’ which research has 
                                                
81 For more information see: 
http://www.communitycare.co.uk/Articles/2007/05/15/104498/uks-first-specialist-drug-and-
alcohol-court-to-start-next.html 
 
82 Both quantitative and qualitative research methods are being used including interviews, 
focus groups and questionnaires. 
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shown children of drug using parents are susceptible to (including depression, social 
isolation and an increased risk of children using drugs in later life), by enforcing so 
called ‘protective factors’ against negative outcomes, such as parental drug 
stabilisation, school attendance and consistency in family routines.  The package 
aims to enable families to make changes to their lifestyle which are necessary to 
ensure the safety and stability of the child within the home environment.  The results 
of the evaluation and experiences of conducting it will also be used to develop the 
National Collaborating Centre for Drug Prevention (NCCDP) toolkit for assessment of 
young person outcomes in generic services.  Results from the second interim report, 
produced by NCCDP researchers at Liverpool John Moores University83,  showed 
that at the six month follow up stage none of the children receiving support from 
Families First had entered into a children’s home or foster care (outside of the 
family), despite nine children having been under a care order at baseline interview; 
reported use of any illicit drug had halved amongst parents between baseline and 
sixth month follow up stages; and in terms of family conflict, there was a significant 
difference in the levels of arguing and fighting reported by parents over the six month 
period examined.  The final report will be available in December 2008.  
The Bouncing Back! prevention programme  
The Bouncing Back! prevention programme aims to pilot and develop good practice, 
knowledge and expertise to engage vulnerable family members, carers and parents 
in drug education initiatives.  The programme has recognised the links between 
positive parenting education and drug awareness (ADFAM 2007).  
3.4 Indicated prevention  
These interventions are designed to prevent the onset of problem drug use in 
individuals who already are experiencing early signs of substance abuse and other 
problem behaviours, including children at risk of individually attributable risk factors 
factors such as Attention Deficit Hyperactivity Disorder.84  
 
NO NEW INFORMATION AVAILABLE 
                                                
83 See: http://www.drugpreventionevidence.info/default.asp Drug users in contact with 
specialist drug services 
84 Attention Deficit Hyperactivity Disorder AD(H)D, sometimes referred to as Attention Deficit 
Disorder (ADD) is a neurological condition which is estimated to affect approximately one per 
cent of children in the United Kingdom.  It is characterised by pervasive inattention and/or 
hyperactivity-impulsivity, resulting in significant functional impairment.  For more information 
see: 
http://www.mind.org.uk/Information/Booklets/Understanding/Understanding+ADHD.htm#What
_is_ADHD  
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4. Problem drug use  
4.1 Overview 
Estimates of problem drug use in the United Kingdom reflect the drugs identified as 
problematic and the methodology used85. Latest estimates for England are for 
2004/05 for use of opiates and/or crack use (327,466), with additional estimates for 
opiate use (281,320), crack use (192,999), and injecting use (137,141).  In Northern 
Ireland estimates are for 2004 for opiate and/or cocaine (including crack cocaine) use 
(3,303), with, also, an estimate for opiate use (1,395).  In Scotland the estimates are 
for 2003 for opiate and/or benzodiazepine use (51,582).  There are no recent 
estimates for Wales.  Based on these, it is estimated that there are 398,845 problem 
drug users in the United Kingdom86.  
 
The Treatment Demand Indicator (TDI)87; measures presentations to services by 
drug users, and data are provided for those in contact with general practitioners, 
outpatient (community-based specialist drug services) and inpatient services.  Latest 
combined data for the United Kingdom are for 2005/06 when there were 128,446 
new demands for treatment.  Opiates, mostly heroin, were the main primary drug 
reported (65%).  Cannabis was the second most reported primary drug (16%), and 
crack and cocaine accounted for six per cent each of primary drug reports.  
Presentations for cannabis have increased over time, and now represent a quarter of 
first ever presentations.88  Current injecting was reported by 24 per cent; 52 per cent 
report having never injected.  Twenty-two per cent were aged between 25 and 29.  
Amongst users of problem drugs, these characteristics have changed little over time. 
4.2 Prevalence and incidence estimates of PDU 
There is no information on incidence of PDUs.  
4.2.1 Prevalence estimates for England for 2004/05 
Research published in 2006 provided estimates of problem drug use for the 149 Drug 
and Alcohol Action Teams (DAATs) areas in the nine Government Office Regions in 
England, as well as a national estimate for England for 2004/05 (Hay et al. 2006a).  
National estimates were derived from the sum of the DAAT estimates.  Estimates are 
for persons aged 15 to 64.  It was not possible directly to obtain estimates of those 
who only use crack (i.e. use crack but do not use opiates) or only use opiates 
(without also using crack).  Estimates were provided for: problem drug users (defined 
as those who use opiates and/or crack), 327,466; opiate users, 281,320; crack users, 
192,999; and for injecting opiate and/or crack users, 137,141.  Drug treatment, 
probation, police and prison data were used to provide these estimates.  Table 4.1 
shows estimates, rates per thousand population and confidence intervals.  
                                                
85 These are based on the capture-recapture method where possible, and where not, by the 
multiple indicator method. 
86 Estimates for Wales (18,402) are extrapolated from results for England. 
87 The TDI is one of the five epidemiological indicators established by EMCDDA to monitor 
the drug situation in the European Union.  Currently it provides a measure of those presenting 
to treatment, for the very first time, or for the first time within the year.  It does not include 
those who are already in treatment in that year.  It can therefore best be described as a 
measure of treatment incidence.   
88 This could, in part be attributed to improved data reporting by young person’s drug 
services. 
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Table 4.1: Problem drug users estimates and rates per 1,000 population aged 15 to 64 for the 
United Kingdom 
Drug Estimate 95% confidence interval Rate 
95% confidence 
interval 
Opiate and/or crack use  327,466 325,945 343,424 9.93 9.88 10.41 
Opiate  281,320 279,753 292,941 8.53 8.48 8.88 
Crack  192,999 188,138 210,763 5.85 5.70 6.39 
Injecting  137,141 133,118 149,144 4.16 4.04 4.52 
Source: Hay et al. 2006a 
 
London has the highest prevalence of problem drug use, and of crack use, but is 
second to Yorkshire and Humberside in terms of prevalence of opiate use.  
Prevalence of injecting drug use is also highest in Yorkshire and The Humber 
(Tables 4.2 to 4.5).89 
Table 4.2: Estimate of problem drug users aged 15 to 64 by Region in England 2004/05: rate 
per 1,000 population and number 
Region Rate per 1,000 population  Numbers 
 Estimate 95% CI Estimate 95% CI 
East of England 6.48 6.18 7.11 23,081 22,029 25,313 
East Midlands 8.23 8.00 9.04 23,142 22,516 25,442 
London 14.35 13.86 15.68 74,417 71,845 81,299 
North East 9.50 8.98 10.59 15,853 14,987 17,683 
North West 11.43 10.39 12.45 51,110 46,455 55,653 
South East 6.40 6.14 7.24 33,854 32,495 38,306 
South West 9.44 9.16 10.21 30,455 29,536 32,936 
West Midlands 10.62 10.17 11.45 36,834 35,276 39,726 
Yorkshire and 
The Humber  11.74 11.43 12.40 38,720 37,708 40,911 
England 9.93 9.88 10.41 327,466 325,945 149,144 
Source: Hay et al. 2006a 
Table 4.3: Estimate of opiate users aged 15 to 64 by Region in England, 2004/05: rate per 
1,000 population and number 
Region Rate per 1,000 population Numbers 
 Estimate 95% CI Estimate 95% CI 
East of England 5.48 5.20 6.05 19,518 18,539 21,558 
East Midlands 7.55 7.40 8.11 21,241 20,815 22,813 
London 10.64 10.15 11.53 55,139 52,611 59,799 
North East 8.22 7.85 9.38 13,729 13,099 15,657 
North West 9.84 9.11 10.79 43,996 40,737 48,221 
South East 5.43 5.15 5.98 28,727 27,267 31,648 
South West 8.54 8.27 9.26 27,541 28,681 29,685 
West Midlands 9.99 9.70 10.71 34,661 33,656 37,173 
Yorkshire and 
The Humber  11.15 10.81 11.83 36,768 35,674 39.028 
England 8.53 8.48 8.88 261,320 279,753 292,941 
Source: Hay et al. 2006a 
 
 
 
                                                
89 Estimates for DAATs and the nine English Regions can be found in treatment plans for 
each team; see, for example: 
http://www.nta.nhs.uk/areas/treatment_planning/treatment_plans_2007_08/trpl1_07_08_york
humber_northeast_northwest.aspx  
UNITED KINGDOM FOCAL POINT REPORT 2007 
 55
Table 4.4: Estimate of crack users aged 15 to 64 by Region in England, 2004/05: rate per 
1,000 population and number 
Region Rate per 1,000 population  Numbers 
 Estimate 95% CI Estimate 95% CI 
East of England 3.96 3.31 6.30 14,102 11,779 22,425 
East Midlands 4.60 4.06 5.91 12,952 11,417 16,627 
London 9.90 9.29 10.77 51,312 48,156 55,850 
North East 4.42 3.38 6.53 7,376 5,636 10,899 
North West 6.65 5.71 7.70 29,752 25,533 34,423 
South East 3.64 3.04 5.02 19,261 16,097 26,554 
South West  5.44 4.81 6.44 17,552 15,509 20,785 
West Midlands 6.00 5.48 7.66 20,827 19,012 26,593 
Yorkshire and 
The Humber  6.02 5.53 7.00 9,865 18,239 23,095 
England 5.85 5.70 6.39 192,999 188,138 210,763 
Source: Hay et al. 2006a 
Table 4.5: Estimate of drug injectors aged 15 to 64 by Region in England, 2004/05. rate per 
1,000 population and number 
Region Rate per 1,000 population  Numbers 
 Estimate 95% CI Estimate 95% CI 
East of England 2.64 1.76 3.67 9,418 6,252 13,061 
East Midlands 4.19 3.73 4.81 11,796 10,487 13,518 
London 3.45 3.12 4.63 17,909 16,161 24,002 
North East 5.37 4.57 6.35 8,959 7,638 10,597 
North West 4.94 4.20 5.64 22,089 18,781 25,204 
South East 2.60 2.28 3.36 13,778 12,044 17,802 
South West  5.41 4.94 6.05 17,444 15,930 19,532 
West Midlands 4.25 3.92 4.90 14,734 13,589 17,007 
Yorkshire and 
The Humber  6.37 6.02 6.91 21,014 19,860 22,788 
England 4.16 4.04 4.52 137,141 133,118 149,144 
Source: Hay et al. 2006a 
 
Estimates of problem drug use and opiate use were stratified by age group; from 15 
to 24, 25 to 34 and 35 to 64 (Table 4.6), and by gender (Table 4.7).  There was 
insufficient information to obtain age or gender-stratified estimates for crack use or 
drug injecting.  Approximately a quarter of problem drug users or opiate users were 
female.  For both estimates the greatest number of users is in the age group 25 to 
34. 
Table 4.6: Estimate of problem drug users and problem opiate users by age in England, 
2004/05 
Type of drug user Age 
 15 to 24  % 25 to 34  % 35 to 64  % 
Problem drug users 72,838 22.23 140,365 42.84 114,459 34.93
Problem opiate users 59,583 21.18 124,004 44.08 97,740 34.74
Source: Hay et al. 2006a 
Table 4.7: Estimate of problem drug users and problem opiate users by gender in England, 
2004/05 
Gender Problem Drug Users Problem Opiate Users 
Male  244,351 208,638 
% 74.62 74.16 
Female 83,116 72,712 
% 25.38 25.84 
Source: Hay et al. 2006a 
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The study is being carried out over a three-year period and will provide prevalence 
estimates at the end of each of the three study ‘sweeps’.  Estimates for 2005/06 are 
due to be published in the autumn of 2007. 
Estimating the national and local prevalence of problem drug use in Scotland 
The National Health Service (NHS) in Scotland has called for expressions of interest 
to carry out research to estimate the national and local prevalence of problem drug 
use in Scotland.  These will use the 15 to 64 age range and will aim to provide 
estimates for opiate use as well as opiate and/or benzodiazepine use.  
4.2.2 Estimates of problem drug use in the United Kingdom 
Revised estimates of problem drug use and of injecting drug use have been 
calculated using the most recent prevalence studies in the United Kingdom (Hay et 
al. 2004; Hay et al. 2006a; Hay et al. 2006b).  These suggest an overall prevalence 
of 398,845 problem drug users (Table 4.8) and 164,036 injecting drug users. (Table 
4.9). 
Table 4.8: Estimate of problem drug use in the United Kingdom: number and rate per 1,000 
population  
Country Estimate 95% confidence interval Rate 
95% confidence 
interval 
England 327,466 325,945 343,424 9.93 9.88 10.41 
Northern 
Ireland 1,395 1,316 1,910 1.28 1.21 1.75 
Scotland 5,1582 51,456 56,379 15.39 15.35 16.82 
Wales 18,402 18,316 19,299 9.93 9.88 10.41 
United 
Kingdom 398,845 397,033 421,012 10.15 10.11 10.72 
Source: Table prepared by G. Hay 2007 
Table 4.9: Estimate of injecting drug use in the United Kingdom: number and rate per 1,000 
population  
Country Estimate 
95% confidence 
interval Rate 
95% confidence 
interval 
England 137,141 133,118 149,144 4.16 4.04 4.52 
Northern 
Ireland90 584 551 800 0.54 0.51 0.73 
Scotland 18,737 17,731 20,289 5.59 5.29 6.05 
Wales 7,707 7,480 8,381 4.16 4.04 4.52 
United 
Kingdom  164,036 158,881 178,614 4.18 4.04 4.55 
Source: Table prepared by G. Hay 2007 
Trends in prevalence of problem drug use  
It is difficult to consider estimates of prevalence in the United Kingdom as providing 
information which can be interpreted in terms of trends, as the methodology is to 
some extent reliant on the quality of monitoring systems by agencies; these have 
improved considerably over time, therefore allowing more reliable, and inevitably 
higher, estimates to be produced.  
 
Millar et al. (2006) investigated whether hypotheses about trends in prevalence of 
problem drug use, prompted by capture-recapture based age specific prevalence 
                                                
90 This table makes the assumption that Northern Ireland shows the same proportion of 
injecting amongst the drug using population.  This assumption may not be entirely appropriate 
and therefore the rate of injecting should not be used in isolation.  However, it is an 
appropriate assumption for the United Kingdom given the size of the confidence interval.  
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estimates, are corroborated by estimates of trends in incidence.91  The paper 
suggests that while estimates of prevalence of problem drug use are important they 
may not discern trends, even where there are comparable serial estimates and that 
information about incidence may provide a complementary approach to measuring 
and forecasting trends.  The authors have used incidence estimation techniques 
used in AIDS epidemiology and show how results may be used to corroborate 
hypotheses about the current and future direction of changes in prevalence.  Despite 
a number of caveats and assumptions the authors conclude that the method can be 
used to provide an evidence base that could help policy makers target resources 
more effectively.  
4.2.3 Problem drug use falling outside the EMCDDA definition 
The available prevalence estimates for Scotland employ the case definition of opiate 
and/or benzodiazepine use.  This is for historical reasons, in particular to achieve 
comparability with studies, such as the Dundee study (Hay and McKeganey 1996) 
where many drug users would be using benzodiazepines such as Temazepam or 
Diazepam when heroin was not readily available.  Benzodiazepines are still used by 
problem drug users (who primarily use opiates) although this has perhaps lessened 
and it is thought that the PDU estimates for Scotland do not include any significant 
numbers of people who only use benzodiazepines; the estimates for Scotland may 
therefore be a good proxy for the prevalence of heroin use.  TDI data for Scotland 
appears to verify this (Table 4.11).  
4.2.4 Problem drug use for which estimates are not available  
The capture-recapture method has been used to estimate the prevalence of problem 
drug use within the United Kingdom.  Different studies employ different case 
definitions, partly to satisfy the policy need for certain estimates, but primarily to 
reflect the availability of suitable data.  A key assumption of the capture-recapture 
method is that it is applied to homogeneous groups of drug users.  Typically, heroin 
users, or heroin and/or crack users show a similar pattern of contact with treatment 
services and criminal justice services is relatively similar.  This is not the case for 
cocaine users, where it is difficult to differentiate (particularly in criminal justice data 
sources) between people who use cocaine problematically and those that use 
cocaine on an occasional or recreational basis.  Thus it has not been possible to 
include problem cocaine use in PDU estimates for the United Kingdom (apart from in 
the specific case of Northern Ireland, where the nature and extent of drug use is 
known to vary significantly from the rest of the United Kingdom).  The prevalence 
estimates for England include crack use, and with the comparatively low levels of 
primary crack use found in previous studies in Scotland, it is felt that this estimate is 
sufficient as a proxy for the United Kingdom. 
4.3 Treatment Demand Indicator 
In 2005/6, 128,446 presentations to treatment services were recorded through the 
Treatment Demand Indicator (TDI); this is an increase of nine per cent from the 
previous year (117,781).  Of known cases, 48 per cent (49,625)92 concerned drug 
users who sought treatment for the first time ever; in Northern Ireland first treatments 
accounted for 62 per cent of treatment presentations.   
                                                
91 Lag correction techniques were used to provide incidence estimates adjusted for time-lag, 
between onset of drug use and its first recorded treatment for heroin users seeking treatment 
in three areas in the North West of England between 1986 and 2000. 
92 In 26,106 cases it is not known whether this is a first treatment or whether the presenting 
drug user has been in treatment previously. 
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4.3.1 Treatment centres  
Reports to the TDI are based on structured treatment93 only and in the United 
Kingdom do not include low threshold services or prison treatment.  The vast majority 
of treatments are reported through outpatient services (94%)94 (Table 4.10). 
Table 4.10: Presentations by centre type in the United Kingdom, 2003/04 to 2005/06 
Centre type  2003/04 2004/05 2005/06 
 n % n % n % 
Outpatient 91,659 91.9 111,434 94.6 121,202 94.4 
GP 3,966 4.0 3,402 2.9 3,833 3.0 
Inpatient  4,038 4.0 2,945 2.5 3,411 2.7 
Total  99,663  117,781  128,446  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
4.3.2 Profile of clients in treatment  
Drugs used 
Opiates (65%) remain the most reported primary drug amongst the TDI population 
and cannabis the second most reported primary drug (16%).  Cocaine and crack 
were each reported by six per cent (Table 4.11).  These are not significantly different 
from previous years (Table 4.16).  There are some variations between parts of the 
United Kingdom.  In Northern Ireland primary opiate use accounts for just 15 per cent 
of presentations, but primary cannabis use accounts for as much as 49 per cent.  
Also in Northern Ireland, 14 per cent of presentations were for primary 
benzodiazepine use, a problem previously regarded as relating to Scotland, but 
which as noted previously, although this is not reflected by the TDI.   In England, 
seven per cent of presentations were for primary crack use, compared to one per 
cent throughout the rest of the United Kingdom, and these accounted for the majority 
of crack presentations (98%) across the country.  While England also accounts for 
the majority of cocaine presentations (89%), Northern Ireland shows the highest 
proportion of primary cocaine users, at nine per cent, although still only accounting 
for 2 per cent of the presentations for cocaine in the United Kingdom. 
Table 4.11: Number and percentage of drug treatment presentations by primary drug of use  
in the United Kingdom, 2005/06  
Drug England Northern Ireland Scotland Wales 
United 
Kingdom 
  n % n % n % n % n % 
Amphetamines 3,412 3.4 10 0.6 205 1.8 507 8.6 4,134 3.5 
Benzodiazepines 1,200 1.2 233 14.0 672 5.8 192 3.2 2,297 1.9 
Cannabis 15,504 15.5 821 49.3 1,588 13.7 880 14.9 18,793 15.8
Cocaine (powder) 6,122 6.1 150 9.0 476 4.1 142 2.4 6,890 5.8 
Crack 6,705 6.7 4 0.2 68 0.6 80 1.4 6,857 5.8 
Opiates 65,514 65.6 244 14.6 7,907 68.2 3,915 66.1 77,580 65.1
Other   1,422 1.4 204 12.2 709 6.1 205 3.5 2,540 2.1 
Sub Total 99,879  1,666  11,625  5,921  119,066  
Not Known  2,801  0  2,051  4,503  9,355  
102,680 1,666 13,676 10,424Total  
79.9% 
 
1.3% 
 
10.6% 
 
8.1% 
 128,446  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
 
                                                
93 Treatment where a care plan should be provided. 
94 Most such services in the United Kingdom are specialist community based treatment 
services. 
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First treatment demands show a slightly different pattern (Table 4.12) with primary 
opiate use accounting for half (50%) of first treatment demands in England and the 
United Kingdom as a whole.  Presentations with cannabis as primary drug accounted 
for a quarter of all first demands in the United Kingdom.  The third highest number of 
first demands were for primary cocaine problems, although accounting for a much 
lower proportion (9%) than primary opiate or cannabis use.  
Table 4.12: Number and percentage of first drug treatment demands by primary drug of use  
in the United Kingdom, 2005/06  
Drug England Northern Ireland Scotland Wales UK 
 n % n % n % n % n % 
Amphetamine 1,576 4.1 6 0.5 133 2.3 97 8.6 1,812 3.9 
Benzodiazepine 586 1.5 204 17.0 306 5.2 57 5.1 1,153 2.5 
Cannabis  9,567 25.1 672 56.0 1034 17.7 233 20.7 11,506 24.8
Cocaine 
(powder) 3,698 9.7 107 8.9 349 6.0 43 3.8 4,197 9.1 
Crack 3,051 8.0 3 0.2 39 0.7 23 2.0 3,116 6.7 
Opiates 18,873 49.5 73 6.1 3,450 59.0 625 55.5 23,021 49.7
Other 810 2.1 136 11.3 533 9.1 49 4.3 1,528 3.3 
Sub Total 38,161  1,201  5,844  1,127  46,333  
Not Known  1,185  0  808  1,299  3,292  
Total  39,346 79.4%  
1,201 
2.4%  
6,652 
13.4%  
2,426 
4.9%  49,625  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
Age  
Forty-two per cent of all treatment presentations were for those aged between 25 and 
34, and 29 per cent were under 25.  As expected those presenting to treatment for 
the first time ever were considerably younger with 37 per cent under the age of 24 
years (Table 4.13).  
Table 4.13: Age of drug users identified through TDI in the United Kingdom, 2005/06  
 Age 
 <25  25 to 34 34> Missing All 
 n % n % n % n n 
All treatments 36,973 29 53,854 42 37,432 29 187 128,446 
First treatments 18,596 37 17,910 36 13,106 26 13 49,625 
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
Gender  
Seventy-two per cent of clients were male and 28 per cent female (Table 4.14).  
There was no difference in those presenting to treatment for the first time (Table 
4.15). 
Injecting status  
Just over half of clients (52%) had never injected , but just under a quarter (24%) 
were currently injecting (Table 4.14).  Males were slightly more likely to be currently 
injecting than females. Those who had never previously been in treatment (first ever 
treatment demands) were less likely to have injected, and less likely to inject 
currently (Table 4.15).  This could reflect the higher number of first treatment 
demands using drugs such as cannabis which is not injected.   
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Table 4.14: Injecting status by gender in the United Kingdom, 2005/06; all treatment  
Injecting status  Male Female Total 
 n % n % n % 
Ever injected, but not 
currently 16,658 24.4 6,598 25.0 23,256 24.6 
Currently injecting (in last 
month) 16,844 24.6 5,445 20.7 22,289 23.5 
Never injected 34,832 51.0 14,321 54.3 49,153 51.9 
Sub Total  68,334  26,364  94,698  
Not known/missing 24,019  9,729  33,748  
Total 92,353 71.9%  
36,093 
28.1%  128,446  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
Table 4.15: Injecting status by gender in the United Kingdom 2005/06; first treatment  
Age  Injecting status  Male Female Total 
 n % n % n % 
Ever injected, but not 
currently 4,486 14.8 1,567 13.7 6,053 14.5 
Currently injecting (in last 
month) 5,105 16.6 1,561 13.7 6,666 16.0 
Never injected 20,677 68.3 8,251 72.5 28,928 69.5 
Sub Total  30,268  11,379  41,647  
Not known 5,697  2,281  7,978  
Total 35,96572.5%  
13,660
27.5%  49,625  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
4.3.3 TDI prevalence trends in the light of other indicators  
Table 4.16 shows the primary drug used by those presenting to treatment over the 
past three years.  The proportion presenting with opiates as a primary drug has 
fallen, though actual numbers have increased, and the TDI continues to identify 
opiate use as accounting for the majority of presentations to services, at around 65 
per cent.  Cannabis, crack and cocaine have risen as a proportion of presentations 
over time.  The TDI, to some extent, reflects trends seen in other indicators.  PDU 
estimates also suggest opiate users account for the majority of problem drug users 
(Table 4.1)95; similarly; are implicated in the majority of drug-related deaths (see 
Chapter 6.2).  First ever treatments offer the same picture, though the relative fall in 
the proportion of primary opiate users relative to the rise in primary cannabis 
presentations is even more accentuated (Table 4. 17).  It is also of note that primary 
cocaine and crack users represent a higher proportion of first ever treatments, 
although with crack users the difference is very small. 
                                                
95 Note that the PDU estimates relate to opiate and/or crack use (England), opiate and/or 
cocaine use (Northern Ireland) and opiate and/or benzodiazepine use (Scotland). 
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Table 4.16: Number and percentage of drug treatment presentations by primary drug in the 
United Kingdom, 2003/04, 2004/05 and, 2005/06  
Drug 2003/04  2004/05 2005/06 
 n % n % n % 
Amphetamines 3,474 3.7 3,731 3.6 4,134 3.5 
Benzodiazepines 1,929 2.1 2,503 2.4 2,297 1.9 
Cannabis 9,849 10.7 14,801 14.1 18,793 15.8 
Cocaine 3,739 4.0 5,093 4.9 6,890 5.8 
Crack 4,980 5.4 5,842 5.6 6,857 5.8 
Opiates 66,012 71.4 70,179 67.0 77,580 65.1 
Other  2,494 2.7 2,662 2.5 2,540 2.1 
Sub Total  92,477  104,811  119,091  
Not Known 7,186  12,970  9,355  
Total 99,663  117,781  128,446  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
Table 4.17: Number and percentage of first drug treatment presentations by primary drug, in 
the United Kingdom, 2003/04, 2004/05 and, 2005/06 
Drug 2003/04  2004/05 2005/06 
 n % n % n % 
Amphetamines 1,455 5.1 1,619 4.1 1,812 3.9 
Benzodiazepines 675 2.3 1,226 3.1 1,153 2.5 
Cannabis 5,289 18.6 8,653 22.1 11,506 24.8 
Cocaine 1,683 5.8 3,016 7.7 4,197 9.1 
Crack 1,722 6.0 2,589 6.6 3,116 6.7 
Opiates 16,656 57.8 20,464 52.3 23,021 50.0 
Other  1,329 4.6 1,525 3.9 1,528 3.3 
Sub Total  28,809  39,092  46,333  
Not Known 1,056  3,405  3,292  
Total 29,865  42,497  49,625  
Source: Standard Tables prepared for United Kingdom Focal Point 
by M. Donmall 2007 
 
Tables 4.6 (see 4.2.1 above) shows that in England 43 per cent and 44 per cent 
respectively of problem drug users and problem opiate users are estimated to be 
aged between 25 and 35.  TDI data suggest similar proportions in this age group 
(43%) (see Table 4.13), with a higher proportion of the TDI being in the younger age 
group, aged under 25 (29%); PDU estimates suggesting 22 per cent of problem drug 
users and 21 per cent of opiate users in this group.  This can be expected given that 
the TDI includes those who use cannabis as primary drug and PDU estimates do not. 
 
In England, a 3:1 ratio of males to females is consistent from both TDI and PDU 
estimates.  Also, in England PDU estimates suggest that 42 per cent of PDUs inject 
(see Table 4.5); this compares with the TDI estimate of 24 per cent currently injecting 
in the United Kingdom (Table 4.14), including primary cannabis users.   
4.4 PDUs from non-treatment sources 
4.4.1 PDU not seen in the TDI population  
See 4.5.1 for estimates of penetration rates of PDUs in the treatment population.   
Northern Ireland, Drug Addicts Index 
In Northern Ireland, a Drug Addicts Index monitors those registered in concurrence 
with the Misuse of Drugs (Notification of and Supply to Addicts) (Northern Ireland) 
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Regulations 1973 which requires any doctor to notify the DHSSPS in writing within 7 
days, if they attend a patient who he considers to be, or has reasonable grounds to 
suspect, is addicted to any of the 14 named controlled drugs.  Those included have 
not necessarily received treatment for drug misuse.  In 2006: 
• there were 288 registered addicts at 31 December 2006, an increase of 27 from 
the 31 December 2005 (261); 
• there were 190 renotifications, compared to 182 in 2005, 100 new notifications, 
and 73 cases were removed; 
• seventy-eight per cent were male (in 2005 72% were male); 
• thirty-four per cent were aged 29 years and under in 2006 (37% in 2005); 
• heroin was the most frequently reported drug (76%), with methadone (26%), and 
cocaine (8%);  
• 42 per cent whose injecting behaviour was known reported currently injecting 
(36% in 2005); and  
• 99 were registered within the last year, 125 had been registered between one 
and five years (DAIRU/DHSSPSNI 2007b). 
Arrestee Survey 
Further information on problem drug users is available through the Arrestee Survey 
(see Chapters 8 and 9) (Boreham et al. 2006).  The provides information on 
dependence (Table 4.18), frequency of use (Table 4.19), injecting status (Table 
4.20), polydrug use (Table 4.21), ethnicity (Table 4.22), identifying treatment contact 
(Table 4.23) as well as education and employment.  In this survey 57 per cent of 
arrestees reported having taken one or more drugs in the last month.  Of these: 18 
per cent reported heroin use; 15 per cent crack use and ten per cent cocaine use; 46 
per cent reported taking cannabis.  Based on the Severity of Dependence Scale 85 
per cent of those who used heroin were dependent, 52 per cent of those would have 
used crack, but less than quarter (23%) who use cocaine (Table 4.18).  Very little 
difference was shown by age.  Heroin and crack users were more likely to use these 
drugs more often than cocaine users (Table 4.19).  Those who used crack were more 
likely to also use heroin than cocaine (Table 4. 21). 
Dependence 
Table 4.18: Proportion of arrested users of heroin, crack or cocaine identified as dependent 
(Severity of Dependence Scale) in England and Wales, 2003-04 by age  
Drug Age 
 17-24 25-34 35+ Total 
 17-24 Weighted base 25-34
Weighted 
base 35+ 
Weighted 
base Total 
Weighted 
base 
Heroin 84 562 84 749 87 262 85 1,575 
Crack  48 637 54 743 57 295 52 1,676 
Cocaine  21 874 23 536 32 203 23 1,613 
Source: Boreham et al. 2006. 
Frequency of use  
The drug most frequently used was heroin (Table 4.19). 
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Table 4.19: Frequency of use of heroin, crack and cocaine by arrestees in England and 
Wales, 2003-04 as a percentage of all arrestees 
Frequency of use  Drug 
 Heroin Crack Cocaine 
5 or more days a week 13 7 2 
3 or 4 days a week 1 2 1 
1 or 2 days a week 1 3 3 
1 or 2 days a month 2 3 5 
A few times a year 1 2 5 
Less often than once a 
year 0 0 0 
Only ever taken once 2 3 5 
Used to take, don't take 
now 8 12 21 
Never taken 72 68 59 
Weighted bases 7,465 7,454 7,440 
Source: Boreham et al. 2006. 
Injecting  
A third of those who had used drugs that could be injected had done so.  The 
proportion was highest amongst those aged between 25 and 34 (Table 4.20). 
Table 4.20: Proportion of arrestees who had ever injected drugs among those who had taken 
drugs that could be injected in England and Wales, 2003-04, by age 
Ever injected 
drugs 
Age  
 17-24 25-34 35+ Total 
Yes  25 42 33 33 
Weighted bases 1,784 1,561 788 4,134 
Source: Boreham et al. 2006. 
Polydrug use 
Those using heroin, crack and/or cocaine (HCC users) were asked about their 
combined use of all three drugs.  Table 4.21 shows the largest groups were those 
who use heroin and crack, followed by those who used cocaine but neither heroin or 
crack, and those who used heroin, but not cocaine or crack.  These results do not 
preclude use of other drugs.  
Table 4.21: Polydrug use in the last month by age amongst arrestees using heroin, crack 
and/or  cocaine in the last month in England and Wales, 2003-04 as a percentage 
Polydrug use Age 
 17-24 25-34 35+ Total 
Heroin only 18 22 18 20 
Crack only 6 8 17 9 
Cocaine (powder) only 36 17 16 25 
Heroin and crack 27 42 35 34 
Heroin and cocaine (powder) 2 1 3 2 
Crack and cocaine (powder) 4 3 3 3 
Heroin and crack and cocaine 
(powder) 7 7 8 8 
Weighted bases 859 868 349 2,077 
Source: Boreham et al. 2006 
Ethnicity  
Table 4.22 shows that amongst arrestees those of mixed race were more likely than 
other groups to be crack users, and both those of mixed race and those described as 
White more likely to be HCC users. 
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Table 4.22: Proportion of arrestees who had used drugs in the last month, by ethnicity in 
England and Wales, 2003/04 
Drug Ethnicity 
 White Mixed Asian Black Other Total 
Heroin 19 17 11 7 8 18 
Crack  15 22 8 14 14 15 
Cocaine(powder) 11 9 4 4 6 10 
HCC  29 30 15 17 19 28 
Any drug 57 69 32 56 42 57 
Weighted bases 6,287 253 288 557 92 7,477 
Source: Boreham et al. 2006. 
Education  
The majority of arrestees said they had finished full-time education at the age of 16 
or younger; 42 per cent being less than 16 and 37 per cent 16.  Forty per cent had 
been excluded from school temporarily and 24 per cent permanently.  Amongst HCC 
users (last year use) 58 had left school before they were 16, and 30 per cent when 
less than 16.  Fifty-eight per cent had been temporarily excluded from school and 38 
per cent permanently excluded.  
Employment  
Among all arrestees 36 per cent were in paid employment, while 51 per cent were 
unemployed.  Amongst HCC users 22 per cent were in paid employment, while 66 
per cent were unemployed.  
 
Other sources of information on drug users are available through interventions for 
young people under 18 arrested for acquisitive and other non-drug offences.  These 
include those referred to arrest referral pilot schemes and showed that use of drug 
associated with problematic drug use was very low: cocaine used by four per cent, 
crack by one per cent and heroin by one per cent96 (Matrix Research and 
Consultancy and Institute for Criminal Policy Research, Kings College 2007) (see 
Chapter 9.3.2).   
 
Analysis looked at use of heroin and crack, and also cocaine, as an indication of 
problematic drug use, all being Class A drugs.  This has proved difficult in 
considering this population with other indicators of problem drug use, in particular the 
PDU and TDI.  However, the survey results do show that cocaine users are probably 
a different group from those who take heroin or crack.   
 
Arrestees who had ever taken heroin, crack and cocaine were asked whether they 
had ever been offered treatment, had ever received treatment, had received 
treatment in the last twelve months and were currently receiving treatment.  Table 
4.23 shows that over half had been in treatment.  
                                                
96 2,327 young people had contact with arrest referral between November 2003 and 
September 2005. 
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Table: 4.23: Lifetime use of heroin, crack and cocaine amongst arrestees who have been in 
contact with treatment services in England and Wales, 2003-04 as a percentage 
Treatment status Ever used drug 
 Heroin Crack Cocaine 
Ever been offered treatment 58 13 4 
Ever received treatment 52 7 2 
Received treatment in the last twelve 
months 34 5 1 
Currently receiving treatment 22 2 1 
Treated in last 12 months , not currently 
receiving treatment 11 2 0 
Treatment long ago 18 3 1 
Weighted base . 2,031 2,386 3,004 
Source: Boreham et al. 2006 
4.4.2 Contact with non-treatment interventions and social and cultural context 
See Chapter 6 for information on needle exchange schemes and drug related 
infectious disease testing.  
4.5 Intensive or frequent patterns of use 
4.5.1 Frequency of use  
By their very nature, estimates of problem drug use are concerned with intensive 
patterns of use.  More sensitive information on frequency of use should be available 
when outcome monitoring becomes a part of treatment monitoring systems (see 
Chapter 5.4.3). 
 
However, information on frequency of use of these problematic drugs is provided 
through the Arrestee Survey (see Table 4.13).  With respect to heroin, crack and 
cocaine, heroin was the drug used most frequently, with very few arrestees reporting 
using cocaine more than once a week.   
4.6 Relationship of PDU estimates, TDI data and General Population Survey 
Most recent PDU estimates are available for England and Northern Ireland (the latter 
reported in the United Kingdom Focal Point report for 2006).  Population survey data 
is based upon a very different population than that reflected in PDU estimates; the 
former identifying very low use of opiates and cocaine based drugs, though it is of 
note that cocaine use has increased within this population.  In England, in 2005/06 
the best estimate for the number of lifetime users of cocaine (powder) was 
2,273,000; for recent use (in the last year) the number was 769,000, and for current 
use the number was 368,000.  Despite these relatively high numbers, no estimate 
could be given for problem cocaine users through research into estimating the 
number of PDUs for England.  Within the British Crime Survey the best estimate for 
opiate users was 272,000 for lifetime use, 47,000 for recent use and 35,000 for 
current use; the latter much lower than the number of estimated PDUs in England 
(281,320.)  For crack users the best estimates were 270,000, 53,000 and 25,000; 
again, for recent and current use, much lower than the estimated number of PDUs 
(192,999).  
 
Given the lack of comparable data on PDUs it is difficult to provide trend data and 
therefore not possible to consider any relationship between drugs identified through 
research estimating the prevalence of problem drug use and general population 
surveys.  It is, however, of interest to consider the treatment population in relation to 
problem prevalence estimates.  
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In Northern Ireland, estimates of prevalence showed evidence of only opiates and 
cocaine as problematic drugs (though it should be noted that research was only 
conducted to establish prevalence of these drugs)and it can be seen that, relatively 
speaking, cocaine presentations reported through the TDI are slightly higher than 
elsewhere in the United Kingdom (9% in Northern Ireland compared to 5% in the 
United Kingdom as a whole). 
 
The TDI distinguishes between all new presentations to treatment each year and first 
ever presentations (that is, first treatment demands).  The number and profile of he t 
first ever treatment demands reflects changes in the emergent population of drug 
users newly entering treatment, while the number and profile of all new presentations 
reflects the wider demands made on the treatment sector.  for the future it is likely 
that EMCDDA will further develop the TDI to record information on all persons in 
treatment, including those in continuous treatment from year to year, so as to achieve 
a much better picture of the total treated population. 
 
At present, TDI numbers cannot be used to consider treatment engagement rates as 
they do not take account of those individuals already in treatment prior to, and during, 
the reporting period.  The National Drug Treatment Monitoring System (NDTMS) for 
England provides a better estimate of engagement, but totals relate to those in 
treatment contact rather than the numbers actually receiving treatment. 
 
TDI data suggest that in England in 2005/06 there were 102,652 presentations, 72 
per cent were problem drug users, using opiates and/or crack as a primary or 
secondary drug.  Sixty-six per cent of presentations used opiates (as a primary or 
secondary drug) and 26 per cent used crack (as a primary or secondary drug) (Table 
4.24). 
Table 4.24: Primary and secondary opiate users, crack users and opiate and/or crack users 
identified in TDI (England), 2005/06 
Problem drug users Presentation 
 n % (N =102,680) 
Opiate and/or crack users (primary or 
secondary) 73,900 72 
Opiate users (primary or secondary) 68,676 67 
Crack users (primary or secondary) 26,272 26 
Source: TDI data pre prepared by NDEC 
 
NTMDS data show that, of those in treatment in 2005/06 (the same year as the latest 
TDI data, but a year on from the PDU estimates), 136,228 were problem opiate 
and/or crack users (Table 4.25), that is 42 per cent of problem drug users.  The 
treatment figure for opiate users constituting 46 per cent (128,630) of the PDU 
estimate of opiate users, while the treatment figure for crack users constitutes 21 per 
cent (39,832) of PDU estimate for crack users.   
Table 4.25: PDU estimates, PDUs identified in TDI and PDUs identified through English 
treatment monitoring system (NDTMS) 
 PDU 
estimates 
(2004/05) 
TDI (2005/06) NDTMS (2005/06)* 
 n n % n % 
Opiate and/or crack users  327,466 73,900 23 136,228 41.6 
Opiate users  281,320 68,676 24 128,630 45.7 
Crack users  192,999 26,272 13 39,832 20.6 
*2005/6 figures from NDTMS are provided by D. Cairns at the National Drugs Evidence 
Centre, 2005/6 figures from NDTMS are by NTA. 
Source: Hay et al. 2006; Standard Tables prepared by M. Donmall 2007, NDEC 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 67
5. Drug-related treatment 
5.1 Overview 
United Kingdom drug strategies identify treatment as being effective in tackling 
problem drug use and, therefore, indicate a need to increase its availability and 
quality.  An indicator measure for the new Public Service Agreements published in 
October 2007 is the percentage change in the number of drug users recorded as 
being in effective treatment. 
 
Drug misuse and dependence: guidelines on clinical management, (updated in 2007) 
and, in England, Models of care for treatment of adult drug misusers: update 2006 
provide the basic framework for drug treatment, offering guidance around the 
structure and range of services to be commissioned in each area, as well as 
guidelines on clinical practice.  The National Institute for Health and Clinical 
Excellence (NICE) also provides guidance in a number of areas.  Treatment 
providers are expected to offer advice and information, care planned counselling, 
structured day care programmes, community prescribing, inpatient drug treatment 
and residential rehabilitation.  In addition, drug misusers are to be offered relapse 
prevention and aftercare programmes; hepatitis B vaccinations; testing and 
counselling for hepatitis B and C and HIV; and needle exchange.  Oral methadone 
maintenance is the most common method used in treating heroin addiction, 
buprenorphine, injectable methadone and heroin are also available. 
 
Coordination and integration between a range of providers is seen as key in helping 
problem drug users reintegrate into society.  While providing treatment remains a 
priority, the role of other service providers of housing, employment, education and 
training has also become important, leading to the concept of Wraparound 
Services.97  This integrated approach is seen through the introduction of the Drug 
Interventions Programme (DIP) in England and Wales, and the establishment of 
Criminal Justice Intervention Teams which have been developed to improve referral 
into treatment through the criminal justice system and for those in prison (see 
Chapter 9). 
 
Improving treatment for young people has been prioritised since 2005. 
 
With access to effective treatment being a priority of the United Kingdom drug 
strategies, treatment capacity has increased substantially.  This has been 
accompanied by significant financial investment.  However, there remain concerns 
about workforce capacity, which are being addressed.  Research initiatives are 
funded centrally to help improve the effectiveness of treatment, and there are also a 
number of other initiatives to increase the capacity and improve the effectiveness of 
treatment, for example nurse prescribing, guidance for pharmacists working with drug 
users, and continued encouragement to expand the role of general practitioners 
(GPs) in the treatment and care of drug misusers.  The health and social outcomes 
associated with treatments have come to prominence in the last year, with attention 
given to measuring these in England and Wales.  In Scotland political debate during 
the last year, about maintenance treatments, particularly methadone, seems to have 
been resolved with an acceptance of the value of this treatment. 
                                                
97 See:  
http://www.drugmisuse.isdscotland.org/eiu/pdfs/eiu_litreviewsum.pdf#search=%22Wrap%20A
round%20Services%20drug%20misuse%20%22  
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5.2 Treatment system 
5.2.1 Numbers in treatment 
In England the numbers in treatment, as well as those presenting to treatment, are 
monitored.  In 2006/07 there were 195,464 individuals, this is a rise of 10 per cent 
from 2005/06 (177,05598).  Elsewhere in the United Kingdom monitoring systems 
provide information on the numbers entering treatment rather than all those in 
treatment during the year (See Chapter 4). 
Welsh National Database for Substance Misuse 
The first annual report from the Welsh National Database for Substance Misuse was 
published in 2006 (WAG 2006a). 
5.2.2 Quality in treatment systems 
There has been a continued process of improving the quality of treatment provision in 
the United Kingdom.  Clinical guidelines have been revised (see below).  In England, 
there have been further reviews of local treatment through the Healthcare 
Commission and the National Treatment Agency (NTA) (see 5.2.3), additional 
guidance on aspects of treatment from the National Institute for Clinical Excellence 
(NICE) (see below), and revised guidance on good practice in care planning and 
work to measure treatment outcomes (see below).  There has also been a 
strengthening of rehabilitation services mirroring comments in the consultation on the 
new national drug strategy (see below), ensuring that the right balance is achieved 
between treatment services that are able to maintain drug users in treatment, and 
services aimed at helping people become and remain abstinent from drug use.  The 
NTA issued updated guidance on needs assessment for adult drug treatment.  Also, 
treatment for young people under 18 years has been highlighted as requiring 
improvement; from 2007, the NTA will take lead responsibility for this (see below).99 
Treatment within the consultation document on a new national drug strategy  
The consultation on the new national drug strategy (see Chapter 1.3.2) states that 
drug treatment will remain a cornerstone of drug strategy, but needs to be more cost-
effective and with more done to help drug users find employment and suitable 
housing.  In addition, more needs to be done for those under 18.  It is suggested that 
future policy should achieve the right balance between maintenance services and 
services aimed at helping people to become and remain abstinent from drug use 
altogether.  The consultation seeks views on a number of questions with respect to 
treatment (HM Government 2007a). 
PSA Delivery Agreement  
New agreements for reducing the harm caused by drugs (and alcohol) were made in 
October 2007 placing responsibility on a number of Government departments to 
meet the targets set (HM Government 2007b).  One indicator measure will be the 
percentage change in the number of drug users recorded as being in effective 
treatment.  
Treatment outcomes  
Treatment effectiveness: retention in Treatment  
In England, retention in treatment for at least 12 weeks is a proxy measure for 
treatment effectiveness.  In 2006/07 75 per cent were retained in treatment for 12 
weeks or more.  However, in order to provide a better indication of progress made by 
                                                
98 These figures are revised form those presented in the previous Focal Point Report, when 
they were given as 181,390. 
99 For more information see: www.nta.nhs.uk  
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those in treatment the need to understand and measure the outcomes of treatment 
was given priority in 2006 by the NTA. 
Outcome Tool 
A Treatment Outcomes Profile (TOP) has been developed in England to monitor the 
outcomes of treatment.100  This tool will be used at the start of treatment and in care 
plan reviews and will be reported through the National Drug Treatment Monitoring 
System (NDTMS) every three months.  Outcomes measured are drug and alcohol 
use; physical and psychological health; social functioning; and offending and criminal 
involvement.  Available documentation includes the Treatment Outcome Profile Form 
(NTA 2007a); a manager's implementation guide (NTA 2007b); a Treatment 
Outcome Profile keyworker's guide (NTA 2007c); and a Treatment Outcome Profile 
service user's guide (NTA 2007d). 
Predicting drug treatment outcomes 
Gossop et al. (2007) reported on a study representing the first large-scale test of the 
capacity to predict illicit drug treatment outcomes from an instrument, the Stages of 
Change and Treatment Eagerness Scale (SOCRATES), purporting to measure 
processes underlying stages of change.101  The main hypothesis was that 'taking 
steps' (making changes in behaviour) should be predictive of less frequent use of 
illicit opiates (heroin and non-prescribed methadone) at follow-up.  Results did not 
support the hypothesis and a negative association was found with benzodiazepine 
misuse.  While readiness for change measures were correlated with heroin use and 
psychiatric symptom scores at treatment intake, they were not associated with illicit 
drug use outcomes.  
Update of Drug misuse and dependence: guidelines on clinical management 
Departments responsible for health in the United Kingdom have updated Drug 
misuse and dependence: guidelines on clinical management (DH 1999).  A draft was 
issued in June 2007 for a three month consultation.102  The guidelines have been 
compiled by an independent working group of clinicians and others to consider the 
significant developments in clinical drug treatment since 1999, when the guidelines 
were last published.  The new guidance was published in September 2007.  
 
The guidelines include the following key principles underlying appropriate care of 
drug misusers are stated as: 
• Drug misusers have the same entitlement as other patients to the services 
provided by the National Health Service. 
• The General Medical Council’s statement that: “It is … unethical for a doctor to 
withhold treatment from any patient on the basis of a moral judgement that the 
patient’s activities or lifestyle might have contributed to the condition for which 
treatment was being sought.  Unethical behaviour of this kind may raise the 
question of serious professional misconduct.” 
• It is the responsibility of general practitioners to provide general medical services 
for drug misusers. Health Authorities, Primary Care Trusts in England and Wales, 
and Health Boards in Northern Ireland and Scotland all have a duty to provide 
                                                
100 For information see: http://www.nta.nhs.uk/areas/outcomes_monitoring/ 
101 The sample comprised 1075 people seeking treatment for drug abuse problems in 54 
treatment agencies in England. The study uses a longitudinal, prospective cohort design. 
Structured interviews were conducted at treatment intake and at 1-year follow-up. Data were 
collected about illicit drug use (frequency of use of heroin, non-prescribed methadone, 
cocaine and amphetamines, and non-prescribed benzodiazepines) and other problems. 
102 see: 
http://www.nta.nhs.uk/areas/clinical_guidance/clinical_guidelines/cgl_update0607/consultatio
n.aspx  
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treatment for drug misusers, to meet local population needs. This should include 
interventions to reduce drug-related harm such as hepatitis B vaccinations and 
needle exchange provision, together with evidence-based drug treatment. 
• Every doctor must provide medical care to a standard which could reasonably be 
expected of a clinician in his or her position. An increasing number of clinicians 
are trained and supported to provide drug treatment under the terms of a contract 
negotiated with their local commissioners. 
National Institute for Health and Clinical Excellence Guidance  
The National Institute for Health and Clinical Excellence103 (NICE 2007b; 2007c; 
2007d; 2007e) published technology appraisals104 and clinical guidelines105 on a 
number of areas relating to treatment.  
Technology appraisal: buprenorphine and methadone for the management of opioid 
dependence  
This appraisal suggests that methadone and buprenorphine are both appropriate as 
substitute drugs for the management of opioid dependence with the dose varying 
depending on the individual.  Supervised consumption is recommended at least for 
the first 3 months of treatment (NICE 2007b).106 
Technology appraisal: naltrexone for the management of opioid dependence 
It is recommended Naltrexone be used as a treatment option for people who have 
been opioid dependent but who have stopped using opioids, and who are highly 
motivated to stay free from the drugs in an abstinence programme (NICE 2007c).  It 
is suggested that treatment should be for an initial period of 3 months, although 
extended treatment may be necessary.107 
Clinical Guidelines: on drug misuse: psychosocial interventions  
NICE suggests that psychosocial interventions are the mainstay of treatment for 
cannabis and stimulant misuse, and also form an adjunct to treatment for opioid 
misuse (NICE 2007d).  It is suggested that the following interventions may be 
offered: brief interventions, self-help, behavioural couples therapy, cognitive 
behavioural therapy, contingency management and psychodynamic therapy.108 
 
Contingency management, providing incentives, such as access to take home 
medication, for positive patient behaviour is not well developed in the United 
Kingdom (Weaver et al. 2007) and therefore, following the publication of the above 
guidelines the NTA is inviting expressions of interest for demonstration sites to 
deliver a range of contingency management approaches to expand the UK evidence 
base.109 
                                                
103 The National Institute for Health and Clinical Excellence advises on when and how drugs 
and other treatments should be used in the NHS in England and Wales. 
104 Technology appraisals are recommendations on the use of new and existing medicines 
and treatments, based on a review of clinical and economic evidence.  The NHS is legally 
obliged to fund and resource medicines and treatments recommended by NICE's technology 
appraisals. 
105 Clinical guidelines are recommendations by NICE on the appropriate treatment and care of 
people with specific diseases and conditions within the NHS. They are based on the best 
available evidence. While clinical guidelines help health professionals in their work, they do 
not replace their knowledge and skills.   
106 For more information see: 
 http://guidance.nice.org.uk/TA114/guidance/pdf/English/download.dspx  
107 For more information see:http://guidance.nice.org.uk/TA115/guidance/pdf/English  
108 For more information see: http://guidance.nice.org.uk/CG51/niceguidance/pdf/English 
109 See: http://www.nta.nhs.uk/areas/treatment_planning/needs_assessment.aspx  
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Clinical guidelines: drug misuse: opioid detoxification 
NICE suggests that pharmacological approaches are the primary treatment option for 
opioid detoxification, with psychosocial interventions providing an important adjunct.  
Methadone or buprenorphine are recommended as the first-line treatments in opioid 
detoxification; though it is suggested that lofexidine may be considered, particularly 
for people with mild or uncertain dependence (including young people); clonidine and 
dihydrocodeine should not be used routinely in opioid detoxification (NICE 2007e).  It 
is also recommended that ultra-rapid detoxification under general anaesthesia or 
heavy sedation should not be offered.  Recommendations are also given on people 
who misuse benzodiazepines or alcohol in addition to opioids.  Contingency 
management is suggested as the only psychosocial intervention with clear evidence 
for effectiveness as an adjunct to effective detoxification.110  
Draft Guidance on the Commissioning of Young People's Specialist Substance 
Misuse Treatment Services  
The NTA have issued draft Guidance on the Commissioning of Young People's 
Specialist Substance Misuse Treatment Services for consultation.111  The 
commissioning guidance will link guidance on needs assessment and planning of 
young people's specialist substance misuse treatment services, which are currently 
under development by the NTA.  
Young people's substance misuse services receive funding via the young people 
substance misuse partnership grant, which is a pool of budgets from the Department 
of Health, the Department for Children, School and Families, the Home Office and 
the Youth Justice Board.  Funding for 2007/2008 will be €36.2 million.  Where there 
is local need, additional funding for young people's treatment can also be met 
through the pooled treatment budget funding allocated to Primary Care Trusts.112 
Other guidance  
Guidance on needs assessment for adult drug treatment  
The NTA has prepared new needs assessment guidance to assist commissioners 
and local partnerships; included are guidance on treatment mapping, gap analysis 
and understanding unmet need, as well as clarification of the role of assessing need 
within the annual commissioning cycle.113 
Guidance in commissioning Tier 4 services  
Two guidance documents have been published for inpatient services (Tier 4114) by 
the NTA.  One offers guidance for local partnerships on the commissioning of Tier 4 
services, and the second gives guidance and definitions on differing models of 
residential rehabilitation.115   
Guidance on good practice in care planning 
The NTA has also produced guidance on good practice in care planning (NTA 
2007e).  It is suggested that good performance in care planning is influenced by a 
number of factors including: having treatment systems which are responsive to user 
needs; good clinical governance and clinical leadership; effective local forums and 
meetings; integration with criminal justice and other treatment services; access to the 
                                                
110 For more information see: http://guidance.nice.org.uk/page.aspx?o=256685&c=91523  
111 For more information see: 
http://www.nta.nhs.uk/areas/young_people/guidance_commissioning_service_delivery.aspx  
112 See: http://www.nta.nhs.uk/areas/young_people/funding.aspx  
113 See: http://www.nta.nhs.uk/news_events/newsarticle.aspx?NewsarticleID=31  
114 Tier 4 treatment services include inpatient assessment, stabilisation and assisted 
withdrawal services, residential rehabilitation services.  
115 See: http://www.nta.nhs.uk/areas/tier_4/default.aspx  
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full range of drug treatment services; good information sharing protocols; good 
systems for recording, sharing and monitoring care plans; regular audits of care 
planning; and integrated care pathways in place. 
DrugScope guidance  
DrugScope has launched a series of publications under the title of The Essentials, 
aimed at professionals working in the drug treatment sector.  These are: The 
Essential Drug and Alcohol Worker (Morrison 2007); The Essential Service Manager 
(Robinson 2006); and The Essential Drug Service Commissioner (Hanton 2006).  
Models of residential rehabilitation for drug and alcohol misusers 
The draft document Models of residential rehabilitation for drug and alcohol misusers  
was reported in the 2006 UK Focal Point report (NTA 2006).  The final version has 
now been published.  
Wales 
There is a thrust to improve services for drug users in Wales (internal communication 
from Welsh Assembly Government; personal) and key performance indicators have 
been published (see below).  Access, availability and standards of care are key 
priorities of the Welsh Assembly Government and work is being undertaken to 
reduce waiting times and improve the quality of care.  A Treatment Framework is 
being developed, to be updated each year.  By April 2008 there will be a programme 
of external thematic reviews of treatment services to see what is happening in the 
field.  This will be run through the Healthcare Inspectorate Wales. Its aim is to secure 
improvements and consistency and lead to new developments.  
 
Also, the Welsh Assembly Government is currently giving consideration to measuring 
outcomes.  A toolkit, the Wales Integrated Substance Misuse Assessment Toolkit, is 
being piloted in Dyfed Powys based on the NTORS domains.  The use of the TOP 
form (see above) is also to be piloted.  
 
There has been an audit of waiting times for Tier 3 services and there will be one for 
Tier 2 services.  Guidance on good practice with respect to waiting times has been 
issued (internal communication from Welsh Assembly Government).  
 
There is to be a review of Tier 4 services.  Research is currently being undertaken on 
guidance for patient journeys, and there are also questions as to how Tier 4 is 
commissioned.  There will be a national conference to highlight issues in December 
2007. 
 
There is an Action Learning Group looking at unit costs, and Local Health Boards are 
to be asked to account for substance misuse costs separately. 
Key Performance Indicators for substance misuse treatment services in Wales 
Key Performance Indicators (KPI) for substance misuse treatment services in Wales 
are now published and apply to alcohol, drugs and other substances (WAG 2006a).  
These are: 
1. Increase local service capacity. 
2. Reduce the number of incidences of unplanned ending of contact with services. 
3. A waiting time of 10 days between referral and assessment. 
4. A waiting time 10 days between assessment and the beginning of treatment. 
5. Young people referred from a Young Offenders Team (YOT) to receive an 
assessment within five days. 
6. Young people referred from a YOT to have a care plan no later than 10 working 
following assessment. 
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7. Reduce the number of incidences of reported acquisitive crime (defined as those 
listed as “trigger offences” for Drug Testing on Charge areas). The target is to 
achieve a reduction of 15 per cent against the baseline year 2003/04 (linked to the 
Home Office Public Service Agreement  target 1: reduce crime by 15%). 
8. All clients who are injecting to be offered information, counselling, screening and 
where appropriate, immunisation against Hepatitis B.  
 
A new Drug and Alcohol Training Oracle website, sponsored by the Welsh Assembly 
Government, has been set up to increase the use of the Drug and Alcohol National 
Occupational (DANOS) standards in Wales by helping to identify the training needs 
of people working in the substance misuse field and to provide information about 
courses and other training opportunities that are available to help them meet these 
needs. 
Scotland 
In Scotland, widespread political and media attention has been given to the current 
drug treatment system, focused more particularly on the effectiveness of methadone 
as a treatment.  Concerns have, to some extent, been associated with a number of 
high profile incidents involving children such as the death last year of a two year old 
boy who drank his parents’ methadone.  In response, the Scottish Government 
launched a wide ranging review of methadone programmes, which concluded that 
methadone should continue to be the mainstay of the treatment system, but included 
a number of recommendations to improve the quality of treatment (see 5.4.2).  
 
As part of this review, in January 2007 a study of the long-term risks posed to 
Scottish society by drug and alcohol abuse was launched.  The Scottish Parliament's 
Futures Forum is to set out its research plan at a conference looking at ways that 
both illegal and legal addiction is affecting many families and communities.116  As part 
of the debate it has been suggested that methadone programmes have been a 
failure because so few become drug free and only 20 per cent of those prescribed 
methadone do not continue to commit crimes (McKeganey et al. 2006).  In February 
2007, the Association of Directors of Social Work (ADSW) called for a Royal 
Commission to ‘settle’ what they describe as the row over methadone prescribing, 
suggesting that the debate over its use as a heroin substitute had become too 
politicised.117 
 
There is also an interest in alternatives to methadone with funding for abstinence 
based treatment services and research suggesting the use of dihydrocodeine (see 
below).  
National Quality Standards for Substance Misuse Services in Scotland  
The National Quality Standards for Substance Misuse Services have been published 
(Scottish Executive 2007a).  There are 11 standard statements, which set out what 
substance misuse service users can expect from treatment services.  It is expected 
that Alcohol and Drug Action Teams (ADATs) and commissioners will incorporate 
them into their monitoring arrangements.   
Stocktake of Alcohol and Drug Action Teams in Scotland  
The remit of the Stocktake of Alcohol and Drug Action Teams (ADATs) in Scotland 
(Scottish Executive 2007e) was to consider the current performance of ADATs and 
their capability to deliver future Ministerial priorities on drugs and alcohol.  Several 
                                                
116 For more information see: http://www.scottish.parliament.uk/nmCentre/news/news-
07/pa07-049.htm 
117 For more information see: 
http://www.theherald.co.uk/news/news/display.var.1204261.0.0.php 
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fundamental questions were posed: is the partnership approach the best way to 
deliver real improvements in combating substance misuse in Scotland; and, if so, are 
ADATs the best model for this?  The overwhelming conclusion was that a partnership 
approach was essential to address substance misuse effectively in Scotland.  It was 
found that on the whole, ADATs do excellent work tackling some of the most 
challenging and complex societal problems that exist in Scotland today.  However, in 
some there were serious shortcomings, including poor leadership, lack of 
commitment and an insufficient understanding of the strategic aims.   
 
It was recommended that for ADATs to be more effective there must be greater 
clarity about what is expected of them and by whom.  There should also be greater 
clarity and openness about the full extent of local expenditure on measures to 
prevent and reduce substance misuse so that ADATs can channel these resources 
more effectively.  Also, composition and size of ADATs should be reviewed to take 
account of structural changes in the wider public sector environment and 
partnerships which have developed in recent years.  And, support for ADATs should 
be strengthened and at the same time more should be expected of them.  
Performance management should be more robust at national and local levels so that 
all ADATs provide an equitable service.  There should be greater consistency in the 
availability and delivery of local services across Scotland. 
5.2.3 Reviews of the drug treatment system  
Improvement Reviews  
The aim of improvement reviews undertaken by the Healthcare Commission is to 
independently assess the quality of treatment services in each DAAT area to 
facilitate improvements in key aspects of these services.118  The small number of 
organisations (approximately 10%) that receive the weakest assessment are 
provided with help to develop an action plan to improve their performance.  In 
2006/2007 the review assessed systems management and services for reducing 
harm.119 
RSA recommendations on evaluation of treatment  
The independent report by the Royal Society for the Encouragement of Arts, 
Manufactures and Commerce (RSA) (2007) (see Chapter 1.2.4) suggests there 
should be: 
• a greater emphasis on drugs treatment as a health measure, with the demands of 
the criminal justice system exerting a lesser influence on the organisation, pattern 
and provision of treatment; 
• availability of a range of different treatment options; 
• easier access to treatment and more responsive services;  
• better integrated services; 
• more varied and flexible services for black and minority ethnic drug users, for 
women and for stimulant users; 
• better ‘wraparound’ services; 
• a better focused role for the criminal justice system in bringing people into 
treatment; and  
• more humane and realistic ways of measuring the effectiveness of treatment.  
                                                
118 For more information see: www.nta.nhs.uk  
119 See: 
http://www.healthcarecommission.org.uk/serviceproviderinformation/reviewsandinspections/i
mprovementreviews/substancemisuse2006-2007.cfm 
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5.2.4 Funding 
It was announced on 29 January 2007 that the 2007/08 Pooled Drug Treatment 
Budget for England is to increase from €550m to €569m.  In addition, €14.7 million 
capital funding will also be distributed120 and € 79.7 million in capital funding is to be 
made available to increase capacity for inpatient and residential (Tier 4) services in 
England in 2007/08 and 2008/09. 
 
In 2005/06 €97.6 million was invested by the Scottish Government to tackle the drug 
problem across Scotland.  €8.8 million a year was allocated for 2005/06 and 2006/07 
to enable more people to enter treatment.121  Of this, ADATs were allocated €5.8 
million a year to establish or develop existing services aimed at increasing the 
numbers entering treatment, expanding the range of drug interventions and reducing 
waiting times.  The remaining €3 million a year, earmarked for criminal justice 
interventions, was not allocated during 2005/06 and therefore for one year only, €2.5 
million of funding has been allocated towards five abstinence based projects.  
5.2.5 Drug treatment in custody  
See chapter 9.3.1. 
5.2.6 Pilot Treatment Projects / Trials 
The Randomised Injectable Opiates Treatment Trial 
A Randomised Injectable Opiates Treatment Trial (RIOTT) began in 2005; 150 
patients are to be recruited.  Participants receive one of three prescriptions at 
random: injectable diamorphine; injectable methadone and oral methadone.  The trial 
aims to assess the effectiveness of injectable diamorphine and injectable methadone 
treatment in England through a system of daily supervised consumption.  The results 
will be reported towards the end of 2008.  (Department of Health – internal 
communication). 
Pilot study: protocol for a randomised controlled trial comparing dihydrocodeine and 
buprenorphine for opiate detoxification 
Sheard et al. (2007) report on a randomised controlled trial methodology to be 
undertaken to compare the open use of buprenorphine and dihydrocodeine for opiate 
detoxification, given in the context of routine care, within Her Majesty’s Prison (HMP) 
Leeds.122  The primary outcome measure is abstinence status at five days post 
detoxification, as determined by a urine test.  Secondary outcomes during the 
detoxification and then at one, three and six months post detoxification will be 
recorded. The reducing regimen of both dihydrocodeine and buprenorphine (over 
less than 16 days) will be at the discretion of the prescribing doctor.123 
Pilot cluster-randomised trial of adjunctive motivational interviewing to reduce crack-
cocaine use 
Mitcheson et al. (2007) report on a pilot trial to explore the effectiveness of an 
adjunctive single session of motivational interviewing to reduce crack cocaine use in 
                                                
120 See: http://www.drugs.gov.uk/news-events/latest-news/2901?version=1 
121 See: http://www.scotland.gov.uk/News/Releases/2006/10/18152439 
122 Randomisation will be random block size, which will be administered centrally in the 
Academic Department of Psychiatry and Behavioural Sciences, University of Leeds. Opaque 
consecutively numbered envelopes will be prepared. If a prisoner is both eligible and 
agreeable the next envelope will be opened and the intervention allocated. 
123 Also see: Wright, N.M.J., Sheard, l., Tompkins, C.N.E., Adams, C.E., Allgar, V.L. and 
Oldham, N.S (2007) Buprenorphine versus dihydrocodeine for opiate detoxification in primary 
care: a randomised controlled trial. BMC Family Practice, 8 
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a methadone maintenance treatment population.124  It is reported that the intervention 
had a modest, but not statistically significant, impact on one crack cocaine measure.  
However, a large, and statistically significant, reduction in heroin use amongst those 
in receiving motivational interviewing was observed.  The authors suggest that the 
study demonstrated it was feasible to incorporate a psychosocial intervention within a 
busy outpatient methadone maintenance programme and the findings support the 
value of undertaking a larger trial. 
Methadone tolerance testing in drug misusers 
Bakker and Fazey (2006) argue that providing new patients with too low a dose of 
methadone does not eliminate mortality associated with starting treatment and may 
not be sufficient to alleviate withdrawal symptoms, thus discouraging addicts from 
entering or staying on treatment.  They suggest that testing methadone tolerance, 
which uses an initial dose that approximates the patient's usual opioid intake, 
provides a better solution and they describe the rationale behind this method, their 
experience of its effectiveness, and safeguards against methadone toxicity.   
Supervised methadone  
In a study of factors associated with outcome variables for supervised methadone 
(Bloor 2007) it was found that pharmacy supervised methadone schemes were seen 
as positive by the majority of users, pharmacists, prescribers and policy makers.125  
However, the issues of privacy, confidentiality and flexibility were a concern.  The 
study also investigated drug-related mortality in the context of supervised methadone 
consumption schemes and found schemes were associated with a reduction in death 
related to methadone; those methadone-related deaths which did occur were most 
often in association with use of a combination of drugs including benzodiazepines.  
Methadone versus dihydrocodeine: a controlled trial  
Robertson et al. (2006) reported on a study designed to define the efficacy of 
dihydrocodeine as an alternative to methadone in the maintenance treatment of 
opiate dependence.126  The primary outcome measure was retention in treatment. 
Eight secondary outcomes included: total illicit opiate use; reported crime; physical 
health; mental health; injecting drug use; overdoses; selling drugs: and being in 
education or work.  Measures were compared over 42 months follow-up.  No 
significant difference in outcomes was found between randomised groups over time.  
Compliance with randomised treatment differed by randomised group and was 
affected by experiences in custody during follow-up.  Those randomised to 
dihydrocodeine were more likely to switch treatments.  It was concluded that these 
results provide evidence that dihydrocodeine is a viable alternative to methadone as 
a maintenance treatment for opiate dependence.  
                                                
124 Twenty-nine participants were cluster randomised by a clinician to motivational 
interviewing or a crack information control condition as part of treatment as usual. 
125 The project compared four different services which have introduced supervised 
methadone schemes.  The study included the following methodologies: epidemiological study; 
service review and evaluation; structured questionnaires; narratives; semi-structured 
interviews; structured case vignette; focus groups; and quantitative and qualitative analysis.  
Nine hundred users were sent questionnaires (response rate 38.9%); 166 community 
pharmacists (response rate 68.8%); 497 GPs (response rate 26.3%) and 29 specialist 
prescribers (response rate 69%).  Semi-structured interviews were carried out on 14 drugs 
users, six community pharmacists, four GPs and three specialist prescribers.  The number of 
participants in the focus groups were three, four, ten and five respectively. 
126 This was a pragmatic open-label randomised controlled study of patients recommended 
for opiate maintenance treatment to test equivalence of the two treatment options with follow-
up continuing for up to 42 months after recruitment.  Two hundred and thirty-five subjects 
(168 male, 67 female) were recruited. Patients were randomised to receive either methadone 
mixture 1 mg/ml or dihydrocodeine, 30 mg or 60 mg tablets. 
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Pilot projects in Scotland  
In 2006 the Scottish Government funded a number of pilot projects which address 
clients’ wider needs in addition to their addiction and include alternatives to substitute 
prescribing.  These are all being independently evaluated. 
Community based intensive support, Edinburgh - LEAP 
Existing treatment provision within the NHS in Edinburgh is being extended to include 
a 12 week recovery programme, using activities and techniques often used in 
residential rehabilitation, adapted for use in a community setting.  In addition to 
comprehensive healthcare, the treatment provided includes proven interventions 
such as counselling, training in life skills, anger management and grief issues, 
parenting skills and exercise.  There is also provision for aftercare, linked with 
housing services and training and employment services. 
Detoxification and extensive support, Forth Valley – FV-TOX 
Following extensive consultation with drug users in the area, an opiate detoxification 
programme has been extended in Forth Valley based in Alloa, attracting drug users 
for whom maintenance treatment was neither suitable nor desired.  This offers more 
drug users a choice of treatment, and increases the number of clients who can be 
accommodated at any one time.  The treatment involves three stages: preparation; 
detoxification; and support and lasts for an average of 3 months. 
Alternative options for rural drug misusers, Dumfries and Galloway 
Abstinence as a treatment option for rural drug misusers coming from a defined 
geographical area is being piloted.  The programme involves three phases: 
preparation; detoxification; and follow-up support.  While preparatory work and 
clinical supervision will be done through existing services, the project is supplying 
intensive community support required by those who enter.  Outcomes monitored 
include not only the level of abstinence achieved but also other social indicators such 
as housing, employment, education and relationships.  
Additional ‘SMART Recovery’ therapy for released prisoners, Inverness  
An existing peer support regime based on the SMART Recovery Inside Out 
Programme has been in use in Inverness prison for the last four years.  Is being 
extended for prisoners who wish to continue it on release into their communities.  
This pilot links prisoners up via an innovative secure computer system called 
Distance Therapy and a SMS phone service to provide a more holistic, integrated 
and cost effective throughcare plan.  
Intensive support project for female ex-prisoners, Cornton Vale 
This pilot is an additional support mechanism for drug addicted women leaving 
Cornton Vale prison.  It is designed to strengthen the support systems around them 
and help establish and prolong engagement with drug services for a period of up to 6 
months post-release.  It is also helping female ex-prisoners to make and sustain 
connections with existing services such as accommodation providers, money advice 
services, child care and further education/employment services.  Project staff provide 
practical support, exploring behaviours that seek to address difficulties and provide 
non-offending options.   
5.2.7 Other research studies on drug treatment  
Attribution of drug use and model of treatment  
Newham and Davies (2007) looked at attributions of drug use by three groups of 
users, those involved with Narcotics Anonymous (n = 5), those from a residential 
rehabilitation unit (n = 6) and students (n = 12).  The study showed that the two 
former groups gave attributions consistent with addiction, while students gave 
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unstable and controllable attributions.  They suggest than adoption of the attribution 
‘addiction’ can be detrimental, increasing self-assessed powerlessness and creating 
a self-fulfilling prophecy whereby users perceive themselves to not be in control, 
whereas when addicts see themselves as in control, they are better able to prevent 
relapse.  
Drug user involvement in treatment decisions 
Fischer et al. (2007) suggest that whilst user involvement has become a key principle 
in the delivery of health and social care services, implementation is not easy.  Their 
research explores a range of related issues: the nature and extent of involvement; 
the desire for involvement amongst practitioners and service users; likely constraints 
on involvement; and the impact and relative importance of involvement on treatment 
users.127  It found variations in concepts of involvement between clients, referrers, 
agency staff and residential staff and that user involvement can be limited by users’ 
deference to staff expertise.  There were differences in power relations between staff 
and their clients; while many practitioners were highly committed to involving their 
clients in referral decision making, service users’ choice of treatment could be 
constrained by limited resources, administrative procedures and agency policies 
regarding client suitability.  It is suggested that willingness on behalf of staff and 
service users to communicate and negotiate with each other appears to be the 
cornerstone of effective user involvement.  The report contains a number of 
recommendations for facilitating user involvement based on early analyses of the 
data, refined through a closed email Delphi group involving practitioners, 
policymakers and service users.  
‘Treatment experienced’ and ‘treatment naıve’ drug agency clients 
A comparison of drug users entering treatment who had had previous experience of 
treatment and those who had not, found that at treatment intake, the former had 
worse drug use and life problems than treatment novices (Neale et al. 2007a).128  
Multivariate analysis showed that three variables; ever injected, ever overdosed, and 
index type, were independently associated with being treatment experienced rather 
than treatment naive.  It is therefore suggested that new drug treatment clients who 
have a prior treatment history seem particularly likely to need advice and support with 
injection-related problems and overdose prevention.  Also, that prison-based services 
can anticipate more treatment experienced drug users than community-based 
services.  It was concluded that there was no evidence that those who are treatment 
experienced have worse drug use outcomes than those who are not. 
Perceptions and experiences of health and social care professionals 
The aim of the study by McLaughlin et al. (2006) was to explore the perceptions that 
a sample of health and social care professionals have of illicit drug users in Northern 
                                                
127 The research is based on an in-depth investigation of drug service users’ and practitioners’ 
experiences of user involvement in four specialist treatment agencies: two community 
prescribing agencies and two residential rehabilitation centres, in England and Scotland. 
128 The study was based upon the DORIS cohort of drug users entering treatment in Scotland.  
The DORIS study is a prospective follow-up study of a cohort of 1007 individuals starting a 
new episode of drug treatment in Scotland in 2001/2002.  These 1007 drug users were 
recruited from 33 drug treatment agencies located across rural, urban, and inner-city areas of 
Scotland.  Entry criteria for the study were (i) having a primary dependence on illicit drugs; (ii) 
being able to give contact details for follow-up interviews; and (iii) attending one of the study’s 
33 recruitment agencies for the first time ever or for the first time in the last 6 months, 
providing a systematic comparison of treatment experienced and treatment naıve drug users.  
Six hundred and fifty-three clients were interviewed on four separate occasions; at treatment 
intake, 8 months, 16 months, and 33 months, using structured questionnaires.  85.5% (558) 
had had some form of previous treatment, many reporting multiple previous treatments, most 
commonly substitute drugs.  
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Ireland.129  The findings from this study show many of the professionals who 
participated held entrenched negative views of people that use illicit drugs.  These 
same professionals admit to having little knowledge or skills to assist users with their 
problems.  This finding supports results from other studies in the UK that highlighted 
the negativity and paucity of professional preparation to deal with this client group. 
User involvement in the recruitment of staff for drug services 
Foster et al. (2007) report on two case studies of user involvement in the recruitment 
of staff for drug services, suggesting that participation in staff recruitment may be a 
practical and meaningful performance indicator for drug services with respect to user 
involvement. 
Time taken to heroin dependence 
Coomber and Sutton (2007) investigated how rapidly heroin users take to became 
physically dependent130 and suggest that the period from first use to addiction, and 
regular use to daily use, may be longer than many assume.  The range reported 
reliably on the temporal transition from regular use to daily use being from one day to 
six years.  The mean was 7.4 months (221 days) and the median, three months (90 
days).  The data suggest that more frequent initial heroin use resulted in a faster 
transition to feeling dependent.   
How do heroin users spend their spare time? 
Research based on DORIS131 looked at leisure activity amongst heroin users (Neale 
et al. 2007b).132  It was found that 59 per cent (359) had at least one leisure interest 
on entering treatment and 86 per cent (521) had at least one interest 33 months after 
entering treatment.  Sport was the most common interest while others included 
reading, writing, poetry, music and photography.  It is suggested that this research 
provides further evidence that many problem drug users participate in ordinary daily 
activities.  
                                                
129 A survey methodology was used.  Community settings across Northern Ireland were 
accessed.  Focus groups and face-to-face interviews were used as data collection methods.  
Thirty-five health and social care professionals took part in this study. 
130 Information was extracted using quantitative data from their qualitative study of a sample 
of ‘street’ heroin users.  The study comprised individuals who were, at the time of interview, 
dependent—or had recently been—on heroin and had become so in a natural (i.e. not in a 
therapeutic) setting.  Recruitment took place between August 2000 and March 2001 through 
five nonresidential treatment/walk-in drug centres in central and South East London.  Data 
collection took the form of semi-structured interviews and was designed to elicit narratives 
from the participants that explored their transitions from first use through to dependent use. 
Seventy-two users were interviewed. 
131 The Drug Outcome Research in Scotland (DORIS) study is based at the University of 
Glasgow’s Centre for Drug Misuse.  It examines the effectiveness of Scotland’s drug 
treatment services and how evidence of what works can be incorporated into treatment.  The 
researchers have recruited 1,007 drug users who are starting a new drug treatment episode 
from across Scotland. For more information see: 
http://www.gla.ac.uk/centres/drugmisuse/DORIS.html  
132 606 heroin users (70% males; 30% females) were interviewed using structured 
questionnaires at treatment entry and again 33 months later.  Univariate analyses were 
undertaken using chi-square tests and independent t-tests. Multivariate analyses were 
undertaken using stepwise logistic regression. 
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Case reports of conversion from dextromoramide to other opiates within addiction 
maintenance treatment 
In light of interruption to the supply of pharmaceutical opiates (see 5.4.2),133 Strang et 
al. (2006) reported on patients who switched to dextromoramide (an opioid analgesic 
structurally related to methadone and used in the treatment of severe pain).  It was 
found that dose conversion ratios varied greatly between patients, with up to a 
threefold variation.   With no rigid formula for conversion, and in the absence of pre-
existing guidance, wide diversity of practice occurred.  It is suggested that clinicians 
should exercise caution in of the process of dose conversion.   
Remission of psychiatric symptoms after treatment 
Gossop et al. (2006), investigating changes in psychiatric symptoms after 
treatment134 found reductions in a range of psychiatric symptoms, with reductions 
occurring rapidly and maintained at follow-up.   
Developing a method for conducting needs assessments for drug treatment: A 
systems approach 
Best et al. (2007a) reported on a method for analysing the extent of need for drug 
treatment in a local area, based on estimated prevalence of problem drug use and 
treatment uptake.  The aim of the project was to develop a method that could be 
replicated in each DAAT in England to assess treatment need among groups both in 
contact with, and out of, treatment.  Data used were derived from national monitoring 
systems for drug treatment and for drug interventions in the criminal justice system.  
These were used in three areas, supplemented by group work with managers and 
staff from treatment providers, service commissioners and other key informants. The 
analysis led to two types of treatment maps, one an assessment of treatment uptake, 
and the second, a visual representation of service configuration that assessed the 
flow of clients into and through the local drug treatment system.   
5.3 Drug-free treatment 
See NICE clinical guidelines on psychosocial interventions (5.2). 
Evaluations of drug free treatment  
Evaluation of pilot psychostimulant service 
An evaluation of a pilot psychostimulant service, Incite, in Aberdeen, commissioned 
by the Scottish Government suggested that the effectiveness of the project could not 
be verified (Human Factors Analysts Ltd 2007).  
Evaluation of crack cocaine treatment and outcome study: England  
The report of the crack cocaine treatment and outcome study (NECTOS), 
commissioned in 2003 and designed to evaluate a series of established specialist 
crack services, was published in 2007 (NTA 2007f).135  It found that while there was a 
demand for all of the services, there were high rates of attrition prior to assessment 
and at the start of treatment.  The assessment of treatment outcomes undertaken 
                                                
133 The methodology was through case report and clinical audit, we report on the opiate 
switch and dose conversion strategies with 14 patients previously receiving dextromoramide 
(Palfium_) as opiate addiction maintenance treatment. 
134 662 drug –dependent adults recruited at admission to treatment in residential rehabilitation 
programmes, outpatient methadone treatment programmes.  Data were collected by 
structured interview at intake, one month, and six months.  
135 Initially ten specialist crack services were to be evaluated, however two services withdrew 
from the evaluation and subsequently three more services closed.  Therefore, the evaluation 
was conducted in five service settings, four of whom provided Tier 3 (structured community-
based services) day services (two of these services also provided Tier 2 interventions) and 
one service provided Tier 4 residential care and was subject to a separate evaluation.   
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was limited.  However, analysis suggested that among clients who were retained in 
treatment at 30 days and 90 days, there were large and statistically significant 
reductions in both the frequency of crack use and the amount clients spent on crack.  
There were also observed increases in the proportions of clients who were abstinent 
from crack; however, these latter differences were not statistically significant. 
Supervising crack-using offenders on Drug Treatment and Testing Orders 
Turnbull and Webster (2007), in research into treatment services provided to crack-
using offenders given Drug Treatment and Testing Orders, found that the numbers of 
primary crack users who had received a DTTO were low, limiting the ability to identify 
best practice in how to engage and retain crack-using offenders in treatment.  It was 
found that 16 per cent (11/70) completed their DTTOs, compared with a national 
figure of 28 per cent.   
5.3.1 Inpatient treatments  
See reviews of residential rehabilitation and Models of residential rehabilitation for 
drug and alcohol misusers in 5.2 above.   
Review of Residential Drug Detoxification and Rehabilitation Services in Scotland. 
As part of the review of treatment in Scotland, consideration was given to residential 
drug detoxification and rehabilitation services (Scottish Executive 2007f).  This 
included the availability, decision-making processes, use and cost of existing 
residential detoxification and rehabilitation services in Scotland.  Alcohol and Drug 
Action Teams (ADATs) were asked to submit information on their local services.  It 
was found that: 
• there are 352 beds available for drug treatment in Scotland, situated across 22 
services; 
• thirty-one beds are dedicated for use by drug misusers only; most are for drugs 
and / or alcohol misusers; 
• approximately 160 individuals were reported to be on waiting lists; 
• all 22 ADAT areas have support services for clients waiting to enter residential 
treatment, largely specialist community services; and 
• a total of €13.3 million was spent on residential detoxification and rehabilitation 
services in 2005/06.  Of this, 68 per cent (€9m) came from local authority budgets 
while 32 per cent (€4.3m) came from NHS Boards. 
 
The review also found considerable variation as to who ultimately refers and 
authorises funding for a client to enter residential drug treatment, from senior social 
workers to Directors of Public Health.  There is also little communication or 
partnership working between residential and community based services, leading to a 
possible risk of clients being left in limbo between the two.   
Detoxification in Rehabilitation  
Best et al. (2007b) compared self-reported treatment provision in 87 residential 
rehabilitation services in England, 34 of whom (39.1%) reported that they offered 
detoxification services within their treatment programmes.  It was found that although 
there were no differences in self-reported treatment philosophies, residential 
rehabilitation services that offered detoxification were typically of shorter duration 
overall, had significantly more beds and reported offering more group work than 
residential rehabilitation services that did not offer detoxification.  Outcomes were 
also different, with twice as many clients discharged on disciplinary grounds from 
residential rehabilitation services without detoxification facilities.  The authors 
question the United Kingdom classification of residential drug treatment services as 
either detoxification or rehabilitation and suggest that there is a need for greater 
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research focused on the aims, processes and outcomes of this group of treatment 
providers. 
5.3.2 Outpatient treatments  
NO NEW INFORMATION AVAILABLE 
5.4 Pharmacologically assisted treatment  
See section 5.2 regarding opioid detoxification and NICE guidelines on 
buprenorphine, methadone, and naltrexone for the management of opioid 
dependence.  
GP prescribing of opioids to opiate-dependent patients 
A secondary analysis of data collected by the NTA on substitute opioid prescribing, 
first published by Strang et al.136 in 2005, explores various aspects of the previous 
study (Hunt and Strang 2007).  In the original analysis, it was found that there was 
much activity among GPs in relation to both seeing opiate misusers (half of the 
sample) and prescribing (half of those who attended an opiate misuser).  However, 
there are serious concerns, with a widespread lack of confidence among GPs about 
providing services to opiate misusers, geographical variability in the type of 
prescribing, level of shared care involvement and low dose dispensing, and 
widespread extensive reliance on weekly take-home prescriptions.  
 
This secondary analysis found that GPs who were in contact with opiate misusers 
differed demographically to those who did not: doctors who were in contact were 
younger; had been qualified and working as GPs for less time; were more likely to be 
male; and more likely to be working in an urban practice.  The provision of payment 
to GPs for prescribing methadone was associated with greater involvement by GPs 
in seeing opiate misusers; where it was offered, GPs saw on average twice as many 
opiate misusers.  Remunerated GPs rated their services as more appropriate and 
reported feeling more confident.  Nearly 80 per cent of GPs in contact with opiate 
misusers were satisfied to some extent with their local community drug team, 
whereas only just over half of those who did not treat an opiate misuser were 
satisfied.  Among those who saw opiate misusers, those who rated the local 
community drug team (CDT) as either very poor or very good had a higher mean 
patient caseload than those who were more ambivalent to the service. The policies of 
the practice also determined whether GPs prescribe.  GPs were more likely to 
prescribe where there was a policy for the management of opiate misusers, where 
there was a limit on the number of opiate misusers who were patients at the practice 
and where there was a limit on the hours during which opiate misusers can be seen 
by a doctor.   
5.4.1 Withdrawal treatment 
See above (5.2) 
                                                
136 In mid-2001, a ten per cent random sample (3,023) of the 30,000 GPs across England and 
Wales was sent self-completion postal questionnaires; a 66 per cent response rate was 
achieved (1,999 out of 3,023). GPs reported data on whether they had seen an opiate 
misuser in the previous four weeks, whether GPs had prescribed substitute drugs to at least 
one misuser who had been treated in the previous four weeks, prescribing, dosing and shared 
care arrangements. 
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5.4.2 Substitution treatment 
Statistics from the Northern Ireland Substitute Prescribing Database  
Statistics from the Northern Ireland Substitute Prescribing Database (SPD), relating 
to individuals referred up to and including the 31st March 2006, were published in 
October 2006 (DAIRU/DHSSPSNI 2006a).  This is the first bulletin reporting 
information collected on the SPD since it was established in April 2004.  During 
2005/06: 
• 419 individuals were in contact with treatment services; and 
• 77 individuals discontinued treatment. 
 
On 31 March 2006: 
• 284 individuals were receiving substitute medication; 
• 259 of those had been stabilised; 
• the same proportion were stabilised on methadone (48%) and buprenorphine 
(48%), the remainder (4%) were stabilised on dihydrocodeine; 
• 226 had been subject to at least one review; 
• almost a quarter (24%) reported heroin as their main problem drug at review 
stage, compared to more than four in five (83%) when first assessed for 
substitute prescribing treatment; and  
• of those who injected, 16 per cent had injected in the four weeks prior to their 
review, compared to over half (53%) who had injected in the four weeks prior to 
assessment. 
Suboxone launched in United Kingdom 
Suboxone, a combination of naloxone alongside buprenorphine, was launched in 
early 2007 as an alternative treatment to methadone and buprenorphine.  The 
formulation is designed to limit the potential for misuse, as well as lowering its street 
value.  It is used for maintenance treatment of opioid dependence.137 
Continued limited supply of diamorphine  
Limited supply of diamorphine, reported in the previous UK Focal Point Reports, 
continues although there has been substantial improvement.138  
Evaluation of methadone prescribing  
Dickinson et al. (2006) reported on changes in prescribing practice at a specialised 
substance misuse service in the United Kingdom which have occurred since the 
introduction of national guidelines on the management of drug misuse (DH 1999).  
The research explored a possible link between the length of time spent in methadone 
maintenance therapy (MMT) and the dosage prescribed.  It found that the guidelines 
had a measurable effect on prescribing practice.139   
Review of methadone in Scotland 
The following reviews of methadone prescribing in Scotland have been published. 
Reducing harm and promoting recovery: a report on methadone treatment for 
substance misuse in Scotland 
A report from the Scottish Advisory Committee on Drugs Misuse (SACDM) 
methadone group (2007a), aimed at advising ministers on the place of methadone in 
the treatment of substance misuse in Scotland, agreed that methadone replacement 
prescribing remains the main treatment for opiate dependency and should be 
                                                
137 See: http://www.nelm.nhs.uk/Record%20Viewing/vR.aspx?id=575267  
138 See: http://news.bbc.co.uk/1/hi/health/6376713.stm  
139 A retrospective analysis of a computerised prescription database between 1996 and 2002 
obtained from Sheffield Care Trust Substance Misuse Service was performed. 
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available within the framework of services across all areas in Scotland.  This, it is 
suggested, reflects the evidence base which supports its effectiveness in the face of 
little current credible evidence to support other approaches, though it was suggested 
that prescribing could be improved significantly in terms of consistency and quality of 
practice and process of care delivery.   Recommendations included integrating 
methadone replacement prescribing into a coherent planned care package and 
improving accountability, performance management, the quality of information and 
the effectiveness and commissioning of services. 
A review of methadone treatment in Scotland: views of carers and users  
The Scottish Drugs Forum (SDF) were commissioned to consult those directly 
affected by or working in the field of substitute prescribing140 on the use of 
methadone and found only a very small number were critical of it (SDF 2007).  
Otherwise, methadone was identified as helping individuals gain stability and reduce 
the chaos in their lives; improve relationships, including improved ability to care for 
dependent children; improve their financial position; assist with the move into 
training, education and employment; and gain or regain self-respect.  However, it 
was also recognised that the effectiveness and impact of clinical prescribing could be 
significantly improved through the provision of consistent standards of high quality 
care; a needs-led rather than service-led help; co-ordinated services which meet the 
full range of needs; swifter access to services; and increased resources.  Lack of 
consistency and the variable quality of services came out strongly across all those 
consulted.  Also, there was a reported need for services to move away from providing 
the kind of help designed to suit their particular working practices, to one which was 
truly responsive to the individual needs of service users. This was viewed as an issue 
of critical importance in improving the impact of treatment by all those consulted, with 
choice, flexibility and information mentioned consistently. 
Review of Methadone in Drug Treatment: Prescribing Information and Practice 
A further review by the Scottish Executive (2007g) sought information, primarily from 
NHS Boards in relation to methadone prescribing practice.  It was found that in 2006:  
• 22,224 people were receiving methadone treatment for drug misuse in Scotland, 
1,093 of which were in prison;  
• at least 12,236 people were on a daily supervised consumption regime; and  
• at least 6,752 people who receive methadone have children living with them all or 
part of the time.  
 
The review also considered the implementation of national guidelines (DH 1999) and 
local guidelines on methadone prescribing. It found that: 
• despite evidence of local interpretation, national guidelines provide the broad 
basis from which NHS Boards and partner agencies have developed local 
guidance on the clinical management of drug misusers; 
• there is some evidence, however, that policy may not be being implemented in 
practice (e.g. submission of SMR data by GPs); 
• some, but not all Boards have provided evidence that national and local 
guidelines are monitored actively; and 
• methadone is likely to remain the prescribers’ drug of choice for maintenance 
therapy for some time; only four Health Boards currently offer buprenorphine as 
an alternative to methadone for maintenance prescribing. 
                                                
140 The views of 250 individuals were taken into consideration 
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The effect of national guidelines on substitute prescribing in England 1995-2005 
A study by Strang et al. (2007a)141 found that positive changes in prescribing for 
opiate addiction had occurred in six out of the seven United Kingdom national 
guidelines issued between 1995 and 2005.  This included greater numbers of opiate 
prescriptions; the increased use of buprenorphine as an opiate substitute; higher 
dose methadone prescribing; a large increase in methadone prescribed in oral 
linctus/syrup formulation, more frequent dispensing; and a larger proportion of 
supervised methadone consumption.  The only negative change in relation to the 
increased involvement of GPs was that the proportion of opiate prescriptions to 
opiate patients from GPs fell from 41 per cent in 1995 to 30 per cent in 2005, 
although there was a 50 per cent increase in patients receiving methadone 
prescriptions from GPs. 
The impact of advanced substance misuse training on GPs’ attitudes, behaviour and 
knowledge 
Strang et al. (2007b) reported on a randomised trial to discover the difference that 
advanced training in drug misuse makes for GPs in England142.  Using a control 
group of general practitioners on the waiting list for training, the study found greater 
improvements in attitudes and behaviour amongst the group assigned a training 
place although only ‘role security’ and ‘situational constraint’ reached statistical 
significance.  A further analysis, undertaken after a subgroup of the control group 
managed to secure training outside of the trial allocation, found that those who had 
attended training showed markedly greater improvements in knowledge, attitudinal 
and prescribing confidence measures and remained more actively involved in 
treating drug misusers than GPs who remained on the waiting list.  
5.4.3 Other medically assisted treatment 
Neuro-Electric Therapy (NET)  
Neuro-Electric Therapy (NET) has been promoted in Scotland recently with television 
programmes following twelve patients, six men and six women, undergoing a week of 
therapy.  The study involving the six men was terminated when it was discovered that 
they had been able to smuggle heroin into the study location.  Five of the women  
were still off drugs a few weeks later.  Promoters of NET have explored the possibility 
of conducting a larger trial with the Scottish Government and others.  Discussions 
have focussed on the need to ensure that evidence of effectiveness is gathered in a 
scientifically credible fashion.143 
                                                
141 A repeat national survey (1995 and 2005) using random one-in-four samples of all 
community pharmacies in England, 1,847 (75% response rate) in 1995 and 2,349 (95% 
response rate) in 2005. Data were obtained on 3,732 (1995) and 9,260 (2005) prescriptions 
dispensed in the preceding month from the 936 and 1,463 pharmacies who were currently 
dispensing. 
142 A two-group randomised trial with training and waiting list control comparison.  The trial 
comprised of 112 GPs working in primary care practices in England who applied for an over-
subscribed, Department of Health funded place on the 6-month Certificate –level training 
course on Drug Misuse from the Royal College of General Practitioners.  GPs were randomly 
assigned to each group with 63 in the training group and 49 in the waiting list control group.  
An initial questionnaire on attitudes, prescribing practices and behaviour was completed by 
both groups before random allocation. After six months a knowledge questionnaire was 
completed on the first day and last day of training for those in the training group and at a 
similar time by post by the waiting list group.  A subgroup of the waiting list group secured 
funding from elsewhere and attended the course and subsequently, further analysis was 
undertaken on this group. 
143 See:http://www.scottish.parliament.uk/business/pqa/wa-06/wa0707.htm and  
http://scotlandonsunday.scotsman.com/index.cfm?id=262972007 
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6. Health correlates and consequences 
6.1 Overview 
The United Kingdom submits two sets of tables to the EMCDDA based on each of 
three definitions of drug-related death (DRD); each is slightly different.  The 
EMCDDA definition refers to those deaths that are caused directly by the 
consumption of one or more illegal drugs and generally occurring shortly after the 
consumption of the substance(s)144.  The definition used by the Office for National 
Statistics (ONS) was established earlier and so provides the longest time series, but 
is a much wider definition than that used by the EMCDDA and includes legal 
drugs.145  DRDs, according to the United Kingdom Drug Strategy, are where the 
underlying cause is poisoning, drug abuse or drug dependence and where any of the 
substances scheduled under the Misuse of Drugs Act 1971 were involved.  This 
definition has been adopted by the General Mortality Registers (GMRs) across the 
United Kingdom.  The Drug Strategy definition is a subset of the ONS definition, with 
the main differences lying in the fact that only controlled drugs are identified. 
 
Based on General Mortality Registers (GMR), DRDs in the United Kingdom rose 
steadily from 1996 until 2000, then fell until 2003, but have since risen.146  However, 
the most up to date data, from the Special Mortality Register (SMR), for 2006 shows 
a fall from the previous year.  Males are more likely to suffer DRDs than females, by 
over 4:1 with the difference closing over the last decade.  Overall, the average age at 
death fell in 2001 and 2002 to 34.0, rising in 2003, 2004, and again in 2005 when it 
was 36.4 years.  Males were approximately four years younger than females at death 
(35.6 years and 39.9 years respectively).  Males are more likely to die at a younger 
age of accidental poisoning, drug dependence, or non-dependent abuse of drugs, 
and females by means of intentional/undetermined poisoning.  Most deaths are 
associated with opiates, chiefly heroin/morphine and methadone, often in 
combination with other drugs and/or alcohol.  Mentions of opiates and morphine rose 
by seven per cent in 2005.  In Scotland, diazepam is more likely to be involved than 
elsewhere in the United Kingdom; for example, in 2005 it was involved in 27 per cent 
of DRDs.   
 
Data from the SMR show that most male accidental poisoning and overdose deaths 
occur amongst young age groups who consume illicit drugs, whereas typically it is 
older females who overdose deliberately on antidepressants and (opioid) analgesics.  
Those who have a history of drug use/abuse die from a drug-related death at a much 
                                                
144 These deaths are known as 'overdoses', 'poisonings' or 'drug-induced deaths'.  This 
definition was agreed by the EMCDDA group of national experts: see methodological notes 
'Drug-related death EMCDDA definition' in the 2005 statistical bulletin and DRD standard 
protocol v3.0.   
145 The ONS definition uses ICD-10 codes equivalent to F11-F16, F18, F19, X40-X44, X60-
X64, Y85, Y10-Y14 from 2000, prior to that IC9 codes 292, 304, 305.2-9, E858-8, E950.0-.5, 
E980.0 -.5, E962.0. 
146 There are two main types of source in the UK for information on 'acute' deaths: three 
General Mortality Registers (GMRs - the General Register Offices for England and Wales 
(GRO), Scotland (GROS), and Northern Ireland (GRONI)) and one Special Mortality Register 
(SMR - the National Programme on Substance Abuse Deaths or np-SAD) based at St 
George’s Hospital Medical School, University of London.  The General Mortality (GMR) data 
are derived from medical death certificates.  Whilst the GMRs for England and Wales, and 
Scotland have established special databases to monitor DRDs, this has not yet happened in 
Northern Ireland.  The UK-wide use of ICD-10 in coding DRDs provides consistency in 
approach.   
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younger age than those without such a history.  However, the average age at death 
(of whatever cause) of drug addicts has risen over time (from 31.2 years in 1997 to 
35.4 years in 2006).  Between two-fifths and a half of those who die are unemployed.  
Two-fifths live alone, and about one in twenty has no fixed abode. Socio-economic 
determinants play a large part in the geographical distribution of DRDs both 
nationally and locally.  There are differences in the types of drug and mode of 
administration, not only between but within regions. 
 
HIV147 prevalence among injecting drug users (IDUs) in the United Kingdom has 
been at around one per cent since the mid-1990s, although in London it has been 
higher, at or near, four per cent.  There is emerging evidence that suggests a 
possible increase in transmission in recent years. There were an estimated 2,000 
people living with HIV infection acquired through injecting drug use in 2004, of whom 
600 were thought to be undiagnosed.  Prevalence of hepatitis C (HCV) has been 
much higher at around 40 per cent of IDUs, and there is evidence of increased 
incidence.  Prevalence of antibodies for hepatitis B (anti-HBc) declined in the early 
1990s, and has levelled off at around 20 per cent.  Outbreaks of other infections 
among IDUs have been increasingly declared,148 following reported increases in 
injecting risk behaviour.  Data for 2006 suggests that prevalence remains stable, 
though HIV is slightly lower than in the previous year, when it increased a little, but 
prevalence remains higher than it was in 2000.  There has been little change in the 
prevalence of hepatitis C in the last year, however, prevalence is again higher than at 
the beginning of the decade. 
 
Prevalence and attribution of dual diagnosis remain difficult to estimate.  Depression, 
anxiety disorders, personality and psychotic disorders are commonly reported, 
although prevalence varies with setting and specific sub-populations.  It has been 
suggested that from 1993 to 1998 there were at least 195,000 co-morbid patients 
and 3.5 million general practitioner (GP) consultations involving such patients in 
England and Wales.  The level of co-morbidity is increasing at a higher rate among 
younger patients, which indicates that co-morbidity may increase in future years. 
Approximately one-third of psychiatric discharges involve a supplementary rather 
than a main diagnosis of drug use.  In these cases, the most common diagnoses 
were schizophrenia, mood (affective) disorders and alcohol misuse.  
                                                
147 Data on the prevalence of blood borne infectious diseases amongst injecting drug users 
(IDUs) are provided by a number of sources.  The Unlinked Anonymous Prevalence 
Monitoring Programme’s (UAPMP) surveys of IDUs in contact with drug services in England, 
Wales and Northern Ireland (Hope et al. 2001; Unlinked Anonymous Steering Group 2002); 
the Centre for Research on Drugs and Health Behaviour’s surveys of IDUs recruited from 
community settings in England (Hunter et al. 2000); and the Scottish Centre for Infection and 
Environmental Health's (SCIEH) surveys of IDUs attending community and drug agency 
settings in Glasgow (Taylor et al. 2000).  SCIEH also holds anonymous epidemiological data 
on all those who have had a named HIV antibody test in Scotland since 1989 (on the HIV 
Denominator Database).  All collect behavioural data and oral fluid for testing for antibodies to 
hepatitis C (anti-HCV).  The main sources of information on newly diagnosed HIV/AIDS 
infections are from voluntary cases reporting from laboratory reports of newly diagnosed 
infections by microbiologists and clinicians.  For England, Wales and Northern Ireland, reports 
are made to the Health Protection Agency’s Communicable Disease Surveillance Centre 
(CDSC) whilst new diagnoses in Scotland are reported to Health Protection Scotland.  
Laboratory report data for England and Wales, Scotland, and Northern Ireland are available 
from the following websites: http://www.hpa.org.uk for England and Wales; 
http://www.hps.scot.nhs.uk/ for Scotland; and http://www.cdscni.org.uk for Northern Ireland.  
148 Methicillin resistant Staphylococcus aureus (MRSA) as a cause of IDU-related sepsis 
(CDR Weekly 2003) and other serious Clostridial infections acquired through contaminated 
drugs have been reported (Jones et al. 2002; McGuigan et al. 2002). 
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Evidence of the extent of other physical health problems associated with problem 
drug use149 are not readily available.  In January 2007, the Department of Health 
issued a health warning after reports of herbal or skunk cannabis contaminated with 
small glass beads came to light.150  It was suggested that whilst the exact potential 
health harm from this contamination is not yet fully determined, inhaling hot glass into 
the mouth, throat, or into the lungs should clearly be avoided.  This was updated in 
May 2007151, suggesting contaminated cannabis is found in approximately 5 to10 per 
cent of herbal cannabis seizure cases examined by the Forensic Science Service.  
 
The impact of maternal drug use on unborn children is well known as is the fact that 
babies are affected by withdrawal from maternal drug use.  In the United Kingdom, 
there is little evidence of HIV transmission to babies through maternal infection 
specifically associated with drugs, but there is a risk of hepatitis transmission, 
particularly HCV, where the risk of transmission amongst babies whose mothers test 
positive is six per cent.  
6.2 Drug related deaths and mortality of drug users 
6.2.1 Direct overdoses and indirect drug-related deaths 
Using the EMCDDA definition of drug related death, the total number of deaths in the 
United Kingdom in 2005 was 1,827 (Figure 6.1), an increase of six per cent since 
2004 (1,721).  The number of deaths per 100,000 population was 3.03.  Differences 
exist between parts of the United Kingdom; in Scotland the rate was 7.30, in England 
and Wales 2.68 and in Northern Ireland 1.51.  
Figure 6.1: Number of deaths using EMCDDA DRD standard definition by country, United 
Kingdom, 1996-2004 
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Source: Compiled by J Corkery with data obtained from General Mortality Registers 2007 
 
                                                
149 These includes thrombosis, blood clots and gangrene as well as health problems that are 
associated with problem drug users’ lifestyles including poor diet. 
150 See: 
http://www.info.doh.gov.uk/doh/embroadcast.nsf/vwDiscussionAll/297D9740D0412C9D80257
2650050A4A0?OpenDocument 
151 See: 
http://www.info.doh.gov.uk/doh/embroadcast.nsf/vwDiscussionAll/B62F8B2DD75DEA088025
72DE0036E4FF 
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The slightly different United Kingdom Drug Strategy definition, which measures the 
impact of the strategy, shows the number of deaths in 2005 was 1,979, higher than 
the EMCDDA definition.  The total number of deaths in 2005 using the ONS definition 
was 3,301, a fall of 2.7 per cent the previous year (3,392); 2004 saw a rise in deaths 
having steadily fallen since 2001 (ONS 2007).  Differences between the three 
definitions are shown in Figure 6.2. 
 
Figure 6.2: Comparison of total number of deaths using three definitions, United Kingdom 
1996 – 2005 
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
1996 1997 1998 2000 2001 2002 2003 2004 2005
ONS ‘Standard’ 
EMCDDA DRD
Uk Drug Strategy 
 Source: Compiled by J Corkery with data obtained from General Mortality Registers 2007 
Age and Gender  
Based on the EMCDDA definition, 79.6 per cent (1,454) of deaths involved males 
and 20.4 per cent (373) females.  The average age of those dying in 2005 was 36.4 
years (SD 11.2), with males (35.6 years, SD 11.2) tending to be about four years 
younger than females (39.9 years, SD 15.4) (Figure 6.3).  Age of death is therefore 
continuing to increase over time (35.6 in 2004).  Age at death tended to be higher in 
Northern Ireland than in the rest of the United Kingdom.  Overall, the highest number 
of deaths occurred in the 30-34 age group; this was true for both males and females.  
In Scotland, however, the average age was higher.  Figure 6.3 shows the number of 
deaths by age group and gender. 
Figure 6.3: Deaths by age and gender United Kingdom, 2004: EMCDDA definition  
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Drugs mentioned on death certificates in the United Kingdom  
Most deaths continue to be associated with opiates (chiefly heroin/morphine and 
methadone), often in combination with other drugs and alcohol.  Table 6.1 shows that 
mentions of heroin and morphine on death certificates increased by 6.7 per cent in 
2004, having declined between 2002 and 2003.  There was also an increase in 
mentions of cocaine (by 14.5%) and ecstasy (by 15%). Methadone deaths remained 
stable.  
Table 6.1: Drug mentions on death certificates in the United Kingdom, 2002 to 2005 
Drug   Year   
 2001 2002 2003 2004 2005 
Heroin/ Morphine 1,204 1,120 873 980 1,046 
Methadone 314 297 289 300 293 
Cocaine 117 160 158 193 221 
Ecstasy 102 114 98 99 114 
Diazepam 284 357 286 222 206 
Temazepam 103 92 106 87 55 
Source: Compiled by J Corkery with data obtained from General Mortality Registers 2007 
DRD in Scotland 2006  
Numbers of deaths in 2006 is available for Scotland only.  Figures published by 
GROS (2007) show that DRDs in Scotland rose to record levels in 2006 (to 421 from 
336 in 2005). Most of this was accounted for by heroin/morphine, although there was 
also an increase in the mentions of methadone.  By contrast, there was a fall in the 
number of deaths in which cocaine was mentioned.  Most of this increase occurred in 
the Greater Glasgow and Clyde NHS Board area. 
6.2.2 Special Mortality Register: The National Programme on Substance Abuse 
Deaths (np-SAD)  
Data from the SMR (np-SAD) database are broadly consistent with those from ONS. 
The np-SAD Annual Report for 2007 (Ghodse et al, 2007) shows that in 2006: 
• there was a decrease of about one per cent over number of recorded by the 
same sources for 2005 (from 1,382 to 1,366); 
• the demographic profile remains consistent with previous reports. The majority of 
cases were males (76%) and under the age of 45 years (71%), and White (96%); 
• about two-thirds of cases had a history of drug abuse or dependence and on 
average, death was 14 years earlier than for those without such a history (this 
was the case throughout the period 1997 to 2006); 
• seventy per cent of cases died in a defined residential address, 23 per cent in 
hospital, and seven per cent elsewhere (e.g. a public place); 
• forty-eight per cent of those who died were unemployed.  Forty-three per cent 
lived with others, compared to 42 per cent who lived alone, whilst four per cent 
were of no fixed abode; 
• opiates/opioids (i.e. heroin/morphine; methadone; other opiates/opioid 
analgesics), alone or in combination with other drugs, accounted for the majority 
(68%) of fatalities.  Heroin/morphine alone or in combination with other drugs, 
accounted for the highest proportion (46%) of fatalities. 
• deaths involving methadone were more likely to be the result of illicit rather than 
prescribed drugs (62% or more); 
• there was an increase in the number of cases involving methadone from 198 to 
217;  
• the proportion of cases involving methadone increased from 12 per cent to 17 per 
cent; 
• the proportion of cases involving alcohol-in-combination increased from 26 per 
cent to 32 per cent; and 
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• the proportion of cases involving heroin/morphine decreased from 46 per cent to 
44 per cent. 
6.2.3 Death associated with Volatile Substance Abuse  
There were 45 deaths associated with Volatile Substance Abuse in 2005 (47 in 
2004).  This is the lowest figure since 1981 and compares with the all-time peak of 
152 in 1990 (Field-Smith et al. 2007).  
6.2.4 AIDS 
Deaths of IDUs (including IDUs who have sex between men) with AIDS accounted 
for 8.4 per cent (1,333/15,914) of the total number of AIDS deaths in England and 
Wales up to the end of March 2007. In Northern Ireland the figure was 5.1 per cent 
(4/79), but in Scotland it was 51 per cent (718/1,408).  The decline in the number of 
deaths of IDU with AIDS seen in recent years has levelled off.  The United Kingdom 
figure of 69 for 2005 (63 in 2004) is about 33 per cent of the peak level in 1995 (212).  
By the end of March 2007, 46 deaths had been reported for 2006; the number is 
likely to increase. (Personal communication to John Corkery from Health Protection 
Agency, 8 May 2007) 
6.2.5 Mortality and causes of deaths among drug users  
The National Treatment Agency (NTA) studies on DRD  
The NTA has recently published a series of studies of drug-related deaths and 
methods of investigating them.  Oliver et al. (2007a) used a matched case-control 
design to estimate the relative risk of fatal opioid overdose associated with 
benzodiazepine and cocaine use.  A group of individuals who died from a heroin 
overdose (the cases) were matched on age and gender to a similar group of living 
heroin users (the controls). They then compared each pair’s recent use of 
benzodiazepines and cocaine using urinalysis data.  A parallel study was conducted 
for methadone overdose fatalities.  Three hundred and fifty heroin-related cases were 
randomly selected, together with all 260 methadone-related ones, from a database 
held by the University of Sheffield containing toxicological findings from around 1,300 
opioid-related deaths occurring throughout England and Wales during 1991–2004.  
Two control groups were obtained from the Sheffield Primary Care Clinic for Drug 
Dependence (PCC).  The control group for the heroin overdose fatalities were 
patients who had recently been referred for assessment, while the control group for 
the methadone overdose cases were a group of methadone maintenance patients 
who had been in treatment for at least three months.  The findings support the status 
of benzodiazepine use as a significant risk factor for opioid overdose, especially for 
methadone-related death in which a near ten times increase in risk of fatal overdose 
was observed.  Benzodiazepines appear to have the potential, in terms of 
pharmacological interaction, of increasing the respiratory depressant effects of 
opioids.  The use of cocaine by opioid-dependent individuals is widespread and has 
previously been associated with poorer treatment outcomes, more chaotic drug use 
and more severe psychopathologies. Despite this, positive cocaine detections are, in 
comparative terms, rarely seen in fatal opioid overdoses.  
 
In another study, Oliver et al. (2007b) examined 15,000 toxicology reports produced 
by the Department of Clinical Chemistry at the Royal Hallamshire Hospital Sheffield 
for various coroners throughout England and Wales, covering the period between 
1991 and 2004.  A database search resulted in 1,586 potential heroin cases and 553 
potential methadone cases.  Levels of methadone and heroin in the blood, along with 
levels of associated drugs, were extracted.  Alcohol was the most commonly 
detected substance in heroin-related fatalities, found in approximately 50 per cent of 
cases, followed by diazepam (34%) and temazepam (13%).  Over 75 per cent of 
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heroin fatalities involved one or more of these substances, with 37 per cent involving 
at least one benzodiazepine.  During the last ten years this pattern has remained 
fairly stable with the exception of temazepam, which after peaking in 1995 has 
reduced in recent years.  In cases of methadone overdose, diazepam was the most 
commonly detected drug (44%), followed by alcohol (33%), morphine (28%) and 
temazepam (21%).  
 
The purpose of a study undertaken by Oliver et al. (2007c) was to adapt and 
describe the psychological autopsy methodology to investigate the psychosocial 
antecedents of opiate misuse deaths both as a research tool and as a standardised 
method for services to investigate such fatalities. A case-control study was 
conducted in which data from a control group of living heroin users, recruited from 
local drug services, were compared to opiate overdose decedents in order to identify 
psychological and social risk factors associated with fatal opiate overdose.  Cases for 
the study were a consecutive sample of individuals who died from an acute non-
deliberate, opiate-related overdose and on whom an inquest was held between April 
2004 and May 2005 at the two South Yorkshire coroners’ courts.  During the study 
period 32 opiate-related inquests took place at the two coroner’s courts.  Of these, 26 
fulfilled the criteria for study inclusion.  Being in a relationship was a protective factor 
for fatal non-deliberate opiate overdose; 87 per cent of cases were single compared 
to 33 per cent in the control group.  More generally, a higher proportion of cases lived 
alone and experienced an isolated or disrupted social network.  The majority of the 
study group met ICD-10 criteria for substance misuse; however, more individuals 
fulfilled these criteria in the control group (93% compared to 64%).  This suggests 
that some of the overdose fatalities were less experienced users and that incomplete 
tolerance or opiate naivety played a role, though the selection of the control group 
from predominately treatment settings may also be relevant.  Overdose fatalities 
were more likely to have been currently diagnosed with a mental health problem and 
be in receipt of a prescription for psychoactive medication.  Despite this, following the 
psychological autopsy interview there was little difference between those who died 
and the control group with respect to meeting the criteria for an ICD-10 psychiatric 
diagnosis not related to substance misuse. 
The relationship between fatal poisonings and other factors 
Morgan et al. (2006a) examined the relationship between fatal poisonings in England 
and Wales from heroin and methadone; seizures of illicit heroin and diverted 
methadone; methadone prescriptions and treatment provision between 1993 and 
2004.  Direct age-standardised mortality rates for males were similar for both drugs, 
increasing from approximately five to 15 per million.  Mortality rates for heroin 
continued to increase until 2000, subsequently decreasing from 30 to 20 per million 
by 2003, and rising again to 24 per million in 2004.  In contrast, mortality rates for 
methadone decreased between 1997 and 2004 to just above 1993 levels.  Among 
females the mortality rate for both drugs was lower than for males throughout the 
study period, remaining relatively stable.  Methadone deaths per 1000 patient years 
remained similar between 1993 and 1997, after which they fell by three quarters.  For 
both heroin/morphine and methadone, deaths were strongly associated with 
seizures. 
Supervised consumption of methadone  
Bloor (2007) lead a study into the practice of supervised consumption of methadone 
in Staffordshire and Shropshire, exploring the beliefs and attitudes of professionals 
involved and also those of services.  All respondent groups believed supervised 
methadone reduced the amount of illicit methadone.  There was no consensus on the 
effectiveness of supervised methadone in reducing drug-related deaths other than 
those directly related to methadone. The majority of users saw supervised 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 93
methadone in a positive way.  Data from Staffordshire and Shropshire showed that, 
in the 3 years since introduction of supervised methadone, there have been no 
methadone-related deaths in the treatment population, compared to four in the three 
years prior to supervised methadone and ten in the three years prior to that.  The 
National Programme on Substance Abuse Deaths (np-SAD) database was used to 
provide data on deaths for the North Staffordshire and Shropshire areas.  The 
available data for 1999 to 2003 did not show any fall in drug-related deaths following 
the introduction of supervised methadone.  Analysis of the deaths due to drug toxicity 
in patients known to treatment services in Staffordshire and Shropshire showed that 
the majority were males (93%) and that the mean age of the group at death was 27.6 
years.  Deaths related to methadone were more likely to occur at weekends (42.8%) 
compared with death from other drugs (22.7%). 
Daily patterns of death 
Morgan et al. (2006b) examined the daily pattern of deaths in 3,098 cases in England 
and Wales between 1993 and 2003 where methadone was mentioned on the 
coroner's certificate of death registration after inquest.  Initially, there was a marked 
excess of deaths occurring on Saturdays.  The rate of decline from 1997 was 
greatest for deaths occurring on Saturdays.  As a result, the Saturday peak 
disappeared. 
The pharmacological, epidemiological, clinical and social issues related to smoking 
methamphetamine 
Schifano et al. (2007) recently commented on the pharmacological, epidemiological, 
clinical and social issues related to smoking methamphetamine as opposed to either 
its injection or ingestion.  Furthermore, they provided data related to 
amphetamine/methamphetamine consumption, treatment demand, seizures, related 
offences and deaths in the United Kingdom (1990-2002).  Peak rates for most 
indicators were reached at the end of the 1990s, declining in the following years.  
The only indicator which did not show a decline was the number of deaths, an issue 
possibly related to a more general increase in stimulant death rates recently 
observed in the United Kingdom. 
Audit of 148 drug overdose deaths involving heroin, methadone, dihydrocodeine, 
cocaine, amphetamine or MDMA 
Hickman et al. (2007a) carried out an audit of 148 drug overdose deaths (involving 
heroin, methadone, dihydrocodeine, cocaine, amphetamine or MDMA) investigated 
by London coroners during 2003.  Poly or multiple drug use was detected in the 
majority of deaths (with at least 69 different combinations), including 66 per cent for 
heroin and 42 per cent for cocaine.  Six categories of death were identified: involving 
an opiate (100, 68%); cocaine (14, 9%); other controlled drug (five, 3%); mixed drug 
overdose (18, 12%); other prescribed drug (five, 3%); and other causes (seven, 5%).  
A witness was present and the death was not instantaneous in 92 (61%) cases, 
although evidence in the coronial file suggested that in the majority of cases the 
overdose went unnoticed until too late to intervene.  In all, 15 (one in 10) of the 
deceased were released from prison within 3 months of death; and 37 (one in four) 
were reported to be receiving a methadone prescription.  
Paracetamol poisoning  
Paracetamol poisoning is the leading cause of acute liver failure in the United 
Kingdom.  The government introduced legislation in 1998 limiting the pack size of 
paracetamol sold in shops.  Several studies have reported recent decreases in fatal 
poisonings involving paracetamol. Morgan et al. (2006a) calculated directly age-
standardised mortality rates for paracetamol poisoning in England and Wales from 
1993 to 2004.  There were about 2,200 deaths involving paracetamol.  The age-
standardised mortality rate rose from 8.1 per million in 1993 to 8.8 per million in 
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1997, subsequently falling to about 5.3 per million in 2004.  After the regulations were 
introduced, deaths dropped by 2.69 per million (p = 0.003).  Trends in the age-
standardised mortality rate for paracetamol compounds, aspirin, and antidepressants 
were broadly similar to paracetamol, increasing until 1997 and then declining.  Non-
drug poisoning suicide also declined during the study period, but was highest in 
1993.  Segmented regression models showed that the age-standardised mortality 
rate for compound paracetamol dropped less after the regulations (p = 0.012) but 
declined more rapidly afterward (p = 0.031).  However, age-standardised rates for 
aspirin and antidepressants fell in a similar way to paracetamol after the regulations.  
Non-drug poisoning suicide declined at a similar rate to paracetamol after the 
regulations were introduced.  The question still remains as to whether the decline in 
paracetamol deaths was due to the regulations or was part of a wider trend in 
decreasing drug-poisoning mortality.  The authors found little evidence to support the 
hypothesis that the 1998 regulations limiting pack size resulted in a greater reduction 
in poisoning deaths involving paracetamol than occurred for other drugs or non-drug 
poisoning suicide. 
The role of substance use in non-drug related deaths  
A study of individuals in contact with drug treatment services in 2003/04 showed that 
103 (0.4%) were confirmed as having died during the year152. The majority of these 
deaths (70.6%) were classified as non-drug related within current definitions. 
However, the main cause of death was the likely result of substance use in two-thirds 
(65.3%) of non-drug related deaths.  These causes of death included 16 deaths due 
to infection (seven of which were various forms of pneumonia), seven due to alcohol 
related liver disease and at least seven through intentional self harm, in addition to 
individual cases of cellulitis, deep vein thrombosis, cerebral and myocardial 
infarctions, asthma and volatile substance inhalation.  Those classified as dying from 
non-drug related deaths were significantly older than those within the category of 
drug related deaths (p = 0.004).  The study concludes that significant numbers of 
drug users die due to poor health as a direct or indirect result of prolonged drug use. 
Not only are these deaths not included within current drug related death statistics but 
in some cases, these deaths are potentially preventable (Beynon and McVeigh 
2007).  
6.3 Drug-related infectious diseases 
Information on infectious disease is based on Shooting Up: Infections among 
injecting drug users in the United Kingdom 2006 (HPA et al. 2007).  
6.3.1 HIV 
The overall prevalence of HIV seen among IDUs in 2006 was similar to that seen in 
recent years, and remains higher than that seen in the late 1990s.  The Unlinked 
Anonymous Prevalence Monitoring Programme (UAPMP) survey of current and 
former IDUs in England, Wales and Northern Ireland indicates an overall HIV 
prevalence of 1.3 per cent in 2006.  In London, the prevalence was four per cent, 
whilst elsewhere in England it was 0.66 per cent.  Combining data for 2005 and 
2006, the prevalence of HIV infection among IDUs in the UAPMP agency survey in 
Northern Ireland was 1.9 per cent and in Wales was 1.1 per cent.  
                                                
152 A cross-sectional study of 27,810 individuals in contact with drug treatment services in the 
North West of England during 2003/04.  Death certificates, verdict of the inquest (where 
appropriate) and causes of death (in accordance with the World Health Organization 
International Classification of Disease Register version 10 were provided by the Office of 
National Statistics for 103 drug treatment clients that were confirmed as having died in 
2003/04. 
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In Scotland, the prevalence of HIV among IDUs is monitored through the surveillance 
of people undergoing voluntary confidential HIV testing.  This found a HIV prevalence 
of 0.79 per cent among IDUs undergoing testing during 2006; this compares with 
prevalences of 1.4 per cent to 3.2 per cent in the early to mid-1990s and 0.5 per cent 
to 0.9 per cent during the period 1998 to 2005. 
 
The annual number of HIV diagnoses among IDUs in recent years has been low and 
relatively stable, at an annual average of 140 reports during the period 1998 to 2006.  
By the end of June 2007, 156 HIV diagnoses, where infection was thought to have 
been acquired through injecting drug use, have been reported in the United Kingdom 
for 2006 (72 in London, 16 in Scotland, and 68 elsewhere).  This figure is like to rise 
further as further reports are received for 2006.  Of the 156 new diagnoses in 2006, 
probable country of infection was reported for 67 per cent (104).  Where reported, 52 
per cent (54) of infections were probably acquired within the United Kingdom and 48 
per cent (50) outside of the United Kingdom, mostly in Southern Europe. 
 
In 2006, 1,038 HIV-infected IDUs were seen for HIV-related treatment or care in 
England, Wales and Northern Ireland, a 19 per cent increase since 2000 when 870 
IDUs were seen for care.  In Scotland, 387 HIV-infected IDUs were seen for HIV-
related treatment or care in 2006, an 11 per cent decrease since 2000 when 436 
IDUs were seen for care. 
6.3.2 Viral hepatitis 
The prevalence of hepatitis C infection among IDUs remains high overall.  Of the 
(current and former) IDUs participating in the UAPMP agency survey in 2006, two 
fifths (41%) had antibodies to hepatitis C153, which is similar to that seen in recent 
years (2005, 42%).  The overall hepatitis C prevalence in England was 43 per cent, 
however, there were very marked regional variations from 22 per cent in the North 
East to 57 per cent in London and 60 per cent in the North West (data from 2005 and 
2006 combined).  The prevalence in Wales and Northern Ireland were lower than 
most of the English regions: combining data from 2005 and 2006, hepatitis C 
prevalence in Wales was 18 per cent, and in Northern Ireland it was 29 per cent.  
 
Those IDUs participating in the UAPMP survey who had ever been homeless were 
more like to have antibodies to hepatitis C (45%) than those who had not (28%).   
 
Amongst current IDUs participating in the UAPMP survey the prevalence of hepatitis 
C has increased since the beginning of the decade, from 33 per cent in 2000 to 42 
per cent in 2006.  There were higher prevalences of hepatitis C infection among 
several sub-groups of current IDUs.  Those who reported injecting crack-cocaine in 
the past four weeks were more likely to have hepatitis C (59%) than those who had 
not (34%).  Higher prevalence was also associated with the use of some injection 
sites: those who had injected into their groins in the past four weeks were more likely 
to have hepatitis C (54%) than those who had not (37%) and those who injected into 
their legs were also more likely to have hepatitis C (49%) than those who had not 
(41%).  
 
The main aim of the National Public Health Service for Wales (NPHSW) cohort study 
of IDUs conducted in South Wales in 2004 was to estimate the incidence of hepatitis 
C among IDUs.  It recruited 700 IDUs and followed up 400 of these over 
approximately one year.  The estimated hepatitis C incidence was approximately 6.5 
per 100 person-years, whilst the prevalence of hepatitis C among all the IDUs 
                                                
153 The sensitivity of the oral fluid test used in the UAPMP agency survey is approximately 93 
per cent. 
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recruited at the start of the study was 26 per cent.   
 
A recent review of epidemiological studies showed that the incidence of hepatitis C 
among IDUs in many parts of Scotland remains high (in the range of 12 to 29 per 100 
person-years). 
 
Overall about one in five IDUs have had hepatitis B infection.  In 2006, 21 per cent of 
the current and former IDUs who took part in the UAPMP survey in England, Wales 
and Northern Ireland had antibodies to hepatitis B core antigen (anti-HBc, a marker 
of previous or current hepatitis B infection)154; this was similar to the level seen since 
1995. 
6.3.3 Sexually transmitted infections 
NO NEW INFORMATION AVAILABLE 
6.3.4 Tuberculosis 
NO NEW INFORMATION AVAILABLE 
6.3.5 Other infectious morbidity 
Cases of wound botulism continue to occur among IDUs in the United Kingdom.  In 
2006, 22 suspected cases were reported, fewer than in each of the previous two 
years, with 28 cases reported in 2005 and 40 in 2004. 
 
In 2006, one of the three cases of tetanus reported to the HPA in England was 
known to have been an IDU, no cases of tetanus were reported for the rest of the 
United Kingdom.  Whilst in 2005, four of the six cases of tetanus reported in the 
United Kingdom were in IDUs, indicating that tetanus continues to affect IDUs, albeit 
at lower numbers than in 2003 and 2004. 
 
Cases of severe infection related to both meticillin resistant Staphylococcus aureus 
and Group A streptococci continue to occur among IDUs. 
6.4 Psychiatric co-morbidity (dual diagnosis) 
6.4.1 Prevalence  
Data on psychiatric discharges in Scotland shows that in 2004/05, six per cent of 
cases had a diagnosis of drug misuse (as either a main or supplementary diagnosis).   
 
The majority of cases which reported drug misuse as a main diagnosis did not record 
a supplementary diagnosis.  In cases where a main diagnosis of drug misuse and 
also a supplementary diagnosis were recorded, the most common supplementary 
diagnoses were mood (affective) disorders (in 16% of those cases) and personality 
disorders (15%).  Where drug misuse was a supplementary diagnosis, the most 
common main diagnosis was schizophrenia (29%) followed by mood (affective) 
disorders (20%) (ISD 2006). 
 
These 2004/05 figures are provisional (due two areas having incomplete information) 
at the time of writing and may therefore, be subject to revision.  
 
                                                
154 The sensitivity of the oral fluid test used in the UAPMP agency survey is approximately 75 
per cent. 
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A study in a semi-rural location in South-East England155 found that 16 per cent of 
patients attending Community Mental Health Teams reported use of illicit drugs in the 
past year, most commonly cannabis.  This is three times the prevalence of the 
general population, but below the prevalence rates found in inner city studies of 
psychiatric co-morbidity (Trathen et al. 2007). 
 
Another study, carried out in Cambridge and South Cambridgeshire found that 
lifetime substance use among individuals with first episode psychosis was double 
that of the general population of a similar age156.   Class A drug use was much 
greater, 55 per cent of participants reported lifetime use compared to 13 per cent of 
the general population.  Cannabis use was reported by 80 per cent of participants 
with half meeting DSM-IV criteria for cannabis abuse or dependence (Barnett et al. 
2007).  
6.4.2 Personality disorders 
The relationship between cannabis use and mental health 
A systematic review published in the Lancet157 looked at the evidence relating to 
cannabis use and psychotic or affective mental health outcomes. It found that 
individuals who had ever used cannabis were at increased risk of a psychotic 
outcome (pooled adjusted odds ratio=1.41, 95% CI 1.20-1.65).  The evidence for 
affective disorders was less consistent.  Although the authors concede that a causal 
link is unlikely to be discovered, they believe there is enough evidence to necessitate 
increased public education about the dangers of cannabis use (Moore et al. 2007). 
Predictions of future trends in schizophrenia 
Hickman et al. (2007b) used modelling techniques to predict future trends in 
schizophrenia assuming a causal link between cannabis use and schizophrenia158.  
The study concluded that between 2000 and 2010 the impact of cannabis on the 
prevalence and incidence of schizophrenia should be observable at least amongst 
men.  It suggests that by 2010, cannabis would have caused 25 per cent of incident 
cases amongst men or 13 per cent if a causal link is assumed to exist only amongst 
heavy users.  Projections for women are slightly lower.  However, the report notes 
that recent epidemiological studies have found stable or falling levels of 
schizophrenia incidence despite increasing levels of cannabis use.  It warns that 
other risk or protective factors may mask the impact of cannabis and that the full 
lifetime risk of young users will not yet have been observed. 
Khat use and mental illness: A critical review 
Warfa et al. (2007)159 looked at the evidence of a causal relationship between khat 
use and mental illness finding a weak association between the two.  They suggest 
                                                
155 A cross-sectional prevalence survey of 1808 patients in a semi-rural area of South East 
England. Interviews with patient’s key workers were conducted and a screening questionnaire 
completed. 
156 The study looked at 123 people referred consecutively to Cameo, a specialist early 
intervention service for people who experience a first episode of psychosis between June 
2002 and June 2005. 
157 35 studies were identified that met the inclusion criteria; 11 studies of psychosis and 24 for 
affective outcomes. 
158 Trends in cannabis use were estimated using the Offending Crime and Justice Survey and 
incidence of schizophrenia was derived from surveys in three English cities 1997-99. The 
model used multiple scenarios and was defined for different birth cohorts. It was run 
separately for men and women. 
159 The authors searched relevant databases using known terms for the drug khat and various 
terms in addition to ‘mental illness’. Searches were limited to quantitative studies and clinical 
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that khat use exacerbates psychological problems caused by pre-existing stressors 
but call for more robust studies taking into account cross-cultural differences and 
confounding factors. 
Ethnic minorities 
A study looking at ethnic differences amongst a community cohort of people with dual 
diagnosis160 found that individuals describing themselves as Black-British were more 
likely to misuse cannabis and have been compulsorily hospitalised or involved in 
violence in the past 18 months than White individuals (Afuwape et al. 2006).  The 
authors emphasise the need for interventions tailored to the needs of different ethnic 
groups. 
6.4.3 Depression 
NO NEW INFORMATION AVAILABLE  
6.4.4 Anxiety 
NO NEW INFORMATION AVAILABLE 
6.4.5 Affective disorders 
NO NEW INFORMATION AVAILABLE 
6.5 Other drug-related health correlates and consequences 
6.5.1 Somatic co-morbidity 
Abscesses 
Symptoms of a possible injecting site infection would appear to be common among 
IDUs, as 35 per cent of IDUs participating in the UAPMP survey in 2006 reported 
they had experienced either an abscess, sore or open wound, possible symptoms of 
an injecting site infection, during the previous year.  The reporting of such a symptom 
was associated with having been homelessness in the last year, with 36 per cent of 
those homeless during the last year reporting a symptom compared with 30 per cent 
of those not homeless during the last year. 
Sepses 
Connolly et al. (2006) identified 20 cases of renal amyloidosis161 in intravenous drug 
users in two London hospitals; two during 1990 and 1994, five during 1995 and 1999 
and 13 between 2000 and September 2005.  All patients were long-term intravenous 
drug users (mean 18.9 years) and had a history of recurrent soft tissue infection.  
Sixty-five per cent (13) required dialysis within one month of diagnosis and of the 
remaining seven, four developed end-stage renal failure between six and 30 months 
later.  Of 17 patients who underwent chronic dialysis, the median overall survival was 
25 months.  There were nine deaths within five years, all due to sepsis. 
Endocarditis 
NO NEW INFORMATION AVAILABLE  
                                                                                                                                         
case reports written in English from 1946 to 2006. Out of an initial 450 identified papers, 24 
met the full criteria for inclusion. 
160 The caseloads of case managers in four adjacent South London Boroughs were screened, 
firstly to find those with clinical diagnoses of a psychotic disorder and then for substance 
misuse. 213 individuals met the inclusion criteria, 55 per cent were White, 8 per cent Black 
Caribbean, 10 per cent Black African and 26 per cent Black British. 146 client interviews were 
conducted with information for the remainder collected through case managers. 
161 Renal deposits of amyloid, especially in glomerular capillary walls, may cause albuminuria 
and the nephrotic syndrome.  The condition is associated with renal failure.  Treatment 
options are limited and the outcome for such patients on renal replacement was poor. 
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Dental health 
NO NEW INFORMATION AVAILABLE  
6.5.2 Non-fatal drug emergencies 
Data are collected for England through Hospital Episode Statistics162 but it is difficult 
to monitor trends in non-fatal drug emergencies as classification is based on ICD10 
codes and the subjective views of the recording clinician.  In 2005/06 there were 920 
inpatient episodes due to a primary diagnosis of acute substance intoxication.  
Eighty-five per cent were classed as emergencies and the most commonly recorded 
drug was multiple or other psychoactive substances (35%).  
 
There were 9,968 finished episodes of poisoning by narcotics and psychodysleptics 
in 2005/06. This figure has risen by almost 50 per cent since 2002-03, with the 
largest increase for those affected by ‘other opioids’.  Cocaine poisonings have also 
increased from 262 episodes in 2000/2001 to 807 in 2005/07 and, despite a drop in 
heroin poisonings until 2003/04 there have been large increases in the past couple of 
years to 1,908 finished episodes in 2005/06. 
 
In Scotland, data are collected on acute inpatient discharges with a diagnosis of drug 
misuse as a factor in treatment163 (ISD 2006).  In 2005/06 there were 5,015 general 
acute hospital discharges with a diagnosis (main or supplementary) of drug misuse, 
78 per cent of which were emergencies. 
 
In Wales during 2006/07 there were 160 inpatient episodes due to a primary 
diagnosis of acute substance intoxication 
 
The Welsh Assembly Government are looking at effective ways of monitoring non-
fatal drug emergencies. 
6.5.3 Other health consequences 
Golding et al. (2007) studied cognitive performance in light current users and ex-
users of ecstasy and a control group.164  The study concluded that current light users 
show a small but significant cognitive impairment, which is no longer detectable in 
ex-users who had not used ecstasy for six months. 
6.5.4 Driving and other accidents 
In a sample of 1,185 fatal vehicle accidents between 1994 and 2005, Clarke et al. 
(2007) found that four per cent involved drugs, the most common being cannabis. 
Drivers who were found to be using drugs had a younger average age than non-drug 
drivers, 28 years compared to 40 years.  The report authors warn that this is likely to 
be an underestimate as toxicology reports were not available in all cases. 
 
Interviews with 26 individuals drawn from the Drug Outcome Research in Scotland 
(DORIS) explored experiences and management of drug driving.  All had been 
                                                
162 Hospital Episode Statistics (HES) is the national statistical data warehouse for England of 
the care provided by NHS hospitals and for NHS hospital patients treated elsewhere.  See: 
http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/HospitalEpisodeStatistics/index.ht
m 
163 This is not comparable with England as it includes supplementary diagnosis as well as 
primary diagnosis and also includes detoxification treatment. 
164 Sixty subjects comprising 20 current light users, 20 ex-users and 20 non-users of ecstasy 
were tested on an extensive battery of cognitive tests.   
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addicted to heroin and admitted to drug driving.165  Strategies for managing risks 
included attempting to limit their drug intake to their tolerance level; delaying driving 
after taking a drug until they felt safe; stopping driving if they felt unsafe while behind 
the wheel; and avoiding driving altogether under the influence of certain drugs.  The 
study suggests that media campaigns or more effective means of detection would 
impact on behaviour and that education on the risks and consequences of drug 
driving should be incorporated into drug rehabilitation programmes (McIntosh et al. 
2007). 
 
An insight gathering exercise among 14 to 17 year olds by Road Safety Scotland, 
published in July 2007, found widespread belief that the ability to drive under the 
influence of drugs would be dependent on the drugs taken and the reaction of the 
individual to the effects of the drugs (TNS System Three 2007).  There was some 
acceptance of drug driving, with some young people knowing others who regularly 
drove after smoking cannabis in the belief that it had a calming effect on their driving.  
There was confusion about the law on drug driving; all knew it was illegal to take 
drugs and reasoned that drug driving would also be illegal, although they had not 
received messages about this issue before.  The research also found a lack of 
awareness of how someone would be caught drug driving and of the penalties 
involved.   
6.5.5 Pregnancies and children born to drug users 
Hospital Episode Statistics show that, in England, during 2005/06, there were 170 
cases of fetus and newborn affected by maternal drugs of addiction (ICD10 code 
P04.4) and 1,276 cases of neonatal withdrawal symptoms from maternal use of 
drugs of addiction (P96.1).  Table 6.2 shows the change from 2003/04 to 2005/06. 
Table 6.2: Effect of maternal drugs of addiction in England 2003/04 to 2005/06 
Primary diagnosis 2003/04 2004/05 2005/06 
Fetus and newborn affected by maternal 
use of drugs of addiction 205 262 170 
Neonatal withdrawal symptom from 
maternal use of drugs of addiction 1,096 1246 1276 
Source: The Information Centre (2007a) 
 
In Scotland in 2004/05 there were 493 maternities for which drug misuse was 
recorded (Table 6.3).  Of births recording drug misuse, 18 per cent were pre-term 
compared to eight per cent of all births and only 69 per cent were recorded as full-
term normal birth weight compared to 90 per cent of all births. 
 
There were 300 recorded cases of foetus and newborns affected by maternal drugs 
of addiction and/or neonatal withdrawal symptoms from maternal use of drugs of 
addiction (ISD 2006).  Changes to recording of drug misuse in pregnancy over this 
period mean that comparison of the figures is not appropriate; earlier figures are 
likely to underestimate the number of maternities where drug misuse was an issue 
and improved data recording from April 2003 will have had an impact on these 
figures.   
                                                
165 Clients were selected randomly from those who reported that they had driven under the 
influence of drugs at stage 4 of the DORIS study, a prospective cohort project. Semi-
structured interviews were conducted in an open ended way.   
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Table 6.3: Diagnosis in Scotland, 2000/01 to 2004/05 
Diagnosis 2000/
01 
2001/
02 
2002/0
3 
2003/0
4 
2004/0
5 
Maternities recording drug misuse 237 241 339 440 493 
Fetus and newborns affected by maternal use of 
drugs of addiction or neonatal withdrawal symptom 
from maternal use of drugs of addiction  
329 258 281 320 300 
Source: ISD Scotland (2006) 
 
A study carried out in the Grampian area of Scotland between June 2002 and 
December 2003166 found that 75 of the 110 babies born to substance misusing 
mothers had Neonatal Abstinence Syndrome (NAS) symptoms, an incidence of 68.2 
per cent (Scottish Executive 2006b).  Of the 26 babies recruited to the study who 
were initially asymptomatic, 12 developed delayed onset NAS and seven required 
treatment.  The majority of treated infants recruited to the study had ceased 
treatment at 20 weeks although almost a quarter  (24.4%) required longer treatment 
and follow-up (12/49 infants). 
 
Twenty-two per cent of babies born to substance misusing mothers were premature 
compared to 9 per cent of all births. Of those recruited to the study, 26 per cent failed 
an eye test and 11 per cent were diagnosed with eye problems. 
 
In Wales during 2006/07 there were 22 cases of foetus and newborns affected by 
maternal drugs of addiction and 77 cases of neonatal withdrawal symptoms from 
maternal use of drugs of addiction (Internal communication - Welsh Assembly 
Government). 
 
                                                
166 Opiate using mothers fulfilled the criteria for recruitment to the study. Eligible mothers were 
identified by their referrers, their own admission of substance misuse, urine screening or by 
clinical diagnosis in the baby. Once identified the Study Nurse carried out recruitment. Of the 
110 mothers identified, 72 infants were recruited to the study and assessed by the family 
health visitor using a modification of the Finnegan score at 2, 4, 8, 12 and 24 weeks.  
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7. Responses to health correlates and consequences 
7.1 Overview 
Drug-related deaths (DRDs), infectious diseases, co-morbidity and other health 
consequences are key policy issues within the United Kingdom drug strategies 
(Scottish Office 1999; National Assembly for Wales 2000; DSD 2002; DHSSPSNI 
2006).   
 
A strategy for England and Wales was published in 2001, focusing on promoting 
treatment, with service providers expected to provide information and advice on how 
to reduce DRD, to educate drug users and their families on resuscitation, educate 
prisoners on the risk of overdose on release from prison, and training of paramedical 
and Accident and Emergency (A&E) staff.  This has been updated in 2007 with the 
publication of a new Reducing Drug-related Harm: An Action Plan.  In Scotland a 
strategy and action plan to reduce DRD was published in 2005.   
 
Throughout the United Kingdom there is information about volatile substances 
available on drug information websites.  The Scottish Government and the Health 
Promotion Agency in Northern Ireland ensure that young people, parents and 
retailers are aware of the dangers of abusing products such as cigarette lighter refills, 
aerosol sprays and glue.  In Scotland 90 per cent of Scottish schools include advice 
on the risks from volatile substance abuse.  
 
In the 1980s, United Kingdom drug policy was led by a public health approach aimed 
at containing HIV transmission.  The subsequent action, involving harm reduction 
measures, is regarded as having been successful in containing HIV amongst 
injecting drug users (IDUs); providing free needles and syringes, promoting the safe 
disposal of used equipment, information campaigns on safer sex and safer injecting; 
and HIV/AIDS counselling, support and testing. The Hepatitis C Action Plan for 
England was developed in 2004, prioritising prevention of infection and disease 
progression. Treatment for infectious diseases is provided as part of the National 
Health Service (NHS), including the provision of anti-retroviral treatment for HIV and 
HCV.  Treatment for wound infections is available through primary care, Accident and 
Emergency (A&E) departments, and in some areas, through needle exchange 
schemes and specialist drug services.  Those in prison have access to HIV and 
hepatitis testing, and vaccination against HBV.  In England, Reducing Drug-related 
Harm: An Action Plan, also focuses on infectious disease.  
 
Standards of care for problem drug users with mental health problems were agreed 
in 2001 (HAS 2001).  Guidance on good practice (DH 2002a) and the provision of 
services were developed in England.  The Department of Health highlighted the need 
for generic health services to work in partnership with other agencies, such as drug 
services (DH 2002b).  Local Implementation Teams (LITs) implement the policy 
requirements described in the guidance, and work in partnership with Drug and 
Alcohol Action Teams (DAATs).  The Scottish Government is to publish a report 
setting out a series of recommendations for change and improvement on awareness 
and for the development of support and service provision for people with co-occurring 
substance misuse and mental health problems. 
 
Maternity services are expected to provide appropriate facilities for the needs of 
pregnant women drug users and their babies, although the approach varies across 
the country.  The Advisory Council on Misuse of Drugs (ACMD 2003), in its Hidden 
Harm report, highlighted concern about the consequences for children of parental 
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drug use.  Since then a number of initiatives have been undertaken to address 
problems identified throughout the United Kingdom, including a Scottish Government 
Action Plan.  
7.2 Prevention of drug-related deaths  
7.2.1 Overdose prevention 
The consultation draft of the updated guidelines on clinical management of drug 
misuse and dependence (DH et al. 2007) sets out actions for the prevention of drug-
related deaths by: 
• providing education and training to drug users and their families on the risks of 
overdose and how to respond effectively; 
• advising drug users on the dangers of combining drugs, especially alcohol and 
benzodiazepines; 
• contributing to effective care pathways between prisons and the community 
• educating new drug misusers that the use of methadone, outside its medical 
purpose, is extremely dangerous; 
• educating new patients starting on methadone and buprenorphine on the risks of 
loss of tolerance; 
• using supervised consumption in the early stages of methadone and 
buprenorphine treatment; 
• requiring that patients moving on to take-home methadone and buprenorphine 
provide details of satisfactory home storage arrangements and recording these in 
the patient’s notes, especially when children are in the home; 
• making use of local specialist support and referral in complex cases, e.g. cases 
of polypharmacy requiring specialist review; and 
• conducting or arranging for mental health assessments in patients who present a 
suicide risk. 
Preventability of drug-related deaths 
In an audit of drug-related overdose deaths in London during 2003, Hickman et al. 
(2007a) found poly-drug use in the majority of cases although opiates were identified 
as the major contributory drug in 68 per cent of cases.  Evidence from coronial files 
showed that, in 61 per cent of cases, a witness was present and death was not 
instantaneous.  However, the authors conclude that three-quarters of these deaths 
would have been difficult to prevent due to a number of factors including the 
intoxication of the witness.  They recommend encouraging a ‘duty of care’ amongst 
drug users to increase capacity for identifying and responding to overdoses.  The 
study also supports other research findings that substitute prescribing and loss of 
tolerance after prison release are key protective and risk factors associated with drug 
overdose deaths.  The National Treatment Agency (NTA) published a more in-depth 
report on the findings including qualitative statements from witnesses (Hickman et al. 
2007c). 
Psychosocial factors 
In the study described above (Hickman et al. 2007c), the authors found that, in the 
majority of deaths, significant health or social events were noted, which may have 
contributed to the subsequent fatal overdose.  Similarly, a study by Oliver et al. 
(2007c) using a control group found that the occurrence of negative life events in the 
past week was more common among those who died from an overdose than among 
the control group167.  The authors conclude that there is evidence to suggest that 
                                                
167 The study used a matched case-control design to evaluate a number of psychosocial risk 
factors for acute non-deliberate fatal opiate overdose. Cases were matched to controls on sex 
and age but  were not achieved on treatment history. There were 15 subjects in each group 
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psychosocial factors play a role in fatal non-deliberate opiate-related overdoses and 
that traditional educational forms of prevention should be expanded to include a more 
proactive monitoring of the psychosocial wellbeing of heroin users.  
 
The Scottish Government has commissioned a qualitative study looking at why those 
present at illicit drug over doses may not contact the emergency services.  
Safer use training 
The NTA’s Action Plan includes the provision of training and guidance to service 
users on how to minimise harm associated with drug use (DH and NTA 2007). 
 
An evaluation of the Peer to Peer Project in Merseyside found that participants’ 
knowledge about safer injecting techniques, prevention of blood borne viruses, what 
actions to take in an overdose situation and other health issues improved after 
training.  The level of confidence and willingness to pass on this information to peers 
increased greatly.  The report recommended the strategic development of the project 
for future expansion (Shaw et al. 2007a). 
First aid training 
NO NEW INFORMATION AVAILABLE  
Consumption rooms 
A systematic review (see 7.3) found little evidence of the effectiveness of drug 
consumption rooms.  
Antagonists 
The clinical guidelines mentioned above (DH et al. 2007), suggest local piloting of 
take-home naloxone with appropriate training for users, relatives and carers and 
highlight the need for further research to establish its effectiveness in the prevention 
of overdose-related deaths. 
 
In a qualitative study with homeless drug users168, Wright et al. (2006) found that the 
majority of participants would be willing to administer naloxone provided they were 
trained in an appropriate manner.  Concerns about how to properly administer 
naloxone precludes its provision “over the counter” but the authors conclude that 
distribution by drug treatment services and a programme of peer training could result 
in public health benefits.  
 
Suboxone was launched in early 2007, as being potentially of value in reducing death 
through overdose (see Chapter 5.4.2). 
7.3 Prevention and treatment of drug-related infectious diseases 
In May 2007, the Department for Health (DH) and the National Treatment Agency 
(NTA) published Reducing Drug-related Harm: An Action Plan (DH and NTA 2007).  
One of its aims is to improve delivery by issuing guidance on reducing drug-related 
harm to commissioners, service users, carers and those working with drug users.  
This includes guidance on hepatitis C, the provision of needle exchange services and 
testing and treatment for blood-borne virus infections in prisons and the community.  
The Action Plan also contains plans for a health promotion campaign, which will be 
                                                                                                                                         
recruited from areas covered by coroner’s courts in South Yorkshire. Key informants were 
interviewed for the case group, most often partners or parents.  
168 In depth  face-to-face interviews with 27 drug users (19 men and 8 women) were 
conducted  in 2002-2003 with homeless drug users across  three sites providing services to 
drug users (one primary care centre and two non-statutory organisations) in a large city. 
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targeted at risk groups such as homeless drug users, speedballers169 and potential or 
new injectors. €2.8 million is being made available in 2007/08 for investing in the 
Action Plan. 
 
In September 2006 the Scottish Government published the Hepatitis C Action Plan 
for Scotland: Phase 1, which will run until August 2008 (Scottish Executive 2006a).  
The prevention strand of the Action Plan focuses on transmission of the virus among 
injecting drug users (IDUs).  One of the aims is to improve the accessibility and 
effectiveness of needle exchange and other harm reduction services at a local level.  
The Scottish Government has provided NHS boards with additional funding of €5.9 
million over the two years of the Action Plan, some of which may be spent on 
prevention.  In April 2007, the Scottish Prison Service began piloting an in-prison 
needle exchange in HMP Aberdeen, which will be reported on in 2009. There are 
also plans to provide injecting paraphernalia to all prisoners leaving prison with an 
identified need by mid-2008.  
 
A systematic review170 of the evidence for the effectiveness of primary prevention 
interventions for Hepatitis C among injecting drug users found that needle exchanges 
reduce the prevalence of HCV although prevalence remains high.  The authors found 
limited evidence evaluating the effectiveness of drug consumption rooms and 
concluded that methadone maintenance is only marginally effective at reducing HCV.  
They warn against over-reliance on one harm reduction intervention and the need for 
expansion of the evidence base (Wright and Tompkins 2006). 
 
The National Public Health Service for Wales (NPHS Wales), with the support of 
Welsh Assembly Government, is developing a costed 'Blood Borne Viral Hepatitis 
Action Plan for Wales'.171  The key aims of the Action Plan include:  
• reducing the transmission of hepatitis infection in Wales;  
• increasing the diagnosis of current infection; and 
• improving the provision of treatment and support to infected individuals. 
 
Later this year the Scottish Government will publish a report on safety, health risks 
and outcomes for injecting drug users using injecting paraphernalia (personal 
communication Scottish Government).  
7.3.1 Prevention 
The Royal College of General Practitioners (RCGP 2007) has published guidance for 
its members on the prevention, testing, treatment and management of hepatitis C in 
primary care.  It recommends ensuring that all drug users have access to local 
needle and syringe services as well as other paraphernalia and that GPs issue 
advice on safer snorting, smoking and how to move away from injecting.  The 
guidance also suggests running a needle exchange in GP surgeries. 
Vaccination 
The consultation draft of the updated clinical guidance for drug misuse and 
dependence in England states that Hepatitis B vaccination should be carried out as 
soon as possible after presentation to all drug users regardless of injecting status.  
To increase take up, the guidance suggests the use of accelerated courses and 
possible incentives such as the issuing of vouchers (DH et al. 2007).  NICE clinical 
guidelines on psychosocial interventions also recommends using material incentives 
                                                
169 Injecting heroin and crack together.  
170 A systematic review of the major electronic databases in 2002 identified 1007 abstracts 
with 18 papers meeting the final inclusion criteria. 
171 See: http://www2.nphs.wales.nhs.uk/icds/page.cfm?pid=519  
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such as £10 (14.6 Euros) shopping vouchers to encourage Hepatitis B vaccination 
NICE 2007d). 
 
A study of hepatitis B vaccination among injecting drug users in England, 1998 to 
2004,172 found that reported uptake rose significantly from 27 per cent to 59 per cent 
(Hope et al. 2007).  However, the study also found that prevalence of antibodies to 
hepatitis B remained stable at 21 per cent.  Prisons (38%) were the most common 
source of vaccination followed by drug services (28%), GPs (17%) and needle 
exchanges (14%).  The authors conclude that, while there have been considerable 
improvements in vaccine uptake, further improvements are necessary including the 
targeting of recent IDUs and wider coverage of vaccination efforts.. A complementary 
paper based on the same study suggests that the risk of HBV infection varies 
between regions and identifies the need for greater evidence establishing the 
effectiveness of vaccination in reducing hepatitis B infection (Judd et al. 2007). 
 
The proportion of IDUs in the UAPMP who have taken up an offer of the hepatitis B 
vaccination has increased markedly over time, rising from 25 per cent, in 1998 65 in 
2006 (self-reported data173).  Self-reported vaccination uptake varied by region and 
country (combining 2005 and 2006 data), and in Wales was 47 per cent and in 
Northern Ireland 76 per cent (HPA et al. 2007). 
 
Sixty per cent of DAATs have on-site hepatitis B vaccination, according to the NTA’s 
2005 survey of needle exchanges with significant differences by region (p<0.001) 
(NTA 2007g).  The NTA’s Action Plan contains plans for a campaign on hepatitis B 
vaccination targeted at drug users most at risk of contracting an infectious disease. 
 
In Wales, in a study of 500 current and recent injectors174, just under half (49%) had 
received one or more hepatitis B vaccinations with 72 per cent of these having 
completed the course.  The most common venue for receiving the vaccination was in 
prison (48%), followed by GP surgery (23%) and drug service (19%), although there 
were regional variations with around half of those from North East Wales and Mid 
and West Wales receiving vaccination from drug services (Smith 2006). 
 
A survey of the 22 Community Drug Teams (CDT) in Wales175 found that, of the 14 
that responded only six provided Hep B vaccination on site, with a further six 
referring clients to a local genito-urinary medicine departments (GUM) or GP. Two 
CDTs had no written protocol to ensure users were vaccinated (Smith and Lyons 
2006). 
Syringe provision programmes 
Northern Ireland is the only country in the United Kingdom with a national syringe 
exchange database monitoring activity in the nine pharmacies that offer syringe 
exchange.  In 2005/06: 
                                                
172 The study combined results from the annual national voluntary unlinked anonymous 
survey of injectors in England (Agency survey) and a survey of IDUs recruited from 
community settings in late 2003 and during 2004 (Community survey). Oral samples were 
taken in the Agency survey and dried blood spot samples in the community survey. 
173 Vaccination uptake data should be interpreted with caution as they are based on self-
reports. 
174 500 valid face-to-face interviews were conducted with ex and current drug users 
opportunistically recruited from various localities across Wales. A community needs 
assessment questionnaire tool was developed to provide quantitative data. 
175 A short questionnaire was sent to all 22 Community Drug Teams in Wales. A response 
rate of 64% was achieved. 
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• there were 8,797 visits to participating pharmacies by users of the scheme, an 
increase of 18 per cent on 2004/05, 
• 85,801 syringes were issued, 
• the proportion of visits involving the return of used equipment fell from 54 per 
cent in 2004/05 to 44 per cent in 2005/06, 
• the rate of return varied greatly across the four health boards, and  
• four per cent of visits were by clients reporting themselves to be new users of the 
needle and syringe exchange scheme (DAIRU/DHSSPSNI 2006b). 
 
A national monitoring scheme for needle exchange is currently being developed in 
England (NTA 2007g). 
 
The Welsh Assembly Government has set up a National Needle and Syringe 
Information Group and are developing a database to improve the collection of 
information on needle and syringe exchange programmes (Welsh Assembly 
Government – personal communication).   
 
A qualitative study with 49 injecting drug users in Wales found that the main source 
of needles and syringes in the previous four weeks was non-pharmacy syringe 
exchange schemes (58%) followed by pharmacy-based schemes (16%). Twenty-two 
per cent of those interviewed reported sharing a needle or syringe in the last four 
weeks. Availability was generally good in larger towns and cities but IDUs in one 
market town reported occasions when the pharmacy had run out of equipment and 
the lack of an alternative accessible facility. The report recommends more mobile 
and outreach services and consultation on introducing vending machine facilities 
(Rhodes and Lyons 2006). 
 
The study by Smith (2006), referred to earlier in this section, with 500 current and ex 
injecting users found that: 
• eighty-eight per cent of current users used a local needle exchange locally; 
• the general perception was that needle exchanges provided a basic service; and 
• twelve per cent reported sharing needles and syringes in the past 4 weeks. 
Paraphernalia and condom provision 
A study by Turning Point (see Chapter 7.3.2) found that nearly half of IDUs (46.4%) 
reported sharing spoons, filters or water and over a third called for a wider range of 
equipment to be made available (Turning Point 2007). 
Information materials 
NO NEW INFORMATION AVAILABLE  
Educational approaches 
NO NEW INFORMATION AVAILABLE  
7.3.2 Counselling and testing 
In England, increasing the proportion of IDUs who are aware of their infection status 
through improved uptake of voluntary confidential testing is one of the aims of the 
Hepatitis C Action Plan for England (DH, 2004).  Of those IDUs taking part in the 
2006 UAPMP survey176, 76 per cent reported having undertaken a voluntary 
confidential test, compared to 29 per cent in 2000 and 67 per cent in 2004. Fifty-four 
per cent of those infected with hepatitis C were aware of their status, compared to 52 
per cent in the previous year’s survey and 40 per cent in 2000 (HPA et al. 2007). 
 
                                                
176 Drug users in contact with specialist drug services. 
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Of UAPMP participants from Wales 45 per cent reported never having a voluntary 
confidential test for hepatitis C in 2005/06, with over half  of those with hepatitis C 
were unaware of their infection.  Less than one in ten (8.6%) of the participants from 
Northern Ireland in 2005/06 reported not having been tested for hepatitis C, and just 
over one quarter the participating IDUs with hepatitis C in the province were unaware 
of their hepatitis C infection (HPA et al. 2007). 
 
A survey177 carried out by the social care organisation Turning Point found that 
22.2% of respondents had never been tested for hepatitis C and 23.1% had never 
been tested for hepatitis B.  The study included three focus groups with current and 
former IDUs in different locations across England. Participants suggested that tests 
offered on a drop-in or rapid access basis would increase uptake.  The report also 
recommended investigating further the option of dried blood spot testing as a means 
to increase uptake (Turning Point 2007). 
 
The NTA’s 2005 survey of needle exchanges in England (NTA 2007f) showed that 
54.5 per cent of DAATs had at least one service that provides on-site hepatitis B 
testing and 51 per cent had at least one service providing hepatitis C testing.  There 
were, however, significant differences by region in the provision of on-site hepatitis B 
and hepatitis C testing (p<0.001). 
 
In the study of 500 current and recent injectors in Wales, only 47 per cent had ever 
had a hepatitis C test, although this varied by region.  Fourteen per cent of those 
tested did not receive their results and 24 per cent tested positive.  Of those testing 
positive, 84 per cent had notified their GP but only 31 per cent had been referred to a 
specialist doctor or hepatitis clinic, all of whom had yet to receive an appointment 
(Smith 2006).  
7.3.3 Infectious disease treatment 
NO NEW INFORMATION AVAILABLE  
7.4 Interventions related to psychiatric morbidity 
The Department of Health published new guidance to improve the care for people 
with concurrent mental health problems and substance misuse.  Dual diagnosis in 
mental health inpatient and day hospital settings recommends that all clinical staff in 
mental health services should have the skills to assess and manage patients with a 
substance misuse problem. It makes clear that substance misuse and mental health 
services must become more integrated and provides ideas and guidance for front-
line managers to help them improve services.  It also contains guidance on service 
planning for groups with different needs such as women and black and minority 
ethnic groups (DH 2007).  
 
The Department of Health also launched a resource to help professionals raise the 
issue of cannabis use with patients and assist in reducing cannabis use. How 
cannabis can affect people with mental health problems - Information for patients and 
practitioners contains information materials in different formats. 
 
In Scotland, a report to issue by the Scottish Government before the end of 2007, 
sets out a series of recommendations for change and improvement on awareness 
and for the development of support and service provision for people with co-occurring 
                                                
177 The questionnaire was distributed in 10 Turning Point needle exchanges between 
December 2006 and March 2007 to people who had injected illegal drugs in the last four 
weeks. The results are based on 874 responses. 
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substance misuse and mental health problems.178  This report supports the model of 
lead agency responsibility as set out in the 2002 Department of Health Guidance (DH 
2002b).  It builds on earlier policy developments, in particular Mind the Gaps – 
Meeting the Needs of People with Co-occurring Substance Misuse and Mental 
Health Problems (Scottish Executive 2003a).  The report will not be prescriptive 
about the particular structure of services that needs to be in place to deliver good 
outcomes.  Instead it proposes models of approach designed to inform change, 
focusing on the key aspects that needs to be in place at each point in the journey of 
care so that all involved in that care can be clear about what needs to be done and 
by whom. The 2007 NHS Quality Improvement Scotland standards for Integrated 
Care Pathways for specific mental health conditions will reinforce this message.   
Capability framework 
A capability framework setting out core competencies required for the delivery of care 
services to people with combined substance use and mental health problems has 
been published.  The framework concentrates on three main strands: values and 
attitudes; utilising knowledge and skills; and practice development (Hughes 2007).  
7.5 Interventions related to other health correlates and consequences 
7.5.1 Somatic co-morbidity 
The 2005 survey of needle exchanges in England found that less than half (46.6%) of 
services provide care for minor infections and dressings (NTA 2007g).  In Wales, 
only 14 per cent of Community Drug Teams that responded to a survey provided in-
house wound care with the remainder referring to a GP or Accident and Emergency 
department (Smith 2006). 
7.5.2 Non-fatal drug emergencies and general health related treatment  
NO NEW INFORMATION AVAILABLE  
7.5.3 Prevention and reduction of driving accidents related to drug use 
The consultation draft of the updated guidance for clinical management of drug 
misuse and dependence addresses the issue of driving while deemed to be drug 
dependent or a drug misuser (DH et al. 2007).  It sets out the responsibilities for 
disclosure of information to the Driver and Vehicle Licensing Authority (DVLA) and 
guidelines for clinicians on how best to inform patients of these responsibilities.  The 
guidance also provides clinicians with risk assessment information and advises how 
best to tackle non-compliance including confidential disclosure to the relevant 
authority. 
7.5.4 Other activities to reduce health consequences  
NO NEW IFORMATION AVAILABLE 
7.5.5 Interventions concerning pregnancies and children born to drug users 
Guidelines on the management of pregnant drug misusers and neonatal care have 
been published (DH et al. 2007).  They highlight the need for joint working and 
coordination across agencies and recommend a written policy on drug-misusing 
parents.  The need to engage early on in pregnancy is emphasised, as are ways to 
stabilise drug use during pregnancy, including substitution treatment.  
 
                                                
178 This follows a consultation process, see:  
http://www.scotland.gov.uk/Publications/2007/06/29120532/4 
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A project in Scotland described in section 6.5.5 used a new assessment tool to 
identify prevalence of neonatal abstinence syndrome (NAS) and delayed visual 
maturation in infants born to drug misusing parents.  The health visitors interviewed 
as part of the project believed the tool increased their awareness of NAS and 
established more open communication with parents; they were less sure about the 
vision screen test.  Parents, who participated in the study were found to be 
appreciative of the improved service.  The results from the study will be used to 
produce local recommendations for service development (Scottish Executive 2006b).  
Maternity Services update 
The 2003 Hidden Harm report (ACMD 2003) recommended ways to improve 
services for pregnant drug users and their babies.  Hidden Harm Three Years On 
presents information on local responses gathered by the ‘Hidden Harm’ Working 
Group179 including improvements to maternity services (ACMD 2007b). 
 
Responses to a snapshot questionnaire sent to DAATs in England180 show that 60 
per cent reported having protocols for the management of neonatal withdrawal.  The 
majority also reported having specialist posts or provision to support drug misusing 
mothers and their babies during and after pregnancy including specialist midwives, 
obstetricians and clinics (ACMD 2007a). 
 
In Scotland, in the majority of ADATs, protocols exist for the management of 
pregnant drug users and neonatal withdrawal. There are similarly specialist posts 
and provision as in England.  The Scottish Government is also funding a project to 
improve delivery of services for children and families affected by drug misuse.  As 
part of the Inequalities Sensitive Practice Initiative in NHS Greater Glasgow and 
Clyde, the project will develop specific guidance to improve how mainstream health 
services, such as maternity services, cater for those affected by inequalities including 
substance misusers. 
Data collection on maternal drug use 
The update on Hidden Harm (ACMD 2007a) sets out the current efforts across the 
UK to improve data collection in maternity services. In Northern Ireland and Wales, 
data on children of those in treatment are routinely collected but there is no maternity 
record.  It is reported that there is a new minimum maternity data set currently being 
developed for routine data collection with the aim of linking with child records and 
efforts are being made to ensure questions meet the recommendations of Hidden 
Harm.  In Scotland, the ACMD report that the maternity record and neonatal 
discharge record includes an optional field for information about the use of drugs in 
pregnancy.  NHS Health Scotland, however, has commissioned an audit of practices 
and opinion on the recording of data on maternal drug use to recommend 
improvements. 
 
The Scottish Government has commissioned externally an evaluation of the impact 
and outcomes of the Dundee outreach services for children and families affected by 
substance use. 
                                                
179 The group was set up to monitor and promote the implementation of the Hidden Harm 
recommendations and first met in February 2004. 
180 Forty seven DAATs returned the snapshot questionnaire, representing just under a third of 
all DAATs. Three regions were not represented  in the snapshot. 
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8. Social correlates and consequences 
8.1 Overview 
A number of studies in the United Kingdom have shown that there is a strong 
association between problem drug use and social exclusion; drug problems are most 
serious in those communities where social exclusion is acute.  Established drug 
markets are an impediment to regeneration, damaging community confidence and 
adding to the poor reputation of the area.  In some parts of the United Kingdom over 
90 per cent of problem drug users are unemployed, a high proportion of the 
homeless are problem drug users (evidence suggesting up to 80 per cent) and 
lacking educational qualifications (studies suggest up to 40 per cent lack any 
GCSEs181).  Also vulnerable young people (those in care, the homeless, truants, 
school excludees and young offenders) are more likely to use drugs, use more often, 
and use a wider range of drugs.  
 
Drug use per se is not a crime in the United Kingdom, but possession, dealing and 
trafficking are specific offences under the Misuse of Drugs Act 1971.  The number of 
persons dealt with has continued to rise since 2001 in the UK.  The main drug 
concerned is cannabis.   
 
General criminal offences routinely recorded by the police do not contain information 
on the offenders’ drug habits, neither do specific drug law offences.  It is therefore not 
possible to provide an accurate estimate of the number of offences that are drug 
related, but there is substantial research evidence of the link between drug use, 
particularly use of heroin and crack cocaine, and acquisitive crime.  Around three 
quarters of the users of these drugs admit to committing crime to support their habit.  
Over two-thirds of those in custody are reported to be problematic drug users.  
However, acquisitive crime, to which drug related crime makes a substantial 
contribution, has continued to fall in recent years.  
 
The economic and social costs of Class A drug use in England are estimated to have 
been around €22.3 billion in 2003/04.  This equates to €63,940 per year per 
problematic drug user.  The associated confidence range is between €22.1 billion 
and €23.3 billion.  The Scottish Government has commissioned research to produce 
an initial estimate of the economic and social costs associated with illicit drug use. 
8.2 Social exclusion  
8.2.1 Homelessness 
The Scottish Government has commissioned research into homelessness and 
substance misuse, in terms of the services provided and whether they are achieving 
the desired outcome.  
8.2.2 Unemployment 
NO NEW INFORMATION AVAILABLE  
                                                
181 GCSEs (General Certificate of Secondary Education) are the principal means of assessing 
pupil attainment at the end of compulsory secondary education in England, Northern Ireland 
and Wales; see: http://www.dfes.gov.uk/qualifications/mainSection.cfm?sId=1.  The 
equivalent in Scotland is the Standard Grade; see : 
http://www.scotland.gov.uk/Publications/2007/03/20130930/1. 
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8.2.3 School drop out 
In England, in 2005/06 there were of a total of 7,990 permanent exclusions, of which 
six per cent (450) were for drug and alcohol related issues, and of 343,840 fixed 
period exclusions 8,360 (2%) were for drug and alcohol related issues (DfES 2007c). 
 
In the survey on Smoking, drinking and drug use among young people in England for 
2006 pupils were asked whether they had ever truanted or been excluded from 
school182 (Fuller 2007).  Eleven per cent of those who had ever truanted, or been 
excluded reported using drugs at least once a month, compared with one per cent of 
those who had never truanted.  
8.2.4 Financial problems 
A literature review of the association between drugs and poverty commissioned by 
the Scottish Drugs Forum (SDF)183 suggested that although there appears to be no 
direct causal link between drug-related problems and poverty, there is a strong 
association (Shaw et al. 2007b).   
 
It is concluded that although relative poverty by itself is not the cause of Scotland’s 
drug problem, narrowing a range of social and economic inequalities should 
contribute significantly to a reduction in high levels of damaging drug use.  
Furthermore, policies focusing on reducing poverty, exclusion and inequalities, per 
se, should help clarify more realistic boundaries for health, social care and criminal 
justice responses to individuals. 
8.2.5 Social network 
NO NEW INFORMATION AVAILABLE  
8.3 Drug-related crime 
8.3.1 Drug offences 
Recorded drug crimes  
Offences under the Misuse of Drugs Act 1971 are recorded by the police.  Statistics 
show that of a total of 5,428,300 recorded crimes in England and Wales in 2006/07 
194,300 (4%) were drug crimes (Nicholas et al. 2007).  This is an increase of nine 
per cent from the previous year (178,500).  Nicholas et al. suggest that increases in 
recent years have been largely attributable to increases in the recording of 
possession of cannabis offences.  From 2005/06 to 2006/07 the offence of 
possession of cannabis increased by nine per cent, which followed an increase of 36 
per cent over the previous year.  It is also noted that these increases coincided with a 
rise in the number of formal warnings for possession of cannabis issued by the police 
and that in 2006/07 the rise was nearly double the increase in the number of offences 
of cannabis possession and indicates the greater use of this method of disposal by 
the police.  The increase in the offence of possession of other drugs was 12 per cent 
in 2006/07 in comparison with the previous year.  
 
In Northern Ireland a total of 121,144 offences were recorded during 2006/07 
compared with 123,194 in 2005/06; a decrease of 1.7 per cent.  Of these 2,411 were 
drug offences, a reduction of 18.1 per cent since the previous year (2,944) (PSNI 
2007). 
 
                                                
182 For methodology used and further details see Chapter 2. 
183 The Scottish Drugs Forum (SDF) is the national non-government drugs policy and 
information agency.  For more information see: http://www.sdf.org.uk 
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Latest information on recorded crime in Scotland is for 2005/06 (Scottish Executive 
2006c).  The total number of crimes recorded by the police in 2005/06 was 417,785, 
five per cent less than in 2004/05.  Recorded drugs crimes increased by six per cent 
from 41,823 in 2004/05 to 44,247 in 2005/06.  
Convictions  
NO NEW INFORMATION AVAILABLE (Information on convictions and disposals for 
drug offences for 2005 will be available in late 2007). 
8.3.2 Other drug-related crime 
There are a number of surveys and monitoring programmes which have measured 
drug use amongst individuals within the criminal justice system, and surveys 
amongst the general population reporting the relationship between self-reported drug 
use and crime amongst those questioned.  As part of the Government’s monitoring of 
the success of its drug strategy reductions in crimes are seen as positive indicators.  
Property crimes 
Crime Statistics is a quarterly update which combines the reporting of police 
recorded crime and the results of the British Crime Survey184 (BCS) (Taylor et al. 
2007).  Results from the British Crime Survey (from April to September 2006) 
showed that overall crime remained stable; as did domestic and vehicle thefts. 
Recorded Crime Statistics showed total recorded crime to be down three per cent 
form the previous quarter.  A number of crime associated with drug users decreased: 
domestic burglary was down by down three per cent; other burglary down by seven 
per cent; vehicle crime down four per cent; and other thefts down five per cent.  
However, robbery was up one per cent and drug offences up nine per cent (Taylor et 
al. 2007). 
Arrestee Survey  
The first representative survey185 of drugs and crime amongst arrestees in England 
and Wales covers the period 1st October 2003 to 30th September 2004 (Boreham et 
al. 2006).  The survey found that 57 per cent of arrestees had taken one or more 
drugs in the last month: 
• 46 per cent reported taking cannabis in the last month; 
• 18 per cent heroin; 
• 15 per cent crack; and 
• 10 per cent powder cocaine. 
 
Reported use of some drugs decreased with age: 
• 57 per cent of 17 to 24 year olds reported cannabis use in the last month 
compared with 28 per cent of those aged 35 years or over;  
• 14 per cent of 17 to 24 year olds reported use of powder cocaine in the last 
month compared with five per cent of those aged 35 years or over. 
 
Eighteen per cent had injected drugs at least once in their lifetime: 
                                                
184 The British Crime Survey (BCS) only covers England and Wales.  The first BCS (1982) 
included lowland Scotland as did the fourth (1988), but since 1993 Scotland has ran its own, 
separate survey. 
185 The survey was carried out in a sample of 60 custody suites, within each of which 
interviewers worked six hour shifts and attempted to interview as many eligible arrestees as 
possible.  Eligible arrestees had to be over 17 years of age, and arrested for committing any 
offence.  In total 7,535 arrestees were interviewed.  The interview consisted of a 20-minute 
computerised interview with a substantial self-completion section, which contained questions 
about offending behaviour, drug and alcohol use and treatment for drugs.  In addition, 
arrestees were asked to provide an oral fluid sample for analysis of recent drug use.  
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• 25 to 34 year olds were most likely to have done so (30%); and 
• 14 per cent of those aged 17 to 24 years and 12 per cent of those aged 35 years 
or over reported having injected. 
 
Dependence was measured using the Severity of Dependence Scale (SDS), which 
uses five questions to measure dependence.  Dependence on heroin was greater 
than on crack or powder cocaine: 
• eighty-five per cent of those who had taken heroin in the last year were 
dependent; and  
• equivalent figures for crack and powder cocaine were 52 per cent and 23 per 
cent respectively 
 
Other characteristics of those who had used heroin, crack and/or cocaine (HCC) in 
the in the 12 months prior to arrest were: 
• sixty per cent were unemployed (compared with 51% who had not used HCC);  
• eighty-two per cent lived in a house (compared with 92% who had not); 
• nineteen per cent arrestees had slept rough in the 4 weeks prior to arrest 
(compared with 8% who had not); 
• eighty-nine per cent were White (compared with 84% who had not used HCC); 
• fifty-three per cent had left school before they were 16 years of age (compared 
with 35% who had not); 
• twenty-six per cent had spent some time in a foster home, children’s home or a 
young person’s unit (compared with 13 per cent who had not); 
• for 57 per cent the reason for arrest was have committed an acquisitive crime186  
(compared with 28% who had not).  
Prolific and other priority offenders  
An impact assessment of the Prolific and other Priority Offender (PPO) 
programme187188 (Dawson and Cuppleditch 2007) (see Chapter 9.3.2) all but one of 
the 48 PPOs interviewed had used illegal drugs.  
Offending, Crime and Justice Survey 2004  
In a report from the 2004 Offending, Crime and Justice Survey (OCJS) delinquent 
youth groups and offending behaviour was examined (Sharp et al. 2006).189  The 
                                                
186 Defined as an offence is committed to obtain money or goods in the last 12 months. 
187 The programme is premised on an understanding of a total offending population of around 
one million, only approximately 100,000 offenders (10% of all active offenders) were 
responsible for half of all the crime committed in England and Wales.  Every Crime and 
Disorder Reduction Partnerships (CDRP) (or Community Safety Partnership in Wales) is 
responsible for setting up and implementing its own PPO scheme. The key criteria for 
selecting PPOs were outlined as follows: the nature and volume of the crimes they are 
committing; the nature and volume of other harm they are causing (e.g. as a consequence of 
their gang leadership or anti-social behaviour); and local criteria, based on the impact of the 
individuals on their communities. 
188 The PPO programme is comprised of three complementary strands: Prevent and Deter - 
aimed at those young offenders who are most at risk of becoming the next generation of 
prolific offenders; Catch and Convict - the goal being to prevent PPOs from offending by 
apprehension and conviction through licence enforcement and by ensuring a swift return to 
the courts for those PPOs continuing to offend; and Rehabilitate and Resettle – which aims to 
rehabilitate PPOs who are in custody or serving sentences in the community through closer 
working between all relevant agencies and continued post-sentence support. 
189 The Offending, Crime and Justice Survey (OCJS) was a longitudinal, self-report offending 
survey for England and Wales.  The aim was to examine the extent of offending, anti-social 
behaviour and drug use among the household population.  Eighty-two per cent of those first 
interviewed in 2003 were interviewed in again in 2004 giving a total ‘panel’ sample of 3,489 
people (3,363 were aged ten to 25 at the time of the 2004 interview).   
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report pointed out that while the NEW ADAM (Bennett and Holloway 2004) study 
found that last year use of cannabis was significantly higher in current gang members 
compared with non-gang members, gang members were no more likely than non-
gang members to have used any of the other drugs asked about.  Rather, they were 
significantly less likely to have used heroin and to have injected a drug in the last 12 
months.  The report also noted, conversely, that studies carried out in the US (on a 
sample of school students and school dropouts) have found that more serious forms 
of drug use were more common in gang members than non-gang members (this 
included heroin and cocaine use) (Fagan 1996).  Sharpe et al. suggest that these two 
very different results may be related to differences in the samples used in these 
studies.  
 
In the report from the OCJS it was found that 45 per cent of young people in 
delinquent youth groups had used an illegal drug in the last year and 11 per cent had 
used a Class A substance.  This was significantly higher than for non-members (15% 
for any drug and 3% for Class A drugs).  Also, the most common delinquent group 
activity carried out together was using drugs; half (51%) of those belonging to a 
delinquent youth group said their group had used drugs together in the last year.  
Given this high proportion, they suggest that it is useful to know the proportion of 
individuals belonging to delinquent youth groups whose group delinquent activity is 
based only around drug use and no other behaviour.  Overall, 13 per cent fell into 
this category and a further 38 per cent had used drugs and committed at least one 
other behaviour.  Almost half (49%) had not used drugs but had engaged in the other 
behaviours.  It is noted that although drug selling and weapons are often considered 
a feature of ‘gangs’, the OCJS shows that these were relatively uncommon among 
the groups measured in the survey.  Just under a fifth of those belonging to a 
delinquent youth group reported that their group had actually sold drugs (18%). 
Young People and Crime: Findings from the 2005 Offending, Crime and Justice 
Survey  
Analysis of the 2005 Offending, Crime and Justice Survey (OCJS) focused on levels 
and trends in youth offending, anti-social behaviour and victimisation amongst young 
people aged 10 to 25 living in the general household population in England and 
Wales (Wilson et al. 2006).  Selling drugs was one of 20 core offences which 
respondents were asked about.   
 
The most commonly reported offence categories reported as having been committed 
in the last 12 months included drug selling; by four per cent (other offences were 
assault, committed by 16%, other thefts, by 11%;.criminal damage, by 4% and 
vehicle-related thefts, by 2%).  Repeat offending was particularly common for the 
selling of drugs.  Among the four per cent of young people who said they had sold 
drugs in the last 12 months, 82 per cent had done so more than once, with 41 per 
cent reporting having done so six or more times. 
 
It was found that young people who took drugs in the last 12 months were 
significantly more likely to have committed an offence than those who did not.  
Selling non-Class A drugs being most common at 16% of all offences.  For both 10 to 
15 year olds and 16 to 25 year olds, factors that were independently strongly 
associated with committing anti-social behaviour included taking any drug (also 
committing an offence in the last 12 months; having friends/siblings in trouble with 
the police; and perceiving parents to have poor parenting skills). 
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Evaluation of Drug Interventions Programme pilots for children and young people: 
drug testing and arrest referral schemes and Testing Requirements  
The evaluation of the drug testing and arrest referral pilot schemes for children and 
young people under 18 years old (Matrix Research and Consultancy and Institute for 
Criminal Policy Research, Kings College 2007)190 found that young people in contact 
with arrest referral reported using a range of substances, the most common of which 
were cannabis (30%), tobacco (30%) and alcohol (23%) (for results of the evaluation 
see Chapter 9.3.2).191  The frequency of use of the latter was high; over half of those 
who reported using each of these substances did so either daily or weekly.  However, 
reported use of cocaine (4%), crack (1%) and heroin (1%) was low.  Similarly, very 
few of the young people tested after charge were found to have used Class A drugs, 
with approximately five per cent testing positive.192  
The concept of drug-related crime 
In a discussion paper Stevens (2007) suggests that the concept of drug-related 
crime, which he argues is a socio-political construction, has dominated recent 
developments in UK drug policy, and it has been assumed that the perceived overlap 
between known offenders and drug users is also present among the much larger 
groups of unknown offenders and drug users.  This assumption, he argues, is 
methodologically suspect and has led to inflated claims of scale, precision and 
causality in political discussions of the link between drugs and crime. 
Illegal prostitution 
As part of the Drug Interventions Programme (DIP), individuals arrested for loitering 
or soliciting for the purposes of prostitution can be drug tested under Inspector’s 
Authority in DIP intensive areas.  Data collected between June 2006 and June 2007 
indicates that, of the 368 women who were tested, 90 per cent tested positive for 
heroin and/or crack cocaine. 
Prescription offences 
NO NEW INFORMATION AVAILABLE  
Violence under the influence 
Results from the British Crime Survey for 2006/07 suggests that victims of violent 
crime believed the offender to be under the influence of drugs in 17 per cent of 
incidents, a decrease from 23 per cent in 2005/06 (Nicholas et al. 2007).  
Driving offences 
The Association of Chief Police Officers (ACPO) Christmas for December 2006 show 
that, of 666 Field Impairment Tests conducted, 251 drivers were arrested for drink or 
                                                
190 The research took place over ten sites and included stakeholder interviews, interviews with 
young people, analysis of monitoring data, analysis of Youth Offending Team (YOT) Asset 
data in pilot and comparator sites and analysis of cost data collected from various sources.  
The evaluation comprised two distinct phases of field research. During the first phase, 
research was undertaken in all ten sites to review the development and early implementation 
of arrest referral and drug testing.  In the second phase, field research focused on the five 
sites that piloted DT(T)Rs. For the purpose of this report, research is reported only for the five 
sites involved in all parts of the evaluation.  Monitoring data were collected by the Home 
Office for all ten sites throughout the pilot. 
191 This pilot was undertaken to see if pilot drug testing and arrest referral schemes for young 
people are an effective means of identifying young people at risk of becoming problem drug 
users and then referring them on to appropriate help to reduce drug use and crime. 
192 Approximately 1,500 individuals were tested 2,000 times between August 2004 and 
October 2005 across five sites, with the vast majority being tested only once.   
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drug impairment offences (37.7 per cent ).  The number testing for drugs rather than 
alcohol is not reported.193 
Date rape  
Operation Matisse: Investigating Drug Facilitated Sexual Assault 
A report from the Association of Chief Police Officers (ACPO)194 concluded that there 
is no evidence to suggest widespread use of the so called 'date rape drug' Rohypnol. 
In most cases, the alleged victims had consumed alcohol voluntarily and in some 
cases, to dangerous levels (ACPO 2006b). 
Toxicology findings from a three year study  
A report from the Forensic Science Service describes the toxicological findings in 
1,014 instances of alleged drug facilitated sexual assault for the period 2000 to 2002 
(Scott-Ham and Burton 2006).  This study found that alcohol, alone or with an illicit 
drug and/or medicinal drug, was present in 46 per cent of cases and illicit drugs were 
detected in 34 per cent; cannabis (26%), cocaine (11%) and MDMA (ecstasy) (5%) 
were the most common.  Gamma-hydroxybutyric acid (GHB) was detected in 2 
cases.  
Advisory Council on the Misuse of Drugs report: drug facilitated sexual assault 
In a report by the Advisory Council on the Misuse of Drugs (ACMD)195, which 
considered the two reports mentioned previously, it is suggested that drug facilitated 
sexual assault, including rapes in which drugs are mixed with alcohol, is a significant 
problem (ACMD 2007b).  The Council recognises two forms of sexual assault: 
• Proactive drug facilitated sexual assault involves the covert or forcible 
administration of an incapacitating or disinhibiting substance, by an assailant, for 
the purpose of sexual assault; and 
• Opportunistic drug facilitated sexual assault involves sexual activity, by an 
assailant, with a victim who is profoundly intoxicated by his or her own actions to 
the point of near or actual unconsciousness, and thus lacks the capacity to 
consent.  
 
However, it is suggested that the incidence of drug facilitated sexual assault is 
unclear, with many victims failing to report the incident and, where victims do report 
the incident, the elapsed time may be too long for drugs to be reliably detected in 
blood or urine.  This particularly applies to alcohol and GHB.  Further, they suggest 
that the most common weapon used in drug facilitated sexual assault, whether 
proactive or opportunistic, is probably alcohol.  
                                                
193 For more information see :  
http://www.acpo.police.uk/pressrelease.asp?PR_GUID={9A7F8325-C3BB-4C75-83EF-
0A8CB09B2D66 
194 Operation Matisse was a twelve month study into the nature of drug-facilitated sexual 
assault (DFSA) in England conducted by the three main services engaged in evidence 
collection for sexual offences: ACPO; the Forensic Science Service (FSS); and Sexual 
Assault Referral Centres (SARCs). Participants in the study were 120 police-referred victims 
who reported to the police that they had experienced or suspected a drug-facilitated sexual 
assault within the previous 72 hours. Blood and urine samples were collected and stored. A 
questionnaire detailing drug, alcohol and food consumption was specifically designed for use 
in this study. Fieldwork was conducted between 1/11/2004 and 31/10/2005. 
195 The ACMD is established under the Misuse of Drugs Act 1971 to keep under review the 
drug situation in the United Kingdom and to advise Government Ministers on measures that 
they feel should be taken for preventing the misuse of drugs or for dealing with the social 
problems connected with their misuse.  
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8.4 Drug use and prison 
8.4.1 Drug use in prison  
England and Wales 
From April 2006 to March 2007, 8.6 per cent Mandatory Drug Testing (MDT) were 
positive, indicating a continued fall in positive tests in prisons in England and Wales 
(10.3% in the previous year) (HM Prison Service 2007). 
Scotland 
Of 903 Addictions Testing Measure (ATM)196 tests carried out in 2005/06, 24 per cent 
were positive for drug misuse which had occurred while in prison (ISD Scotland 
2006).  A further 10 per cent were positive tests where the prisoner may have 
misused the drugs for which they tested positive before entry to prison.  These data 
are not comparable with MDT results previously reported. 
 
In Scotland, an annual Prisoner Survey is undertaken.  Results in 2007 (10th Prisoner 
Survey) showed that seven out of ten prisoners (69%) reported that they used illegal 
drugs in the year before coming into prison (ISD Scotland 2006).  Half of the 
prisoners (51%) reported that they had used drugs in prison at some point in the 
past.  The majority of those individuals (82%) reported that their drug use had 
changed during their current period in prison with most of these prisoners (74%) 
reporting a decrease in drug use in prison. 
 
Less than a third (30%) reported that they had used illegal drugs in the month 
immediately prior to survey completion.  A small minority of prisoners (3%; 100) 
reported injecting drugs in prison in the last month.  Of this minority, most (80%) 
stated that they had shared injecting equipment. 
  
The Scottish Prison Service (SPS) also undertook a Pre-release Survey in 2006/07 in 
an attempt to measure progress against Offender Outcomes.  This was conducted 
following a survey of all those prisoners who had been sentenced to six months 
imprisonment.   Each prisoner was contacted prior to release and asked to complete 
a short questionnaire to assess the impact of their imprisonment in terms of the 
Offender Outcomes.  Results in relation to substance misuse and future offending 
showed that: 
• two in five respondents (40%) reported that they were not a drug user; 
• of those who indicated that they were drug users, in response to the question: 
“My drug taking has decreased in prison during this sentence.”, 83 per cent 
indicated that their drug use had decreased, 14 per cent that it had remained at a 
similar level, and 4 per cent that it had increased; and 
• in response to the question: “My chances of not coming back into prison in the 
next twelve months have improved during this prison sentence”, two-thirds (63%) 
expressed the view that their chances of not coming back into prison had 
improved during this prison sentence (Internal communication ISD Scotland 
2006). 
                                                
196 An Addictions Testing Measure (ATM) was introduced in 2005, replacing Mandatory Drug 
Testing (MDT) in Scotland.  ATM is carried out on five per cent  of the prison population, three 
times a year.  The results are anonymous and cannot be attributed to the individual tested.  
This contrasts with the previous system of MDT for which tests were carried out monthly on 
10% of the prison population and were attributable to specific prisoners, with penalties for 
positive results.  By making the results of the new measure anonymous prisoners who had 
taken drugs did not attempt to conceal the fact.  This measure is designed to better inform the 
interventions required for prisoners, rather than penalising them.  Participation in the ATM 
tests is voluntary for all prisoners.  For these reasons the results of ATM are not comparable 
with previous figures published which were obtained through MDT. 
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Northern Ireland  
Mandatory Drug Testing (MDT) has not been implemented.  However, voluntary drug 
testing (VDT) is carried out in each establishment.  Of 3,811 VDTs carried out 
between 1 December 2005 and 31 November 2006, 79.09 per cent were negative.197  
8.5 Social costs  
An updated estimate of the economic and social costs of Class A drug use in 
England and Wales is €22.26 billion in 2003/04, equating to €63,940 per year per 
problematic drug user (Gordon et al. 2006).198  The associated confidence range is 
between €22.1 billion and €23.3 billion.  It is suggested that problematic Class A drug 
use accounts for most of the total costs (99%, or €22.1 billion).  Drug-related crime 
accounts for the largest proportion of cost (90%, or €20.1 billion).  
 
The Scottish Government has commissioned research to assess the scale and 
impact of illicit drugs in Scotland, the research will produce an initial estimate of the 
economic and social costs associated with illicit drug use. 
 
Reuter and Stevens (2007) in their report on drug policy in the UK suggest that 
estimates used to provide crime costs are in fact debatable, as they are extrapolated 
from a relatively small number of highly criminally active drug users in the National 
Treatment Outcome Research Study (NTORS) sample to the much larger population 
of problematic drug users. 
                                                
197See:http://www.niprisonservice.gov.uk/module.cfm/opt/14/area/Drug%20Report/page/drugs
eizures/ 
198 Since the original estimates were first published in 2000, a number of methodological and 
data improvements have been made to estimate the economic and social costs of Class A 
drug use.  These relate to the inclusion of additional health harms, criminal justice system 
costs of drug-related crime, victim costs of drug-related crime and the more up to date and 
estimates of the prevalence of problematic drug use.  It is suggested that given these 
changes, total cost estimates in 2000 and 2003/04 are not comparable. 
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9. Responses to social correlates and consequences  
9.1 Overview 
Social reintegration is a key element of the drug strategies in the United Kingdom.  
Responsibility for responding to the social correlates and consequences discussed in 
Chapter 8 rests with a number of Government departments and agencies.  There are 
various programmes to help drug users.  The Supporting People Programme, 
introduced in 2003, provides housing related support to vulnerable groups generally, 
including people with drug problems.  Progress2work (p2w), initiated in 2002 
supports those who are drug free or stabilised, in gaining employment.  The Building 
Safer Communities Fund aims to build communities that are resistant to drugs.  
Social inclusion programmes such as Positive Futures can bridge the gap between 
universal and targeted services (see Chapter 3).   
 
The Drug Interventions Programme (DIP) was established in England and Wales in 
2003 to reduce drug-related crime.  DIP is a major programme designed to ensure 
that offending problem drug users access not only treatment services, but also other 
services addressing other needs, for example accommodation and employment, to 
assist in reintegration.  In Scotland drug testing on arrest is being piloted and also, 
Drug Treatment and Testing Orders; each designed to help access drug users into 
treatment.  
 
In prison a balance is struck between deploying robust security measures and 
supporting the rehabilitation of offenders.  Measures to prevent drugs entering prison 
include: clearly-defined searching procedures covering all possible routes; passive 
and active drug dogs with passive dogs available to all prisons; CCTV surveillance of 
all social visits areas and low-level fixed furniture in Category C (low security) prisons 
and above; comprehensive measures to tackle visitors who smuggle or attempt to 
smuggle drugs, including closed visits, visit bans and police arrest.  Since April 2006, 
in England and Wales, responsibility for prison health services has been fully 
devolved to the National Health Service, and an Integrated Drug Treatment System 
(IDTS) has been developed to improve the availability and quality of drug treatment 
in prison, bringing it on a par with treatment in the community.  For the first time in 
the United Kingdom a syringe – exchange programme is currently being piloted in 
one Scottish prison.  
 
Current attention is also focused on the impact of the parental drug use on children 
(see Chapters 3 and 13).  In addition, there is a growing number of responses to 
neighbourhood problems associated with problem drug use, including drug dealing.  
For example, the Anti-Social Behaviour Act 2003 seeks to stop the use of premises 
for drug dealing.  Also, there is guidance to tackle the inappropriate disposal of drug 
paraphernalia. 
9.2 Social reintegration 
The Social Exclusion Task Force, based in the Cabinet Office, has invited 
researchers to contribute to its Families-At-Risk Review.  This call for evidence is 
seen as an opportunity to help identify key lessons from practice and research that 
will be used to inform the direction of the review, and improve outcomes for some of 
the most excluded children and families.  The review covers all services for adults.199  
 
                                                
199 See: 
http://www.cabinetoffice.gov.uk/social_exclusion_task_force/publications/families_at_risk/ 
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In an article on drugs, crime and social exclusion, Seddon (2006) suggests that the 
drug-crime link should be understood as being underpinned by the processes of 
social exclusion.  
9.2.1 Housing 
It is noted in the consultation document on the new Drug Strategy that the support 
drug users need to re-establish their lives (including housing, employment and 
education) is not always readily available (HM Government 2007).  
 
In a research paper by Clare (2006), housing is seen as a commodity in demand 
amongst a group of people for whom accommodation may be problematic, insecure 
or non-existent.  Consequently it has an exchange value and can be bartered for 
other commodities or services, including drugs, sex, money or goods. 
Comprehensive Rent Deposit Model  
A second quarterly progress update and two seminar reports produced in July 2006 
and March 2007 about the Comprehensive Rent Deposit Model reported in the 
previous United Kingdom Focal Point report are available on CD-ROM and the 
www.drugs.gov.uk website.  Whilst funding ended March 2007, practice and learning 
continues to be promoted.   
Preventing Homelessness  
Working in partnership with Communities and Local Government (a Government 
Department), the Ministry of Justice, the Department of Health, the National 
Treatment Agency and the Home Office, the Drug Interventions Programme has 
been able to: 
• Continue to promote practice and learning from the implementation of the 
Comprehensive Rent Deposit Model in 13 DAT areas.  Quarterly progress 
updates and seminar reports produced in July 2006 and March 2007 are available 
on CD-ROMs and the www.drugs.gov.uk website.   
• Gain agreement of the use of common housing terminology to be used to describe 
housing/accommodation status.  This has been adopted in the revised Drug 
Interventions Record (DIR) used from April 2007. 
9.2.2 Education, training 
NO NEW INFORMATION AVAILABLE  
9.2.3 Employment 
NO NEW INFORMATION AVAILABLE  
9.2.4 Basic social assistance 
Families of drug misusing offenders  
A consultation, Partners in Reduction: Engaging and Involving Families in the 
Reduction of Substance Related Problems in Prison, published in 2005, and a review 
report published by the National Offender Management Service (NOMS) Prison 
Service Drug Strategy Unit, identified gaps in provision and support for families of 
drug misusing offenders at points in the criminal justice system, particularly around 
arrest and on release. Around Arrest, Beyond Release: the experiences and needs of 
families in relation to the arrest and release of drug using offenders, was 
subsequently commissioned by DIP to further inform what provision may be needed 
to support families of drug using offenders.  This report was circulated to 
stakeholders in July 2006. 
See also DIP, below.  
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9.3 Prevention of drug related crime 
9.3.1 Assistance to drug users in prison 
In England and Wales the Drug Interventions Record (DIR), which is used with many 
drug-misusing offenders to improve continuity of care, has been reviewed.  The 
revised form introduces a requirement for a follow-up assessment.200 
Prevention 
See Mandatory Drug Testing in England and Wales, and the Addictions Testing 
Measure in Scotland (Chapter 8.4).  In Northern Ireland, while legislative authority for 
Mandatory Drug Testing (MDT) has been provided by Parliament it has not been 
implemented.  Voluntary drug testing (VDT) is carried out in each establishment to 
act as a deterrent to prisoners.  
Harm reduction 
See section on treatment in prison below. 
Treatment 
In 2006 the Home Office was taken to court over their failure to offer any treatment to 
prisoners suffering opiate withdrawal on the grounds that this was damaging to 
prisoners’ welfare and possibly a factor in ‘self-destructive behaviours’.  These cases 
concern action against medical practice in prison which dates back to the early 
1990s.  The Home Office agreed to compensate six prisoners.201 
Clinical Management of Drug Dependence in the Adult Prison Setting 
In England and Wales, new guidance recognises the need for more humane drug 
treatment for prisoners, better coordinated with any treatment they may already have 
been receiving and better preparation for their release. Clinical Management of Drug 
Dependence in the Adult Prison Setting (DH 2006a) describes how clinical services 
should develop during the next two years as increasing resources permit.  It is 
formulated as a treatment model, covering reception up to and beyond 28 days 
thereafter.  It sets out the key components: reception screening; assessment; clinical 
management and psychosocial interventions.  It is suggested that while detoxification 
may remain the preferred method of clinical management, a range of clinical 
treatment options are required to manage the varied and complex needs of this 
patient group.  
Guidance on the delivery of drug treatment services to meet the prisons needs of 
black and minority ethnic prisoners. 
Roy et al. (2007) have published guidance to support those responsible for the 
development and delivery of drug treatment services, which meet the needs of Black 
and minority ethnic prisoners.  The guidelines were commissioned by the National 
Offender Management Service for England and Wales. 
Social reintegration 
See Drug Interventions Programme in section 9.3.2 below with respect to England 
and Wales.  
 
The Home Office suggests that there is growing evidence supporting the benefits of 
involving families of drug misusers in the treatment process.  Initial findings from the 
Partners in Reduction: Engaging and Involving Families in the Reduction of 
                                                
200 For more information see: 
 http://www.drugs.gov.uk/drug-interventions-programme/guidance/DIR 
201 For more information see: 
http://www.politics.co.uk/news/public-services/prisons/prison-rehabilitation/prisoners-
compensated-over-cold-turkey-treatment-$457586.htm 
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Substance Related Problems in Prisons (NOMS 2005) consultation, and a review 
report produced by NOMS Prison Service Drug Strategy Unit (DSU), identified gaps 
in provision and support for families of drug misusing offenders at points in the 
criminal justice system, particularly around arrest and on release.  Around Arrest, 
Beyond Release: the experiences and needs of families in relation to the arrest and 
release of Drug using offenders (Home Office 2007d) was subsequently 
commissioned by the DIP team at the Home Office to further inform what provision 
and support may be needed to support families of drug using offenders.  This report 
was completed and circulated to stakeholders in July 2006. 
Community links 
See Drug Interventions Programme in section 9.3.2 below with respect to England 
and Wales  
9.3.2 Urban security policies in the prevention of drug related crime  
The Drug Interventions Programme (DIP) 
It is reported by the Home Office that since the onset of DIP in 2003 recorded 
acquisitive crime, to which drug related crime makes a significant contribution has 
fallen by 20 per cent (Home Office internal communication). 
 
There has been a large increase in the number of drug-misusing offenders entering 
treatment through DIP; currently there are over 3,000 drug misusing offenders a 
month entering treatment, compared with just over 400 in March 2004.  It is reported 
that this number has increased markedly since April 2006 when testing on arrest and 
required assessment was introduced.  The target to engage I,000 offenders per week 
in treatment by March 2008 has been exceeded.  As at January 2007, over 75,000 
drug misusing offenders had entered treatment through DIP since the programme 
began.   
 
Since 1 April 2007, there have been two parts to the required assessment: the initial 
and the follow-up assessment.  Sanctions exist, and will be enforced, against those 
who fail to attend and remain for either part without good cause.  The Home Office 
publication Rebalancing the Criminal Justice System in favour of the law abiding 
majority (2006) included a commitment to align the Prolific and Priority Offenders 
(PPO) Programme more closely with the Drug Interventions Programme.  Good 
practice guidance for partnerships was drawn up and published following widespread 
consultation with practitioners and a series of regional stakeholder events. 
 
By June 2007, over 96 per cent of Prolific and Priority Offender schemes had 
successfully aligned with DIP, with plans to do so in. 
 
It is also suggested that there is some evidence that offenders who completed Drug 
Treatment and Testing Orders (DTTOs), the predecessor of the Community Order 
with a Drug Rehabilitation Requirement (DRR), have greater reductions in offending 
and drug use than those who failed to complete.  Numbers of offenders starting and 
completing DRRs are rising.  Numbers starting DTTOs/ DRRs have increased from 
about 6,000 in 2000 to nearly 16,000 in 2007.  Completions have increased from 
about 28 per cent to 44 per cent in the same period.  Latest data (Sept 07) indicates 
that 84 per cent per cent of offenders on DRRs are retained in treatment for at least 
12 weeks. Courts appear to have confidence in the DTTO/DRR.  They are made in 
over 90 per cent of cases where they have been proposed in pre-sentence reports. 
(Home Office internal communication). 
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Evaluation of the Restriction on Bail Pilot 
An evaluation of the Restriction on Bail (RoB) Pilot202203 found that it was successful 
in terms of channeling defendants into drug treatment, but its impact on drug use and 
offending is less clear (Hucklesby et al. 2007). 
Evaluation of Drug Interventions Programme pilots for children and young people  
An evaluation of pilot drug testing on charge and arrest referral schemes204 for young 
people aged 18 years and younger considered the effectiveness of such 
programmes as a means of identifying young people at risk of becoming PDUs and 
referring them for appropriate help to reduce drug use and crime (Matrix Research 
and Consultancy and Institute for Criminal Policy Research, Kings College 2007).205  
The evaluation also considered Drug Treatment and Testing Requirements 
(DT(T)Rs).  
 
The research found that in the drug testing on charge schemes few young people 
used Class A drugs (5%).206  A higher proportion of those who tested positive were 
older (10% of 17 year olds compared to 3% of 14 year olds).  
 
Amongst those involved in arrest referral schemes, self-reported use of Class A 
drugs was also low, cocaine (4%), crack (1%) and heroin (1%).207  However, use of 
alcohol (23%), tobacco (30%) and cannabis (30%) was high and over half of those 
who reported using each of these substances did so at least weekly.  Drug offences 
formed a low proportion of the arrests.  Arrest referral schemes identified and 
addressed a broad range of issues beyond offending and substance misuse and 
were effective in offering referrals for those who were not already in contact with 
services and also for those who were at an early point in their substance misuse.  
However, no change in subsequent offending was identified. 
 
                                                
202 The report drew on monitoring data collected in the pilot sites, reconviction and treatment 
data, court observations and interviews carried out with 61 defendants and 124 staff and 
stakeholders. 1,315 defendants had RoB imposed. 
203 Restriction on Bail forms part of the Government’s Drug Interventions Programme and 
provides for defendants who have tested positive for a specified Class A drug to be granted 
conditional bail if they have agreed, when offered, to undergo an assessment and participate 
in any proposed follow-up, including treatment.  The RoB condition was piloted in three areas 
(Manchester, Nottingham and Salford) between May 2004 and October 2005.  
204 Arrest referral schemes for children and young people (10 to 17 year olds) were piloted in 
ten areas; all were operational from August 2004.  On-charge drug testing of 14 to 17 year 
olds under Section 5 Criminal Justice Act (CJA 2003), piloted in five areas, has been 
operational from August 2004.  Statutory powers to test young people at the pre-sentence 
stage and while on licence also exist under the CJA 2003 but were not enacted during the 
evaluation period.   
205 The research took place over ten sites and included stakeholder interviews, interviews with 
young people, analysis of monitoring data, analysis of Youth Offending Team (YOT) ASSET 
data (The ASSET form is a tool used to assess why the young person has committed a crime 
and how to prevent them offending again) in pilot and comparator sites and analysis of cost 
data collected from various sources.  The evaluation comprised two distinct phases of field 
research. During the first phase, research was undertaken in all ten sites to review the 
development and early implementation of arrest referral and drug testing. In the second 
phase, field research focused on the five sites that piloted DT(T)Rs. For the purpose of this 
report, research is reported only for the five sites involved in all parts of the evaluation.  
Monitoring data were collected by the Home Office for all ten sites throughout the pilot. 
206 Approximately 1,500 individuals were tested 2,000 times between August 2004 and 
October 2005 across five sites, with the vast majority being tested only once. 
207 2,327 young people had contact with arrest referral between November 2003 and 
September 2005. 
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The evaluation found insufficient evidence to roll out drug testing for under 18s. Due 
to the low number of DT(T)Rs issued during the research period there was 
insufficient evidence to support a wider roll out of DT(T)Rs and be able to draw any 
firm conclusions on their impact. 
Citizen participation 
NO NEW INFORMATION AVAILABLE  
Drug Treatment and Testing Orders in Scotland  
Drug Treatment and Testing Orders (DTTOs), superseded in England and Wales by 
Drug Rehabilitation Requirements (DRRs), continue to be applied in Scotland.  
Currently they are only handed down by the courts for high-tariff offenders, largely 
those convicted of large amounts of acquisitive crimes, but are to be extended to 
lower tariff offenders.  As the number of courts able to DTTOs has been extended to 
all Scottish courts, with the exception of District Courts, the number of orders 
imposed has increased to approximately 600 per year.  An evaluation of the pilot 
schemes pointed to DTTOs having had a positive and dramatic impact on drug use 
and offending which was sustained for at least 6 months into the orders.  Offenders 
reported marked reductions in drug use and drug-related offending since being 
placed on a DTTO, with an average weekly expenditure of €84 on drugs six months 
into a DTTO compared to a weekly expenditure of €719 before being given an 
order.208 
Drug testing on arrest in Scotland  
In June 2007, the Police, Public Order and Criminal Justice (Scotland) Act 2006 
launched mandatory drug testing and referrals for all those brought to custody aged 
16 and over. Three pilot schemes have been set up in Glasgow, Edinburgh and 
Aberdeen.  Post conviction measures also exist.209 
Multi-agency collaboration 
See DIP above.  
Throughcare and aftercare 
See DIP above. 
Peer Led Support  
There is a growing understanding that the gains made in health, improved social 
circumstances and reduction in offending, which arise from successfully completing 
drug treatment in the community or prison, may be lost if ongoing support is not 
provided to drug users.  Peer led support is seen as part of the aftercare package of 
support.  Currently, it is provided in a variety of different ways across England and 
Wales.  Peer-led approaches for ex-drug users to meet diverse needs: A Practice 
Guide (Home Office 2006b) suggests a clear pathway from treatment into peer led 
support should be identified and that good practice and differing approaches should 
be shared more consistently. 
24/7 Client Phone Line for DIP clients  
The 24-hour, single point of contact phone numbers are now available to support DIP 
clients in 93 per cent of DAAT areas (140) in England, and in Wales.210   
                                                
208 For more information see: http://www.scotland.gov.uk/News/Releases/2001/09/160 
209 For more information see: http://www.scotland.gov.uk/News/Releases/2006/10/12103849 
210 See: http://www.drugs.gov.uk/drug-interventions-programme/strategy/throughcare-
aftercare/  
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Prolific and other priority offenders  
An impact assessment of the Prolific and other Priority Offender (PPO) programme 
(Dawson and Cuppleditch 2007) examined the implementation, interventions and 
outcomes of the first cohort of prolific and priority offenders who entered the PPO 
programme in 2004 (See Chapter 8.3.1 for information on methodology).211  All but 
one of the 48 PPOs interviewed had used illegal drugs. .  The preceding Early 
Findings from the Prolific and Other Priority Offenders Evaluation (Dawson 2005) 
examined Offender Assessment System (OASys) reports to identify factors linked to 
offending.  This found that the PPO cohort presented higher levels of most 
criminogenic needs than the OASys sample, including those around drug misuse. 
Sixty-one per cent of the PPO cohort had needs relating to drugs misuse, compared 
to 26 per cent of the OASys sample. 
 
It was found that: 
• in the 17 months following entry onto the programme there has been a 43 per 
cent reduction in offending ; 
• in this time there was a reduction of 62 per cent in the overall level of convictions; 
• the average rate of offending fell from 0.51 convictions per month per PPO in the 
12 months prior to entry onto the scheme, to 0.39 for the 12 months following 
entry, a reduction of 24 per cent; and  
• there was a marked decrease in the number of days between committing their 
offence and being sentenced in court in the year following entry on the 
programme.  
 
However, researchers concluded that it is not possible to state the extent to which 
the reduction in offending observed in the PPO cohort was solely attributable to the 
PPO intervention.  
Victim support interventions 
NO NEW INFORMATION AVAILABLE  
Prostitution  
The Government’s coordinated strategy on prostitution (published in January 2006) 
recognised the need to reform the offence of loitering or soliciting for the purposes of 
prostitution, in order to meet the needs of those involved in prostitution and to 
address directly the factors that keep them tied to the street. Provisions in the 
Criminal Justice and Immigration Bill (published in June 2007) include proposals to 
introduce a new penalty for those convicted of this offence. The new penalty, which 
will be available as an alternative to a fine, will require the offender to attend a series 
of three supervised sessions to begin to address the reasons behind their 
involvement in prostitution, which could include sessions with a drug treatment 
agency. 
 
                                                
211 A number of complementary research methods were used which, when taken together, 
aimed to provide a reasonable indication of the impact of the PPO programme. The methods 
used were a combination of offender interviews, PPO staff interviews, an analysis of the 
offending of PPOs prior to and following their entry onto the PPO programme, and an attempt 
to draw comparisons between any changes in PPO offending with an appropriate control 
group identified using a statistical technique called Propensity Score Matching (PSM). A total 
of sixty interviews were undertaken with PPOs from PPO schemes in each of the ten 
Government Office regions.  Forty-eight interviews were with PPOs currently on the scheme 
at the time of the interviews, whilst 12 had been deselected.   Fifty-two interviews were 
undertaken with key PPO staff (representing police, probation and Crime and Disorder 
Reduction Partnership representatives) from one PPO scheme in each of the ten Government 
Office regions.  
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The Scottish Government recently published Guidance for Local Authorities and their 
Community Planning Partners on Tackling Street Prostitution (Scottish Government 
2007).  This focuses on five key elements of a comprehensive strategy to address 
street prostitution: 
• challenging attitudes which lead to a demand for prostitution; 
• preventing vulnerable young people from becoming involved in prostitution; 
• minimising the harm and risk encountered by women who are involved in street 
prostitution; 
• assisting women to leave prostitution; and 
• enforcing the law, disrupting street sex markets and protecting communities 
affected by the presence of street prostitution. 
 
The Prostitution (Public Places) (Scotland) Act 2007), which come into force in 
October 2007 will provide Scotland with the toughest legislation on kerb crawling in 
the UK and sends an unequivocal message to those who create the demand for 
street prostitution.212 
Rape  
In their report on drug facilitated sexual assault Advisory Council on the Misuse of 
Drugs (ACMD 2007b) (See Chapter 8.3.) recommended that: 
• the Association of Chief Police Officers (ACPO) enhance evidence gathering so 
that the forensic science services can test for date rape drugs;  
• the Department of Health ensure hospitals have early evidence kits to allow for 
similar tests;  
• the Government seek advice on whether the Sexual Offences Act should be 
strengthened;  
• drug facilitated sexual assault should be part of the British Crime Survey (BCS) 
213 and be recorded by police; and  
• schools and other educational establishments should alert people to take 
common sense measures, such as minding drinks, to avoid being a victim.  
 
To avoid being a date rape victim the ACMD is encouraging people to:  
• avoid going to a club, pub or party alone;  
• not accept a drink from strangers;  
• not share or exchange drinks;  
• not leave your drink unattended even when going to the toilet; and  
• be a friend by watching out for others, and be aware of any changes in their 
behaviour.  
 
The Scottish Government’s Know the Score information and media campaign, 
developed with the Scottish Crime and Drug Enforcement Agency (SCDEA), Who’s 
Keeping an Eye on your Drink214 campaign, has been complemented by local police 
force initiatives, including the Get Real DVD which includes information about drug 
assisted sexual assault (DASA).  The DVD is used by police officers in their work 
with schools.  SCDEA are working with partners who provide support and advice to 
victims and to obtain better data on Scottish trends and frequency.   
 
                                                
212 See: http://www.scptland.gov.gov.uk/Publications/2007/09/prostitutionact2007 
213 The British Crime Survey is a continuous victimisation survey in which a representative 
sample of adults aged 16 or over living in private households are asked about their 
experience of crime.  
214 This campaign has run repeatedly since winter 2003/4, usually in the run-up to the 
Christmas 
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An independent assessment of the sensitivity and specificity of two commercially 
available ‘drug-facilitated sexual assault’ drug detector kits highlighted concerns 
regarding their use by the general public215 (Beynon et al. 2006).  Neither of the 
tested kits demonstrated high levels of sensitivity, specificity or utility under 
laboratory conditions.  For example, the kits correctly identified the presence of a 
drug in only 69 per cent of cases. The authors concluded that the use of these kits by 
the public in the night-time environment needs further investigation as they may 
create a false sense of security (false negatives) and undue concern (false positives) 
among kit users. 
Interventions for drug-using offenders in the courts, secure establishments and the 
community: Cochrane Systematic Reviews 
In a systematic review of interventions for drug-using offenders in the courts, secure 
establishments and the community, Perry et al. (2006)216 concluded that there was 
limited evidence of the effectiveness of drug treatment programmes for drug-using 
offenders in the courts or the community.  However, it was found that therapeutic 
communities with aftercare showed promising results for the reduction of drug use 
and criminal activity in drug using offenders.  The lack of evidence is reported to be 
partly due to broad range of studies and the wide range different outcome measures 
presented.  It was suggested that standardised outcome measures and costing 
methodology would help improve the quality of research conducted in the area.   
Analysis of drug policy  
Reuter and Stevens (2007) in their analysis of the United Kingdom drug strategy 
argue that given that there are many other influences on crime in addition to drug 
use, including “unemployment, inequality, demographics, fashion, the availability and 
price of consumer goods, detection and imprisonment rates and the use of locks and 
other situational crime prevention measures”, and given the lack of correlation 
between British crime rates and the prevalence of Class A drug use it is difficult to 
discern the effect of drug policy on overall crime rates and “therefore, changes in 
crime rates are not directly indicative of the effectiveness of drug policy.” 
 
They further suggest that, given that the link between drugs and crime is much more 
complicated, it is unlikely that drug treatment can achieve the reductions in overall 
crime rates that have been claimed for it. 
 
McSweeney et al. (2006) reporting findings from their pan–European study of 
coerced treatment suggest that, increasingly, measures are being introduced that 
coerce drug users, identified through the criminal justice system, into treatment, 
through provisions of the 2005 Drugs Act and the ‘Tough Choices’ agenda (both 
reported in the previous United Kingdom Focal Point report), in particular, the Drug 
Rehabilitation Requirement.  It is noted that pan-European research on clients 
entering treatment through the courts report significant and sustained reductions in 
drug use and offending and also improvements in other areas of social functioning, 
as did those entering treatment through non-criminal justice routes.  However, it is 
argued that coerced treatment, particularly given high expectations of offenders, may 
not always be appropriate.  
                                                
215Standard drug doses of GHB, ketamine, temazepam, flunitrazepam were added to 
solutions of cola, beer, ‘alcopop’ and distilled water. Testing was undertaken in accordance 
with instructions on the packaging of each kit. Each kit was tested 10 times for each 
drink/drug or placebo combination. Two independent raters scored each test result 
(presence/absence of drug) according to the kit instructions.  
216 Twenty four studies, 8,936 participants, met the inclusion criteria of Randomised 
Controlled Trials designed to reduce, eliminate or prevent relapse in drug using offenders for 
the review. 
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Diversity manual 
A diversity manual has been issued by the Home Office217, this is to be employed by 
regional crime and drug teams and local partnerships to assist in:  
• understanding the legislation requiring public sector bodies to eliminate 
discrimination and promote equality; 
• identifying key tasks relating to diversity; 
• identifying the needs of all local communities; 
• engaging local communities; and 
• delivering services appropriate to the needs of specific communities. 
Expressions of interest for drug detection using low angle x-ray scatter 
The Home Office has called for expressions of interest in research to investigate 
whether low angle x-ray scatter has the potential to be able to detect illicit drugs, 
quickly, in an operational environment.  The basis of the work, with reports and data 
forming the majority of the deliverables, includes: 
• the population of a database containing diffraction profiles of illicit drugs, 
cutting agents, packaging and other pertinent substances; 
• development of a model for detection of illicit drugs; 
• investigation of the statistical quality of the data; 
• refinement and testing of the developed model; 
• investigation into defeating mechanisms; and 
• system design, identifying components and practicality of use. 
 
It is required that prototype design be finalised within two years.218  
Review of the reporting of crime statistics 
An independent review has made recommendations on changes that should be 
made to the production and release of crime statistics219 suggesting a shift from the 
publication of aggregate national figures to a system of communication which 
encompasses data at local level between police and their neighbourhood 
communities (Home Office 2006c).  Amongst a number of recommendations was that 
the British Crime Survey sample frame should be extended to include those under 16 
and those living in group residences as soon as practical after taking the advice of 
those with relevant expertise and piloting the changes.   
                                                
217 For more information see: http://drugs.homeoffice.gov.uk/publication-search/drug-
strategy/DiversityManual 
218 For more information see: http://scienceandresearch.homeoffice.gov.uk/hosdb/drug-
detection/  
219 These are police recorded crime statistics and the British Crime Survey.  
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10. Drug markets 
10.1 Overview 
The United Kingdom Threat Assessment of Serious Organised Crime 2006/07 report 
suggests that, “The United Kingdom is one of the most lucrative markets in the world 
for traffickers in Class A drugs (heroin, cocaine powder, crack cocaine, ecstasy)”.  
The overall picture is one of ready availability throughout the United Kingdom (SOCA 
2006).  
 
Heroin: Most identified supply chains to the United Kingdom follow well-established 
trafficking routes.  The primary trafficking route is overland from Afghanistan to 
Europe, transiting from Iran to Turkey before being moved to the Balkans, and then 
overland to Europe.  In addition, a large amount of Afghan heroin arrives directly by 
air routes from Pakistan, via couriers and parcels. 
 
Cocaine: The Iberian Peninsula, predominantly Spain, and the Netherlands, continue 
to be the main entry points into Europe for shipments of cocaine from the South 
Americas (primarily Colombia and Venezuela).  Shipment routes transiting the 
Caribbean and West Africa are also common with organised crime groups.  It is 
believed cocaine enters the United Kingdom via ports in the South East of England.  
 
Ecstasy: Almost all of the ecstasy consumed in the United Kingdom is manufactured 
in the Netherlands or Belgium, and commonly enters by sea through Harwich, 
Felixstowe and Dover.  A greater number of sites making up tablets have been found 
than laboratories, mostly in the North of England.  Synthetic drug production in the 
Netherlands and Belgium relies heavily upon precursor chemicals made in China, 
obtained through criminal networks from Chinese companies.  
 
Cannabis: Cannabis is imported into the United Kingdom from Europe in bulk by 
serious organised criminals, sometimes in mixed loads alongside Class A drugs, and 
in smaller amounts for sale and for personal use.  In addition, there are indications 
that intensive hydroponic cultivation of cannabis is occurring in the United Kingdom. 
 
The overall picture of United Kingdom drugs distribution appears increasingly 
complex and diverse.  However London, Birmingham and Liverpool continue to be 
important centres for the distribution of all types of drugs to all areas of the United 
Kingdom.  Dual supply of heroin and crack cocaine are now well established in most 
parts of the United Kingdom and not solely at street level. In Scotland, the main 
source of heroin from Liverpool via the Glasgow area. Crack cocaine seizures have 
risen, particularly in Aberdeen and Edinburgh; however there is a lack of intelligence 
that supports the existence of 'crack houses' in Scotland. 
 
In general the quantity of seizures has been rising in the United Kingdom; cannabis 
being the most seized drug.  However, SOCA reports that arrests and seizures 
mainly in Class A drugs have achieved short-term disruptions rather than a sustained 
reduction in the size of the United Kingdom drugs market.  
 
The most recent estimate of the size of the illicit drug market in the United Kingdom 
is £5.3 billion (€7.7 billion) in 2003/04, with a wide margin of error of £4.0 billion to 
£6.6 billion220.  The Scottish Government has commissioned research to assess the 
                                                
220 The study used a survey-based demand side approach to estimate market size. Data from 
the Schools Survey 2003, the Offending Crime and Justice Survey 2003 and the Arrestee 
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scale and impact of illicit drugs in Scotland.  One part of this will aim to produce an 
initial estimate of the size/value of the illicit drug markets in Scotland. 
10.2 Availability and supply 
10.2.1 Availability in the general population 
Given the prevalence of drug in the population (see Chapter 2), questions on drug 
availability are not reported for the adult population.  
10.2.2 Availability amongst school children 
The Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS) 
(see Chapter 2) asks questions on whether pupils had ever been offered drugs and 
ease of obtaining drugs.  In 2006: 
• 53 per cent of 15 year olds had ever been offered drugs, a fall from 63 per cent in 
2004; 
• The most common drug to have been offered was cannabis (44%) followed by 
ecstasy (18%), poppers (16%) and cocaine (13%); 
• 48 per cent of 15 year olds believed it was very easy or fairly easy to obtain drugs 
compared to 58 per cent in 2004; and 
• Only 27 per cent of those who had never tried drugs thought drugs were easy to 
obtain compared to 88 per cent of those who took drugs each day. 
 
The survey also asked where pupils had obtained their drugs from the last time they 
had used them.  Seventy-four per cent of 15 year olds who had taken drugs obtained 
them from a friend (the same age or older), four per cent from a brother or sister and 
one percent from parents.  Amongst 13 year olds who had taken drugs, six per cent 
had obtained them from a brother or sister and eight per cent from a parent (including 
step parent) (ISD Scotland 2006). 
10.2.3 Production, sources of supply and trafficking patterns within the country and 
some from and towards other countries 
Research suggests that the overall picture of United Kingdom drugs distribution is 
increasingly complex and diverse.  London, Birmingham, Bristol, Nottingham, 
Glasgow and Liverpool are important centres for the distribution of all types of drugs 
to all areas of the United Kingdom.  Dual supply of heroin and crack cocaine is now 
well established in most parts of the United Kingdom and not solely at street level 
(Government internal communication).    
 
The Home Office has commissioned research involving interviews with convicted 
drug traffickers and dealers to understand how high level drug dealers operate and 
how markets for illicit drugs work.  The results are due to be published in autumn 
2007. 
10.3 Seizures 
Latest information on seizures in the United Kingdom is for 2005 and provided 
information for all law enforcement agencies except for customs data for Scotland.  
There were 189,032 seizures of drugs in the United Kingdom in 2005, a 42 per cent 
increase from the previous year.  Increases are reported for all drugs, the largest 
                                                                                                                                         
Survey 2003-04 were analysed to estimate the prevalence of drug use, frequency of use 
quantity used and expenditure on drugs by juveniles, the general adult population and adult 
arrestees.  Estimates of price and quantities were compiled from a number of sources 
including NICS price data and FSS purity data. The estimate was based on data sources for 
England and Wales and extrapolated to the United Kingdom as a whole. 
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being for herbal cannabis (74.2%), cannabis plants (44.6%), and cocaine (51.5%).  
There was a decrease in the quantity of seizures for a number of drugs including 
herbal cannabis, cannabis resin, cocaine, crack and heroin (Table 10.1).   
Table 10.1: Number of seizures of drugs by law enforcement agencies in the United Kingdom, 
2003 to 2005 
Drug  2003 2004 2005 % change 
from 2004  
Amphetamines 6,952 7,254 8,656 + 19.3
Cannabis – herbal 36839 42,814 74,575 + 74.2
Cannabis – resin 60,068 52,218 59,204 + 13.4
Cannabis plants  2,904 2,995 4,331 + 44.6
Cocaine  7,707 8,763 13,272 + 51.5
Crack 4,814 4,974 6,479 + 31.3
Ecstasy type 
substances  
7,577 7,388 7,539 + 2.0
Heroin 12,965 13,674 16,402 + 20.0
LSD 131 152 229 + 50.7
Source: complied from Standard Table by J. Corkery 
 
The quantity of cannabis plants seized increased substantially, as did LSD and 
amphetamines  (Table 10.2).  
Table 10.2: Quantity of seizures of drugs by law enforcement agencies in the United 
Kingdom, 2003 to 2005 
Drug  Unit measure 
for quantities 
2003 2004 2005 % change 
from 2004 
Amphetamines Kg 1,626 1,389 2,330 + 57.7
Cannabis – herbal Kg 29,412 21,496 20,650 - 3.9
Cannabis – resin Plant 65,379 64,920 50,395 - 22.4
Cannabis plants  Kg 83,972 95,103 212,971 + 124.0  
Cocaine  Kg 7,773 4,644 3,862 - 16.8
Crack kg 253 135 58 - 57.0
Ecstasy type 
substances  
tablet 
(000s) 
7,435 4,991 3244 - 35
Heroin  2,732 2,260 1,970 - 12.8
LSD dose 
(000s 50 23 131 
+ 469.6
Source: complied from Standard Table by J. Corkery 
 
In Scotland, police have closed more than 66 cannabis factories in the last 12 
months. Each drug factory, set up in either homes or business properties, was 
capable of housing up to 1000 plants and producing around €150,000 worth of 
cannabis (Internal communication September 2007, The Scottish Crime and Drug 
Enforcement Agency).  
Research 
Morgan et al. (2006a), looking at the association between availability of heroin and 
methadone and fatal poisoning in England and Wales between 1993 and found that 
trends in fatal heroin poisoning closely track heroin seizures.  They suggest that this 
lends support for the thesis that seizure data may be indicators of drug availability. 
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10.4 Price/purity 
10.4.1 Price of drugs at street level 
Drug prices in the United Kingdom come from a number of sources.  Law 
enforcement agencies221 collect national data on drug prices while the Independent 
Drug Monitoring Unit (IDMU)222 survey festival goers.  DrugScope conduct a random 
snapshot of drug prices in different areas of the United Kingdom but do not compile a 
national average223. 
 
Pudney et al.’s (2006) report on estimating the size of the illicit drug market suggests 
that price data in the United Kingdom is underdeveloped and that there is a need for 
more systematic monitoring of prices.  
Mean price of illicit drugs in the United Kingdom 
Data from law enforcement agencies show that the average price of amphetamines, 
crack, ecstasy and heroin fell in 2006, whilst cocaine and cannabis herb prices 
remained stable (Table 10.3) 
Table 10.3: Law enforcement agencies: Mean price of illegal drugs in the United Kingdom, 
2003 to 2006 
2003 2004 2005 2006 
Drug  
(price per gram) Exchange 
rate: 
€1.4246* = £1 
Exchange 
rate: 
€ 1.4401* = £1
Exchange 
rate: 
€ 1.4725* = £1 
Exchange 
rate: 
€ 1.486* = £1 
£9.00 £8.00 £10.00 £9.00 Amphetamines €12.82 €11.52 €14.73 €13.37 
£2.54 £2.54 £2.64 £2.68 Cannabis herb €3.62 €3.66 €3.89 €3.98 
£2.32 £2.00 £1.94 £2.12 Cannabis resin €3.31 €2.88 €2.86 €3.15 
£55.00 £51.00 £49.00 £49.00 Cocaine €78.35 €73.45 €72.15 €72.81 
£19.00 £18.00 £19.00 £18.00 Crack (per 0.2g) €27.07 €25.92 €27.98 €26.75 
£5.00 £4.00 £4.00 £3.00 Ecstasy** 
€7.12 €5.76 €5.89 €4.46 
£62.00 £55.00 £54.00 £52.00 Heroin €88.33 €79.21 €79.52 €77.27 
£3.00 £3.00 £3.00 £3.00 LSD €4.27 €4.32 €4.42 €4.46 
 
*Conversion rates are the monthly rates quoted by the Bank of England (December monthly 
averages – spot exchange rate) Euro to Sterling.  The source data in pounds (£) are provided 
in whole pounds. 
** Average price per tablet 
Source: Law Enforcement Agencies 
 
                                                
221 Seizures by police and HM Customs and Revenue 
222 IDMU is an independent commercial research organisation conducting research including surveys of 
drug users. They estimate drug prices by distributing random questionnaires at pop festivals combined  
in recent years with a web-based survey. 
223 Information collected by journalists from Druglink, the organisation’s magazine, who call drug 
services and police forces in 20 areas of the United Kingdom. 
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Average prices from the IDMU show similar trends with cannabis and LSD prices 
having remained stable and amphetamine and ecstasy prices falling.  Cocaine 
prices, however, continued to fall in 2006 (Table 10.4) 
 
Heroin and crack prices are difficult to estimate accurately as they are often sold in 
‘bags’ or ‘rocks’, which have been estimated to weigh 0.2g.  However, gram sale 
prices of crack reported by a small number of individuals in the IDMU survey are 
considerably lower than those based on bag or rock prices; the average price for a 
gram of crack in 2006 in rock prices is €131.81 compared to €68.60 for a gram sold 
as a gram.  This suggests that a rock of crack may be greater than 0.2g and is 
supported by laboratory analysis estimating the average weight to be around 0.3g (L. 
King personal communication). 
Table 10.4: Independent Drug Monitoring Unit: Mean price of drugs at street level 2004 to-
2006 
2004 2005 2006 Drug  
(price per gram) Exchange rate:
€ 1.4401* = £1 
Exchange rate:
€ 1.4725* = £1 
Exchange rate: 
€ 1.486* = £1 
£10.19 £9.37 £8.97 Amphetamines €14.67 €13.80 €13.33 
£5.69 £5.92 £5.74 Cannabis herb*** €8.19 €8.72 €8.53 
£2.83 £2.70 £2.62 Cannabis resin €4.08 €3.98 €3.89 
£45.27 £46.24 £43.18 Cocaine €65.19 €68.09 €64.17 
£83.52 £145.66 £89.85 Crack (per g) €120.28 €214.48 €133.52 
£3.59 £3.44 £3.03 Ecstasy** 
€5.17 €5.07 €4.50 
£54.74 £69.08 £54.99 Heroin €78.83 €101.72 €81.72 
£3.95 £3.90 £3.74 LSD €5.69 €5.74 €5.56 
*Conversion rates are the monthly rates quoted by the Bank of England (December monthly 
averages – spot exchange rate) Euro to Sterling.  The source data in pounds (£) are provided 
in whole pounds. 
**Average price per tablet      
***sinsemilla 
Source : Independent Drug Monitoring Unit 
10.4.2 Purity of drugs at street level and composition of drugs/tablets 
Information on the purity of drugs and composition of tablets is from the Forensic 
Science Service Ltd, covering most of England and Wales.  Latest data are for 2006 
and are shown in Table 10.5.  Potency of cannabis resin fell to 2004 levels after a 
rise in 2005 and potency of herbal cannabis fell close to 2003 levels.  The purity of 
heroin fell, though not by much and there has been no clear long-term trend since at 
least 1984.  Purities rise and fall almost randomly over short (months) and longer 
periods (1 to 2 years) with the long-term mean around 40 to 45 per cent for heroin (L. 
King - personal communication in 2006). Purity of ecstasy, cocaine and crack 
dropped considerably in 2006 while there was a small drop in the mean purity of 
brown heroin. 
 
Research suggest states that while average purity of cocaine seized by police has 
fallen, purity of cocaine seized by HM Revenue and Customs has remained stable, 
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suggesting increased adulteration within the United Kingdom (Government internal 
communication). 
Table 10.5: Street level mean percentage purity of drugs in the United Kingdom, 2003 to 2005 
Drug*  Year 
 2003 2004 2005 2006 
Amphetamines 10.8 9.0 10.1 10.6 
Cannabis resin 9.8 3.4 5.3 3.3 
Cocaine  51.2 42.4 42.7 34.5 
Crack 69.6 63.7 64.8 49.5 
Ecstasy 64.5 66.7 66.3 48 
Herbal Cannabis 10.7 12.7 13.5 11.3 
Heroin (brown) 32.7 39.9 46.5 43.5 
Heroin (white) - 50.0 -  
*For cannabis products the % THC content is shown; for ecstasy mg of MDMA base per 
tablet/unit is shown; and for other illicit drugs the % of pure substance is shown. 
Source: Forensic Science Service Ltd 2006 
10.4 Estimating the size of the United Kingdom illicit drug market 
A study by Pudney et al. (2006) estimated the size of the illicit drug market in the 
United Kingdom to be £5.3 billion (€7.7 billion224) in 2003/04, with a wide margin of 
error of £4.0 billion (€5.8 billion) to £6.6 billion (€9.6 billion)225.  The estimate was 
based on six categories of illicit drugs; cannabis, amphetamines, ecstasy, powder 
cocaine, crack and heroin.  It found that: 
• crack and heroin accounted for the largest expenditure share, 28 per cent and 23 
per cent respectively; 
• cannabis and cocaine accounted for about a fifth each; and 
• in volume terms the cannabis market was by far the largest, 20 times the volume 
of the heroin market. 
 
The authors estimated that 59 per cent of the market (by expenditure) is attributable 
to adult arrestees, 32 per cent to other adults and nine per cent to juveniles.  
Cannabis, cocaine and ecstasy were dominant in the general adult population whilst 
crack, heroin and amphetamines were common amongst the arrestee population. 
The Scottish Government has commissioned research to assess the scale and 
impact of illicit drugs in Scotland.  One part of this will aim is to produce an initial 
estimate of the size/value of the illicit drug markets in Scotland. 
                                                
224 Bank of England annual spot exchange rate, 1 April 2003 – 30 March 2004. 
225 The study used a survey-based demand side approach to estimate market size. Data from 
the Schools Survey 2003, the Offending Crime and Justice Survey 2003 and the Arrestee 
Survey 2003-04 were analysed to estimate the prevalence of drug use, frequency of use 
quantity used and expenditure on drugs by juveniles, the general adult population and adult 
arrestees.  Estimates of price and quantities were compiled from a number of sources 
including NCIS price data and FSS purity data. The estimate was based on data sources for 
England and Wales and extrapolated to the United Kingdom as a whole. 
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PART B: SELECTED ISSUES 
SUMMARY 
Public expenditures 
Labelled expenditure on drugs in the United Kingdom is collected at a national level 
and provides a good indication of government spend.  However, much of the 
expenditure data is aggregated at programme level and, without a detailed 
interrogation of local expenditure documents, it is difficult to classify using broad 
headings.  In 2005/06, labelled expenditure in the United Kingdom is estimated at 
€1.5 billion.  Using a number of sources, it is possible to identify and estimate 
attributable proportions of unlabelled expenditure across multiple government 
functions such as health, public order and safety, social protection and education.  
Estimated unlabelled expenditure for 2005/06 is €7.3 billion, two-thirds of which is 
public order and safety expenditure with almost a quarter (24%) spend on child and 
family social work.  Estimated overall expenditure is €8.7 billion which amounts to 
0.48% of GDP or €144.43 per capita.  
Vulnerable groups of young people 
There is a wealth of evidence to suggest that vulnerable young people, including 
looked after children, children of drug using parents, homeless youth, young 
offenders, school excludees and truants, those involved in commercial sex work and 
those from some black and minority ethnic groups, are more likely to use drugs than 
those not described as vulnerable.  As in the general population cannabis remains 
the most used drug, and amongst the very young, volatile substances.  While such 
young people are also at higher risk of being problematic drug users, evidence 
suggests use of heroin, crack and cocaine remains low.  Drug use is often one of 
many problems associated with vulnerable youth, many of whom belong to more 
than one group.  Therefore, while current drug strategies in the United Kingdom 
focus on the needs of these young people, policies on drug misuse are linked to 
wider programmes to meet the needs of the young, and to ensure that they are 
provided with appropriate interventions.  These are focused around integrated 
working between services at the local level to plan interventions, and the 
development of a common framework for assessing need, used by all professionals 
in contact with the young.  Early intervention strategies are becoming more common, 
particularly those that target families, rather than the child in isolation.  
Drug-related research  
An underlying principle of drug strategy in the United Kingdom is that it should be 
evidence based.  The overwhelming majority of drug research is funded through 
Government.  Examples of research informing drug policy by providing an evidence 
base predate current strategies, for example, the Task Force responsible for the a 
review of the effectiveness of drug treatment commissioned a number of pieces of 
research, which led to an understanding of the effectiveness of treatment and the 
major policy initiative to substantially increase treatment capacity.  Research is often 
undertaken to address specific gaps in knowledge, such as research into estimating 
the number of problem drug users.  Research into the effectiveness of prevention 
programmes has been funded and one of the largest education research 
programmes ever run aims to design, deliver and evaluate school prevention 
(Blueprint).  
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Chapter 11 Public expenditures 
This chapter has been written to provide information to the EMCDDA on a basis 
which will be as consistent as possible with that obtained by the other European 
National Focal Points. The aim of this is to enable the EMCDDA to report on drug-
related expenditure across Europe in a document to be published in 2008. The 
chapter therefore follows, as far as practicable, detailed guidelines established by the 
EMCDDA. A full and comprehensive study obtaining, for example, information from 
local agencies would be beyond the resources of the UK Focal Point. The figures 
presented should therefore, in many cases, be taken as indicative estimates and not 
definitive. Furthermore, they do not necessarily represent the most appropriate way 
of presenting the information for national purposes. 
 
The chapter distinguishes between labelled and unlabelled expenditure.  Labelled 
expenditure is spend included in budget and/or year-end reports that is drug-specific, 
and is proactive in that it is linked to the achievement of specific policy aims.  
Unlabelled expenditure, conversely, is often reactive with spend arising as a 
consequence of drug use.  This includes policing, prison accommodation and some 
health consequences.  However, unlabelled spend can also be proactive such as 
expenditure related to providing drug education in schools.  For the purposes of this 
chapter, labelled spend relates to drug-related expenditure with a departmental 
budget line that is drug specific while unlabelled spend relates to non-drug specific 
expenditure where a proportion may be attributable to drug use.  The distinction 
between proactive and reactive spend, used in previous United Kingdom cost 
research, is not made in this chapter. 
11.1 National estimates of LABELLED drug-related expenditures 
In the United Kingdom, responsibility for the drug strategy lies with a number of 
departments with the Home Office providing the overall lead.  Devolution of powers 
to the administrations in Northern Ireland, Scotland and Wales means it is 
increasingly difficult to produce a United Kingdom estimate of drug-related 
expenditure. This is compounded by devolution of spend to the local level across the 
United Kingdom.  
 
Her Majesty’s Treasury breaks down government spend using the Classification of 
the Functions of Government226 (COFOG) categories (see 11.2.1).  However, no 
information is available on how each individual drug-related expenditure item (listed 
in Table 11.1) is classified using COFOG. The monitoring of United Kingdom drug-
related expenditure is often linked to programme expenditure which presents 
difficulties when trying to disaggregate programme components into COFOG 
categories. This is also true of attempts to categorise expenditure using Reuter’s 
classification of drug-related programmes as primarily enforcement, harm reduction, 
prevention or treatment programmes (Reuter 2006).  
11.1.1 Results and analysis of national drug-related expenditure 
Table 11.1 presents national labelled drug-related expenditure for the United 
Kingdom financial year 2005/06.  This covers the period from 1st April 2005 to 31st 
March 2006.  As mentioned above, expenditure is monitored for individual 
programmes and funding streams.  Consequently it is difficult to combine data from 
across the United Kingdom to provide a simplified table of drug-related expenditure.  
 
                                                
226 For further information see: http://unstats.un.org/unsd/cr/registry/regcst.asp?Cl=4  
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Table 11.1 shows that in 2005/06 labelled drug-related expenditure amounted to 
€1465.1million (£1001.5m). 
Table 11.1: Labelled drug-related expenditure in the United Kingdom, 2005-06 classified by 
COFOG and Reuter 
Expenditure €m* £m COF
OG 
Reuter 
England 
Local Mainstream Funding 298.4 204 07.2 Treatment 
Pooled Treatment Budget (includes 23.1m 
transfer to YPSMG) 
437.4 299 07.2  Treatment 
National Treatment Agency central costs 15.9 10.9 01.1 Treatment 
YPSMPG (Young People Substance 
Misuse Partnership Grant)  
63.6 43.5 07.2 Prevention 
High Focus Areas 1.8 1.2 10.7 Prevention 
Drug strategy administration (HO) 13.0 8.9 01.1  
Blueprint 1.8 1.2 09.7 Prevention 
Drugs Intervention Programme (DIP) 
(including capital) 
209.2 143.0 03.6 Treatment/Harm 
reduction 
FRANK 9.1 6.2 09.5 Prevention 
Drug Prevention Advisory Service Dowry 7.0 4.8 09.5 Prevention 
Partnership Support Funds 16.5 11.3 01.5 Prevention 
Pompidou Group 0.3 0.2 01.1 Harm reduction 
Positive Futures 8.5 5.8 10.7  
10.9 
Prevention 
Home Office programme management. & 
capacity building 
1.5 1.0 01.5? Prevention 
Research & Monitoring 8.9 6.1 01.5  
Prison area co-ord/HQ staff 2.2 1.5 03.4 Enforcement 
Prison capital 1.0 0.7 03.4 Enforcement 
Prison clinical services 16.5 11.3 03.4 Treatment 
Prison treatment 28.4 19.4 03.4 Enforcement 
Prison CARATS (Counselling, 
Assessment, Referral, Advice and 
Throughcare Services) 
39.1 26.7 03.4 Treatment/Harm 
Reduction 
Voluntary testing in prisons 15.2 10.4 03.4 Enforcement 
Supply reduction in prisons 9.1 6.2 03.4 Enforcement 
Drug testing on license 1.6 1.1 07.2 Enforcement 
Drug Treatment & Testing Orders/ Drug 
Rehabilitation Requirement  
61.4 42.0 07.2 Treatment 
Prospect programme 4.5 3.1  Enforcement 
Youth Justice Board custody 10.2 7.0 03.4 Enforcement 
Youth Justice Bd. Resettlement Prog. 18.3 12.5 03.4 Treatment 
Overseas drug-related assistance 8.8 6.0 01.2 Enforcement 
England total 1309.3 895.0   
Northern Ireland 
Allocation to DACTs 1.0 0.7  Treatment/Prev’n 
Allocation to regional projects 2.3 1.6   
Allocation to Local Action Plan Projects 2.6 1.8  Treatment/Prev’n 
Substitute prescribing allocation 1.3 0.9 07.1 Treatment 
Policy development/research 0.3 0.2 07.5  
Public information campaigns 0.3 0.2  Prevention 
Needle and Syringe Exchange Scheme 0.1 0.1 07.4 Harm reduction 
Youth counselling services 0.9 0.6  Harm Reduction 
Dual diagnosis 0.3 0.2 07 Treatment 
Other expenditure 0.6 0.4   
Northern Ireland total 9.8 6.7   
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Scotland 
Treatment Programmes 34.7 23.7 07.2 Treatment 
GP Training on Drugs 0.6 0.4  Treatment 
Research & Statistics 0.9 0.6   
Education 1.3 0.9 09.5 Prevention 
Arrest Referral 0.7 0.5  Enforcement 
Drug Courts 2.8 1.9 03.1 Enforcement 
DTTOs 10.5 7.2 07.2 Treatment 
Time Out drug centre for women drug 
offenders 
2.5 1.7  Treatment 
DAT Association and Support 2.3 1.6   
Scottish Crime and Drug Enforcement 
Agency 
37.3 25.5  Enforcement 
Scottish Drug Forum 0.7 0.5 07.1 Treatment 
Scotland Against Drugs 2.2 1.5   
Scotland total 97.6 66.7   
Wales 
Revenue allocations to Community Safety 
Partnerships 
13.6 9.3  Treatment/Preven
tion/Harm 
Reduction/Enforc
ement 
Capital allocations to CSPs 4.4 3.0   
Central initiatives/pilot projects 3.5 2.4  Treatment/Preven
tion/Harm 
Reduction/Enforc
ement 
Policy development, implementation & 
training 
1.2 0.8   
Local Health Board ring-fenced funding 13.0 8.9 07.2 Treatment 
Drug Interventions Programme 7.3 5.0  Treatment 
Social Housing Grant Programme 2.9 2.0 10.6 Harm Reduction 
Drug testing on charge 1.2 0.8  Enforcement 
Operation Tarian 1.3 0.9  Enforcement 
Wales total 48.4 33.1   
United Kingdom total 1,465.1 1,001.5   
* Bank of England annual average spot exchange rate 1 April 2005 to 31 March 2006 1.4629 
Source: Figures provided by government departments 
 
Drug misuse services often do not stand in isolation and form part of many publicly 
funded programmes including education and crime reduction and other services that 
could provide support to problem drug users.  In recognition of the need to resource 
these programmes to respond to drug misuse, the Government has made specific 
contributions towards national budgets for pubic services.  For example, in England, 
the 2001 Budget allocated €28.9 million (£20m) additional funding for 2003/04 in 
recognition of the need for extra support for job seekers who are problem drug users 
(Cabinet Office 2001).  While this activity continues, there is no requirement to report 
how much of the Jobcentre Plus expenditure is directed exclusively towards meeting 
the needs of problem drug users and therefore we are unable to include the figures in 
the analysis of labelled spend above. 
 
This means that comparison with drug expenditure figures reported in previous Focal 
Point reports (i.e. a total of £1,483 million (€2,169 million) for 2005/06) is difficult as 
the current analysis relates only to labelled drug-specific expenditure identified as 
such in departmental accounts.  Furthermore, in addition to expenditure such as the 
Jobcentre funding above and similar funding such as regeneration monies, Table 
11.1 excludes estimated expenditure of €549 (£380m) (figure for 2003/04) for 
proactive supply reduction activities by United Kingdom enforcement agencies 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 140
(Cabinet Office 2001).  This is due to the fact that drug-related work by enforcement 
agencies is often part of wider objectives and the drug-related expenditure is not 
always readily identifiable within departmental accounts.  
COFOG classification 
Where possible labelled drug-related expenditure has been classified using COFOG 
categories. The majority of expenditure is categorised under COFOG 03 Public order 
and safety and COFOG 07 Health but there is also significant spending under the 1st 
level categories of 01 General Public Services (mainly research & development), 09 
Education and 10 Social Protection. 
 
As expenditure is often programme or funding stream based, it can be categorised 
under a number of headings. For example the Young People’s Substance Misuse 
Partnership Grant (YPSMPG) in England is funded by the Home Office, Department 
of Health, Department for Children, Schools & Families (formerly known as the 
Department for Education and Skills), and the Youth Justice Board and funds 
activities such as prevention, education, support and advice services and treatment. 
Monies are distributed amongst local partnerships throughout England and can be 
used by them to finance a number of activities to address local needs. 
 
Similarly in Wales national expenditure is recorded at the level of allocations to 
Community Safety Partnerships (CSPs). CSPs are responsible for tackling substance 
misuse and delivering substance misuse local action plans (including alcohol).  
Spending is determined at a local level and the classification of drug-related 
expenditure is only possible by examining budgetary documents at a local level, far 
beyond the resources available to the UK Focal Point for completion of this chapter.  
Similar problems are encountered when examining spend in Northern Ireland.  
 
See 11.1.2 for discussion of local spending by partnerships. 
Reuter classification 
Using Reuter’s classification where possible (Reuter 2006), the majority of drug-
related expenditure is for treatment followed by enforcement, prevention and harm 
reduction.  Although harm reduction features less explicitly than the other 
classification, it is often part of programmes or funds with other primary aims.  
 
Similar difficulties to the COFOG categorisation are encountered using Reuter’s 
taxonomy of drug-related spend.  Local Action Plan expenditure in England contains 
elements of treatment, prevention and harm reduction, which are difficult to 
disaggregate.  Furthermore, some expenditure such as research and information, 
policy and strategy and overseas drug-related assistance cannot be classified under 
the four programme division without detailed examination of each project.   
11.1.2 Breakdown of local expenditure 
National spend is often grouped by programme or funding stream making it difficult to 
disaggregate the different elements. As expenditure is based on local needs and 
priorities, a substantial amount of programme expenditure is delegated to a local 
level where agencies have discretion over expenditure decisions and monitoring 
requirements are kept to a minimum wherever possible.  This means that collation of 
a detailed breakdown of labelled spend by COFOG categories or by Reuter’s drug 
programme divisions would only be possible by placing additional burdens on local 
agencies.   
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England 
In England local Drug and Alcohol Area Team (DAAT) partnerships are required to 
provide expenditure documents to the National Treatment Agency (NTA), who are 
responsible for performance management issues. These documents are not publicly 
available and, at a national level, spend is assumed to be equal to allocation.  While 
it is possible to break down monies allocated under the pooled treatment budget 
(PTB) to the level of treatment type, data on local mainstream funding spend is not 
available centrally.  Some DAATs may publish financial breakdowns at their own 
discretion.  For example a breakdown of 2005/06 spend by Staffordshire County 
DAAT appends the Staffordshire Police Authority Reform and Management 
Committee Report (Staffordshire Police Authority 2006). This contains expenditure 
broken down to include pharmacy fees, education costs, needle exchange costs and 
user involvement costs. Given the level of aggregate in the national data we are 
placing the entirety of the expenditure against COFOG 07.2 and Reuter “Treatment” 
but this example illustrates some of the limitations of the analysis we are able to 
prepare in the United Kingdom. 
Scotland 
Each local Alcohol and Drug  Action Team (ADAT) partnership is required to submit 
to the Scottish Executive an annual plan for tackling drug misuse in their area.  
These corporate action plans are available on the Drug Misuse Information Scotland 
website227 and contain previous year’s expenditure broken down under three 
headings: drug services; alcohol services; and drug and alcohol services.  By 
examining these local documents it is possible to allocate expenditure more 
accurately to the COFOG or Reuter classifications.  
Wales  
In April 2003, a ring-fence for substance misuse services was introduced at 0.4 per 
cent of the Local Health Board’s (LHB) discretionary allocation.  An Audit 
Commission Review of NHS Substance Misuse Treatment Services encountered 
difficulties in discovering the actual expenditure of LHBs on substance misuse.  The 
final report recommended the introduction of a formal framework to identify 
substance misuse expenditure (WAG 2004a).  As yet this has not happened and the 
figure contained in Table 11.1 refers to the value of the 0.4 per cent ring-fenced 
allocation.  However, there are wide variations in substance misuse spending, with 
some LHBs spending much more than 0.4 per cent and some possibly less (WAG 
2004b).  The requirement to account for LHB substance misuse spending will 
possibly be resurrected following a change of government.  
11.2 Attributable proportion definitions of NON-LABELLED drug –related 
expenditure  
11.2.1 Overall national health and law enforcement expenditures 
HM Treasury collects annual data on government expenditure by COFOG functions 
(HM Treasury 2007) and makes it publicly available on the HM Treasury website.228  
Data are presented at both 1st and 2nd level, however the level of detail required for 
2nd level health expenditure is not available. Data in Table 11.2 are from 2005/06. 
 
                                                
227 See http://www.drugmisuse.isdscotland.org/dat/cap/dat.htm  
228 See http://www.hm-
treasury.gov.uk/economic_data_and_tools/finance_spending_statistics/pes_publications/pesp
ub_pesa07.cfm  
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Table 11.2: Total government expenditure in the United Kingdom, 2005/06 by COFOG 
functions 3: Public Order and Safety and 7: Health 
COFOG Function €m £m 
3. Public order and safety 42,862 29,299 
3.1 Police services 2,693 1,841 
3.3 Law courts 9,074 6,203 
3.4 Prisons 5,234 3,578 
7. Health 129,791 88,722 
Source: HM Treasury (2007) 
11.2.2 Attributable proportions of non-labelled drug-related expenditure – Public 
order and safety 
By looking at various data sources and research, it is possible to provide a rough 
estimate of some of the expenditure by government on drugs and the consequences 
of drug use. 
Police services 
Since 2003/2004, it is mandatory for each police force in England and Wales to 
submit annual Activity Based Costing (ABC) data to the Home Office229.  This uses 
the financial outrun for any year and sets it against activity data and management 
information.  The data can give an indicative estimate of both the direct and indirect 
cost of policing drugs.  During 2005/06, the direct cost of drugs offences using ABC 
data is estimated at €539.7 (£368.9m). 
 
The indirect police costs of drug-related crime are more difficult to estimate but are, 
nevertheless, important as they account for a large amount of government 
expenditure related to drugs.  Furthermore, such crimes act as a trigger for spend 
related to labelled costs, such as probation orders with treatment conditions, for 
example Drug Treatment and Testing Orders or Drug Rehabilitation Requirements 
(DTTOs/DRRs). 
 
Using the ABC data, which lists expenditure against incident codes, in combination 
with survey data that provides evidence of the link between drugs and crime, an 
estimate of the indirect costs of policing drugs can be generated.  The main surveys 
used are: 
• Arrestee Survey 2003/04: the proportion of those arrested for each type of 
offence that reported taking heroin, crack or cocaine in the last 12 months 
(Boreham et al. 2006). 
• NEW-ADAM: the proportion of those arrested for each type of offence that 
reported taking heroin, crack or cocaine in the last 12 months (Holloway and 
Bennett 2004). 
• British Crime Survey 2005/06: the proportion of victims that believed the offender 
to be under the influence of drugs (Walker et al. 2006).  
Where survey data is not available, subjective judgements by a senior member of the 
Association of Chief Police Officers (ACPO) have been provided.  Table 11.3 sets out 
the proportions against incident and provides the source of the estimate. 
                                                
229 For further information see: http://police.homeoffice.gov.uk/finance-and-business-
planning/index/ and http://police.homeoffice.gov.uk/news-and-
publications/publication/finance-and-business-
planning/ABC_Manual_of_Guidance_v2_21.pdf?view=Binary  
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Table 11.3: Estimates of the proportion of criminal activity that is drug-related in England and 
Wales 
Incident % Drug-
related 
Source 
Violence against the person – S20 23 BCS 05/06 
Violence against the person – S47 23 BCS 05/06 
Sexual offences 9 Arrestee Survey 03/04 
Burglary - dwelling 63 Arrestee Survey 03/04 
Burglary - commercial 63 Arrestee Survey 03/04 
Robbery 35 NEW-ADAM survey 
Theft of/or from motor vehicle 26 NEW-ADAM survey 
Deception/fraud 28 NEW-ADAM survey 
Theft other 41 Arrestee Survey 03/04 
Criminal damage 27 Arrestee Survey 03/04 
Other crime 34 Arrestee Survey 03/04 
RTC fatal/serious 5 Subjective estimate 
RTC minor injury/damage 5 Subjective estimate 
Public disorder 29 Arrestee Survey 03/04 
Sudden/suspicious death 5 Subjective estimate 
Complaint/nuisance 10 Subjective estimate 
Prostitution 60 Subjective estimate 
Intelligence research/analysis 50 Subjective estimate 
Maintaining and developing partnerships 20 Subjective estimate 
Community involvement 20 Subjective estimate 
Domestic dispute 10 Subjective estimate 
  
This puts the indirect costs of drug-related police work in England at €2.3 (£1.6 
billion).  Added to the direct costs, the overall police expenditure for 2005/06 is an 
estimated €2.9 (£2.0 billion). 
 
In Scotland, grant aided expenditure (GAE) for police spend in 2005/06 was €1.5 
billion (£1billion) (Scottish Executive 2006d).  In a review of expenditure in Scotland 
(Scottish Executive, 2000) anecdotal police reports estimated that 30 per cent of all 
recorded crime was drug-related.  This appears to be consistent with England and 
Wales and will be used here as an estimate of the direct and indirect costs of drug-
related police work.  This puts estimated expenditure at €440.5m (£301.1m). 
 
In Northern Ireland during 2005/06 total revenue spend was €1,254.9m (£857.8m) 
(PSNI 2006).  No national estimates of drug-related police costs are available and, 
given the relatively large spend by the police force and the lower estimates of 
problem drug use, it would be inappropriate to use the same method for estimation 
as for Scotland or to extrapolate from England and Wales.   
 
The total estimated unlabelled police expenditure for the United Kingdom is €3.4 
billion (£2.3 billion). 
Law courts 
Her Majesty’s Court Service (HMCS) is responsible for managing the magistrates' 
courts, the Crown Court, county courts, the High Court and Court of Appeal in 
England and Wales.  The Scottish Court Service and the Northern Ireland Court 
Service are responsible for the administration of courts in Scotland and Northern 
Ireland respectively.  It is not possible to estimate expenditure by looking at annual 
accounts for these agencies as there is a lack of information on which to base 
assumptions.   
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In 1999, however, the Home Office published research on the cost of criminal justice 
which estimated the average cost per person proceeded against in the courts 
(including sentence).  This figure includes costs to all criminal justice agencies such 
as the Legal Aid Board and Crown Prosecution Service (Home Office 1999).  
Uprating for inflation230, it gives a cost of €4,794 (£3277) for 2005/06.   
 
Using the proportion of crime attributed to drugs (as above) and data on receptions to 
prisons, a rough estimate can be made.  This is likely to be a large underestimate as 
it includes only those found guilty and receiving a custodial sentence.  Table 11.4 
shows that, in 2005/06, there were 35,679 receptions in the United Kingdom that may 
be attributable to the use or selling of drugs.  Assuming all receptions have a court 
case attached, estimated expenditure on courts is €171m (£116.5m) for 2005-06.   
Table 11.4: Receptions to prison attributable to drugs in the United Kingdom, 2005-06 
Country Receptions to prison 
England and Wales 30,846 
Scotland 4,291 
Northern Ireland 542 
Total 35,679 
Source: Home Office (2006d), Scottish Executive (2006d), NIO (2006b) 
Prisons 
Data on the average daily adult prison population by offence is available across the 
United Kingdom.  Table 11.5 shows expenditure in 2005/06 on adult prisoners 
sentenced for drug offences using the annual cost of a prisoner place.  Data from 
England and Wales and Scotland is a cross-sectional analysis of those in custody at 
30th June 2005 assuming the proportion remains similar throughout the year.  Data 
from Northern Ireland uses the average daily population in 2005.  The total 
expenditure for 2005/06 is estimated at €535.9m (£366.3m). 
 
It is not possible to estimate expenditure based on annual receptions to prison and 
average sentence length although these data are available.  This would require 
detailed information on date of reception and historical data on prisoners possibly 
dating back a large number of years. 
Table 11.5: Expenditure on accommodating drug offenders in prison in the United Kingdom, 
2005-06  
Prison population Cost (€) Cost (£) 
England and Wales  
Sentenced 414,471,397 283,321,756 
Remand 68,925,768 47,115,844 
Scotland   
930 custody x £30,338 41,274,758 28,214,340 
472 fine x 10 days at £83.25 
per day 
57,486 39,296 
Northern Ireland  
57 custody and 31 remand  
x £85, 935 
11,062,859 7,562,280 
Source: Home Office (2006d), Hansard 8th May 2007 Column 87W, Scottish Executive 
(2006e), Scottish Prison Service (2006),  NIO (2006a; 2006b) 
                                                
230 Using HM Treasury’s GDP deflator. See: http://www.hm-
treasury.gov.uk/economic_data_and_tools/gdp_deflators/data_gdp_fig.cfm  
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The proportion of non-drug offences attributable to drugs has been calculated using 
the same data sources for police costs (see above).  While these data sources relate 
to England and Wales, the same proportions have been used to calculate 
expenditure in Scotland and Northern Ireland. 
 
In England and Wales expenditure on prison places for those convicted/suspected of 
non-drug offences which can be attributed to drug use is €784.3 (£536.1m).  This 
assumes an average of 18,819 prisoners throughout the year.  In Scotland the 
estimated expenditure is €64.5m (£44.1m), while in Northern Ireland the figure is 
€31.9m (£21.8m).  The total United Kingdom expenditure for non-drug offences is 
€880.7m (£602m).   
 
The total estimated figure for prison expenditure attributable to drugs is €1,416.5m 
(£968.3m). 
11.2.3 Attributable proportions of non-labelled drug-related expenditure – Health 
Medical products, appliances and equipment 
Expenditure on injecting paraphernalia in Northern Ireland is labelled while spend in 
England and Wales is decided locally and can be funded by local Primary Care Trust 
(PCT) mainstream funding, LHB ring-fenced funding and additional NHS monies.  In 
Scotland in 2005/06, €12.3m (£8.4m) was supplied for blood-borne virus prevention 
work, which could include needle exchanges but spend is not broken down further 
and additional monies could be spent231.  The spend on Hepatitis B and C 
vaccination and testing are not available. 
 
Methadone prescribing costs are included in the PTB for England. In Scotland for 
2005-06 expenditure on methadone prescribing was €17.8m (£12.2m).  
Primary care services 
Godfrey et al. (2002) estimate the cost of GP visits by problematic drug users using 
data from the National Treatment Outcomes Research Study (NTORS).  However, 
the study does not determine whether the visit was drug-related nor does it compare 
the figure with the average GP visit by non-drug users.  Therefore estimates of GP 
costs are not included here.  
Outpatient services 
Expenditure for outpatient service use as a consequence of drug misuse are not 
available. 
Acute inpatient hospital services 
Hospital statistics for inpatient episodes232 are collected for England, Northern 
Ireland, Scotland and Wales by diagnosis using the International Classification of 
Diseases 10th revision (ICD-10)233 codes.  However, data is published differently for 
each country. Data for Northern Ireland were provided by DHSSPSNI and for Wales 
by Health Solutions Wales. 
 
                                                
231 See: http://www.scottish.parliament.uk/business/pqa/wa-07/wa0222.htm  
232 Caution must be taken when interpreting these statistics as one patient may have a 
number of episodes attached to their hospital stay. 
233 See: http://www.who.int/classifications/apps/icd/icd10online/  
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Data presented here are likely to be an underestimate of the true costs to the health 
service of drug use as they relate only to inpatient stays.   
Drug misuse diagnosis 
Hospital episode statistics (HES) in England are published on the HES website234 
and provide data on primary diagnosis at four digit code level.  Data also include 
information on emergency admissions and the number of bed days.  Admissions due 
to drug misuse are recorded using ICD-10 codes F11 to F19 (excluding F17).  Table 
11.6 shows that in 2005/06 there were 4,905 finished episodes where drug misuse 
was the primary diagnosis resulting in 92,875 bed days, an average of 5.3 per 
episode.  The data excludes codes ending .2 as these are likely to be treatment 
inpatients and may be funded by labelled expenditure.  A unit cost of €342 (£234) per 
bed day and €113 (£77) for a lower cost A&E entry (Curtis and Netten 2006) for 
those admitted as an emergency gives an overall estimated cost of €32.2 million 
(£22m).  This is likely to be a large underestimate as it includes only those whose 
primary diagnosis is drug misuse and would exclude, for example, a patient 
presenting with a wound infection caused by intravenous drug use. 
Table 11.6: Finished hospital episodes with a primary diagnosis of drug misuse in England 
2005/06 
Primary diagnosis Finished episodes Emergency Bed days
Mental & behavioural disorders due to psychoactive substance use 
F11 Opioids 846 63% 8,680
F12 Cannabinoids 976 83% 22,104
F13 Sedatives or hypnotics 106 80% 1,429
F14 Cocaine 329 91% 1,788
F15 Other stimulants 404 76% 5,818
F16 Hallucinogens 104 91% 770
F18 Volatile substances 23 87% 613
F19 Multiple drugs or other 2,117 80% 51,673
Source: The Information Centre (2007a) 
 
Data from Scotland provide information on episodes with a diagnosis of drug misuse 
in any position at the three digit code level and could therefore include those in 
hospital for drug treatment.  In 2005/06 there were 5,015 inpatient discharges with a 
diagnosis of drug misuse (ISD Scotland 2006).  Using available cost data for 
speciality group cases235, estimated expenditure for 2005/06 is €15.1m (£10.3m). 
                                                
234 See: 
http://www.hesonline.org.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=537  
235See: http://www.isdscotland.org/isd/costs-book-detailed-
Tables.jsp?pContentID=3601&p_applic=CCC&p_service=Content.show&  
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Table 11.7: General acute inpatient discharges with a diagnosis of drug misuse by type of 
admission in Scotland, 2005/06 
Type of admission Discharges 
General medicine 2,831 
Cardiology 71 
Communicable diseases 240 
Respiratory medicine 99 
General surgery 296 
General surgery (excl. vascular) 315 
A & E 227 
Anaesthetics 106 
Orthopaedics 385 
Plastic surgery 45 
Gynaecology 46 
Other 354 
Total 5,015 
Source: ISD Scotland (2006) 
 
In Wales, data are available at only the three digit ICD-10 code level and 
consequently could include treatment episodes covered in labelled expenditure.  The 
data covers all mentions of drug misuse using codes F11 to F19  (excluding F17).  In 
2005/06 there were 2,136 discharges with a diagnosis of drug misuse with a total of 
20,130 bed days, an average of 10.6 per episode.  Using English unit costs of €355.5 
(£243) per bed day (Curtis and Netten 2006), the total cost is €7.2m (£4.9m).  No 
information on emergency status is available. 
 
In Northern Ireland there were 254 episodes with any diagnosis of drug misuse, a 
total of 974 bed days.  No data, however, is available on the type of admission or the 
unit cost per bed day. 
 
The total estimated expenditure for the United Kingdom is €54.4m (£37.2m). 
Maternity costs 
In England in 2005/06 there were 170 fetus and newborn affected by maternal use of 
drugs of addiction (ICD-10 code P04.4) and 1,276 recorded with the primary 
diagnosis of neonatal withdrawal symptom from maternal use of drugs of addiction 
(ICD-10 code 96.1), with a total of 17,597 bed days (The Information Centre 2007a).  
At a cost of €629 (£430) per bed day (Curtis and Netten 2006), the overall estimated 
expenditure for 2005/06 is €11.1m (£7.6m). 
 
In Wales for the same period, there were 22 and 76 respectively with a total of 1,451 
bed days at an overall cost of €0.9m (£0.6m) using unit costs at the same level as 
England. Data for Scotland are for 2004/05 and show 300 neonatal discharges with a 
diagnosis of ICD-10 codes P04.4 or P96.1.  Using average number of bed days and 
cost data for England, expenditure  is estimated to be €1.6m (£1.1m).  
 
Scottish data show that in the period 2004/05 there were 493 maternities for which 
drug misuse was recorded but there is no cost data on which to base estimates of 
expenditure consequences for maternity services.  This is true across the United 
Kingdom and consequently expenditure by maternity services is probably an 
underestimate. 
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In Northern Ireland in 2005/06 there were six episodes relating to neonatal 
withdrawal symptom from maternal use of drugs of addiction at a unit cost of €887 
(£606) (DHSSPSNI 2007a), giving a total of €5,319 (£3,636). 
 
The total estimated expenditure for the United Kingdom is €13.6m (£9.3m). 
Poisoning 
Data from England show that in 2005/06 there were 9,968 episodes of poisoning by 
narcotics or psychodysleptics (ICD-10 code T40), with 98 per cent being 
emergencies (The Information Centre 2007a).  At a reference cost of €667 (£456) per 
episode (DH 2006b) and assuming emergency cases required paramedic services at 
€473 (£323) per patient journey, overall expenditure for 2005/06 is €11.3m (£7.7m).  
In Wales there were 1,256 T40 episodes, with no information available on the 
proportion that were emergencies, giving an estimated expenditure of €0.9m (£0.6m). 
Data from Northern Ireland show that there were 847 episodes with any T40 
diagnosis mention, 97 per cent of which were emergencies.  Using an average cost 
of €554 (£379) (DHSSPSNI 2007a) and paramedic costs from English unit cost data, 
the overall expenditure is €0.9m (£0.6m). 
 
No data are currently available for Scotland.   
 
The total estimated expenditure for the United Kingdom is €13m (£8.9m).  
Hepatitis C costs 
Estimates in England suggest that 88 per cent of individuals with hepatitis C are 
current or former IDUs (HPA 2006).  Using this proportion, in 2005/06 there were 
3,081 inpatient episodes due to chronic viral hepatitis C (ICD-10 code B18.2) and 
818 due to acute hepatitis C (B17.1) (The Information Centre 2007a).  Using 
reference costs data and adjusting for different costs for elective and non-elective 
(calculated as percentage emergencies) total expenditure amounts to €12.4m 
(£8.5m).  In addition, €31.5m (£21.5m) was spent on drugs to treat hepatitis C issued 
by hospitals (NICE 2007f).236 
 
In Wales there were 206 episodes of acute hepatitis C and 462 episodes of chronic 
viral hepatitis attributable to intravenous drug use assuming 90% of infections were in 
IDUs (HPA 2006).  This puts estimated expenditure at €1.8m (£1.2m) for 2005/06 
using reference costs for England. 
 
In Northern Ireland, the proportion of new infections that were IDUs was reported to 
be 93 per cent in 2005 (HPA 2006).  Data from DHSSPS shows that, in 2005/06 
there were 128 acute hepatitis C episodes and 54 chronic.  Using the same cost 
adjustments as for England, the overall expenditure is €0.3m (£0.2m) (DHSSPSNI 
2007a).  There are no data from Scotland. 
 
In 2005/06 there were 60 liver transplants where the primary liver disease was 
hepatitis C.  Using proportions for England (88%) and a Department of Health 
reference cost of €34,827 (£23,807) (DH 2006b), total expenditure amounts to €2.5m 
(£1.7m). 
 
Total estimated expenditure for the United Kingdom is €48.4m (£33.1m). 
                                                
236 Calculated  for 2005/06 using data for 2006 and percentage change on previous year. 
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Costs associated with treating HIV-infected individuals 
Data on HIV-infected individuals are provided by the Survey of Prevalent HIV 
Infections Diagnosed (SOPHID)237 (HPA 2006b). In 2005 there were 1,366 HIV-
infected individuals seen for care in the United Kingdom who were current or past 
IDUs.  Research carried out by the British HIV Association (BHIVA) estimates the 
cost of treating a HIV-infected individual to be €23,406 (£16,000) per year (Aidsmap 
2006).238  This gives an estimated cost of €32m (£21.9m). 
11.2.4 Attributable proportions of non-labelled drug-related expenditure – other 
categories 
While much government expenditure is related to health or law enforcement, there 
are also other important areas of spend such as education and social protection. 
 
Education 
In England, the most recent estimates of teacher time spent on drug education in 
primary and secondary schools are from 2002 (Ofsted 2002). Using data on the 
number of pupils and average class sizes, Table 11.8 calculates the total time spent 
on drug education in England during 2005/06. The estimated cost of teacher time is 
€0.85 (£0.58) per minute (Jones et al. 2007) meaning the total estimated expenditure 
on drug education  in England for 2005/06 amounts to €102.7m (£70.2m) 
Table 11.8 Calculation of teacher time spent on drug education in England 2005/06 
Year Nos No. 
classes* 
Hours 
spent 
Total time 
spent 
(hrs) 
Reception 800,200 30,426 4 121,704 
Year 1 543,600 20,669 5 103,345 
Year 2 559,200 21,262 5.5 116,941 
Year 3 564,600 21,468 5.5 118,074 
Year 4 579,300 22,027 6 132,162 
Year 5 544,500 20,703 7 144,921 
Year 6 558,100 21,221 9 190,989 
Year 7 613,000 28,512 8 228,096 
Year 8 573,000 26,651 7 186,557 
Year 9 592,700 27,567 9.5 261,887 
Year 10 594,400 27,647 8 221,176 
Year 11 578,900 26,926 6.5 175,019 
Year 12 & 13 188,200 8,753 2 17,506 
Total 2,018,377 
*Based on average school size of 26.3 for primary schools and 21.5 for secondary school  
Source: Ofsted (2002); DfES (2006a), (2006b) 
 
In Scotland data sources provide information on the number of pupils per year group, 
the proportion of schools at each year group providing drug education and the 
average time spent on drug education by those schools who provide drug education 
(Scottish Executive 2006f; 2006g: 2006h).  Data on the average size of secondary 
school classes is patchy and the most recent data is from a 2003 study estimating 
Maths and English class size for years S1 and S2 at 25.5 pupils (Scottish Executive 
                                                
237 A cross-sectional survey of all individuals with diagnosed  HIV infection who attend for 
HIV-related care at an NHS site in England, Wales and Northern Ireland. 
238 Research was carried out in 27 HIV clinics across the United Kingdom between 1996 and 
2002. 
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2004). Using the same cost per minute as in England, the total estimated expenditure 
for Scotland amounts to €3.7m (£2.5m)  
 
In Northern Ireland in 2005/06 there were 313,737 primary and secondary school 
pupils with an average class size of 20.5 for primary school and 14.4 for secondary 
school239.  There are, however, no studies estimating the time spent by teachers on 
drug education so it is not possible to produce a figure for expenditure.  In Wales 
local police forces provide drug education in schools so estimates cannot be 
calculated. 
 
Total estimated expenditure for the United Kingdom is €106.4m (£72.7m). 
Social protection 
Unemployment benefits 
It is possible to estimate spend on unemployment benefits by using problem drug use 
(PDU) estimates and findings from NTORS, which suggest that 81 per cent of those 
not in treatment and 79 per cent of those in treatment are unemployed (Gossop et al. 
1998). The most recent PDU estimates for the United Kingdom are for 2004/05 and 
give a central estimate of 398,845240.  National Drug Treatment Monitoring System 
(NDTMS) data suggest that 42 per cent of  problem drug users were in treatment in 
England during 2005/06 (using 2004/05 PDU estimates).  Extrapolation to the United 
Kingdom gives a figure of 231,330 not in treatment and 167,515 in treatment. 
 
Unemployment benefits are paid at a lower rate to those under 25 with another band 
for 16 and 17 year olds.  As there are no data on PDUs aged under 18, the rate for 
18 to 24 year olds is used for all those under 25. The figures are adjusted to take into 
account differences in the proportion of PDUs who are under 25 in England (21%) 
and Scotland (30%).  PDU estimates for Northern Ireland  are not broken down by 
age so, as with Wales, they are extrapolated from England.  The calculations are not 
adjusted to account for the impact of age on treatment status.    
 
Included in the calculations is the cost per person of administering unemployment 
benefits calculated as 10.6 per cent of the total expenditure on unemployment 
benefits.241  This gives an estimated figure of €27.8m (£19m) for 2005/06. 
Table 11.9: Cost of unemployment benefits for problem drug users in the United Kingdom, 
2005/06 
 Under 25 years old Over 25 years old 
Number of PDUs unemployed 70,861 248,853 
Annual rate of benefit242 €65.23 (£44.59) €82.36 (£56.30) 
Administration costs 10.6% 10.6% 
Total cost €5.1m (£3.5m) €22.7m (£15.5m) 
 
The relationship between drug use and unemployment is complex and assuming a 
causal link will tend to overstate the cost of drug use (Godfrey et al. 2002).  However, 
this calculation only takes into account expenditure on unemployment benefits for 
PDUs and it may underestimate the impact of recreational drug use on benefit costs.   
Furthermore, there is insufficient data to estimate the cost of providing housing 
                                                
239 http://www.inca.org.uk/2313.html#433_Class_size  
240 Range 397,033 – 421,012, 95% CI 
241 http://www.dwp.gov.uk/publications/dwp/2006/dr06/annexa/Table2.asp  
242 Using 2007/08 rate and HM Treasury’s GDP deflator. See: http://www.hm-
treasury.gov.uk/economic_data_and_tools/gdp_deflators/data_gdp_fig.cfm  
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benefit to drug users as drug agencies do not routinely collect housing status data or 
do so in insufficient detail (Home Office 2004). 
Social Services 
Expenditure on personal social services is provided for England (The Information 
Centre 2007b), Scotland (Scottish Executive 2007e) and Wales (LGDUW 2007).  
Northern Ireland has joint Health and Social Services Boards (HSSB) so separate 
costs are not available for substance misuse and HIV/AIDS clients as they are 
accounted for in labelled costs or in the health costs calculations in section 11.3.3 . 
Personal social services for substance misuse 
Personal social services in England provide services for people with substance 
misuse problems and are paid for through social services revenue support grants 
supplemented by various grants such as the carers grant, council tax and other rates.  
Monies are not ring-fenced and are allocated to different services according to local 
priorities. Some local authorities have pooled budgets with local PCTs but this is 
excluded from data on net expenditure.  Funding is similar in other parts of the United 
Kingdom. 
In England for 2005/06, expenditure on personal social services for adults with 
substance misuse problems (including alcohol) was €132.2m (£90.4m).  In Scotland 
expenditure for 2005/06 was €37.9m (£25.9m) and in Wales €8.6m (£5.9m). 
 
In a review of expenditure on tackling drug misuse in Scotland (Scottish Executive 
2000), the authors estimated that two-thirds of substance misuse community care 
spending was on drug misuse.  This may be an overestimate as alcohol has been 
given increased policy importance in recent years but no other estimate is available.   
Extrapolation to England and Wales gives an overall figure of €119.2m (£81.5m) for 
the United Kingdom. 
Personal social services for adults with HIV/AIDS 
In England expenditure on personal social services for those with HIV/AIDS was 
€22.8m (£15.6m), in Scotland €2.5m (£1.7m) and in Wales €0.12m (£0.08m). Using 
the proportion of HIV-infected individuals seen for care in 2005 who were infected 
through intravenous drug use (HPA 2006b), overall estimated expenditure is €0.9m 
(£0.6m). 
Personal social services for people with mental health problems 
There are many studies of the prevalence of co-morbidity but findings differ 
depending on which substances are included (alcohol, opiates, crack cocaine and 
other drugs) and which definition is used (dependency or harmful use).  Furthermore,  
while substance use often exacerbates mental health problems there is insufficient 
evidence to assume a causal link. Data from Scotland (Scottish Executive, 2000) 
suggests that 10 per cent of mental health community care service expenditure for 
adults aged 18 to 64 is attributable to drug use.  The same figure is used here for the 
whole of the United Kingdom including Northern Ireland (DHSSPSNI 2007b) although 
there is a need for more robust estimates.  The total estimated expenditure for 
mental health personal social services attributable to drug misuse is therefore 
€172.6m (£118m). 
Child and Family social work 
Research on the relationship between substance misuse and child and family social 
work often does not distinguish between drug and alcohol use.  There are also wide 
variations amongst studies depending on when and where the study was carried out 
and whether incidence or prevalence was used.  The measure employed to assess 
the impact of drug use also has an impact on findings, for example including only 
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cases where drug use was a ‘major factor’ or played a ‘central role’ or cases where 
drug use was mentioned.  
 
This raises questions about the causal link between drug use and child welfare 
concerns and highlights the complexity of the relationship between drug use and 
social impacts as well as the difficulty in attributing expenditure consequences . For 
example, one study found parental mental illness in a quarter of cases with 
substance misuse concerns (Forrester and Harwin 2006).  However, the only 
statistically significant differences from non-substance misuse cases were the  
existence of parental convictions and having a parent experiencing violence. 
 
One incidence study carried out in an inner London Borough243 found that 34 per cent 
of families allocated for long-term social work intervention had substance misuse 
issues, 59 per cent of those involved concerns about drug use (Forrester and Harwin 
2004; 2006).  In another study in an anonymous English city244, substance misuse 
raised concerns for child welfare in 22 per cent of cases, over half of these involved 
drug or drug and alcohol use (Hayden 2004).   
Hart and Powell’s prevalence study245 (2006) found that children of parents with drug 
problems accounted for an average of 19 per cent of the authorities’ looked after 
population and 20 per cent of children on child protection registers. 
 
In a review of expenditure on drugs in Scotland (Scottish Executive 2000), a figure of 
30 per cent was used to estimate drug-related spend although it is unclear whether 
this includes alcohol.  In Scotland, research from Glasgow City Council found that 40 
per cent of Child Protection Orders made in 1998-1999 cited drug-related risk.  In 
Dundee, 70 per cent of children subject to child protection case conferences had 
parents with substance misuse problems, a rise of 33 per cent from 1998/99 and, in 
October 2000, 53 per cent of children on the child protection register had parents 
with problems related to substance misuse (Scottish Executive 2001). 
 
The higher proportions in the Glasgow and Dundee studies may reflect the existence 
of substance misuse concerns amongst more serious cases. Thus in the Forrester 
and Harwin study (2006), 40 per cent of cases involving children on the child 
protection register (CPR)  and 62 per cent of children subject to care proceedings 
involved substance misuse concerns. This supports the findings of a literature review 
undertaken for the Department of Health which showed that at referral stage, 20 per 
cent of parents had a substance misuse problem, increasing to 25 per cent at first 
enquiry, 25 to 60 per cent at child protection conference and 70 per cent for those 
subject to care proceedings (Cleaver et al., 1999). 
 
Due to the higher costs involved in such cases, when using the proportion of overall 
caseloads and applying it to expenditure, estimates may be lower than they are in 
reality.  However, social services expenditure is not broken down in sufficient detail to 
enable more complex calculations and, where it is, does not correspond exactly to 
the existing research on parental substance misuse. 
 
                                                
243 All case-files going for long-term allocation in four London local authorities over the period 
of one year, 2000-2001 were allocated to the parental substance misuse (PSM) sample when 
concern about PSM was noted on the social work file by any professional. 
244 Research was carried out in a city social work department. Social workers completed a 
one-sided questionnaire on cases where they felt PSM raised concerns for a child’s welfare. 
245 All new and existing cases where parents were identified as drug users were identified by 
children’s social services between January and March 2004 in two local authorities; one a 
small, deprived northern unitary authority and the other a large southern, wealthy county. 
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For the purposes of this chapter, the most recent estimate by Forrester and Harwin 
(2006) that 20 per cent of cases in England involve drug use concerns will be used 
although further research centring on causality would be useful.   This will also be 
extrapolated to Wales.  Considering the higher proportion in studies carried out in 
Scotland and the higher rate of problem drug use in Scotland, 30 per cent will be 
used for Scotland.  For Northern Ireland there is no research available on which to 
base assumptions and, given the much lower rate of problematic drug use, it would 
not be appropriate to extrapolate from England to estimate the proportion of the 
€208m (£142m) expenditure on child and family social work  attributable to drug use.   
Overall the estimated expenditure on child and family work attributed to drug use is 
estimated at €1.76 billion (£1.2billion). 
11.2.5 Overall costs attributable to drugs 
Table 11.10 shows unlabelled and labelled government expenditure attributable to 
drugs.  For 2005/06 drug-related government expenditure is estimated at around 
£5.9 billion, 83 per cent of which is unlabelled costs.  Over half of the estimated 
expenditure is on public safety and order but the importance of social protection 
expenditure is also evident with almost a quarter (23.8%) of  overall expenditure 
falling into this category, the majority on child and family social work (Table 11.10).   
Table 11.10: Overall estimated unlabelled government expenditure attributable to drugs in the 
United Kingdom 2005/06 
Category €m £m 
% of 
overall 
spend 
Police  3,321 2,270 45.8 
Law courts 171 116.5 2.4 
Prison – drug offenders 535.9 366.3 7.4 
Prison – other offences 880.7 602 12.1 
03 Public Order & Safety expenditure 4,908.3 3,355.2 67.7 
Methadone prescribing (Scotland) 17.8 12.2 0.2 
Inpatient – drug misuse 54.4 37.2 0.8 
Inpatient – maternity 13.6 9.3 0.2 
Inpatient – poisoning 13 8.9 0.2 
Inpatient – hepatitis C 48.4 33.1 0.7 
HIV costs 32 21.9 0.4 
07 Health expenditure 179.2 122.6 2.5 
Drug education in schools 106.4 72.7 1.5 
09 Education expenditure 106.4 72.7 1.5 
Unemployment benefits 27.8 19.0 0.4 
PSS – substance misuse 119.2 81.5 1.6 
PSS – HIV/AIDS 0.9 0.6 <0.1 
PSS – mental health 172.6 118.0 2.4 
PSS – Child and family 1,760 1,200 24.2 
10 Social protection expenditure 2,080.5 1,419.1 28.6 
Total unlabelled expenditure 7,274.4 4,954.8 100 
Total estimated labelled and unlabelled expenditure amounts to €8.7 billion (£6 
billion), of which 16.8 per cent is labelled expenditure and 83.2 per cent is unlabelled.  
Using these estimates, expenditure per capita is €144.43 (£98.73)246 and overall 
expenditure amounts to 0.48 per cent of United Kingdom GDP.247 
                                                
246 Based on ONS population figure of 60.2 million in the middle of 2005. 
247  Based on OECD GDP for United Kingdom, 2005. 
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11.3 National studies on drug-related public expenditures: methods and 
results, and networks of EU experts 
National reports concerned with drug-related public expenditure form part of ‘cost of 
drug misuse’ studies, rather than public expenditure only.  
 
Reuter (2004) refers to a report on A Strategic Budget published in 2001 in the 
United Kingdom providing a breakdown of expenditure for particular categories of 
drug control (Home Office Memorandum submitted to the House of Commons inquiry 
: How Effective is our Drug Policy), no longer available.  He states that  the focus was 
on three issues; integration of targeted and “related” expenditures, the distinction 
between agency and programme labels and devolution of budgets to lower level 
governments, with funds divided on the basis of goals, which facilitates performance 
measurement of strategic objectives.  
 
In 2001 the Home Office commissioned a study to look at the economic and social 
costs of Class A drug use in England and Wales in 2000 (Godfrey et al.2002).   The 
model used in this study involved an estimation of the prevalence of total drug users, 
identifying a typology of three types of drug users: 
• young recreational users – defined as those taking Class A drugs aged under 25 
but not in the problem user group; 
• older regular users – defined as those regularly taking Class A drugs aged 25 or 
over but not in the problem user group; and  
• problem users – users of any age whose drug use is no longer controlled or 
undertaken for recreational purposes and where drugs have become a more 
essential element of the individual’s life.  
 
Next estimates of the prevalence of different consequences attributed to the drug 
users of different types were identified.  These prevalence estimates were combined 
with estimates of the unit costs of each type of consequence to yield the economic 
and social cost estimates.  
 
For young recreational users, it was estimated that there were a total of €9.9 
million248 (£6 million) health service and criminal justice costs in the year, translating 
to a cost of €12.32 to €24.64 (£7.50 to £15) per user depending on whether a lower 
or higher estimate of the number of young recreational users is used.  Total social 
costs for this group was estimated at €47.3 million (£28.8 million), a cost per user 
between €59 and €118 (£36 and £72).  These social costs included an estimate of 
the full costs of premature deaths from ecstasy use.  Older regular users were 
estimated to cost around €10.2 million (£6.2 million), a cost per user between €4.9 
and €9.9 (£3 and £6).  Estimates for young recreational and older regular users 
excluded any allowance for productivity effects and effects from driving and drug 
taking.  For problem drug users, total economic costs range from €4.8bn to €8.7bn 
(£2.9bn to £5.3bn), based on low to high estimates of the number of problem drug 
users (the medium estimate was €5.7bn (£3.5bn)), €17,082 (£10,402) per user per 
annum.  Total economic and social costs for this group increase the range of figures 
to between €16.6bn and €28.6bn (£10.1bn and £17.4bn), €58,224 (£35,455) per user 
per annum. 
 
This research was updated in 2006 for 2003/04 using the same methodology 
(Gordon et al. 2006).  However a number of data sources have improved since then, 
including improved estimates of the prevalence of problematic drug use, and costs 
relating to the criminal justice system.  Based on the methodological and data 
                                                
248 Bank of England annual spot exchange rate for 2000 at 1.6422 
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updates, the economic and social costs of Class A drug use were estimated to be 
around €22.3 billion249 (£15.4 billion) in 2003/04, equating to €63,940 (£44,231) per 
year per problematic drug user.  The associated confidence range was between 
€22.1 billion and €23.3 billion (£15.3 billion and £16.1 billion).  It was estimated that 
problematic Class A drug use accounts for most of the total costs (99%, or €22.1 
billion (£15.3 billion)).  Drug-related crime was the domain that accounted for the 
largest proportion of cost (90%, or €20.1 billion (£13.9 billion)). 
 
A study of the economic and social costs of drug is to be undertaken in Scotland, and 
in Wales. 
 
                                                
249 Bank of England annual spot exchange rate for financial year 2003/04 at 1.4456. 
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12. Vulnerable groups of young people  
12.1 Profile of main vulnerable groups 
United Kingdom drug strategies use the term ‘young people’ to refer to those up to 
and including the age of 24.  Young people under 18 are classed as minors and 
wherever possible in this chapter separate data has been presented to reflect this. 
12.1.1 Children living in government care institutions  
In the United Kingdom, looked after children are those who are legally ‘looked after’ 
by the local authority or health and social services departments.  They may or may 
not be the subject of a care order.  Typically, they may be in residential care, special 
schools or in foster care.  Some may be in ‘kinship’ care (where they are looked after 
by a member of their family) (Home Office 2005). 
Demographic characteristics 
Around 81,000 children were looked after in the United Kingdom in 2005/06 (60,900 
in England250; 2,436 in Northern Ireland251; 12,966 in Scotland252 and 4,800 in 
Wales253).  This equates to around 55 looked after children per 10,000 population 
aged under 18254.   Scotland and Wales had a higher proportion of looked after 
children (116 children per 10,000 and 70 children per 10,000 respectively) than 
England and Northern Ireland (55 children per 10,000 and 56 children per 10,000 
respectively). 
 
In the United Kingdom there were more boys than girls in the looked after system 
(55% male, 45% female).  The majority of these children in England, Northern Ireland 
and Wales were in foster care (70% in England; 63% in Northern Ireland; 74% in 
Wales), whereas in Scotland this figure was only 29 per cent.  In Scotland over half 
(56%) were looked after at home with their parents or with family and friends, with a 
further 13 per cent in residential accommodation. 
 
In 2005/06 in the United Kingdom, 64 per cent of looked after children were aged 
between five and 15 (4% were under one; 15% were between one and four; and 17% 
were over 16).  In England and Wales,255 most (43%) were in the age range of 10 
to15 years and just under a fifth (19%) were aged between five and nine.  In Northern 
Ireland and Scotland, around a third (35%) of looked after children were aged 
between five and 11 and a third (34%) were between the ages of 12 and 15.  Around 
70 per cent of looked after children in the United Kingdom had been in the system for 
at least 12 months.    
 
Black children and children of mixed ethnic origins are over-represented in the looked 
after system, whilst some other ethnic minority communities are underrepresented 
(e.g. Asian and Asian British) (Home Office 2005).  In 2005/06 around 20 per cent of 
looked after children in the United Kingdom were from Black and Minority Ethnic 
                                                
250 See: http://www.dfes.gov.uk/rsgateway/DB/SFR/s000691/SFR44-2006.pdf 
251 See: http://www.dhsspsni.gov.uk/statistics_and_research-cib_looked-after-children  
252 See: http://www.scotland.gov.uk/Resource/Doc/159750/0043434.pdf 
253See:http://www.dataunitwales.gov.uk/Documents/Data_Set/PSS/2005_06/lgd01006_01_ch
ildren_2005_06_v1_eng.pdf 
254 Using mid-2006 population estimates the UK population of young people age 0 to 19 is 
14,733, 600 see: http://www.statistics.gov.uk/statbase/Expodata/Spreadsheets/D9668.xls  
255 There were reporting differences in some of the age categories: England and Wales 
reported on ages five to nine; and ten to 15, whereas, Northern Ireland reported ages five to 
11 and 12 to 15.) 
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(BME) backgrounds, whereas the general BME youth population is estimated to be 
around 14 per cent. 
Other problems  
Looked after children are more likely to: 
• have a lower educational attainment than children in the general population 
(DfES 2007a; Scottish Executive 2007i); 
• be unemployed on leaving school (Home Office 2005);   
• be cautioned or convicted of an offence (DfES 2007a); and 
• be physically or mentally disabled (ONS 2003; ONS 2004a,b) (see 12.4).   
12.1.2 Early school leavers / academic failure  
In the United Kingdom, education is compulsory for children aged five to 16 
(Education Act 1996).  Each local education authority has a duty to provide suitable 
education (in or out-of-school) for children of compulsory school age who, by reason 
of illness, exclusion from school or otherwise, may not for any period receive suitable 
education unless such arrangements are made for them256. 
Demographic characteristics  
In the United Kingdom between 2004 and 2005 there were 759,100 pupils in their 
last year of compulsory education (51% male and 49% female) (DfES 2006d).  Three 
per cent of these pupils (around 22,800) did not gain any graded qualifications257.  Of 
these, 62 per cent were male and 38 per cent female.  It is estimated that there are 
around 2 million young people of working age258 in the United Kingdom with no 
qualifications (21% of those aged 16 to 19 and 8% of those aged 20 to 24).  
Excludees and Truants  
‘Excludees’ are those who have been expelled (permanently excluded) or suspended 
(temporarily excluded) from school. ‘Truants’ are those who miss school through 
unauthorised absence, including parentally condoned absence where no appropriate 
explanation has been supplied.  
Demographic characteristics  
In the United Kingdom in 2005/06 there were 9,939 permanent exclusions from 
schools (around 1 pupil per 1,000 of the school population)259.  In the same period 
there were 400,654 fixed period exclusions/ suspensions (around 41 pupils per 1,000 
of the school population).  The majority of exclusions occur in secondary schools.  
 
Boys are more likely to be permanently excluded, to receive a fixed exclusion and to 
receive it at an earlier age than girls; they represent around three quarters of the total 
number of permanent exclusions each year (80% in England, 74% in Northern 
Ireland, 78% in Scotland and 73% in Wales). (DfES 2007c; DENI 2007b; Scottish 
Executive 2007g; WAG 2007a).   
                                                
256 A Pupil Referral Unit (PRU) is a type of school maintained by an LEA for children who, because 
of exclusion or other reasons are not able to attend a mainstream or special school. There are 
currently over 421 PRUs in England. In 2002-03, 17,523 pupils attended Pupil Referral Units 
(PRUs) at some point during that year. They do not have to provide a full National Curriculum, but 
should offer a basic curriculum which includes English, mathematics, the sciences, PSHE and ICT. 
This flexibility is intended to ensure that more time is spent addressing the child's behavioural 
problems, for example through counselling, citizenship or PSHE programmes. 
http://www.dfes.gov.uk/exclusions/alternative_provision_policies/pupil_referral_units.cfm 
257 See: http://www.dfes.gov.uk/rsgateway/DB/VOL/v000696/Chapter_3.xls 
258 Working age is defined as males aged 16-64 and females 16-59 including unpaid family 
workers, those on government employment and training programmes, or those who did not answer 
259See: http://new.wales.gov.uk/topics/statistics/headlines/schools2007/hdw200703211/?lang=en 
for school population numbers 
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In England in 2004/05, pupils of Black or Mixed ethnic origin had a higher exclusion 
rate (8%) than White (6%) and Asian pupils (2%) (DfES 2006e).  Pupils with Special 
Educational Needs (SEN) are over 3 times more likely to be permanently excluded 
from school than the general population.  Each day, over 54,000 pupils miss school 
without permission and an estimated 7.5 million school days are missed each year 
through truancy260. 
Other problems  
Children who are not in school are more likely to be:  
• unemployed after leaving school;  
• drawn into crime and anti-social behaviour261(Edmonds et al. 2005); and 
• at greater risk of gaining a criminal conviction in adulthood (McAra and McVie 
2007). 
12.1.3 Youth in families with drug and/or alcohol use 
Demographic characteristics 
It is estimated around two per cent of children under 16 in the United Kingdom262 
have one or both parents with serious drug problems (between 250,000 to 350,000 
children) (ACMD 2007a).  The available data are based on people in treatment so 
this may be an underestimation.  In the United Kingdom it is estimated that up to 1.3 
million (one in eleven) young people are living with parents who misuse alcohol 
(Cabinet Office 2004). 
Other problems  
Young people who live in families with substance or alcohol misuse may be affected 
by: 
• poor parenting or parental absence;  
• lack of basic necessities (food, heat, safe environment);  
• poor educational attainment; and 
• emotional, cognitive, behavioural and other psychological problems (ACMD 2003; 
Aberlour 2007). 
12.1.4 Homeless youth  
Definition 
In the United Kingdom the term ‘youth homelessness’ generally refers to young 
single people aged between 16 and 25 years old who do not have accommodation in 
the UK or elsewhere; or if they do have accommodation, it is not reasonable for them 
to occupy.  Under the law, even if someone has a roof over their head they can still 
be homeless, because they may not have any right to stay where they live or their 
home may be unsuitable to live in.  Pleace and Fitzpatrick (2004) defined a young 
person as ‘homeless’ if they do not have, or are imminently going to lose, 
accommodation that they could reasonably be expected to occupy.  Homelessness 
can range from ‘rooflessness’ or sleeping rough, to living in bed and breakfast 
accommodation and hostels, or an inability to leave unsatisfactory housing 
conditions.  The ‘visible homeless’ are those such as rough sleepers and hostel and 
night shelter residents.  The ‘hidden homeless’ are those who, for example, may 
bestaying temporarily with family and friends (‘sofa surfing’).  In most circumstances, 
local authorities in the United Kingdom have a statutory duty to provide 
                                                
260 See: http://www.dfes.gov.uk/schoolattendance/truancysweeps/ accessed 17th July 2007 
261 See: http://www.dfes.gov.uk/schoolattendance/truancysweeps/ accessed 17th July 2007 
262 UK mid-2006 population estimates that the number of people in the UK under 16 is 
11,537,000 see: http://www.statistics.gov.uk/pdfdir/popest0807.pdf accessed 19th September 
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accommodation for homeless people under 18 (in addition to 18 to 20 year olds who 
were formerly in care) and older people if they are judged to be in priority need. 
Demographic characteristics 
According to official statistics, in 2005/06 there were nearly 51,000 homeless263 
people under the age of 25 in the United Kingdom (36,770 in England264 ; 3,375 in 
Northern Ireland265; 9,943 in Scotland266 and 851 in Wales267).  In England and Wales 
in that period, nine per cent of all homeless acceptances by local authorities were 
from young people aged 16 and 17 or care leavers aged 18 to 20 years old.  In 
England, more than a third (39%) of new cases of homelessness that year were 
young people aged under 25 (DCLG 2007) and in Northern Ireland this figure was 20 
per cent268.  In the first quarter of 2007, over half (53%) of homeless acceptances in 
Wales were for the under 25 age group (WAG 2007b).  
However, it has been reported that this age group are less likely than other age 
groups to seek advice about their homelessness problems (Kenrick 2007)269 and that 
statistics in England are only collected for people who have been accepted as 
homeless by local authorities, rather than for all applicants as in other parts of the 
United Kingdom270, so the actual numbers of homeless youths could be higher. 
 
Black and minority ethnic (BME) households are over-represented among England’s 
homeless population, 57 per cent of young people assisted by the homeless charity 
Centrepoint271 are from BME backgrounds, while the BME youth population in 
England is around 14 per cent according to the 2001 Census.  According to 
Centrepoint, around 40 per cent of young homeless people have no qualifications 
and around a fifth of them have been looked after by a local authority.  
Other problems  
Being homeless has been associated with increased risk of:  
• offending and risk-taking behaviour;  
• poorer education and employment prospects;  
• experiencing difficulties accessing training and health care;   
• being vulnerable to poor physical and mental health; (Shelter 2005; Wincup et. al 
2003);  
• being a victim of crime; and 
•  financial and/ or sexual exploitation (Scottish Executive 2002)  
 
                                                
263 In England this means that they were accepted as Homeless by their Local Authority and 
in the rest of the UK it means that they presented themselves as Homeless to their Local 
Authority (regardless of whether they were accepted as homeless). 
264 See: http://www.communities.gov.uk/index.asp?id=1508508  
265 http://www.simoncommunity.org/FAQs/ 
266 See: http://www.scotland.gov.uk/Publications/2006/09/25151544/0  
267 See: http://www.dataunitwales.gov.uk/eng/Project.asp?nc=B05C&id=3676  
268 See: http://www.simoncommunity.org/FAQs/  
269 See: http://www.youthaccess.org.uk/news/upload/locked%20out%20article.pdf 
270 See: http://www.centrepoint.org.uk/content/view/268/41/ 
271 See: http://www.centrepoint.org.uk/content/view/37/21/  
UNITED KINGDOM FOCAL POINT REPORT 2007 
 160
12.1.5 Young offenders  
Definition 
In England, Wales and Northern Ireland,272 young people aged 10 to 17 found guilty 
of, or cautioned for, an indictable offence are defined as young offenders (YOs).  
Young offenders are also defined as those aged between 18 and 20 within the prison 
population273.  In Scotland, a young person is any child aged between eight and 15 
years of age at the time of an offence referral or any person aged 16 and over who is 
already the subject of a supervision requirement.274  
Demographic characteristics 
In England and Wales in 2005/06, 85,467 young people came into contact with the 
youth justice system for the first time (around 1.4% of the 10 to 17 age group).  
Young males were four times more likely to have committed an offence than young 
females.  In the same period, 301,860 offences resulting in a disposal275 were 
committed in England and Wales, of these 80.6 per cent were by males and 19.4 per 
cent by females.  Young people in the between the ages of 14 and 17 committed the 
vast majority of offences (84.5%) (YJB 2006a).  In Great Britain276 there are 
approximately 3,424 young offenders aged between 15 and 17 years of age in 
custody, 97 per cent of these are male (3,314 males,110 females)277 (Scottish 
Executive 2007k). 
Other problems  
Young offenders are likely to:  
• have a wider range of needs than the non-offending population; 
• have been in care, witnessed violence in the home or been the victim of crime; 
• have insufficient access to healthcare, particularly for mental health (Healthcare 
Commission 2006); 
• have housing problems (Shelter 2005);  
• re-offend with 41 per cent of young offenders in 2004 committing a further 
offence within one year which led to a pre-court disposal or a conviction in court 
(Whiting et al. 2006); and 
• be convicted as adults (McAra and McVie 2007). 
12.1.6 Youth in deprived places/neighbourhoods and/or with high drug availability278 
Definition 
Dimensions of deprivation in an individual area include variables such as income, 
employment, education and health.  They are usually identified and measured 
separately.  These dimensions are then aggregated to provide an overall measure of 
multiple deprivation.279 
                                                
272 See: http://www.cjsni.gov.uk/index.cfm/area/information/page/young_crimes  
273 See: http://www.hmprisonservice.gov.uk/adviceandsupport/prison_life/youngoffenders/ 
274 See: http://www.childrens-hearings.co.uk/pdf/Scottish per cent20Youth per cent20Justice 
per cent20Baseline.pdf 
275 Pre-court disposal (e.g. Reprimand or Final Warning or a court disposal) NB data refers to   
number of offences not numbers of offenders 
276 England, Scotland and Wales 
277 See: http://www.hmprisonservice.gov.uk/adviceandsupport/prison_life/juvenileoffenders/  
278 ACORN is a geo-demographic classification used to identify and understand the United 
Kingdom population. It combines geography with demographics and lifestyle information to 
categorise United Kingdom postcodes into 5 categories, 17 groups and 56 types. Information 
showing this relationship can be found at http://www.cci.co.uk/acorn/acornmap.asp  
279 Indices of deprivation identify areas of multiple deprivation at the small area level. Based 
on a methodology developed by the Social Disadvantage Research Centre at the University 
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Demographic characteristics 
It is difficult to quantify how much of the United Kingdom is deprived as there are 
English, Welsh and Northern Ireland and Scottish Indices of Deprivation which are 
not directly comparable; they contain some similar but some different indicators and 
domains, cover varying time periods and have differences in the way they are 
compiled280 (Scottish Executive 2006j).  In the United Kingdom in 2004, 16.4 per cent 
of children lived in workless households (WAG 2005).  In England, nearly a quarter 
(22%) of local authority areas are classed as ‘deprived’ 281 (ODPM website 2007).   In 
Wales, figures for 2002/03 indicate that 30 per cent of children lived in low-income 
households282.  Across Scotland, 14 per cent of the population (over 700,000 people) 
are income deprived, just under a sixth (15%) of the most deprived areas283 contain 
around a third of Scotland's income and employment deprived working age 
population (36% and 33% respectively) (Scottish Executive 2007i). 
Other problems  
Youths living in deprived areas may be affected by: 
• unemployment; 
• low incomes; 
• poor health;  
• higher than average crime rates; 
• inadequate housing (ONS 2007); 
• lower educational attainment (DfES 2007d); and 
• higher mortality rates (Baker et al. 2006);  
                                                                                                                                         
of Oxford, separate indices have been constructed for England, Northern Ireland, Scotland 
and Wales. Though not directly comparable, each index is based on the concept that distinct 
dimensions of deprivation such as income, employment, education and health can be 
identified and measured separately. These dimensions, sometimes referred to as 'domains' 
are then aggregated to provide an overall measure of multiple deprivation and each individual 
area is allocated a deprivation rank and score.  The indices are used to help target policies 
and funding, and reinforce a common goal to improve the quality of life in disadvantaged 
communities. However, the indices may not be used together to create a single UK index.  
280 See: 
http://www.neighbourhood.statistics.gov.uk/dissemination/Info.do;jsessionid=ac1f930cce678c
81da7dcfc48d1bb63d93378684660.e38Qa3mPbh4Kai0NaNiKc3iTb3n0n6jAmljGr5XDqQLvp
Ae?page=Indices_of_deprivation.htm&bhcp=1 
281 These areas are classed as deprived in that they are eligible to receive Neighbourhood 
Renewal Fund (NRF). The Neighbourhood Renewal Fund (NRF) aims to enable England's 
most deprived local authorities, in collaboration with their Local Strategic Partnership (LSP), 
to improve services, narrowing the gap between deprived areas and the rest of the country. 
The allocation for 2006-08 is based upon the Indices of Deprivation 2004. 86 local authority 
areas (out of a total of 388) are now eligible to receive Neighbourhood Renewal Fund (NRF).  
282 Households with incomes below 60 per cent of median income 
283 The Scottish Index of Multiple Deprivation (SIMD) is the Scottish Executive's official 
measure for identifying small area concentrations of multiple deprivation across all of 
Scotland. The SIMD is relevant to polices and funding wholly or partly aimed at tackling or 
taking account of the causes and effects of concentrations of multiple deprivation. The Index 
is based on the small area statistical geography of data zones which contain on around 750 
people.  The domain ranks are combined using the ratios 12:12:6:6:4:1:2 in the following 
order: Current Income, Employment, Health, Education, Skills and Training, Geographic 
Access, Housing and Crime http://www.scotland.gov.uk/Topics/Statistics/Browse/Social-
Welfare/TrendSIMD (SIMD 2006) 
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12.1.7 Ethnic minorities  
Definition 
The term 'ethnic minority' is mainly used to denote people who are in the minority 
within a defined population on the grounds of 'race', colour, culture, language or 
nationality. 
Demographic characteristics 
According to the 2001 Census:  
• 14 per cent of under 16 year olds (1,629,141 people) in the United Kingdom are 
from minority ethnic groups;284  
• 24 per cent of the BME population were under 16 whilst this figure was 20 per 
cent for White British; and 
• non-White groups are more likely to live in England than other United Kingdom 
countries (they made up 9 per cent of the total population of England and only 2 
per cent in both Scotland and Wales)285. 
Other problems  
• Unemployment rates for people from some non-White ethnic groups286 are 
generally higher than those from White ethnic groups (ONS 2004c);  
• a large proportion of minority groups live in urban areas, and these are more 
likely to contain deprived local areas (Jacobs and Tinsley 2006); and  
• some ethnic groups show lower educational attainment than the national average 
e.g. Black minority ethnic groups, Bangladeshi, Pakistani and pupils of Mixed 
White and Black Caribbean heritage (DfES 2007e).  
12.1.8 Party goers  
Demographic characteristics 
A recent Mintel survey287 found that total nightclub admissions were estimated to be 
around 179 million in 2006, with a fairly even gender split: 
• those in the 18 to 24 and 24 to 35 year old age ranges are the main audience for 
nightclubs (clubbing was found to dwindle significantly after the age of 25);  
• 79 per cent of 15 to 19 year olds, and 92 per cent of 20 to 24 year olds have ever 
been to a nightclub (in 2006 there were estimated to be 5.6 million 18 to 24 year 
olds in the United Kingdom); 
• 4.6 million adults visited nightclubs once a month or more, and 78 per cent of 
those were 15 to 24 year olds (42% 15 to 19 year olds and 36% 20 to 24 year 
olds); 
• 73 per cent of 15 to 19 year olds and 72 per cent of 20 to 24 year olds go to a 
nightclub either on special occasions or more regularly; and 
• in 2006, 240 music festivals took place in the United Kingdom, the ten most 
popular had an estimated capacity of 745,000 people. 
                                                
284 Minority ethnic group in this case has been taken to mean anyone in the 2001 Census who 
defined themselves in any category other than ‘White British’ see 
http://www.statistics.gov.uk/downloads/theme_compendia/foe2004/FocusonEthnicity.zip  
285 See: http://www.statistics.gov.uk/statbase/product.asp?vlnk=10991  
286 In 2003/04 unemployment rates for: Bangladeshi (18%), Mixed ethnic origin (17%), Black 
African (15%), Pakistani (14%) and Black Caribbean (13%) men were around 3 times higher 
than for White British men (5%).  Unemployment rates were around 3 times the rate of White 
British women (4%) for the following groups:  Pakistani (17%), Black African (12%), Mixed 
ethnic origin (12%), and Black Caribbean (12%).  
287 Mintel Nightclubs United Kingdom report December 2006 a sample of 2010 internet users 
were asked about their clubbing habits  
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Other problems  
There is no evidence that party goers as a group experience particular problems, 
however there are some risks that this group can be exposed to such as fighting or 
violent crime, hearing damage from loud music, risk of injury in crowded venues 
(Anderson et al. 2007; Kilfoyle and Bellis 1997; RNID 2007). 
12.2 Drug use and problematic drug use among vulnerable groups (from 
special studies) 
Results from the 2003 Offending, Crime and Justice Survey (OCJS) showed that, 
while those in vulnerable groups represented less than a third (28%) of young people 
in the sample, they accounted for 61 per cent of recent Class A drug users (Becker 
and Roe 2005).   Analysis of vulnerable young people288 from the 2004 OCJS 
suggested that they were more likely to take any drug, Class A drugs and be frequent 
users than young people who were not classed as vulnerable (Budd et al. 2005).  
Young people who were in more than one vulnerable group were also more likely to 
be frequent users and report higher levels of any and Class A drug use than those in 
only one category of vulnerability. 
12.2.1 Children living in government care 
Prevalence 
Research has shown that looked after children report higher levels of all illicit drug 
use than the general population and use drugs more frequently.  In one study, 75 per 
cent of the sample had ever used drugs and 73 per cent had tried cannabis (52% 
monthly and 34% daily cannabis users) (Ward et al. 2003289).  However, it has been 
reported that up to 30 per cent of the looked after population may be described as 
existing problematic users, or potentially problematic users (Edmonds et al. 2005).   
Primary drug (by age and gender) 
As in the general population, cannabis was the most commonly reported drug used 
by children looked after by local authorities in England, Scotland and Wales (ONS 
2003, ONS 2004290; Ward et al. 2003).   
Patterns of drug use 
Ward et al. (2003) reported in their study that cannabis and solvents were first used 
at 14 years of age, little gender differences were reported. 
                                                
288 Identified as vulnerable to heightened levels of drug use in a report based on the 2003 
sweep of the OCJS e.g. ever in care; ever homeless; truants; those excluded from school and 
serious or frequent offenders (Becker and Roe 2005). 
289 A 12-month study funded by the Home Office Drugs and Alcohol Research Unit was 
carried out between July 2001 to June 2002.  It examined young care leavers’ patterns of 
drug use as they moved from care to live independently.  A survey was conducted with 200 
young people in the process of leaving care, or having recently left care.  A sub-sample of 30 
were selected to participate in an in-depth interview on their experiences of care and leaving 
care, with a focus on recent changes in their progress towards independent living and 
associated changes in patterns of drug use. These interviews were carried out six months 
after the first interview contact. The sample consisted of young people aged 13-24 years, 
average age 18 years.  
290 A series of reports presenting data from national surveys of the mental health of young 
people looked after by local authorities in England, Scotland and in Wales.  The survey was 
carried out in England by the ONS for the Department of Health between October 2001 and 
June 2002.  A total sample of 2,500 child identifiers (approximately 1 in 18 of all looked after 
children) excluding those in short term placements, was drawn from the anonymised 
database of looked after children held by the Department of Health, proportional to the 
number of children looked after in each authority. Equivalent surveys took place in Scotland 
and in Wales in 2002/03. 
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Social and geographical profiles 
In an ONS study, looked after children in Scotland were nearly twice as likely as their 
English counterparts, and one and a half times more likely than their Welsh peers to 
smoke, drink alcohol and take drugs (15%, 8% and 10% respectively) (ONS 2004). 
Trends in the last 10 years 
NO INFORMATION AVAILABLE 
12.2.2 Early school leavers/ academic failure 
School Excludees and Truants 
Edmonds et al. (2005) state that there is a great deal of evidence from the United 
Kingdom to suggest a strong association between truancy, exclusion and drug use, 
though there is no evidence of causality.  There is also evidence to suggest an 
association between lack of involvement with the education system and elevated 
levels of illicit drug use (MORI 2004; Powis et al. 1998).  Reasons put forward for this 
include: greater exposure to drugs, greater opportunity to use as a result of not being 
under parental/ teacher supervision during the day and/or mixing with older people 
who are not in education. In addition, there is strong evidence to suggest that school 
attendance is a protective factor against drug misuse and individual students are 
more likely to initiate drug use in schools where truancy is high.  Furthermore, regular 
attendance at school will increase the level of exposure to school-based universal 
drug prevention initiatives. 
Prevalence  
Latest data from the English school survey291 show that in 2006, nearly a fifth (19%) 
of pupils reported past truancy, 12 per cent reported having been excluded and a 
quarter of pupils reported one or both of these.  As in previous years, pupils who had 
truanted or been excluded from school were more likely to say they took drugs at 
least once a month (11%) and to have used a Class A drug (14%) than those who 
had not truanted or been excluded (1% in both cases).  Pupils who had ever been 
excluded from school were nearly twice as likely as those who had not to have taken 
drugs in the last month (odds ratio = 1.80).  Pupils who had ever truanted were 2.4 
times more likely to have taken drugs in the last month (Fuller et al. 2007).  
 
Analysis of latest SALSUS292 data showed that, in Scotland, 70 per cent of 13 year 
olds who had never truanted had never used drugs compared to only two percent of 
13 year olds who had truanted more than 10 times.  Similarly, 60 per cent of 15 year 
old pupils who had never truanted had never used drugs compared to only four per 
cent of 15 year old pupils who have truanted more than 10 times (ISD Scotland 
2007). 
 
Latest data for England and Wales is taken from the British Crime Survey 2005/06  
(BCS) showing that:   
                                                
291 A national survey of secondary school pupils aged 11 to 15 carried out by the National 
Centre for Social Research (NatCen) and the National Foundation for Educational Research 
(NFER) on behalf of the Information Centre for health and social care and the Home Office.  
8,200 pupils in 290 schools in England completed the surveys in the autumn term of 2006. 
292 Scottish Schools Adolescent Lifestyle and Substance Use Survey is carried out among 13 
and 15 year old school pupils in Scotland.  In Autumn 2006 23,180 pupils took part in the 
survey. 
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• lifetime and last year use of any drug is approximately twice as high amongst 
former truants293 within the 16 to 24 year old age group than among non-truants 
(66% compared to 34% and 40% compared to 18% respectively), while last 
month use is almost three times greater (26% compared to 9.1%); 
• lifetime and last year use of any illicit drug amongst former excludees in the 16 to 
24 year old age group is more than one and a half times greater than use 
amongst those in the same age group who had never been excluded (66% 
compared to 41% and 39% compared to 22% respectively); and 
• almost two-thirds of excludees also reported that they had ever truanted, this 
group reported the highest levels of lifetime and last year drug use (75.8% and 
47.1%) (Roe and Man 2006).  
Primary drug (by age and gender) 
Cannabis (34%) is the most common drug used recently by former truants and 
excludees, followed by cocaine and ecstasy (Roe and Man 2006).  
Patterns of drug use 
NO INFORMATION AVAILABLE  
Social and geographical profiles 
NO INFORMATION AVAILABLE  
12.2.3 Youth in families with drug and/or alcohol use 
In the NCCDP annual review of drug prevention, Sumnall et al. (2006a) reported that 
drug use in the family can influence future individual drug using behaviours, but 
exactly how is unclear and it does not necessarily directly lead to increased drug use.  
Analysis of 2006 SALSUS data found that, of those who had reported ever using 
drugs, six per cent of 13 and five per cent of 15 year olds obtained drugs from a 
brother or sister and six per cent of 13 year olds and one per cent of 15 year olds 
reported obtaining drugs from a parent (Maxwell et al. 2007).  In a report based on 
the Edinburgh Study of Youth Transitions and Crime (ESYTC) and looking at family 
functioning, McVie and Holmes (2005) found that at age 15 young people whose 
parent(s) had used drugs during the previous year were more than twice as likely to 
have used a drug themselves in the same period than those whose parent(s) had not 
used a drug (Table 12.1).  
Table 12.1: Percentage of 15 year olds who have used drugs in the last year by parental 
drinking and drug use, Scotland 
 ‘Any’ drug use at age 15 
Yes 38 
No 26 
Parents drink excessively in an average week 
Significance =p<.001 
Yes 55 
No 26 
Parents used drugs in the last year 
Significance =p<.001 
Source: McVie and Holmes 2005 
Primary drug (by age and gender) 
NO INFORMATION AVAILABLE  
Patterns of drug use 
NO INFORMATION AVAILABLE  
                                                
293 In 2005/06 the British Crime Survey (BCS) included questions for respondents aged 16 to 
24 that allowed identification of those who had ever truanted e.g. skipped school without 
permission for a whole day and those who had ever been excluded from school. 
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Social and geographical profiles 
NO INFORMATION AVAILABLE  
Trends in the last 10 years 
NO INFORMATION AVAILABLE 
12.2.4 Homeless youth 
Prevalence  
Evidence suggest prevalence and frequency of drug use amongst homeless youth 
tends to be greater than in the general population (Wincup et al. 2003; Edmonds et 
al. 2005).  Wincup et al. (2003294) reported high lifetime, last year and last month 
prevalence rates for drug use amongst young homeless people (95% of the sample 
had used drugs). Seventeen per cent of the sample were identified as problem drug 
users and a further 14 per cent had been problem drug users in the past. 
Primary drug (by age and gender) 
In research by Wincup et al.(2003) cannabis was the primary drug used (94% of the 
sample had ever used, 80% in last year, 68% in last month and 53% in last week).  
Fourteen was the typical age that they began using drugs.   
Patterns of drug use 
Again, based on the research by Wincup et al: 
• At least half of interviewees had used cannabis, amphetamine, ecstasy, LSD, 
magic mushrooms, cocaine and poppers;  
• two in five of the homeless young people had used heroin; and 
• prevalence of use in the last year, last month and last week indicate that for many 
use of drugs is ongoing rather than experimental, particularly for cannabis, 
heroin, crack cocaine and ecstasy (Wincup et al. 2003). 
Social and geographical profiles 
NO INFORMATION AVAILABLE 
Trends in the last 10 years 
NO INFORMATION AVAILABLE 
                                                
294 Over an 18 month period from January 2001, data were gathered in four case study areas 
in England and Wales. The main methods used were interviews with young homeless people 
and professionals who work with them. The research team conducted interviews with 160 
young people aged 25 and under who were in contact with homelessness services. These 
divided almost equally across the four case studies. Purposive sampling techniques were 
employed in order to gain access to different experiences of homelessness, for example 
rough sleeping, living in hostels and staying with friends on a temporary basis, and to explore 
the different experiences of young people of different ages, sex and ethnic origins. In each 
area young people were contacted through key organisations, both in the voluntary and 
statutory sector that provided services for young homeless people. The interviews 
investigated a wide range of issues and responses were recorded on a questionnaire4 that 
included both closed and open-ended questions. The interview was divided into seven 
sections covering personal characteristics; experiences of homelessness; health issues 
(physical and mental health, health care); substance use; risky behaviours (for example, 
injecting drugs); experiences of crime and victimisation, and finally a self-assessment of their 
current needs. The interviews took place in a variety of settings, mainly hostels and day 
centres, and lasted between one hour and two and a-half-hours.  
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12.2.5 Young offenders 
There have been a large number of studies that show a strong association between 
delinquency, offending and drug use.  Most studies, however, suggest that rather 
than directly causing offending, these may simply be other expressions of a general 
tendency to delinquency (Goulden and Sondhi 2001; Lloyd et al. 1998; Borrill et al. 
2003; Budd et al. 2005).  Results from the 2005 OCJS reported that young people 
who had taken drugs in the previous year were significantly more likely to have 
committed a frequent or serious offence than those who had not taken drugs (46% of 
those who had taken drugs had committed an offence compared to 19% who had not 
taken drugs) (Wilson et al. 2006). 
 
The ESYTC considered drug use and offending amongst young people.295  The 
findings suggests that there is an incremental increase in both variety and frequency 
of offending from the non-user group to the multiple user group, with the scale of 
difference being least between the double and triple user groups.  This is true for 
each age group (McVie and Bradshaw 2005).  A separate report on the ESYTC 
looked at patterns of referral to Children’s Hearings in Scotland (McAra and McVie 
2005).296  Ten per cent of the cohort were referred to a reporter for drug and alcohol 
misuse and a further three per cent for offences under the Misuse of Drugs Act 
(1971).  In another 11 per cent of cases drug and/or alcohol was raised as an issue.  
The report does not provide an analysis by age.   
 
A Home Office report on the evaluation of the Drug Interventions Programme (DIP) 
pilot for young people reported that between November 2003 and September 2005 
2,327 young people aged 10 to 17 had contact with arrest referral.  The most 
common substance used was cannabis (30%) and use of cocaine (4%), crack (1%) 
and heroin (1%) was low.  Most had been arrested for acquisitive crimes such as 
theft and burglary, drug offences were low (Home Office 2007e). 
Primary drug (by age and gender) 
The evaluation of the Drug Interventions Programme (DIP) for children and young 
people (Home Office 2007e) reported that the most common substance used by the 
2,237 young people involved in the pilot was cannabis (30%). The use of cocaine 
(4%), crack (1%) and heroin (1%) was low. 
Patterns of drug use 
The results of the DIP pilots found that a range of substances were used. The 
frequency of cannabis use was high, over half of those that used cannabis did so on 
a daily or weekly basis (Home Office 2007f). 
                                                
295 In this study two measures of delinquent behaviour were used: variety of offending (a 
count of the number of different offending behaviours the respondent had engaged in) and 
volume of offending (the cumulative frequency of offending across all the offending 
behaviours asked about).  Fifteen items of anti-social or delinquent behaviour were used to 
create both of these measures.  These were: fare dodging; shoplifting; noisy or cheeky in 
public; joyriding; theft from school; carrying a weapon; graffiti; vandalism; housebreaking; 
robbery; theft from home; fire-raising; assault;  theft from vehicle; and truanting from school.  
The four substance use sub-groups (non- regular users, single substance users, two 
substance users and three substance users) were compared in terms of their mean variety 
and volume of self-reported delinquency at ages 13 to 15.   
296 The Scottish children’s hearings system is based on a coherent vision of criminal and 
social justice known as the “Kilbrandon” philosophy. According to this philosophy juvenile 
offending and other troublesome behaviours (including drug or alcohol misuse) should be 
regarded as manifestations of deeper social and psychological malaise and/or failures in the 
normal upbringing process.  The aim is to address the needs of the child.  The system deals 
with young people aged between 8 and 16 years referred on offence grounds and from birth 
to age 16 referred on a range of care and protection grounds.  
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Social and geographical profiles 
NO INFORMATION AVAILABLE   
Trends in the last 10 years 
NO INFORMATION AVAILABLE 
12.2.6 Youth in deprived places/ neighbourhoods and/or with high drug availability 
In a further ESYTC report, McVie and Norris (2006) reported that characteristics of 
the neighbourhoods in which young people live do play a role in influencing aspects 
of their (delinquent and) drug using behaviour, although their impact is relatively 
weak in comparison to the effect of individual characteristics, such as gender and 
personality.   Whereas delinquency and hard drug use are partially explained by 
negative neighbourhood characteristics (such as greater deprivation in the case of 
delinquency and higher crime rates for hard drug use), more frequent cannabis use is 
greater within prosperous neighbourhoods but also within areas in which there is 
greater social disorganisation . 
 
Analysis of SALSUS (ISD Scotland 2006) found no significant difference in drug use 
by pupils in the most deprived areas. Similarly, analysis of the 2006 English School 
Survey (Fuller et. al 2007) found no relationship between recent drug use and 
income and socio-economic status (Fuller 2007). 
Primary drug (by age and gender)  
At age 16, 32 per cent of young people living in deprived areas of Edinburgh reported 
recent cannabis or Class A drug use (McVie and Norris 2006). 
Patterns of drug use 
NO INFORMATION AVAILABLE   
Social and geographical profiles  
Less than one percent of drug users reported ‘hard drug’ use (i.e. heroin, crack). 
Whereas delinquency was correlated with cannabis use, analysing geographic areas, 
aggregation of indicators of drug use and deprivation revealed that the highest areas 
of drug use were not always the areas with the highest levels of deprivation. 
Frequent cannabis users were more likely to live in areas of affluence.   
Trends in the last 10 years 
NO INFORMATION AVAILABLE 
12.2.7 Ethnic minorities 
Edmonds et al. (2005) report that, although young people from BME communities 
have generally lower levels of drug use than the general population, there are 
significant variations in use between ethnic groups.  Young people of mixed ethnicity 
tended to have higher levels of drug use.   Latest data from the 2006 school survey 
for England showed that pupils of mixed ethnicity and Black pupils were more likely 
to report current drug use than White pupils (odds ratio = 2.26 and 1.90 respectively).  
Among other minority ethnic groups, the odds of recent drug use were not 
significantly different from white pupils (Fuller 2007).  
Primary drug (by age and gender) 
As with the wider population, cannabis was the most widely reported drug used 
among all ethnic groups (Fountain et al. 2003).  
Patterns of drug use 
In England according to the 2005 school survey, pupils of mixed ethnicity were more 
likely than any other group to have taken drugs in the last year (25%), with similar 
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prevalence across genders.  The proportions of White and Black pupils who had 
used drugs in the last year were similar (19% and 17% respectively).  There were 
few gender differences amongst White pupils, whereas among Black pupils 14 per 
cent of boys and 20 per cent of girls reported that they had taken drugs in the last 
year.  Thirteen per cent of ‘other’ ethnicity and 12 per cent of Asian pupils reported 
last year drug use.  Fourteen per cent of Asian boys and 16 per cent of boys of 
‘Other’ ethnicity reported recent drug use compared to nine per cent of Asian girls 
and 10 per cent of ‘Other’ girls.  A similar pattern exists for current drug use.  Pupils 
of mixed ethnicity were more likely to report current drug use (16%) with the 
prevalence of current drug use among other groups ranging from eight per cent of 
Asian pupils to 11 per cent of White pupils (NatCen/NFER 2006). 
Social and geographical profiles 
NO INFORMATION AVAILABLE  
Trends in the last 10 years 
NO INFORMATION AVAILABLE  
12.2.8 Party Goers 
Prevalence  
Research has shown that young people who go to nightclubs are more likely to use 
drugs more frequently and in larger quantities (O’Hagan 1999; Measham et al. 2001).  
Higher drug use has also been associated with the frequency of going to pubs and/or 
bars (Riley et al. 2001).  Recent analysis of the BCS has shown an association 
between frequency of visits to nightclubs and/or pubs and wine bars with cocaine 
powder use.  Sixteen to 29 year olds who made frequent visits to nightclubs reported 
almost three times the level of current cocaine use as those who had not been to a 
club in the past month (4.2% compared to 1.6%).  Those who had been to pubs or 
bars were over four times more likely to report current cocaine use than those  who 
visited pubs or bars less frequently (7.3% compared to 1.7%) (Roe and Man 2005).  
Latest data from the 2006 school survey for England reported a relationship between 
recent drug use and whether pupils had been to a pub, bar or club in the last month.  
Those who had been in any of those places were 1.4 times more likely to have taken 
drugs in the last month (NatCen/NFER 2007).  
 
An annual survey was carried out with readers of Mixmag (a specialist dance music 
magazine) until 2005 (McCambridge et al. 2005).  However, as the mean age in each 
survey was approximately 24 or older, it has not been reported on here. 
Primary drug (by age and gender) 
NO INFORMATION AVAILABLE 
Patterns of drug use 
NO INFORMATION AVAILABLE  
Social and geographical profiles 
NO INFORMATION AVAILABLE  
12.2.9 ESPAD 
Drug use by siblings 
According to latest ESPAD297 data: 
                                                
297 The UK participates in the European School Survey Project on Alcohol and other Drugs 
(ESPAD), which is undertaken amongst 15 and 16 year olds in about forty European 
countries.  Data are collected every fourth year. The next data collection will be carried out 
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• A quarter of all United Kingdom students had older siblings who smoked 
cannabis, 2.5 times the European average and 3 per cent took ecstasy (in line 
with the European average) 
• for male students 22 per cent had older siblings that smoked cannabis and six 
per cent took ecstasy (European average 10% cannabis, 3% ecstasy) 
• for female students 28 per cent had older siblings that smoked cannabis and nine 
per cent took ecstasy (European average 10% cannabis, 3% ecstasy) 
 
Results for all ESPAD countries showed that, among European students, having an 
older sibling who uses a particular substance was associated with more use by the 
younger sibling.  
Single parents 
Significantly higher cannabis use was found among those living with a single parent 
in the United Kingdom, as was the case with over 70 per cent of ESPAD countries 
(21 of the 29). 
Truancy (ESPAD data) 
According to ESPAD data, truancy is associated with increased use of cannabis 
among United Kingdom students as is the case for all ESPAD countries. 
Parental supervision (ESPAD data) 
Significantly higher cannabis use was found among students whose parents did not 
know what they were doing on a Saturday night in the United Kingdom and in 97 per 
cent of ESPAD countries (30 of the 31)  (ESPAD 2003). 
12.3 Vulnerable groups among the treated population 
12.3.1 Description of treated population by vulnerable groups  
Government figures show that five per cent of looked after children were identified as 
having a substance misuse problem in 2006, with nearly two thirds of them (63%) 
receiving an intervention (DfES 2007a). 
 
Data from the NDTMS298 National Young People report for England show that 
between April 2006 and March 2007, 21,765 young people (aged between 9 and 17) 
received treatment for drugs and/or alcohol. Between April and August 2007, 16,355 
young people (aged between 9 and 17) received treatment with 6,060 new 
presentations.  In 2003/04299 6,536 11 to 17 year olds received treatment for drugs    
only in England, this equated to five per cent of the treatment population.  In the 18 to 
24 age category 29,616 people received treatment, equating to 23.6 per cent of the 
treatment population. It is worth noting that in 2003/04 it wasn't mandatory for Young 
People’s services to report to NDTMS so numbers appear low in comparison to 
2006/07 data.  NDTMS treatment referral figures for the North West region of 
England in 2005/06 (Khundakar et al. 2007) reported that in the general population 
                                                                                                                                         
during the spring of 2007 and the results are to be published the following year. So far three 
ESPAD surveys have been conducted, with 1995 as the starting year. 
298 See: http://www.ndtms.net/NatEnglandPerformanceReport.aspx?AllAgesOrYP=YP . The 
National Drug Treatment Monitoring System (NDTMS) relates to the process of collecting, 
collating and analysing information from and for those involved in the drug treatment sector. 
All drug treatment agencies must provide a basic level of information to the NDTMS on their 
activities each month known as the Core Data Set 
299 See: http://www.nta.nhs.uk/areas/facts_and_figures/0304/default.aspx 
http://www.nta.nhs.uk/areas/facts_and_figures/0304/docs/NDTMS_200304_bulletin_Jul_05.d
oc 
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the main source of referral into drug treatment was via self-referral.  However, this is 
dependent on age. Whilst 40 per cent of episodes in the 25 to 29 year age range self-
referred into treatment services, only eight per cent of treatment episodes in under 18s 
came from self referral and a third came from the Criminal Justice System (CJS), which 
includes Youth Offending Teams (YOTs). 
 
Treatment Demand Indicator (TDI) data for 2005/06 show that there were 16,021 
presentations by individuals under the age of 19 in the United Kingdom, representing 
12 per cent of the total TDI population.   Of these, 2,787 (17%) were under the age of 
15 of which 68 per cent (1,895) were first presentations.  Amongst the 15 to 19 age 
group there were 13,234 treatment presentations and 61 per cent of these were first 
presentations.  The gender split was approximately 70 per cent male and 30 percent 
female. 
 
Beckett at al. (2004) reported on 103 young people attending drug services in Stoke-
on-Trent and Newcastle300.  Sixty per cent of respondents lived in areas of moderate 
or high material deprivation but there was no direct relationship between material 
deprivation in the areas in which respondents lived and their level of problematic drug 
use. 
12.4 Correlates and consequences of substance use among vulnerable groups  
12.4.1 Psycho-social and health problems related to substance use  
Vulnerable young people often experience a number of psycho-social and health 
problems, some of which may be related to the consequences of substance use.  
However, the relationship is complex and attribution is difficult to ascertain. 
Children living in government care institutions  
In 2006, rates of cautions or convictions for offences were almost three times higher 
amongst looked after children aged 10 or over (9.6%) than for all children (DfES 
2007a).  Nearly a fifth of care leavers experience homelessness within two years of 
leaving care and it is estimated that between a quarter and a third of all people 
sleeping on the streets have spent time as children being looked after by local 
authorities (Shelter 2005).  Looked after children are also more likely to have no 
qualifications than those in the general population, in 2005/06 around half of care 
leavers had no qualifications301 when they left (57% in England, 50% in Scotland, 
48% in Wales). 
Early school leavers / academic failure  
Children who are not in school are more likely to be unemployed after reaching 
school leaving age302 and some studies have found an association between lack of 
involvement with the education system and elevated levels of criminality (Edmonds et 
al. 2005). The recent evaluation of the Drug Interventions Programme pilot for young 
people reported that a fifth of 14 and 15 year olds who had contact with arrest referral 
                                                
300 Interviewed using a structured questionnaire.  46 parents were also interviewed between 
June 2001 and June 2002. Respondents’ average age at interview was 16.3 (range: 11 to 20) 
and they had been using drugs for an average of 3.6 years. The primary aim of the study was 
to define the hierarchy of risk and protective factors among the adolescents attending 
designated drug services and to understand the direct and indirect links between these 
factors.  
301 See: http://www.dfes.gov.uk/rsgateway/DB/SFR/s000691/SFR44-2006.pdf; 
http://www.scotland.gov.uk/Resource/Doc/159750/0043434.pdf; and 
http://www.dataunitwales.gov.uk/Documents/Data_Set/PSS/2005_06/lgd01006_01_children_
2005_06_v1_eng.pdf. 
302 See: http://www.dfes.gov.uk/schoolattendance/truancysweeps/ accessed 17th July 2007  
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had been excluded or had truanted from school (Home Office 2007e).  Children 
(particularly boys) who are excluded from school, or leave as soon as they reach 16, 
are at greater risk of gaining a criminal conviction in adulthood (McAra and McVie 
2007). 
Youth in families with drug and/or alcohol use 
Problems faced by children living in families with drug and alcohol use include poor 
parenting or parental absence, lack of basic necessities (food, heat, safe 
environment), poor educational attainment and emotional, cognitive, behavioural and 
other psychological problems (ACMD 2003; Aberlour 2007). 
Homeless Youth  
Homelessness can be associated with offending and risk-taking behaviour such as 
self-neglect, self-harm, suicide, and substance use.  Young homeless people are 
vulnerable to poor physical and mental health and are more likely to experience a 
variety of medical problems, such as infectious diseases and nutritional disorders 
and they can have difficulties in accessing health care services.  Homelessness can 
have long-term implications for education, employment prospects and difficulties 
accessing and completing training courses (Shelter 2005).  Mental health problems 
are disproportionately high amongst young homeless people (Wincup et al. 2003) 
(see also Taylor et al. 2006).  Lack of stable accommodation can put young 
homeless people at risk of being a victim of crime and of financial and/ or sexual 
exploitation (Scottish Executive 2002). 
Young Offenders 
Involvement with the criminal justice system can lead to housing problems for young 
people (Shelter 2005).  Young offenders are more likely to have truanted or been 
excluded from school; be under-achieving at school; associate with criminal peers; 
not live with both parents; have a learning disability; have been in care; been 
subjected to poor parenting; witnessed violence in the home or been the victim of 
crime.  (YJB 2003; Healthcare Commission 2006).   They often have more health 
needs than the non-offending population and have insufficient access to healthcare, 
particularly mental health.  In a recent review303 of community healthcare for young 
offenders it was found that in 2004/05, 18 per cent of the young people that took part 
in the review had physical health issues, 42 per cent had substance misuse issues 
and 44 per cent had emotional or mental health needs (Healthcare Commission 
2006).  Re-offending rates are high, in 2004, 41 per cent of young offenders 
committed a further offence within one year which led to a pre-court disposal or a 
conviction in court (Whiting et al. 2006).   Research conducted in Scotland has found 
that young people who have been involved with the juvenile justice system are three 
times more likely to be convicted as adults than those who have not (McAra and 
McVie 2007). 
Youth in deprived places/neighbourhoods and/or with high drug availability 
Living in deprived areas is associated with unemployment, poor health and crime 
(ONS website 2007).  It can also be associated with lower educational attainment. In 
England in 2005/06, 53 per cent of pupils in Neighbourhood Renewal Fund (NRF) 
areas achieved five or more A* to C grades at GCSE or equivalent compared to 60.3 
per cent of pupils in non-NRF areas. In 2006, a third of teenagers from 
disadvantaged backgrounds achieved five A* to Cs at age 16 compared to 57 per 
cent of all pupils (DfES 2007d).  In Scotland, pupils registered for free school meals 
                                                
303 The review is based on the findings of 50 inspections of youth offending teams (45 in 
England and 5 in Wales) that were published between 2003 and 2006.  During the 
inspections the views of young offenders were gained through face to face interviews, a 
postal questionnaire and an electronic questionnaire. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 173
scored less well in exams on average than those who were not.  Similarly, pupils who 
lived in the top 15 per cent of the most deprived areas had lower than average exam 
tariff scores than those in the other 85 per cent of areas (Scottish Executive 2007i).   
Studies have shown that those living in more deprived areas have higher mortality 
rates than those living in less deprived areas (Baker et al. 2006).  Some studies have 
also found a relationship between deprivation and mental disorder.  In 2004, 10 per 
cent of those aged five to 16 in the general population had a clinically diagnosable 
mental disorder, 18 per cent of boys and 13 per cent of girls living in households with 
a gross weekly income of under £100 had a mental disorder (Green et al. 2005).  
Ethnic minorities  
Unemployment rates for people from some non-White ethnic groups are generally 
higher than those from White ethnic groups (ONS 2004c).  In general, a far greater 
proportion of minority groups live in urban areas, which are more likely to contain 
deprived local areas (Tinsley and Jacobs 2006).  Social exclusion and deprivation 
are high in many of these areas and these are risk factors that can be associated 
with problematic drug use (Fountain et al. 2003).  In England in 2005/06, some ethnic 
groups showed lower educational attainment than the national average e.g. Black 
minority ethnic groups, Bangladeshi, Pakistani and pupils of Mixed White and Black 
Caribbean heritage are below the national average at GCSE and equivalent. 
Chinese, pupils of Mixed White and Asian heritage, Irish and Indian pupils 
consistently achieve above the national average across Key Stages 2, 3 and 4 (DfES 
2007e).  
Party Goers 
The night-time economy is a setting in which violent crime commonly occurs (Finney 
2004).  In a recent study,304 11 per cent stated they had been involved in a fight in a 
pub, bar or nightclub, in the street, or both whilst on a night out during the past twelve 
months (13% of males and 8% of females) (Anderson et al. 2007).  There is a 
potential for sustaining minor injuries in dark, noisy, unventilated and crowded 
venues (Bellis and Kilfoyle 1997) and loud music in venues such as nightclubs, bars 
and concerts can lead to hearing damage.  A recent report showed that 70 per cent 
of clubbers, 68 per cent of gig-goers and 44 per cent of people who go to bars 
experience the symptoms of hearing damage after their night out, such as dullness of 
hearing or tinnitus (ringing in the ears) (RNID 2007305). 
12.4.2 Criminal behaviours 
See above.  Latest data from the Offending Crime and Justice Survey306 (Wilson et 
al. 2006) reported that young people who had taken drugs in the past 12 months 
were significantly more likely to have committed a serious offence307 and/ or to have 
                                                
304 The study targeted young people aged 18 to 35 years old who visit pubs, bars and 
nightclubs. The survey was conducted opportunistically between the hours of 5pm and 11pm 
on different nights of the week in 18 pubs, bars and nightclubs across Liverpool. Interviewers 
completed the questionnaires by interviewing participants on a one to one basis. A total of 
424 questionnaires were completed during the course of the study. 
305 In 2005, 1381 face-to-face surveys were conducted with 16-30 year olds from England, 
Scotland and Wales. They asked questions about exposure to loud music, experiences of 
ringing in ears and use of hearing protection products.  
306 The Offending, Crime and Justice Survey (OCJS) is the longitudinal, self-report household 
survey for England and Wales.  It was first conducted in 2003 and will be repeated annually 
until 2006.  The main aim is to examine the extent of offending, anti-social behaviour and drug 
use among the household population, particularly among young people aged 10 to 25. 
307 Serious offences include the following: theft of a vehicle; burglary; robbery; theft from a 
person; assault resulting in injury; selling class A drugs 
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been a frequent offender308 than those who had not taken drugs.  Nearly half (46%) 
of those who had taken drugs in the past 12 months had committed an offence 
compared to 19 per cent who had not taken any drug.  
 
Sixty-two per cent of drug users aged between 10 and 17 had committed an offence 
in the last 12 months, compared with a quarter (23%) of those who had not taken 
drugs. The equivalent figures for 18 to 25 year olds were 40 per cent and 15 per cent 
respectively (Table 12.2). (Wilson et al. 2006). 
 
In 2005 over 50 per cent of young offenders in custody reported Class A drug use in 
the past year, among the highest for any at risk group (DfES, HO and DH 2005).  
Table 12.2 Proportion of 10 to 25 year olds who committed an offence in the last 12 months 
by drug status, England and 2005  
 No 
drugs 
Any 
drugs 
   
Non-
class A 
drugs 
Class A 
drugs 
Not 
frequent 
user 
Frequent 
user 
 % % % % % % 
All 
Non-offender 81  *54 58 *48 78 *40 
Offender 19 *46 42 *52 22 *60 
Serious offender 9 *24 20 *31 11 *30 
Frequent offender 4 *18 15 22 5 *28 
 
10 to 17 year olds 
Non-offender 77 *38 42 *26 74 *31 
Offender 23 *62 58 *74 26 *69 
Serious offender 11 *33 31 40 12 *37 
Frequent offender 4 *25 23 35 6 *33 
 
18 to 25 year olds       
Non-offender 85 *60 66 *52 82 *44 
Offender 15 *40 34 *48 18 *56 
Serious offender 7 *21 14 *30 9 *27 
Frequent offender 3 *15 12 *20 4 *25 
 
Unweighted bases       
All 3,680 896 611 285 4,232 345 
10 to 17 2,309 347 284 63 2,522 135 
18 to 25 1,371 549 327 222 1,710 210 
 
* indicates a significant difference between no drugs and any drugs, Class A and non-Class A drugs, 
frequent and non-frequent users, within age groups. 
Source: Wilson et al. 2006 
 
Data from the Arrestee survey309 (Boreham et al. 2006) reported on prevalence of 
drug use in young people in the 17 to 24 year old age bracket.  Two thirds of 
                                                
308 Frequent offenders are those young people who committed six or more offences, including 
the less serious, in the last 12 months 
309 In the period covered by this report (1st October 2003 to 30th September 2004) the first 
Arrestee Survey was carried out in a national sample of 60 custody suites, including both DIP 
intensive and other areas in England and Wales. Within each custody suite, interviewers 
worked six-hour shifts and attempted to interview as many eligible arrestees as possible. 
Arrestees were eligible if they were 17 years or over and arrested on suspicion of committing 
any offence (not just the trigger offences targeted by DIP interventions). In total interviewers 
worked 5043 shifts and interviewed 7535 arrestees. The interview consisted of a 20-minute 
computerised interview with a substantial self-completion section, which contained the most 
sensitive questions about offending behaviour, drug and alcohol use and treatment for drugs. 
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arrestees (65%) had used drugs in the past month (66% male, 58% female, 28% 
heroin, crack and/or cocaine (HCC) for both sexes): 
• 57 per cent had used cannabis in the last month (59 % male, 47% female) 
• 14 per cent had used powder cocaine (14 % male, 8% female),  
• 15 per cent had used heroin (14 % male, 21% female),  
• 12 per cent had used crack (12% male, 17% female). 
  
Responses to drug problems among vulnerable groups 
12.5 Policy and legal development  
12.5.1 National and legal development  
Reducing the use of drugs, particularly by young people, is a central aim of United 
Kingdom drug strategies.  The first United Kingdom drug strategy does not 
specifically refer to vulnerable young people but does give consideration to the needs 
of young people at risk of transition from regular to problematic use (United Kingdom 
ADCU 1998).  The Updated National Drug Strategy (Home Office 2002) includes a 
target to reduce the use of Class A drugs and the frequent use of any illicit drug 
among all young people under the age of 25 by 2008 (especially by the most 
vulnerable), noting that vulnerable young people are more at risk of developing drug 
problems than other young people.  The recent consultation document outlining 
proposals for a new national drug strategy to begin in 2008 suggests that there is a 
need to reach out more effectively to the most vulnerable and the most at risk young 
people (HM Government 2007a).  
 
In Scotland and Wales, the needs of vulnerable young people were referred to in 
earlier drug strategies.  In Scotland, the 1999 Drugs Strategy refers to "support for 
children and young people in vulnerable situations” (Scottish Office 1999).  The 
Welsh substance misuse strategy specifically mentions that action to tackle 
substance misuse and work with vulnerable young people is required (National 
Assembly for Wales 2000). 
12.5.2 Strategies and policies for social exclusion that refer to vulnerable groups 
The Hidden Harm report by the Advisory Council on the Misuse of Drugs (ACMD 
2003) on children of drug using parents can be regarded as a catalyst for policies 
designed to respond to the needs of this vulnerable group.  Its publication coincided 
with proposals by the United Kingdom government for significant reform of children's 
services; in particular the recognition of the need to have more integrated working 
between services to better address the often multiple needs of some children and 
young people.  In England and Wales, the Children's Act 2004 provided the context 
for this.  The Every Child Matters: Change for Children programme in England 
focuses on the well-being of children and young people up to the age of 19 (DfES 
2004a).310  This programme embraces five key outcomes for every child, namely: ‘be 
healthy’; ‘stay safe’; ‘enjoy and achieve’; ‘make a positive contribution’; ‘achieve 
economic well-being’, requiring a range of departments and organisations to work 
together for the benefit of children.  Choosing not to take illegal drugs is identified as 
a key aim within the ‘be healthy’ outcome of the programme.  Every Child Matters: 
Change for Children: Young People and Drugs (DfES, HO and DH 2005) is a joint 
strategy published by the previous Department for Education Skills (DfES311), the 
                                                                                                                                         
In addition, arrestees were asked to provide an oral fluid sample for analysis of recent drug 
use. 
310 For more information see: http://www.everychildmatters.gov.uk/ 
311 The work of the Department for Education Skills in the area of children and young people 
is now the responsibility of the Department of Children, Schools and Families. 
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Home Office and the Department of Health (DH).  It links Every Child Matters and the 
national drug strategy and sets out how children’s services and Drug Action Teams 
should work together to target vulnerable young people. 
 
The Children’s Act and guidance under the Every Child Matters programme includes 
the following elements designed to maximise integrated working: 
• the development of integrated Children's Services Trusts led by local authorities; 
• the production of annual Children's Services Plans; 
• a Common Assessment Framework (CAF) to promote earlier recognition and 
assessment of children with additional needs; 
• a new joint inspection process, the Joint Area Review, based on a detailed 
Outcomes Framework based on the five key outcomes; 
• a set of common core skills and knowledge for all workers with children and 
young people, linked to a comprehensive workforce development programme; 
and 
• the establishment of a Local Safeguarding Children Boards (LSCB) by every 
Local Authority.  
 
In addition, linked to Every Child Matters, the National Service Framework for 
Children, Young People and Maternity Services (DH 2004a) sets out a ten-year 
programme of improvement in children's health and well-being, including that of the 
unborn child, setting standards for the care of children, young people, and for 
maternity services.  Delivery of this is the responsibility of the National Health Service 
(NHS) in partnership with Children's Service Trusts.  This framework also states that 
staff from all agencies should identify children and young people at risk of misusing 
drugs or alcohol and should provide them with access to prevention and treatment 
services. 
 
One key element of integrated working is that staff from any one service should not 
presume to have the skills to address all problems in isolation, but instead should 
work with other services whose staff have the skills to do so, and that this should be 
done in an integrated manner, presuming a sharing of information, knowledge and 
skills.  
 
Every Child Matters: Change for Children – Young People and Drugs sets out how 
those responsible for the delivery of children and young people's services and the 
drugs strategy can co-operate and plan comprehensive responses for children and 
young people who are using or otherwise affected by drug misuse; developing a 
Young People and Drugs Delivery Plan.  Responsibility for performance 
management of this lies with the cross-departmental Young People and Drugs 
Programme Board.  To support this the Home Office and the former DfES (now the 
DCSF) established Joint Regional Teams within each regional government office 
from February 2005, consisting of regional DfES, National Treatment Agency (NTA), 
public health, youth justice and drugs and crime staff. 
 
Drugs: guidance for schools (DfES 2004b) proposed that schools should provide 
supportive relationships, encourage school attendance and identify and respond to 
the drug-related needs of vulnerable pupils. 
 
The Welsh Assembly Government's strategic policy with respect to children and 
young people is set out in Children and Young People: Rights to Action (WAG 
2004c).  In some respects it is similar to the policy in England, including a 
requirement on all authorities to produce three year strategic Children and Young 
People's Plans, a Common Assessment Framework (CAF), and Local Safeguarding 
Children Boards (LSCB), but there are no Children’s Trusts, nor are there integrated 
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structures under a single director.  Instead, the approach in Wales is based on the 
statutory duty to co-operate between local authorities and their statutory partners, as 
set out in the Children's Act.   
 
In Scotland, Children: Better Integrated Children’s Services (Scottish Executive 2001) 
highlighted the need for integrated services.  Getting Our Priorities Right (Scottish 
Executive 2003b) set out a comprehensive approach to unifying and integrating 
services focusing on the children of substance misusing parents.  A Children’s 
Charter (Scottish Executive 2004) outlined the needs and expectations of children 
and young people in relation to their protection from harm, as did Getting it right for 
every child.312  An Integrated Children's Services Planning313 framework requires the 
development of a single plan agreed with all relevant agencies (e.g. local authorities, 
NHS Boards, police, child protection and the voluntary sector), to deliver integrated 
services for all children and young people, including those who are vulnerable and at 
risk.  An Integrated Assessment Framework, together with an electronic record based 
on a child's needs is required of all services in contact with children and young 
people.  The planning framework is backed by a Quality Improvement Framework for 
Integrated Children's Services314 and by multi-agency joint inspections of children's 
services.315  In 2007, an Action Framework for children and young people’s health in 
Scotland (Scottish Executive 2007j) sets out action to be taken to enhance 
integration.   
 
In Northern Ireland, the Children (Leaving Care) Act 2002 and the Protection of 
Children and Vulnerable Adults Order 2003 seek to protect children. 
12.5.3 Definitions and concepts of vulnerability in the national context  
There are slight variations in the designation of vulnerability in policy documents, 
reflecting both the different drug strategies and differences in need.  In Scotland, 
young people who are vulnerable, excluded or in the most impoverished groups 
include looked after children, homeless young people, travellers and young 
offenders, as well as those living in more deprived communities (Scottish Office 
1999).  In the Welsh substance misuse strategy, vulnerable young people include; 
pupils excluded from schools, truants, looked after children, young offenders, young 
homeless and children of substance-misusing parents and young people not in 
education, work or training (National Assembly for Wales 2000).  In the consultation 
document on the new national drugs strategy, vulnerable groups include: young 
offenders; looked-after children; young homeless people; children who truant or are 
excluded from school; young people who have been sexually exploited or who work 
in the sex industry; and children whose parents misuse drugs or alcohol (HM 
Government 2007a).  In its 2007 guidance, the National Institute for Health and 
Clinical Excellence (NICE) suggests that vulnerable and disadvantaged children and 
young people aged under 25 who are most at risk of misusing substances include: 
those whose family members misuse substances; those with behavioural, mental 
health or social problems; those excluded from school and truants; young offenders; 
looked after children; those who are homeless; those involved in commercial sex 
work; and those from some Black and minority ethnic groups. 
                                                
312 For more information see: 
http://www.scotland.gov.uk/Publications/2005/07/25112327/23294 
313 For more information see: 
http://www.scotland.gov.uk/Topics/Government/DataStandardsAndeCare/ChildrenandFamilie
s/IAF 
314 For more information see http://www.scotland.gov.uk/Publications/2006/04/27135008/0 
315 For more information see: http://www.hmie.gov.uk/services/default.asp 
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12.6 Prevention and Treatment  
Having set in place a framework, within wider generic responses to meeting the 
needs of young people (in particular the vulnerable), strategies encompass two 
distinct areas for action; preventing vulnerable young people from becoming problem 
drug users; and for those who are already experiencing problems, providing 
appropriate treatment.  Current strategies are, in effect, based on prevention, early 
intervention and treatment.  There are a number of policy documents and guidance 
on prevention, both in general and in the particular context of the vulnerable.  In the 
latter case, premised on their higher risk of becoming drug users.   
 
The National Institute for Health and Clinical Excellence (NICE) 316 has produced 
guidance on community-based interventions317 to reduce substance misuse among 
vulnerable and disadvantaged children and young people (NICE 2007a).  This 
provides advice on helping young people access the right support and services and 
outlines effective individual, family and group-based support, which can improve 
motivation, family interaction and parenting skills.  These reflect the series of 
recommendations for prevention produced by, for example, the NTA and reviews 
from the National Collaborating Centre on Drug Prevention (NCCDP).  The latter 
include that by Burrell et al. (2005) which describes an approach to service provision 
based on the four-tiered model of service which is premised on the idea that such an 
approach enhances the ability of a range of agencies to work closely together to 
provide a seamless service.  Also, from the NCCDP are research reports on drug 
prevention amongst vulnerable groups (Edmonds et al. 2005), a report on drug 
prevention effectiveness within the grey literature (McGrath et al. 2006) and a more 
recent report on the evidence base for prevention initiatives (Sumnall et al. 2006b) 
(see below). 
 
NICE makes recommendations with respect to different groups of children and young 
people: 
• all those under the age of 25 who are vulnerable and disadvantaged;  
• those who are vulnerable and disadvantaged, aged 11 and 16 years, and 
assessed to be at high risk of substance misuse, and their parents or carers;  
• children aged 10 to 12 who are persistently aggressive or disruptive and 
assessed to be at high risk of substance misuse and their parents or carers; and 
• those who are vulnerable and disadvantaged under 25 who are problematic 
substance misusers (including those in schools or further education). 
 
For any child or young person under the age of 25 who is vulnerable and 
disadvantaged, local strategic partnerships are expected to develop and implement a 
strategy to reduce substance misuse amongst this group as part of a local area 
agreement.  In addition, practitioners and others who work with this group (NHS, 
local authorities and the education318, voluntary, community, social care, youth and 
criminal justice sectors) are expected to screen for drug misuse or risk of misuse.  It 
is also recommended that they work with parents or carers, education welfare 
services, children’s trusts, child and adolescent mental health services, school drug 
advisers or other specialists to either provide support or referral to appropriate 
service providers.  
 
For those aged 11 to 16 assessed to be at high risk of substance misuse it is 
recommended that parents or carers should be offered a family-based programme of 
                                                
316 See: http://guidance.nice.org.uk/PHI4/guidance/pdf/English/download.dspx 
317 Community-based interventions are defined as interventions or small-scale programmes 
delivered in community settings, such as schools and youth services. 
318 In schools this includes teachers, support staff, school nurses and governors. 
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structured support over two or more years.  More intensive support (for example, 
family therapy) is recommended for families who need it. 
 
For children aged 10 to 12 who are persistently aggressive or disruptive and 
assessed to be at high risk of substance misuse, it is recommended they be offered 
group-based behavioural therapy over one to two years before and during the 
transition to secondary school.  It is recommended that sessions take place once or 
twice a month and last about an hour, each session focusing on coping mechanisms 
such as distraction and relaxation techniques: help develop the child’s organisational, 
study and problem solving skills; and involve goal setting.  In addition, it is suggested 
that parents or carers be offered group-based training in parental skills on a monthly 
basis, over the same time period (as the child).   It is recommended that sessions 
focus on stress management, communication skills and how to help develop the 
child’s social-cognitive and problem solving skills and advise on how to set targets for 
behaviour and how to establish age related rules and expectations for their children. 
 
NICE also recommends that vulnerable and disadvantaged children and young 
people aged under 25 who are problematic substance misusers (including those 
attending secondary schools or further education colleges) should be offered one or 
more motivational interview(s) according to the young person’s needs.  Each session 
should last about an hour and the interviewer should encourage them to discuss their 
use of both legal and illegal substances, reflect on any physical, psychological, 
social, education and legal issues related to their substance misuse and set goals to 
reduce or stop misusing substances. 
 
In Scotland guidance is provided on assessing young people at risk (EIU 2004).  
Drug use prevention among young people  
The National Collaborating Centre on Drug Prevention has looked at evidence of the 
effectiveness of practice (Sumnall et al. 2006b).  This follows an earlier review of the 
evidence in McGrath et al. (2006).  Key findings include: 
• there is a limited amount of evidence to suggest that brief interventions may 
successfully help young people to moderate their drug use; 
• moderately intensive family-based interventions can have a positive effect upon a 
wide range of outcomes, including drug use, problem behaviours, educational 
engagement, and offending; 
• approaches in nightlife settings should promote healthy lifestyles in addition to 
consideration of drug use; and 
• there is often little consideration of non drug-related outcomes in prevention 
projects (e.g. health).  
12.6.1 Treatment for young problematic drug misusers 
In England, a target has been set to increase the number of young people under 18 
with drug problems entering, receiving and completing treatment programmes by 50 
per cent between 2004 and 2008, with NTA monitoring performance (HM Treasury 
2004).  In 2005 the NTA provided guidance on the essential elements of a young 
people’s substance misuse treatment services (NTA 2005).  In addition, a directory of 
substance misuse services for young people in England has been published by 
NTA319 and a directory of residential services for young people under 18s.320  A 
recent joint review by DfES and NTA found that there is still considerable regional 
                                                
319 For information see: 
http://www.nta.nhs.uk/about_treatment/treatment_directories/young_people/default.aspx 
320 For information see: http://www.nta.nhs.uk/programme/national/Young per cent20people 
per cent20directory.pdf 
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variation in investment, access and quality of provision for under 18s, not necessarily 
reflecting local needs.  From April 2008 the NTA is to take on a leadership role for 
young people's substance misuse treatment in England.321   
Young Offenders  
As with young people in other vulnerable groups, in England and Wales, each stage 
of the youth justice system is seen as an opportunity to identify those at risk of 
becoming problematic users or who are in need of specialist treatment (YJB 2006b; 
WAG 2006b).  All are expected to receive screening for substance misuse issues 
and those identified with a problem to receive an assessment within five working 
days, and within 10 working days of this, access to early intervention or treatment 
services.  
 
At the end of the 2005/2006 period, performance statistics for England showed that 
92.7 per cent of young offenders accessing youth offending teams received a 
substance misuse screening.   
 
In addition, the Drug Interventions Programme322 in England has piloted youth-
centred models of arrest referral and drug testing for 14 to 17 year olds charged with 
those crimes that are most often linked to drugs.323  An evaluation of these schemes 
found few young people involved in the arrest referral pilots to be problematic drug 
users and only five per cent using Class A drugs, therefore, there was insufficient 
evidence to demonstrate its effectiveness.  Sumnall et al. (2006b) (see earlier) found 
some evidence that interventions for young offenders may reduce rates of offending, 
re-offending and imprisonment in the short term. 
Persistent truants and school excludees  
NICE (2007) (see above) recommend drug misuse assessments be carried out in 
school or pupil referral units and that, those found to use drugs or be at risk of using 
them, should receive appropriate support with the aim of returning them to 
mainstream education.  In their review of drug prevention, Sumnall et al. (2006b) 
(see earlier) found some evidence that community based truancy interventions have 
significant effects upon psychosocial factors that subsequently modulate drug use 
and that school-based social work schemes evaluated in the United Kingdom have 
some short term effect on drug use. 
Looked after children 
In the Care Matters green paper, the former DfES set out the steps it will take, 
together with local delivery partners, to improve outcomes for children and young 
people in care, including addressing drug misuse (DfES 2006f).  
Homeless Young People 
There is a lack of guidance on effective prevention and treatment for homeless young 
people. Existing documents mostly centre on policy, service delivery and 
engagement with adult drug users. NICE (2007) reported no United Kingdom 
guidance for this population. 
 
                                                
321 For more information see: www.nta.nhs.uk  
322 For more information see: http://www.drugs.gov.uk/drug-interventions-programme/ 
323 Arrest referral schemes for children and young people (10 to 17 year olds) were piloted in 
ten areas; all were operational from August 2004.  On-charge drug testing of 14 to 17 year 
olds under Section 5 Criminal Justice Act (CJA 2003); piloted in five areas have been 
operational from August 2004.  Statutory powers to test young people at the pre-sentence 
stage and while on licence also exist under the CJA 2003 but were not enacted during the 
evaluation period.   
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Children and young people with behavioural, mental health or social problems 
NICE (2007) provided guidance around monthly, group-based behavioural therapy 
sessions for children aged 10 to 12 who are persistently aggressive  or disruptive and 
assessed to be at high risk of substance use.   It also recommends that group-based 
training in parenting skills for the parents or carers of the children should take place 
at the same time. 
Ethnic Minorities 
There is a lack of guidance on effective prevention and treatment for ethnic 
minorities. Existing documents mostly concerns policy, service delivery and 
engagement with adult drug users. NICE (2007) reported no guidance for this 
population. 
12.6.2 Institutional responses  
Custodial establishments are required to develop a youth resettlement plan with the 
young person and their Youth Offending Team (YOT) worker prior to their release, 
which should include substance misuse where relevant.  Secure establishments and 
specialist substance misuse services are expected to work together to improve 
continuity of care between custody and the community.  It is expected that 
information from specialist assessments, care plans and resettlement plans be 
shared, with consent, to reduce the need for repeat assessments and improve the 
young person’s journey through the system.  In some cases the YOT will act as a 
main conduit for this information; in other complex cases, the specialist substance 
misuse services will assume this role (NTA 2007h). 
12.6.3 Responses in the area of social exclusion 
There are two major drug prevention related initiatives in this area, social inclusion 
programmes such as Positive Futures and an initiative focused in deprived areas, the 
High Focus Area (HFA) initiative.  In addition, there are more generic initiatives, and 
it should be noted that policy throughout the United Kingdom is now looking towards 
such initiatives, seeing drug misuse as just one of many issues for young people that 
require addressing and developing early intervention programmes, that aim to 
improve the ability of children to reach their potential.  These include programmes 
such as Sure Start324, targeting the very young.  
Positive Futures  
Positive Futures was launched in 2000, and is a national sports and activity based 
social inclusion programme using sport and leisure activities to engage with 
disadvantaged and socially marginalised young people aged between 10 and 19.  It 
is funded by the Home Office Crime and Drug Strategy Directorate and managed by 
Crime Concern.  Currently, it operates through over 120 local projects across 
England and Wales.  The Home Office suggests that Positive Futures is not a 
‘diversionary’ or a sports development programme as traditionally understood and 
practiced.  Rather, it is a ‘relationship strategy’ which seeks to engage with young 
people through an ability to teach or help them learn something they think is 
worthwhile, using sport and other activities as a basis for establishing relationships 
with young people who have otherwise become alienated and distanced from 
mainstream social policy agencies and ‘authority’ figures.  Its aim is to ‘have a 
                                                
324 Sure Start is a government programme in England which aims to achieve better outcomes 
for children, parents and communities by increasing the availability of childcare for all 
children, improving health and emotional development for young children, and supporting 
parents as parents and in their aspirations towards employment.   For more information see: 
http://www.surestart.gov.uk/ 
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positive influence on participants’ drug use, physical activity and offending behaviour 
by widening horizons and access to lifestyle, educational and employment 
opportunities within a supportive and culturally familiar environment’ (Home Office 
2003).  A final report outlines the key findings from the programmes (Crabbe et al. 
2006) and focuses on processes rather than outcomes giving guidance on how to run 
future projects.  
 
The Scottish Executive has published an Evaluation and Description of Drugs 
Projects Working with Young People and Families funded by Lloyds TSB Foundation 
Partnership Drugs Initiative (PDI) (McIntosh et al. 2006).  This report provides case 
study process and outcome evaluation of four projects in Scotland.  Positive changes 
were reported by young people in both use of substances and risk factors for use. 
PDI is a funding initiative providing grants to voluntary sector organisations working 
with children and young people affected by drugs and alcohol misuse.  Current 
projects funded by this initiative are targeted on such groups as pre-teen drug users, 
children growing up in families affected by parental drug use, and those who are 
developing problem behaviours, including drug and alcohol misuse, in their mid 
teens. The Scottish Executive provided €5.1 (£3.5) million funding to the PDI 
between 2000 and 2005, with a further €1,010,000 (£750,000) agreed for financial 
year 2006/07. 
High Focus Areas  
In England, a High Focus Areas (HFA) initiative was launched in April 2005 in 30 
local authority areas to support faster and sustained progress in implementation of 
universal, targeted and specialist services as set out in strategic guidance Every 
Child Matters: Young People and Drugs, and to learn from their experience.  The 
areas were selected on the basis of local need and levels of current service 
provision, including deprived/high crime areas where drug misuse problems are 
prevalent.  Objectives are to develop and test a best practice model for wider 
dissemination; and to make an early and sustained impact on delivery of drug 
services for children and young people. 
12.6.4 Responses to public nuisance  
There is no specific response for young people at risk of drug use per se with respect 
to public nuisance, although powers provided to the police and Local Authorities 
through the Anti-Social Behaviour Act 2003, which is designed to tackle nuisance 
associated with properties used for the sale and use of crack and other drugs can be 
used.  Also, Anti-Social Behaviour Orders (ASBOs) were introduced following the 
Crime and Disorder Act 1998.325   The Respect agenda is a cross-Government 
strategy aimed at tackling bad behaviour and nurturing good behaviour326. 
12.6.5 Trends and changes in recent year 
The most important trend in recent years has been the move towards seeing drug 
prevention amongst the vulnerable, and, more particularly prevention and treatment 
of problematic drug use amongst this group, as being part of a more generic 
response to tackling a wider range of health and social problems, rather than just 
seeking to address drug use in isolation from other problems.   
                                                
325 For more information see: 
http://www.crimereduction.gov.uk/antisocialbehaviour/antisocialbehaviour55.htm 
326 For more information see: http://www.respect.gov.uk 
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12.6.6 Early intervention strategies  
Early intervention strategies in the United Kingdom tend to be defined in terms of 
strategies both aimed at reducing substance misuse and related risk-taking 
behaviour among vulnerable groups, such as the programme in the London 
Boroughs of Lambeth, Southwark and Lewisham Health Authority, targeting young 
offenders, children of drug using parents, socially excluded young people, and young 
people excluded from school (Ghate et al. 2003) or, more recently projects such as 
those targeting very young people where there are problems in their families, such as 
substance misuse (see section on children of drug using parents for projects in 
Wales). 
 
The National Institute for Health and Clinical Excellence (NICE) has issued national 
standards calling for anyone who works with young people to identify those who are 
vulnerable to drug problems, and intervene at the earliest opportunity - before they 
start using drugs at all or before they get into worse problems if they are already 
misusing drugs. It gives advice on stepping in and helping young people access the 
right support and services, and outlines effective individual, family and group-based 
support which can improve motivation, family interaction and parenting skills.  It also 
recommends that local strategic partnerships develop and implement substance 
misuse reduction strategies for vulnerable young people based on local area profiles 
that should be developed on the basis of age, factors that make them vulnerable  and 
other locally agreed characteristics.  
12.6.7 Selective prevention for families at risk 
Children of drug using parents  
As noted previously, the ACMD report on the children of drug using parents, Hidden 
Harm, may be seen as a catalyst in terms of a government response to the needs of 
vulnerable young people as a whole, coinciding as it did with policy designed to 
enable young people to reach their potential (ACMD 2003).  ACMD made a number 
of recommendations with respect to these young people.  A further report was 
recently published describing the extent to which the recommendations have been 
implemented and points to areas where work is still required (ACMD 2007a).  It is 
suggested that despite sustained policy developments regarding children, there is 
evidence of differing levels of priority accorded to the actual and potential harm 
experienced by them across the four countries, and therefore the depth and breadth 
of implementation has been markedly different.  
 
In Wales there are two specific initiatives to support the children of substance 
misusing parents: 
• Option 2 is a family intervention service that responds to a crisis that could result 
in children having to be taken into care.  The aim of the service is to develop and 
encourage new behaviours within the family so that they can move beyond the 
crises.  
• An Early Parental Intervention Service Programme is being developed and 
piloted.  The focus of the service is on families where an adult’s substance 
misuse has been identified as having an impact on their parenting capacity.  The 
aim is to deliver early preventative services in order to prevent a crisis that could 
result in children being taken into care (Internal communication Welsh Assembly 
Government).  
 
Sumnall et al. (2006b) found that high intensity, family-based intervention 
programmes with children of drug using parents have shown to have an effect on 
drug-related behaviours.  
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The Bottling It Up report (Turning Point 2006) found that there are currently gaps in 
service provision for children who are affected by parental alcohol misuse.  The 
research was based on interviews with children and parents affected by alcohol 
misuse and highlighted the far-reaching consequences of parental alcohol problems 
on everyone in the family.  It found that families generally received little support to 
help address the practical and emotional issues that arise.  If an adult problematic 
drinker accesses services, they largely find their role as a parent is not addressed.  
Many parents told Turning Point that they were struggling to meet their children’s 
basic care needs or provide adequate emotional support, and children had to rely on 
either their own coping strategies or resilience, or the support of others to get by.  It 
was also reported that staff in adult alcohol services often feel ill-equipped to meet 
the needs of children of misusing parents, and therefore concentrate on adults. In 
children’s services, many staff feel that they lack the knowledge, skills and 
confidence to address parents’ substance related problems even where they affect 
children.  Very few professionals are confident about addressing the needs of both 
client groups.  As a result, significant gaps exist in specialist provision and where 
services do exist, the focus is primarily on parental drug misuse, rather than alcohol. 
The report calls for direct services for children of alcohol-misusing parents to meet 
their specific needs, as well as providing support directly to their parents so that they 
can improve their parenting.  It goes on to say that services that work with alcohol-
misusing adults should have protocols in place to protect children, and to provide 
prompt access to a wider range of specialist services when required.  
Engaging vulnerable families  
The Bouncing Back! prevention programme aims to pilot and develop good practice, 
knowledge and expertise to engage vulnerable family members, carers and parents 
in drug education initiatives.  The programme recognises the links between positive 
parenting education and drug awareness (ADFAM 2007).  The project work includes 
workshops for parents, filmmaking and drama with young people, group work with 
fathers and drug education for foster carers.  The projects produced resources for 
working with families, including resources for practitioners, DVDs, magazines and 
toolkits.  All the projects illustrated that with good partnership working, innovation, 
significant resources and planning, vulnerable and diverse families can become 
involved in drug and alcohol prevention programmes.  The Department of Health is 
funding the production of a training/ resource pack as a follow-up to this programme.  
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13. Drug-related research in Europe 
13.1 Research structures  
13.1.1 Drug-related research in national policy 
A United Kingdom Drug Strategy, Tackling Drugs to Build a Better Britain, was 
launched in 1998 (UKADCU 1998).  One of the underlying principles of the strategy 
was that it should be evidence based and the strategy identified the research and 
information needs for each of its four aims: preventing drug use amongst young 
people; safeguarding communities; providing treatment; and reducing availability.  In 
2002, the updated Strategy (DSD 2002) set out progress in developing the evidence 
base including the development of a performance management framework. A three 
month consultation on the development of the new Drug Strategy ran from July to 
October 2007. 
 
The devolved administrations have their own drug strategies.  In Scotland, Tackling 
Drugs in Scotland: Action in Partnership (Scottish Office 1999) explicitly laid out the 
role of information and research in implementing the Drug Strategy.  This was 
complemented by the Scottish Drug Misuse Information Strategy to “support the 
implementation of current Government policies, and provide a basis for monitoring 
their application and continuing appropriateness” (Scottish Office 1998). 
 
Similarly, a key component of the Welsh Strategy, Tackling Substance Misuse in 
Wales: A Partnership Approach (National Assembly for Wales 2000) is to address 
the substance misuse information and research gap and improve the evidence base 
for evaluating progress.  The Strategy expires in 2008 and consultation on a new 
strategy has identified seven key themes, one of which is to further develop the 
evidence base. 
 
Northern Ireland launched a new combined drugs and alcohol strategy in 2006 
(DHSSPSNI 2006) with monitoring, research and evaluation identified as one of five 
supporting pillars.  Main areas of research will be identified through various new 
groups although as yet no definite priorities have emerged. 
13.1.2 Relationship between research and policy 
The need for policy to be evidence based is a central tenet of the government’s 
policy making agenda (Cabinet Office 1999) and the different drug strategies 
throughout the United Kingdom all place a strong emphasis on research.   
Research evidence for policy making 
There are concrete examples of research informing drug policy by providing an 
evidence base on which to make policy decisions. In the 1990s, the Task Force 
responsible for the Effectiveness Review327 commissioned nine research projects 
including the National Treatment Outcomes Research Study (NTORS) concluding 
that ‘treatment works’, now an established principle of drug strategies across the 
United Kingdom (MacGregor 2006).  
 
Research is often undertaken to address a specific knowledge gap. In Scotland, a 
review of drug misuse research was undertaken in 2000 to identify a programme of 
research in support of the Scottish Drug Misuse Strategy.  The report by McIntosh 
                                                
327 The Taskforce was established in April 2004 to look at the effectiveness of treatment for 
people who misuse drugs. It ran for 2 years and had a budget of £1 million.  
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and McKeganey (2000) assessed the contribution of research to the Strategy and 
suggested improvements to the evidence base, including the need for a clear 
research strategy. 
 
In Wales, ten research projects were recently commissioned by the National Public 
Health Service for Wales (NPHS Wales), with the support of Welsh Assembly 
Government (WAG) to provide evidence for the upcoming Blood Borne Viral Hepatitis 
Action Plan for Wales.  The programme includes research estimating the prevalence 
of problem drug use and incidence of Hepatitis C amongst IDUs in full and feeds in to 
the strategy. 
 
Similarly, research estimating prevalence of problem opiate and problem cocaine use 
was commissioned in Northern Ireland in recognition of its importance in formulating 
policy (Hay et al. 2006b). 
Linking research with policy development: Blueprint 
Blueprint is the largest research programme ever run in England.  The five year 
programme commenced in 2003 and will run at an overall cost of around £6.5 million 
with the aim of designing, delivering and evaluating an evidence-based drug 
prevention programme.  At all stages of the programme’s development existing 
evidence on drug prevention programmes has been reviewed and supplemented with 
culturally-specific research on teaching and learning practice in addition to market 
research with pupils, teachers and parents.  
 
The research strategy employed by Blueprint places evidence at the heart of drug 
education from needs assessment and curriculum development to policy 
development and evaluation. The final evaluation, due to be published in 2008 will 
assess the relationship between education and outcomes across all elements of 
programme. The research combines process, impact and outcome evaluation, uses 
quantitative, qualitative and economic methods and comprises 12 inter-related 
evaluation components. It is hoped that the evaluation will be ‘formative’ in that it may 
guide changes to programme design and delivery (Baker 2006). 
13.1.3 Main national structures for drug-related research 
Government coordination bodies for drug-related research 
The UK Drug Strategy is a cross-government initiative with the Home Office taking 
overall responsibility for delivery. The Department of Health has responsibility for 
treatment targets and a programme of research to support this. The devolved 
administrations also commission and fund research to support the development of 
their drug strategies. 
Drug-related research in England 
Crime and Drugs Analysis and Research is an embedded Home Office Research, 
Development and Statistics team that undertakes drugs research and analysis328.  
The team is responsible for developing and maintaining the evidence base that 
supports the Government’s Drug Strategy.  In addition to on-going work to monitor 
performance and measure progress against the Home Office’s Public Service 
Agreements, the team undertakes analysis of the nature and scale of problematic 
drug use and the impact of interventions to tackle it.  Major pieces of research 
undertaken include PDU estimates, cost studies, sizing the drug market and the 
Arrestee Survey. 
 
                                                
328 See http://www.homeoffice.gov.uk/rds/drugs1.html  
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The Drug Misuse Research Initiative (DMRI)329 was a £2.4 million programme of 
research between 2000 and 2005. Based within the Department of Health Policy 
Research Programme it comprised 14 studies on drug misuse.  Phase two 
ROUTES330 (research on understanding treatment experiences and services) 
comprises of 10 projects related to drug treatment and will run between 2005 and 
2008 at a cost of around £1.4 million.  
 
The National Treatment Agency (NTA) also has a remit to undertake research to 
develop the evidence base related to treatment, for example, an ongoing programme 
of epidemiological research from the National Drug Evidence Centre at the University 
of Manchester.331  Other government departments, such as the Department for 
Transport occasionally carry out drug-related research projects.  A recent example is 
Drug Futures332, a programme run by the Office for Science and Technology (OST) 
based at the former Department for Trade and Industry (DTI).  The programme 
explored the impact that scientific and technological advances may have on our 
knowledge and understanding of addiction and drug use.  
The Alcohol and Drugs Policy Branch (ADPB) within the Department for Health, 
Social Services and Public Safety Northern Ireland (DHSSPSNI) has lead policy 
responsibility for delivery of the New Strategic Direction (NSD)333. The Drug and 
Alcohol Information and Research Unit within DHSSPSNI is the main coordination 
branch for drug-related research linked to the NSD. Both are based in the same 
government department and work closely together in linking research and policy, and 
through widespread dissemination of research findings this feeds into practice. Other 
organisations such as the Health Promotion Agency also conduct drug-related 
research on occasion specifically linked to the delivery and evaluation of public 
information campaigns. Other locally based research is also commissioned through 
the four Drug and Alcohol Coordination Teams based in each of the Health Boards. 
Major pieces of research include the Drug Prevalence Survey carried out with 
Ireland. 
Drug Analytical Programme in Scotland  
The Drugs Analytical Team co-ordinates analytical activity relating to drugs within the 
Scottish Executive.  It sits within a broader Justice Analytical Programme and 
combines research, statistical, and economic analysis in order to develop and 
promote use of the evidence base on key drugs policy issues.  The Team works 
closely with analytical colleagues in other areas, and in particular with health on 
alcohol-related issues and the Information Services Directorate (ISD Scotland) which 
collates and disseminates information from a wide range of sources including the 
Scottish Drug Misuse Database and a national study of Prevalence of Problem Drug 
Use in Scotland.  The current analytical programme includes research on 
homelessness and substance misuse, drug deaths, police and prison staff 
occupationally exposed to blood and/or body fluids, and a project to assess the scale 
and impact of illicit drug markets in Scotland.  Statistical work around drug treatment 
data management and drug seizures is also an ongoing part of the team’s work. 
 
                                                
329 See http://www.mdx.ac.uk/www/drugsmisuse/  
330 See http://www.lshtm.ac.uk/research/dmri/  
331 See http://www.medicine.manchester.ac.uk/ndec/ 
332 See 
http://www.foresight.gov.uk/Previous_Projects/Brain_Science_Addiction_and_Drugs/index.ht
ml  
333 See 
http://www.dhsspsni.gov.uk/index/stats_research/public_health/statistics_and_research-
drugs_alcohol-2.htm  
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Drug-related research in Wales 
Based within the Community Safety Division of the Welsh Assembly Government’s 
Department for Social Justice and Local Government, substance misuse research 
forms part of the department’s overall research and evaluation plan.  
Research institutions and organisations 
Many universities carry out drug-related research within relevant research institutes, 
centres and groups.  Some of those most actively involved in drug-related research 
are listed in Table 13.1. 
Table 13.1: University research groups and institutes currently undertaking drug-related 
research 
Research institution University 
Addictions Research Group Keele University 
Birmingham Alcohol, Drugs, Gambling & Addiction 
Group  
University of Birmingham 
Centre for Addiction Research & Education 
Scotland 
University of Dundee 
Centre for Drug Misuse Research University of Glasgow 
Centre for Public Health  Liverpool John Moores 
University 
Centre for Drugs & Health Behaviour  London School of Hygiene & 
Tropical Medicine 
Department for Health Science  University of York 
International Centre for Drugs Policy  
and  
Department of Addictive Behaviour  
St. George’s, University of 
London 
Mental Health Research and Development Unit  University of Bath 
National Addiction Centre  Kings College London 
National Drug Evidence Centre  University of Manchester 
Oxford Substance Misuse Research Group  Oxford Brookes University 
Scottish Addiction Studies  University of Stirling 
Drug & Alcohol Research Group Middlesex University 
 
In addition, a number of non-academic organisations undertake drug-related 
research when commissioned to do so. This includes survey organisations, general 
research institutes and charities.  
Main funding frameworks 
A review of drugs research in 2000 claimed that research funded by government 
departments dominated the total national research effort (MacGregor 2000). This 
remains the case with the government directly funding the majority of drug-related 
research in the United Kingdom.  Government research is occasionally carried out in-
house but is often commissioned from outside providers using competitive tendering 
for contracts.  In addition to research programmes such as ROUTES, money is 
available for individual research studies. In Northern Ireland, £0.2 million has been 
allocated for policy development/research in 2007/08.  
 
Research Councils also provide funding for academic research, including drug-
related research.  The Economic and Social Research Council (ESRC) is a publicly 
funded, independent organisation that funds research and training in social and 
economic issues. In 2006/07 £99.8 million was spent on research, 25 per cent of 
which was on research programmes, 17 per cent on research centres and 27 per 
cent on research grants.  Drug-related research projects can be funded through 
direct research grants such as the current £0.23 million Governing drug-related crime 
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in the risk society project grant and can also form part of a larger linked research 
programme such as the recently published Risk, protection and substance misuse 
amongst young offenders project which was one of five projects funded from the 
£1.41 million priority network programme, Pathways Into and Out of Crime: Risk, 
Resilience and Diversity. 
 
Similarly, the Medical Research Council provides funding for medical research and is 
currently funding a number of projects on addiction.  They range from small grants of 
£60,000 for a two year project, Pathfinder - An investigation of trait impulsivity and 
vulnerability to drug addiction to the five year £2 million project on Neural and 
psychological basis of compulsive drug seeking and relapse prevention in drug 
addiction. 
 
Another major source of funding for drug-related research is the Joseph Rowntree 
Foundation, a social research charity spending around £10 million per year on 
research and development.  A Drug and Alcohol Research Programme ran from 
2001 to 2005 at a cost of £1.5 million; funding a large number of drug-related 
research projects and a small number of alcohol projects.  However, in 2007 a new 
programme of research began with a sole focus on alcohol.  
 
In Scotland, the Robertson Trust sponsors drug-related research as a major topic in 
one of its four priority areas.  Other research funding organisations may provide ad-
hoc funds for drug-related research but it is not, or has not recently been an identified 
priority area for research. 
13.2 Main recent studies and publications 
13.2.1 Main recent studies since 2000 
There is a wealth of high-quality research studies across the United Kingdom, which 
makes it difficult to isolate individual projects for attention.  Some important large 
projects such as Blueprint have been mentioned previously so will not be included in 
this section. 
Drug Treatment Outcomes Research Study 
In England, DTORS (Drug Treatment Outcomes Research Study)334 is currently 
running and will provide a valuable update to research on treatment outcomes.  The 
research is being carried out by the National Drug Evidence Centre (NDEC) at the 
University of Manchester and the National Centre for Social Research (NatCen). 
Funded by the Home Office, the cost of the project is estimated to be around £2 
million. 
 
Background: The National Treatment Outcome Research Study (NTORS)335 was a 
study carried out in England and Wales between the years 1995 and 2000 and was 
able to make a clear case for the effectiveness and cost-effectiveness of treatment. 
Since NTORS the UK has seen some major changes in treatment provision that 
make it necessary to reinvestigate the impact of different drug treatment pathways on 
treatment outcomes 
 
Objectives: The aims of the research are to: evaluate the impact of drug treatment 
on a range of outcome measures; establish which types of treatment pathways 
produce the best outcomes for particular sub-groups of drug users; provide a cost-
benefit analysis of drug treatment based on the outcome measures; and explore 
                                                
334 See: http://www.dtors.org.uk/DTORSHome.aspx  
335 See: http://www.dtors.org.uk/NTORS.aspx  
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reasons for the non take-up of drug treatment of problematic drug users who refuse 
or drop out of treatment. 
 
Methods: DTORS is divided into three separate study components. A quantitative 
study will follow a baseline sample of drug users from 100 randomly selected DATs 
and will adopt a longitudinal cohort design comprising of  survey interviews with 
clients at the outset of treatment and at three and 12 months. The qualitative 
component consists of in-depth interviews with both service providers and service 
users selected using purposive sampling.  Finally the cost-benefit analysis will use 
cost consequences analysis to descriptively compare the costs and outcomes of drug 
treatment. Cost benefit analysis will be used to estimate the net benefit (cost) of drug 
treatment 
 
Results/conclusions: Early indicative findings are due late 2007 with further reports 
to be published during 2008. 
Estimating the National and Local prevalence of problem drug use in Scotland 
Background: There is a recognition that the prevalence of problem drug misuse 
should be an essential part of the evidence base used to formulate policy (Hay et al. 
2006b). However, until 2001 there had been no robust national estimates of problem 
drug use due to a lack of reliable data sources and methodological difficulties. The 
increased use of monitoring systems across the public sector improved reliability 
while the capture-recapture method has become an accepted method for estimating 
problem drug use. The estimates published in Scotland were the first robust national 
estimates utilising the capture-recapture method and will be described here. 
 
Objectives: To provide national and local estimates of the prevalence of problematic 
drug misuse within Scotland in 2000 (Hay et al. 2001). 
 
Methods: The study utilised the capture-recapture methodology. The method 
involved collating information on drug misusers in contact with a wide range of 
agencies to provide a minimum enumeration of the known drug misusing population. 
Statistical methods were then applied to these collated data to obtain an estimate of 
the size of the hidden population, which combined with the known data provided an 
estimate of the total prevalence of drug misuse. 
 
Results/conclusions: The study provided the first ever national and local estimates 
of problematic drug use and showed that there were problematic users in rural as 
well as urban areas. The report also showed that it is possible to provide reliable 
estimates and paved the way for future estimates.  The study has been repeated to 
provide estimates for 2003 and will be repeated again to provide 2006 estimates. 
 
Since 2001 England (Hay et al. 2006a), Northern Ireland (Hay et al. 2006b) and 
Scotland (Hay et al. 2004) have all published national estimates while Welsh 
estimates are currently being produced.  In England a three year programme to 
provide consecutive annual estimates is underway. 
Substitute prescribing for opiate dependence in Northern Ireland 
Background: In Northern Ireland the number of people dependent on heroin was 
traditionally small and far below the levels in other parts of the United Kingdom.  
Consequently there was no formal substitute prescribing system in Northern Ireland 
although individual doctors could prescribe heroin substitutes. 
 
In 2002, however, estimates of problem heroin use were published putting the 
number between 695 and 1250 (McElrath 2002).  To complement these findings, 
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DHSSPSNI commissioned a review of research on substitute prescribing for opiate 
dependence in Northern Ireland (McElrath 2003). 
 
Objectives: To review the research evidence for substitute prescribing for opiate 
dependence. 
 
Methods: An international literature review of both clinical and observational studies. 
 
Results/conclusions: The final report set out 19 recommendations, the principal 
recommendation being the introduction of a methadone maintenance programme in 
Northern Ireland.  DHSSPSNI accepted this recommendation leading to the 
publication of national guidelines on substitute treatment for opiate dependence 
(DHSSPSNI 2004) . 
13.2.2 Peer-reviewed scientific journals 
Table 13.2 lists drug-related research articles published in scientific journals during 
2006.  
Table 13.2: Drug-related articles published in scientific journals by UK based researchers in 
2006 
Reference 
Aceijas, C., Friedman, S., Cooper, H., Lucas Wiessing, Stimson, G., Hickman, M. 
(in press) Estimates of injecting drug users at the national and local level and 
gender and age distribution. Sexually Transmitted Infections. 
Afuwape, S., Johnson, S., Craig, T., Miles, H., Leese, M., Mohan, R. and 
Thornicroft, G. (2006). Ethnic differences among a community cohort of individuals 
with dual diagnosis in South London. Journal of Mental Health 15 (5): 551-567. 
Baker, P.J. (2006). Developing a Blueprint for evidence-based drug prevention in 
England. Drugs: education, prevention and policy.13: 17–32. 
Bakker, A. and Fazey, C. (2006). Methadone tolerance testing in drug misusers. 
British Medical Journal 333: 1056-1059. 
Bargagli, A M., Hickman, M., Davoli, M., Perucci, C A., Schifano, P., Buster, M., 
Brugal, T. and Vicente, J. (2006). Drug related mortality and its impact on adult 
mortality in eight European Countries. European Journal of Public Health 16: 198-
202. 
Barnes, T.R., Mutsatsa, S.H., Hutton, S.B., Watt, H.C., Joyce, E.M. (2006). 
Comorbid substance use and age at onset of schizophrenia. British Journal of 
Psychiatry 188: 237-42. 
Barrowclough, C., Haddock, G., Fitzsimmons, M. and Johnson, R. (2006). 
Treatment development for psychosis and co-occurring substance misuse: A 
descriptive review. Journal of Mental Health 15 (6): 619-632. 
Bennett, J. and Whale, R. (2006). Galactorrhoea may be associated with 
methadone use. British Medical Journal 332: 1071. 
Bennett, T. and Holloway, K. (2006). Variations in drug users’ accounts of the 
connection between drug misuse and crime. Journal of Psychoactive Drugs 38(3): 
243-254. 
Beynon, C.M., Sumnall, H.R., McVeigh, J., Cole, J.C. and Bellis, M.A. The Ability 
of Two Commercially Available Quick Test Kits to Detect Drug-Facilitated Sexual 
Assault Drugs in Beverages. Addiction. (in press) 
Beynon, C.M. and McVeigh, J, (in press). The role of Substance use in non-drug 
related deaths: a cross sectional study of drug treatment clients in the North West 
of England. Journal of Substance Use. 
Beynon, C.M. and Bellis, M.A. and McVeigh. J. (2006). Trends in drop out, drug 
free discharge and rates of re-presentation: a retrospective cohort study of drug 
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treatment clients in the North West of England. Public Health 6: 205. 
Bloor, M., Neale. J, and McKeganey, N. (2006). Persisting local variations in 
prevalence of hepatitis C virus among Scottish problem drug users: Results from 
an anonymous screening study. Drugs: education, prevention and policy 13 (2): 
189–91 
Bolding, G., Hart, G., Sherr, L. and Elford, J. (2006) Use of crystal 
methamphetamine among gay men in London. Addiction 101: 1622-1630 
Boylan, J., Braye, S., Worley, C. (2006). Life's a gas? The training needs of 
practitioners and carers working with young people misusing volatile substances.  
Social Work Education 25 (6): 591-607. 
Cameron, I., Matheson, C., Bond, C., van Teijlingen, E., Wardell, F., Cronkshaw, 
G. and Lawrie, T. (2006) A national survey of nurses working in the management 
of illicit drug misuse in Scotland. International Journal of Drug Policy 17: 442-446 
The Criminal Justice and Immigration Bill 2006-07. The Stationary Office, London 
Clare, P. (2006). The commodity and exchange value of housing in the domestic 
economy of drug users.  Drugs: education, prevention and policy 13 (5): 461-472. 
Coggans, N. (2006) Drug education and prevention: Has progress been made? 
Drugs: education, prevention and policy 13 (5): 417-422 
Cole, J.C., Michailidou. K., Jerome. L. and Sumnall, H.R. (2006). The effects of 
stereotype threat on cognitive function in ecstasy users. Journal of 
Psychopharmacology 20: 518-525. 
Connolly, J.O., Gillmore, J.D., Lachmann, H.J., Davenport, A., Hawkins, P.N. and 
Woolfson, R.G. (2006). Renal amyloidosis in intravenous drug users. QJM: An 
International Journal of Medicine 99(11): 737-742. 
Crome, I. (2006). Overview: Beyond guidelines and guidance—psychosocial 
perspectives on treatment interventions for young people with substance problems 
in the United Kingdom. Drugs: education, prevention and policy 13 (3): 203-224. 
Day, E., Best, D., Ison, J., Keaney, F., Strang, J. and Buntwal, N. (2006). Do 
psychiatrists make a difference?  Impact of levels of medical input to the range of 
treatment provided in in-patient drug detoxification services. Drugs, education, 
prevention and policy 13 (6): 577-585. 
Day, E., Eggen, J., Ison, J., Copello, A. and Fazil, Q. (2006). Ethnicity and 
attempts at self-detoxification from opioid drugs. Drugs: education, prevention and 
policy 13  (1): 93–103 
Dickinson, G. L., Rostami-Hodjegan, A., Lagundoye, O., Seivewright, N., Pratt, P. 
and Lennard, M. S. (2006). A six-year evaluation of methadone prescribing 
practices at a substance misuse treatment centre in the UK. Journal of Clinical 
Pharmacy and Therapeutics 31: 477-484. 
Duke, K. (2006) Out of crime and into treatment? The criminalisation of 
contemporary drug policy since Tackling Drugs. Drugs: education, prevention and 
policy  13 (5) 409-416 
Forrester, D. and Harwin, J. (2006). Parental substance misuse and child care 
social work: Findings from the first stage of a study of 100 families. Child and 
Family Social Work 11: 325-335. 
Frischer M., Heatlie H., Hickman, M. (2006). Prevalence of problematic and 
injecting drug use for Drug Action Team areas in England. Journal Public Health 
28: 3-9 
Godfrey, C. Evidence-based illicit drug policy: the potential contribution of 
economic evaluation techniques. De Economist 154(4): 563-580 
Gordon, R., McDermott, L., Stead, M. and Angus, K. (2006) The effectiveness of 
social marketing interventions for health improvement: What's the evidence? 
Public Health 120: 1133-1139 
Gossop, M., Manning, V. and Ridge, G. (2006). Concurrent use and order of use 
of cocaine and alcohol: behavioural differences between users of crack cocaine 
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and cocaine powder. Addiction 101: 1292-1298 
Gossop, M., Marsden, J. and Stewart, D. (2006). Remission of psychiatric 
symptoms among drug misusers after drug dependence treatment. Journal of 
Nervous Mental Disease 194(11): 826-32. 
Gregory, M. (2006). Characteristics of drug misusers in custody and their 
perceptions of medical care. Journal of Clinical Forensic Medicine. Online early 
access 
Hickman, M., Hope, V., Platt, L., Higgins, V., Bellis, M., Rhode, T., Taylor, C. and 
Tilling, K. (2006). Estimating the prevalence of injecting drug use: a comparison of 
multiplier and capture-recapture methods in four cities, three in England and one 
in Russia. Drug and Alcohol Review 25: 131-140. 
Holland, R., Vivancos, R., Maskrey, V., Sadler, J., Rumball, D., Harvey, I. and 
Swift, L. (2006). The prevalence of problem drug misuse in a rural county of 
England. Journal of Public Health 28(2): 88-95. 
Holloway, K.R., Bennett, T.H., Farrington, D.P. (2006). The effectiveness of drug 
treatment programs in reducing criminal behaviour: A meta-analysis. Psicothema 
18(3): 620-629. 
Hope, V. D., Hickman, M., Tilling, K. Capturing crack-cocaine use: estimating the 
prevalence of crack cocaine use in London using capture-recapture with 
covariates. Addiction. 100: 1701-8. 
Hunt, I.M., Kapur, N., Robinson, J., Shaw, J., Flynn, S. et al. (2006). Suicide within 
12 months of mental health service contact in different age and diagnostic groups: 
National clinical survey. British Journal of Psychiatry 188(2): 135-142. 
Jayakody, A.A., Viner, R.M., Haines, M.M, Bhui, K.S., Head, J.A., Taylor, S.J.C., 
Booy, R., Klineberg, E., Clark, C. and Stansfeld, S.A. (2006). Illicit and traditional 
drug use among ethnic minority adolescents in East London. Public Health 120: 
329-338. 
Kemp, P., Neale, J., and Robertson, M., (2006) Homelessness among problem 
drug users: prevalence, risk factors and trigger events. Health and Social Care in 
the Community. 14 (4):319-328. 
Lakker, C. How successful is the dual diagnosis good practice guide? British 
Journal of Nursing 15(14): 787-90. 
MacGregor, S. (2006) Tackling drugs together: ten years on. Drugs: education, 
prevention and policy  13 (5) 393-398 
MacLeod, J., Davey Smith, G., Hickman, M. (2006). Does cannabis use cause 
schizophrenia? Lancet 367: 1055. 
Marsden, J., Stillwell, G., Barlow, H., Boys, A.., Taylor, C. Hunt, N. and Farrell, M. 
(2006). An evaluation of a brief motivational intervention among young ecstasy 
and cocaine users: no effect on substance and alcohol use outcomes. Addiction. 
101: 1014. 
McArdle, P., Gilvarry, E., McCarthy, S., McIntosh, J., McKeganey, N. (2006). 
Intercity differences in drug use by pre-teenage school children. European 
Addiction Research 12: 182-186. 
McCrystal, P., Percy, A. and Higgins, K. (2006). Drug use patterns and behaviours 
of young people at an increased risk of drug use during adolescence. International 
Journal of Drug Policy 17: 393-401. 
McIntosh, J. and Saville, E. (2006). The Challenges Associated with Drug 
Treatment in Prison. The Probation Journal 53(3): 230-247. 
McIntosh, J., MacDonald, F. and McKeganey, N. (2006) Why do children 
experiment with illegal drugs? The declining role of peer pressure with increasing 
age. Addiction Research and Theory 14 (3): 275-287. 
McKeganey, N., Bloor, M., Robertson, M., Neale, J. and MacDougall, J. (2006). 
Abstinence and drug abuse treatment: Results from the Drug Outcome Research 
in Scotland study. Drugs: education, prevention and policy 13 (6): 537-550. 
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McKeganey, N. (2006). Safe injecting rooms and evidence based drug policy. 
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13.3 Collection and dissemination of research results 
13.3.1 Information flows 
Focal Point structure 
The United Kingdom Focal Point is based at the Department of Health and the North 
West Public Health Observatory, Liverpool John Moores University.  Members of the 
Focal Point team collate data and information from a number of partners including 
relevant government departments, the devolved administrations and leading experts 
in the United Kingdom.  
Information collection and dissemination 
There is an expert for each of the epidemiological indicators who provide valuable 
data and information about their relevant fields.  Workshops are held to discuss and 
agree what data is available for each indicator in the United Kingdom and each year 
the experts compile a report on the status of implementation of the relevant indicator. 
 
Standard tables and structured questionnaires are completed in collaboration with 
the relevant partners taking into account data available in each of the four 
administrations.  The Annual Report is completed by Focal Point staff with 
contributions from experts and consultation with partners. 
 
In addition to workshops on the key indicators, the Focal Point is an active member 
of the Research and Information Working Group (RIWG).  RIWG provides a network 
for the exchange of information between those involved in government drugs 
research and promotes good practice when developing drug-related research. 
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The Focal Point maintains a listing of current research and recent publications 
including journal articles.  This is circulated amongst RIWG members and sent to 
those involved with the Pompidou Group. 
 
The listing is also available on the Focal Point website which also contains 
information about the work of the Focal Point and provides access to recent standard 
tables and the UK Focal Point’s Annual Report.  It is envisaged that the UK Focal 
Point website will continue to develop and provide a valuable resource for the 
dissemination of detailed country specific drugs data, information and research in the 
UK. 
13.3.2 National scientific journals 
Six of the major national journals dedicated to drug or addiction research are 
described below.  All abstracts are published in English.  By definition some of these 
are not national journals but international.  
Drug research journals 
Addiction is an international monthly journal published by the Society for the Study 
of Addiction.  It contains peer-reviewed research reports on alcohol, illicit drugs, 
tobacco and gambling.  
 
Addiction Research & Theory is published six times a year by Informa Healthcare.  
It is an international cross-disciplinary peer-reviewed journal and focuses on the 
context of substance use and misuse 
 
Drugs, Education, Prevention and Policy is published by Informa Healthcare six 
times a year.  It is a refereed journal and publishes research on policy, prevention 
and harm reduction issues regarding the use of alcohol, tobacco and other drugs.  
Although it does contain international contributions, the majority are national. 
 
The International Journal of Drug Policy is published six times a year by the 
International Harm Reduction Association. It aims to publish material on the social, 
political, legal, and health contexts of illicit and licit psychoactive substance use.  The 
journal is international in focus. 
 
The Journal of Substance Use is published six times a year by Informa Healthcare. 
Articles are peer-reviewed and cover a wide range of topics related to illegal and 
legal drug use including prevention, treatment and policy.  Although it publishes 
international research, the focus is predominately national. 
 
Taylor & Francis have commissioned a new journal, Mental Health and Substance 
Use: Dual Diagnosis which will commence publication in February 2008.  There will 
be three editions a year focusing on current trends and perspectives related to 
coexisting mental health and substance use.  The journal will be peer-reviewed and 
international in focus. 
Other national disciplinary scientific journals 
There is a plethora of journals in the United Kingdom that occasionally publish 
relevant drug-related research.  It is therefore impractical to provide details of each.  
Table 13.3 lists a selection of national journals that have published drug-related 
research articles in the past two years.   
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Table 13.3: National disciplinary scientific journals publishing drug-related research since 
Autumn 2005 
Journal title 
Advances in Psychiatric Treatment 
British Journal of Criminology 
British Journal of Psychiatry 
British Journal of Social Work 
British Medical Journal 
Child & Family Social Work 
Critical Social Policy 
Emergency Medicine Journal 
Epidemiology & Infection 
Health and Social Care in the Community 
Health Education 
International Journal of Epidemiology 
Journal of Clinical Pharmacy and Therapeutics 
Journal of Mental Health 
Journal of Psychiatric & Mental Health Nursing 
Journal of Psychopharmacology – this is just drugs 
QJM: An International Journal of Medicine 
Sexually Transmitted Infections 
Social Science & Medicine 
Social Work Education 
The Lancet 
The Probation Journal 
13.3.3 Other means of dissemination 
Websites dedicated to research 
Drug Misuse Information Scotland336 provides information, statistics and research on 
drug misuse in Scotland as well as links to other UK research. Drugscope’s337 
website includes a comprehensive library of drug literature from the UK and beyond. 
 
The National Collaborating Centre for Drug Prevention (NCCDP)338 hosts a Drug 
Prevention Evidence website, which provides details of research carried out both by 
the NCCDP itself and other organisations. 
National drug conferences 
Conferences listed in Table 13.4 are annual national conferences, which include an 
element of research dissemination.  There are also many practical conferences and 
one-off conferences. 
                                                
336 See: http://www.drugmisuse.isdscotland.org/ 
337 See: http://www.drugscope.org.uk/ 
338 See: http://www.drugpreventionevidence.info/ 
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Table 13.4: National drug conferences with an element of research dissemination 
Conference Organiser 
Annual Reducing Drug-Related Deaths Conference North West Ambulance 
Service NHS Trust 
National Conference on Injecting Drug use Exchange Supplies 
National Drug Treatment Conference Exchange Supplies 
DrugScope National Conference DrugScope 
Managing Drug Users in General Practice Royal College of 
General Practitioners  
Annual Drug & Alcohol Professionals Conference Federation of Drug & 
Alcohol Professionals 
ANSA (Association of Nurses in Substance Abuse) 
National Conference 
ANSA 
National Drugs Conference ACPO 
Centre for Addiction Research & Education Scotland University of Dundee 
 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 199
UNITED KINGDOM FOCAL POINT REPORT 2007 
 200
Bibliography 
Aberlour (2006). Have We Got Our Priorities Right? Children living with parental 
substance use. Aberlour, Stirling. Available: 
http://www.aberlour.org.uk/pdfs/priorities_final.pdf [accessed 24/09/07] 
 
Aberlour (2007). A Matter of Substance? Alcohol or Drugs: Does it make a difference 
to the child? Aberlour, Stirling. 
 
Acevedo, B. (2007).  Creating the cannabis user. A post-Structuralist analysis of the 
re-classification of cannabis in the United Kingdom (2004–2005). The International 
Journal of Drug Policy In Press. Available online at: www.sciencedirect.com  
 
ACMD (Advisory Council on the Misuse of Drugs) (2003). Hidden Harm: responding to 
the needs of children of problem drug users. ACMD, London. Available: 
http://drugs.homeoffice.gov.uk/publication-search/acmd/hidden-harm [accessed 
24/09/07] 
 
ACMD (Advisory Council on the Misuse of Drugs) (2006). Pathways to Problems 
Hazardous use of tobacco, alcohol and other drugs by young people in the United 
Kingdom and its implications for policy. ACMD, London. Available: 
http://drugs.homeoffice.gov.uk/publication-search/acmd/pathways-to-
problems/Pathwaystoproblems.pdf [accessed 24/09/07] 
 
ACMD (Advisory Council on the Misuse of Drugs) (2007a). Hidden Harm 3 years on 
Exec Summary. ACMD, London. Available: http://www.drugs.gov.uk/publication-
search/acmd/HiddenHarm20071.pdf?view=Binary. [accessed 24/09/07] 
 
ACMD (Advisory Council on the Misuse of Drugs) (2007b). Drug Facilitated Sexual 
Assault. Home Office, London. Available: 
http://www.drugs.gov.uk/publication-search/acmd/ACMDDFSA.pdf?view=Binary 
[accessed 24.05.07] 
 
ACPO (Association of Chief Police Officers) (2006a). Policing Cannabis. Use of 
Cannabis Warnings Guidelines. Association of Chief Police Officers, London. 
http://www.kent.police.uk/About%20Kent%20Police/Policy/pdfs/acpo%20cannabis%2
0guidelines%20-%20final%20version%2020%20nov%2006.pdf [accessed 05.10.07] 
 
ACPO (Association of Chief Police Officers) (2006b). Operation Matisse. Investigating 
Drug Facilitated Sexual Assault. Association of Chief Police Officers, London. 
Available: http://www.acpo.police.uk/policies.asp [accessed 24.05.07] 
 
ADFAM (2007) Bouncing Back! ADFAM, London. Available: 
http://www.adfam.org.uk/docets/Bouncing%20Back!.pdf [accessed 23.06.07] 
 
Afuwape, S., Johnson, S., Craig, T., Miles, H., Leese, M., Mohan, R. and Thornicroft, 
G. (2006). Ethnic differences among a community cohort of individuals with dual 
diagnosis in South London. Journal of Mental Health 15 (5) 551-567. 
 
Aidsmap (2006). Aids treatment update 156. 
http://www.aidsmap.com/en/docs/C054DB23-FB3D-4960-A49D-53A8C60B7A14.asp 
[accessed 10.10.07] 
 
Anderson, Z., Hughes, K., Bellis, M.A. (2007). Exploration of young people’s 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 201
experience and perceptions of violence in Liverpool’s nightlife. Centre for Public 
Health, Liverpool. Available: http://www.cph.org.uk/cph_pubs/reports/CH/Liverpool 
per cent20Violence%20report.pdf  [accessed 24/09/07] 
Anti-Social Behaviour Act (2003). The Stationery Office, London. Available: 
http://www.opsi.gov.uk/acts/acts2003/20030038.htm [accessed 13.08.07] 
 
Baker, A., Griffiths, C., Romeri, E. (2006). Mortality by deprivation and cause of death 
in England and Wales, 1999-2003. Health Statistics Quarterly Winter 2006 32 19 - 34. 
ISSN: 1465-1645 Available: 
http://www.statistics.gov.uk/articles/hsq/HSQ32-mortalitybydeprivation.pdf [accessed 
24/09/07] 
 
Baker, P. J. (2006). Developing a Blueprint for evidence-based drug prevention in 
England. Drugs: Education, Prevention & Policy 13 (1) 17-32. 
 
Bakker, A. and Fazey, C. (2006). Methadone tolerance testing in drug misusers. 
British Medical Journal 333 1056-1059. 
 
Barnett, J., Werners, U., Secher, S., Hill, K., Brazil, R. et al. (2007) Substance use in a 
population-based clinic sample of people with first-episode psychosis. British Journal 
of Psychiatry 190 515-520. 
 
Becker, J and Roe. S. (2005). Drug use among vulnerable groups of young people: 
findings from the 2003 Crime and Justice Survey. Home Office Findings 254. Home 
Office, London. Available:http://www.homeoffice.gov.uk/rds/pdfs05/r254.pdf [accessed 
22.08.06]  
 
Beckett, H., Heap, J., McArdle, P. et al. (2004) Understanding problem drug use 
among young people accessing drug services: A multivariate approach using 
statistical modelling techniques (Home Office Online Report 15/04). 
http://www.homeoffice.gov.uk/rds/pdfs04/rdsolr1504.pdf  [accessed 31.10.2007] 
 
Bennett, G., Rigby, K. (1990). Psychological change during residence in a 
rehabilitation centre for female drug misusers. Part I. Drug misusers. Drug and 
Alcohol Dependence 27 149-157.  
 
Bennett, T.H., Holloway, K. and Williams, T (2004), Drug use and offending: summary 
results from the first two years of the NEW-ADAM Programme, Research Findings 
No. 179, Home Office Research and Statistics Directorate. London: Home Office 
http://www.homeoffice.gov.uk/rds/pdfs04/r179.pdf [accessed 31.10.07] 
 
Best, D., Day, E. and Campbell, A. (2007a). Developing a method for conducting 
needs assessments for drug treatment: A systems approach. Addiction Research and 
Theory 15 (3) 263 – 275. Available: 
http://www.informaworld.com/smpp/title~content=t713454341 (accessed 09.08.07) 
 
Best, D., Meier, P. and Day, E. (2007b). Detoxification in Rehabilitation in England: 
Effective continuity of care or unhappy bedfellows? Journal of Substance Use 12 (4) 
293 300. Available: http://www.informaworld.com/smpp/title~content=t713655978 
(accessed 09.08.07) 
 
Beynon, C.M. and McVeigh, J. (2007). The role of substance use in non-drug related 
deaths: A cross sectional study of drug treatment clients in the North West of England. 
Journal of Substance Use. 12 (1) 39-47. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 202
 
Beynon, C.M., Sumnall, H.R., McVeigh, J., Cole, J.C, and Bellis, M.A. (2006) The 
Ability of Two Commercially Available Quick Test Kits to Detect Drug-Facilitated 
Sexual Assault Drugs in Beverages. Addiction 101 (10) 1413-1420.  
 
Bloor, R. (2007). Supervised methadone in Staffordshire and Shropshire. A study of 
factors associated with key outcome variables. National Treatment Agency for 
Substance Misuse Research briefing: 25. National Treatment Agency for Substance 
Misuse, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_rb25_supervised_methadone.pdf 
[accessed 13.09.07] 
 
BNF (British National Formulary) (2005). British National Formulary. British Medical 
Association and Royal Pharmaceutical Society of Great Britain.  British Medical 
Journal Books, London. 
 
Boreham, R., Fuller, E., Hills, A. and Pudney, S. (2006). The Arrestee Survey Annual 
Report: Oct 2003 – Sept 2004. England and Wales. Home Office Statistical Bulletin 
04/06. Home Office, London. Available:  
http://www.homeoffice.gov.uk/rds/pdfs06/hosb0406.pdf [accessed 23.02.07] 
 
Borrill, J., Madden, A., Martin, A., Weaver, T., Stimson, G., Farrell, M. and Barnes, T. 
(2003) Differential substance misuse treatment needs of women, ethnic minorities and 
young offenders in prison: prevalence of substance misuse and treatment needs. 
Online report 33/03. Home Office, London. Available: 
www.homeoffice.gov.uk/rds/pdfs2/rdsolr3303.pdf [accessed 24/09/07] 
 
Brown, M. and Bolling, K. (2007). 2006 Scottish Crime And Victimisation Survey: Main 
Findings. Scottish Government Social Research. Scottish Government, Edinburgh. 
 
Budd, T., Sharp, C. Weir, G., Wilson, D. and Owen, N. (2005). Young People and 
Crime: Findings from the 2004 Offending, Crime and Justice Survey. Home Office, 
London. Available: http://www.homeoffice.gov.uk/rds/pdfs05/hosb2005.pdf [accessed 
24/09/07] 
 
Burrell, K., Jones, L., Sumnall, H., McVeigh J., Bellis, M. A. (2006). Tiered approach 
to drug prevention and treatment among young people. John Moores University. 
Centre for Public Health, Liverpool. Available: 
http://www.drugpreventionevidence.info/web/NCCDP_Reports164.asp [accessed 
23.06.07] 
 
Cabinet Office (1999). Modernising Government White Paper, Cm 4310 
(London: The Stationery Office) Available: 
http://www.cabinetoffice.gov.uk/moderngov/whtpaper/index.html [accessed 04.07.07]  
 
Cabinet Office (2001). Communities Against Drugs UK Anti-drugs Coordination Unit 
Cabinet Office, London. Available: 
http://www.dh.gov.uk/prod_consum_dh/idcplg?IdcService=GET_FILE&dID=639&Ren
dition=Web  [accessed 31/10/07] 
 
Cabinet Office (2004). Alcohol Harm Reduction Strategy for England, 2004, Strategy 
Unit, London. Available: 
http://www.cabinetoffice.gov.uk/strategy/downloads/su/alcohol/pdf/CabOffce%20Alcoh
olHar.pdf [accessed 24/09/07] 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 203
Central Survey Unit (2007). Knowledge and Use of Alcohol, Cigarettes and Drugs 
Primary School Survey 2006. Central Survey Unit. Drug and Alcohol Information and 
Research Unit in the Department of Health, Social Services and Public Safety, 
Belfast.  
 
Children’s Act (2004). The Stationery Office, London.  
 
Clare, P. (2006). The commodity and exchange value of housing in the domestic 
economy of drug users.  Drugs: education, prevention and policy 13 (5) 461-472. 
 
Clarke, D., Ward, P., Truman, W. and Bartle, C. (2007). Fatal vehicle-occupant 
collisions: An in-depth study. Road Safety Research Report No. 75. London: 
Department for Transport. 
 
Cleaver, H., Unell, I. and Aldgate, J. (1999). Children’s needs – parenting capacity: 
The impact of parental mental illness, problem alcohol and drug use, and domestic 
violence on children’s development. The Stationery Office, London. 
Connolly, J.O., Gillmore, J.D., Lachmann, H.J., Davenport, A., Hawkins, P.N. and 
Woolfson, R.G. (2006). Renal amyloidosis in intravenous drug users. QJM: An 
International Journal of Medicine 99 (11) 737-742. 
 
Coomber, R. and Sutton, C. (2007). How quick to heroin dependence? Drug and 
Alcohol Review 25 (5) 463 – 471. Available: 
http://www.informaworld.com/smpp/title~content=t713412284 [accessed 02.05.07] 
 
Crabbe, T., Bailey, G., Blackshaw, T., Brown, A., Choak, C. et al. (2006). Knowing the 
score Positive Futures Case Study Research: Final Report. Positive Futures Team 
and Crime Concern. Available:  
http://www.drugs.gov.uk/publication-search/young-
people/0607_YPSMPG11?view=Binary [accessed 23.07.07] 
 
Crime and Disorder Act (1998). The Stationery Office, London.  
 
Curtis, L. and Netten, A. (eds.) (2006). Unit Costs of Health and Social Care 2006 
PSSRU, University of Kent. Available: 
http://www.pssru.ac.uk/pdf/uc/uc2006/uc2006.pdf [accessed 17.10.07] 
 
DAIRU (Drug and Alcohol Research Unit) / DHPSSPNI (Department of Health, Social 
Services and Public Safety Northern Ireland) (2004). Young Persons Behaviour and 
Attitudes Survey. Department of Health, Social Services and Public Safety Northern 
Ireland, Belfast. 
 
DAIRU (Drug and Alcohol Research Unit) / DHPSSPNI (Department of Health, Social 
Services and Public Safety Northern Ireland) (2006a). Statistics from the Northern 
Ireland Drug Misuse Database: 1 April 2005 - 31 March 2006. Department of Health, 
Social Services and Public Safety Northern Ireland, Belfast. Available: 
http://www.dhsspsni.gov.uk/drug_misuse_mar05.pdf [accessed 18.10.07] 
 
DAIRU/DHSSPSNI (Department of Health, Social Services and Public Safety 
Northern Ireland) (2006b). Statistics from the Northern Ireland Needle and Syringe 
Exchange: 1 April 2005 – 31 March 2006. Available: 
http://www.dhsspsni.gov.uk/index/stats_research/public_health/statistics_and_researc
h-drugs_alcohol-2.htm  [accessed 01.08.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 204
DAIRU (Drug and Alcohol Research Unit) / DHPSSPNI (Department of Health, Social 
Services and Public Safety Northern Ireland) (2007a). Primary School Survey 2006 - 
Knowledge and use of Alcohol, Cigarettes and Drugs. Department of Health, Social 
Services and Public Safety, Northern Ireland. Available: 
http://www.dhsspsni.gov.uk/ps_report__jan_07.pdf [accessed 18.10.07] 
 
DAIRU (Drug and Alcohol Research Unit) / DHPSSPNI (Department of Health, Social 
Services and Public Safety Northern Ireland) (2007b). Statistics from the Northern 
Ireland Drug Addicts Index 2006. Available at: 
http://www.dhsspsni.gov.uk/index/stats_research/stats-pubs.htm [accessed 16.10.07] 
Dawson. P (2005) Early findings from the Prolific and other Priority Offenders 
evaluation. Development and Practice Report 46. London: Home Office. 
http://www.homeoffice.gov.uk/rds/pdfs05/dpr46.pdf [accessed 31.10.07] 
 
Dawson, P. (2007). The National PPO evaluation – research to inform and guide 
practice. Home Office Online Report 09/07. Home Office, London. Available:  
http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0907.pdf [Accessed 23.02.07]  
 
Dawson, P. and Cuppleditch, L. (2007). An impact assessment of the Prolific and 
other Priority Offender programme. Home Office Online Report 08/07. Home Office, 
London.  Available: http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0807.pdf 
[accessed 23.02.07] 
 
DCLG (Department for Communities and Local Government) (2007). Tackling youth 
homelessness. Policy Briefing 18, DCLG, London 
 
De Leon, G., Jainchill. N., Wexler. H, (1982). Success and improvement rates five 
years after treatment in a therapeutic community. International Journal of Addictions 
17 (4) 703-747.  
 
DENI (Department for Education Northern Ireland) (2007a). Suspension Statistics 
2005/06. Department for Education Northern Ireland, Belfast. Available: 
http://www.deni.gov.uk/suspensionstats2005-06web.pdf  [accessed 24/09/07] 
 
DENI (Department for Education Northern Ireland) (2007b). Expulsion Statistics 
2005/06. Department for Education Northern Ireland, Belfast. Available:  
http://www.deni.gov.uk/expulsion_statistics_2005.pdf [accessed 24/09/07] 
 
DfES (Department for Education and Skills) (2004a). Every child matters: change for 
children. Department for Education and Skills 
DfES (Department for Education and Skills) (2004b). Drugs: guidance for schools. 
Department for Education and Skills, London. 
 
DfES (Department for Education and Skills) (2006a). Pupil characteristics and class 
sizes in maintained 
schools in England, January 2006 Department for Education and Skills, London. 
Available: http://www.dfes.gov.uk/rsgateway/DB/SFR/s000654/index.shtml  
 
DfES (Department for Education and Skills) (2006b) Schools and pupils in England, 
January 2006. Department for Education and Skills, London. Available: 
www.dfes.gov.uk/rsgateway/DB/SFR/s000682/index.shtml [accessed 10.10.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 205
DfES (Department for Education and Skills) (2006c). Children looked after in England 
(including adoption and care leavers): 2005-2006. Department for Education and 
Skills, London. Available: 
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000691/SFR44-2006.pdf [accessed 
23.09.07] 
 
DfES (Department for Education and Skills) (2006d). Education and Training Statistics 
for the United Kingdom 2006. Department for Education and Skills, London. Available: 
http://www.dfes.gov.uk/rsgateway/DB/VOL/v000696/index.shtml [accessed 23.09.07] 
 
DfES (Department for Education and Skills) (2006e). Permanent and fixed period 
exclusions from schools and exclusion appeals in England, 2004/05 Department for 
Education and Skills, London. Available: 
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000662/SFR24-2006.pdf [accessed 
23.09.07] 
 
DfES (Department for Education and Skills) (2006f) Care matters: transforming the 
lives of children and young people in care. Department for Education and Skills, 
London. 
 
DfES (Department for Education and Skills) (2007a). Outcome indicators for looked 
after children: Twelve months to 30 September 2006, England. National Statistics 
First Release. Available: 
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000727/index.shtml [accessed 03.09.07] 
 
DfES (Department for Education and Skills) (2007b). Care Matters: Time for Change. 
White Paper.  The Stationary Office, London. Available:  
http://www.dfes.gov.uk/publications/timeforchange/index.shtml [accessed 23.07.07] 
 
DfES (Department for Education and Skills) (2007c). Permanent and Fixed Period 
Exclusions from Schools and Exclusion Appeals in England 2005/06. Department for 
Education and Skills, London.  Available:  
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000733/SFR21-2007.pdf [accessed 
20.07.07] 
 
DfES (Department for Education and Skills) (2007d). National Curriculum 
Assessments, GCSE and Equivalent Attainment and Post-16 Attainment by Pupil 
Characteristics, in England 2005/06. Department for Education and Skills, London. 
Available:  
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000708/SFR04_2007v1.pdf [accessed 
24/09/07] 
 
DfES (Department for Education and Skills) (2007e). GCSE and equivalent 
examination results in England 2005/06 (revised). Department for Education and 
Skills, London. Available: 
http://www.dfes.gov.uk/rsgateway/DB/SFR/s000702/index.shtml [accessed 24/09/07] 
 
DfES (Department for Education and Skills), HO (Home Office) and DH (Department 
of Health) (2005). Every child matters: change for children, young people and drugs. 
Department for Education and Skills, Home Office and Department of Health, London. 
Available: 
http://www.everychildmatters.gov.uk/_files/9660D91BB1755A6E288998AAE145297F.
pdf [accessed 11.09.07] 
 
DfES (Department for Education and Skills), HO (Home Office) and DH (Department 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 206
of Health) (2006). The Children Act Report 2004 and 2005. Department for Education 
and Skills, London Available: 
http://www.everychildmatters.gov.uk/_files/EN0761B1%20Children%20Act.pdf 
[accessed 23.09.07] 
 
DH (Department of Health) (1999). Drug misuse and dependence – guidelines on 
clinical management. The Stationery Office, London. 
 
DH (Department of Health) (2002a). Mental Health policy implementation: dual 
diagnosis and good practice. Department of Health, London. 
 
DH (Department of Health) (2002b). Models of care for substance misuse treatment: 
promoting quality, efficiency and effectiveness in drug misuse treatment services. DH, 
London. 
(http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndG
uidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4008118&chk=v
olva5. [Accessed 31.10.07] 
 
DH (Department of Health) (2004a) National service framework for children, young 
people and maternity services. Department of Health, London. Available:  
http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/ChildrenServic
es/Childrenservicesinformation/DH_4089111 [accessed 23.09.07] 
 
DH (Department of Health) (2004b). Hepatitis C Action Plan for England. Department 
of Health, London. 
 
DH (Department of Health) (2006a). Clinical management of drug dependence in the 
adult prison setting including psychosocial treatment as a core part. Department of 
Health, London. Available: http://www.dh.gov.uk/assetRoot/04/14/10/23/04141023.pdf 
[Accessed 23.02.07] 
 
DH (Department of Health) (2006b). NHS reference costs 2005/06. 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd
Guidance/DH_062884  [accessed 10.10.07] 
 
DH (Department of Health) (2007). Dual diagnosis in mental health inpatient and day 
hospital settings. Department of Health, London. 
 
DH (Department of Health), DHSSPSNI (Department of Health, Social Services and 
Public Safety Northern Ireland), WAG (Welsh Assembly Government) and The 
Scottish Government (2007). Drug misuse and dependence: UK guidelines on clinical 
management. The Stationery Office. London Available: 
http://www.nta.nhs.uk/areas/Clinical_guidance/clinical_guidelines/cgl_update0607 
[accessed 24.10.07] 
 
DH (Department of Health) and NTA (National Treatment Agency). (2007). Reducing 
Drug-Related Harm: An Action Plan. Department of Health, London: Available: 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd
Guidance/DH_074850 
 
DH (Department of Health), HO (Home Office) and DfES (Department for Education 
and Skills) (2005). Out of sight...not out of mind: children, young people and volatile 
substance abuse: a framework for VSA. Department of Health, London.  Available: 
http://www.dh.gov.uk/assetRoot/04/11/56/05/04115605.pdf  [accessed 23.09.07] 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 207
 
DH (Department of Health), The Scottish Office Department of Health, Welsh Office, 
Department of Health and Social Services, Northern Ireland (1999). Drug misuse and 
dependence – guidelines on clinical management. The Stationery Office. London. 
Available: http://www.dh.gov.uk/assetRoot/04/07/81/98/04078198.pdf. [accessed 28. 
07.07].  
 
DHSSPSNI (Department of Health, Social Services and Public Safety Northern 
Ireland) (2004). Northern Ireland guidelines on substitution treatment for opiate 
dependence. Department of Health, Social Services and Public Safety Northern 
Ireland, Belfast. Available: www.dhsspsni.gov.uk/niguide_substitute_treatment.pdf 
[accessed 18.10.07] 
 
DHSSPSNI (Department of Health, Social Services and Public Safety Northern 
Ireland) (2005). Children Order Statistical Bulletin 2005. Available: 
http://www.dhsspsni.gov.uk/children_order_statistical_bulletin_2005.pdf [accessed 
24.09.07] 
 
DHSSPSNI (Department of Health, Social Services and Public Safety Northern 
Ireland) (2006). New Strategic Direction for Alcohol and Drugs (2006 – 2011). A 
Consultation Document. Department of Health, Social Services and Public Safety 
Northern Ireland, Belfast. Available: 
http://www.dhsspsni.gov.uk/new_strategic_direction_for_alcohol_and_drugs_(2006-
2011).pdf [accessed 01.07.07] 
 
DHSSPSNI (Department of Health, Social Services and Public Safety Northern 
Ireland)  (2007a).  Reference costs 2005/06. Available: 
http://www.dhsspsni.gov.uk/search_results.htm?pubtitle=&pubkeywords=reference+c
osts&pubclass=%25&pubyear=all&Search=Search  
 
DHSSPSNI (Department of Health, Social Services and Public Safety Northern 
Ireland) (2007b). Summary of HPSS expenditure in Northern Ireland 2005-2006.  
 
Dickinson, G. L., Rostami-Hodjegan, A., Lagundoye, O., Seivewright, N., Pratt, P. and 
Lennard, M. S. (2006). A six-year evaluation of methadone prescribing practices at a 
substance misuse treatment centre in the UK. Journal of Clinical Pharmacy and 
Therapeutics 31 477-484. 
 
Dillon, L., Chivite-Matthews, N., Grewal, I., Brown, R., Webster, S et al (2007) Risk, 
protective factors and resilience to drug use: identifying resilient young people and 
learning from their experiences. Home Office Online Report  
Available: http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0407.pdf  [accessed 
10.10.07] 
 
The Drugs Act 2005. Her Majesty’s Stationary Office, London. 
 
DSD (Drugs Strategy Directorate) (2002). Updated Drug Strategy. DSD, Home Office, 
London. http://drugs.homeoffice.gov.uk/publication-search/drug-strategy/updated-
drug-strategy-2002.pdf?view=Binary [accessed 05.10.07] 
 
Duke, K. (2006). Out of crime and into treatment? The criminalisation of contemporary 
drug policy since Tackling Drugs. Drugs: education, prevention and policy 13 (5) 409-
416. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 208
Edmonds, K., Sumnall, H., McVeigh, J. and Bellis, M.A. (2005) Drug prevention 
among vulnerable young people. National Collaborating Centre for Drug Prevention. 
Liverpool John Moores University, Liverpool.  Available: 
http://www.drugpreventionevidence.info/documentbank/Q1.pdf [accessed 23.07.07] 
 
Education Act (1996). Her Majesty’s Stationary Office, London. 
 
EIU (Effective Interventions Unit) (2004). Young people with, or at risk of developing, 
problematic substance misuse: A guide to assessment. Effective Intervention Unit. 
Scottish Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Publications/2004/10/20010/43974 [accessed 13.08.07] 
 
Enver, S., Eades, C., Garside and R. Rutherford, M. (2007). Impact of policies and 
strategies: Ten years of criminal justice under Labour. An independent audit. The 
Centre for Crime and Justice Studies, King’s College, London. Available:  
http://www.kcl.ac.uk/depsta/rel/ccjs/ten-years-of-labour-2007.pdf [accessed 22.04.07] 
 
Fagan, J. (1996) Gangs, Drugs and Neighbourhood Change. In Huff, R.C (Ed). Gangs 
in America. 2nd Ed. Thousand Oaks: Sage. 
 
Field-Smith, M. E., Butland, B. K., Ramsey, J. D. and Anderson, H. R. (2007). Trends 
in deaths associated with Volatile Substance Abuse, 1971 to 2005. Report 20. 
Division of Community Health Sciences, St George's, University of London. Available 
at: http://www.vsareport.org [accessed 13.09.07] 
 
Finney A, (2004). Violence in the night-time economy: key findings from the research. 
Home Office, London. Available: http://www.homeoffice.gov.uk/rds/pdfs04/r214.pdf 
[accessed 23.09.07] 
 
Fischer, J., Jenkins, N., Bloor, M., Neale, J. and Berney, L. (2007). Drug user 
involvement in treatment decisions. Joseph Rowntree Foundation, York. Available: 
http://www.jrf.org.uk/bookshop/details.asp?pubID=868 [accessed 20.03.07] 
 
Fitzgerald, N. (2006). Final Report for Glasgow City Council Education Services and 
Greater NHS Greater Glasgow and Clyde. Create Consultancy, Glasgow. Available:  
http://www.createconsultancy.com/documents/DrugEducationCreateConsultancyFinal
Report.pdf [accessed 23.07.07] 
 
Fordham, K., Jones, l., Sumnall, H., McVeigh, J. and Bellis. M. (2007). The economics 
of preventing drug use: An introduction to the issues. Liverpool John Moores 
University, Liverpool. (Available: 
http://www.drugpreventionevidence.info/web/NCCDP_Reports164.asp [accessed 
23.07.07] 
 
Forrester, D. and Harwin, J. (2004). Social work and parental substance misuse in 
Phillips, R. (ed.) (2004). Children exposed to parental substance misuse: Implications 
for family placement. British Association for Adoption and Fostering, London 115-131.
 
Forrester, D. and Harwin, J. (2006). Parental substance misuse and child care social 
work: Findings from the first stage of a study of 100 families. Child and Family Social 
Work. 11: 325-335. 
 
Foster, J., Tyrell, K., Cropper, V. and Hunt, N. (2007). Two case studies of user 
involvement in the recruitment of staff for drug services. Drugs: education, prevention 
and policy 14 (1) 89-94. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 209
 
Fountain, J., Bashford, J., Winters, M., Patel, K. (2003). Black and minority ethnic 
communities in England: a review of the literature on drug use and related service 
provision. National Treatment Agency, London, Centre for Ethnicity and Health, 
Preston. Available: 
http://www.uclan.ac.uk/facs/health/ethnicity/reports/documents/BMELiteraturereview.p
df [accessed 23.09.07] 
 
Frischer, M., Crome, I., Macleod, J., Bloor, R. and Hickman, M. (2007). Predictive 
factors for illicit drug use among young people: a literature review. Home Office Online 
Report 05/07. Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0507.pdf [accessed 23.07.07] 
 
Fuller, E. (ed.) (2007). Smoking, drinking and drug use among young people in 
England in 2006. National Centre for Social Research, London. 
 
Ghate, D., Brazier, L. and Moran, P. (2003). Briefing Paper for Policy Makers, Service 
Planners and Practitioners: Four Early Intervention Substance Misuse Projects in 
South London. Policy Research Bureau, London. Available: 
http://www.prb.org.uk/research%20projects/project%20summaries/P123.htm 
[accessed 23.09.07] 
Ghodse, H., Corkery, J., Oyefeso, A., Schifano, F. and Tonia, T. (2007). Drug-related 
deaths in the UK: Annual Report 2007. Drug-related deaths reported by Coroners in 
England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; Police 
forces in Scotland; & the Northern Ireland Statistics and Research Agency – Annual 
Report January-December 2006 and 19th Surveillance Report July-December 2006. 
International Centre for Drug Policy, St George's University of London. 
 
GLADA (Greater London Alcohol and Drug Alliance) (2007). The highs and the lows. 
A report from the Greater London Alcohol and Drug Alliance. Greater London 
Authority, London. 
 
Godfrey, C. Eaton, G., McDougall, C. and Culyer, A. (2002). The economic and social 
costs of Class A drug use in England and Wales, 2000. Home Office research study 
249. Home Office, London. 
 
Golding, J.F., Groome, D.H., Rycroft, N. and Denton, Z. (2007). Cognitive 
performance in light current users and ex-users of ecstasy (MDMA) and controls. The 
American Journal of Drug and Alcohol Abuse 33 (2): 301-307. 
 
Gossop, M., Marsden, J. and Stewart, D. (2006). Remission of psychiatric symptoms 
among drug misusers after drug dependence treatment. Journal of Mental and 
Nervous Disease 194 (11) 826 32. 
 
Gossop, M., Stewart, D. and Marsden, J. (2007). Readiness for change and drug use 
outcomes after treatment. Addiction 102 (92) 301–308. 
 
Gordon L, Tinsley L, Godfrey C, Parrott S. (2006) The economic and social costs of 
Class A drug use in England and Wales, 2003/04. In: Singleton N, Murray R, Tinsley 
L, editors. Measuring different aspects of problem drug use: methodological 
developments. Home Office Online Report. London: Home Office; 16/06:2006. 
http://www.homeoffice.gov.uk/rds/pdfs06/rdsolr1606.pdf [accessed 31.10.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 210
Goulden, C. and Sondhi, A. (2001). At the margins: drug use by vulnerable young 
people in the 1998/99 Youth Lifestyles Survey. Home Office Research Study 228. 
Home Office, London. Available: http://www.homeoffice.gov.uk/rds/pdfs/hors228.pdf 
[accessed 23.09.07] 
 
Green, H., McGinnity, A., Meltzer, H., Ford, T. and Goodman, R, (2005). Mental 
Health of Children and Young People in Great Britain. Department of Health, London. 
 
GROS (General Register Office Scotland). (2007). Drug-Related Deaths in Scotland 
in 2006. General Register Office (Scotland), Edinburgh. Available: 
http://www.gro-scotland.gov.uk/files1/stats/drug-related-deaths-2006/drug-related-
deaths-2006.pdf [accessed 13.09.07] 
 
Hansard  Written answers 8th May 2007 Column 87W.  Available: 
http://www.publications.parliament.uk/pa/cm200607/cmhansrd/cm070508/text/70508w
0019.htm [accessed 17.10.07] 
 
Hanton, P. (2007). The Essential Drug Service Commissioner. DrugScope, London. 
 
Hart, D. and Powell, J. (2006). Adult drug problems, children’s needs: Assessing the 
impact of parental drug use. National Children’s Bureau, London. 
 
HAS (Health Advisory Service) (2001).  Substance misuse and mental health co-
morbidity (dual diagnosis). Standards for Mental Health Services, HAS, London 
 
Hay, G. and McKeganey, N. (1996) Estimating the prevalence of drug misuse in 
Dundee, Scotland: an application of capture-recapture methods. Journal of 
Epidemiology and Community Health 50 (4) 469-472. 
 
Hay, G., McKeganey, N. and Hutchinson, S. (2001). Estimating the national and local 
prevalence of problem drug misuse in Scotland. Centre for Drug Misuse, University of 
Glasgow. Available: 
www.drugmisuse.isdscotland.org/publications/local/Prevalence.pdf [accessed 
18.10.07] 
 
Hay, G., Gannon, M., McKeganey, N., Hutchinson, S. and Goldberg, D. (2004). 
Estimating the national and local prevalence of problem drug misuse in Scotland. 
Centre for Drug Misuse Research, University of Glasgow and SCIEH, Glasgow. 
Available:  
http://www.drugmisuse.isdscotland.org/publications/abstracts/prevalence3.htm 
[accessed 23.08.07] 
 
Hay, G., Gannon, G. MacDougall, J., Millar, T., Eastwood, C. and McKeganey, N. 
(2006a). Local and national estimates of the prevalence of opiate use and/or crack 
cocaine use (2004/05) in Singleton, N., Murray, R. and Tinsley L. Measuring different 
aspects of problem drug use: methodological developments. Home Office Online 
Report 16/06. Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs06/rdsolr1606.pdf [accessed 23.08.07] 
 
Hay, G., Higgins. K., Gannon, M. and Carroll, C. (2006b). Estimating the Prevalence 
of Problem Opiate and problem Cocaine Use in Northern Ireland. Drug and Alcohol 
Information and Research Unit, Department of Health, Social Services and Public 
Safety Northern Ireland, Belfast. Available: 
http://www.dhsspsni.gov.uk/index/stats_research/public_health/statistics_and_researc
UNITED KINGDOM FOCAL POINT REPORT 2007 
 211
h-drugs_alcohol-2.htm [accessed 17.10.07] 
 
Hayden, C. (2004). Parental substance misuse and child care social work: Research 
in a City social work department in England.  Child Abuse Review 13 18-30. 
 
Healthcare Commission and HM Inspectorate of Probation (2006). Let's talk about it - 
A review of healthcare in the community for young people who offend. Available: 
http://www.healthcarecommission.org.uk/_db/_documents/YOTs_report.pdf 
[accessed 23.09.07] 
 
Hickman, M., Carrivick, S., Paterson, S., Hunt, N., Zador, D., Cusick, L. and Henry, J. 
(2007a). London audit of drug-related overdose deaths: characteristics and typology, 
and implications for prevention and monitoring. Addiction 102 (2) 317-23.  
 
Hickman, M., Vickerman, p., Macleod, J., Kirkbride, J. and Jones, P.B. (2007b). 
Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis 
use on historical and future trends in schizophrenia in England and Wales. Addiction 
102 597-606.  
 
Hickman, M., Carrivick, S., Cusick, L., Zador, D., Paterson, S. and Hunt, N. (2007c). A 
taxonomy of preventability of overdose death: A multi-method study. Research 
Briefing 23.  National Treatment Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/news_events/newsarticle.aspx?NewsarticleID=18 [accessed 
01.08.07] 
 
Hickson, F., Weatherburn, P., Reid, D., Jessup, K. and Hammond, G. (2007). 
Consuming passions: Findings from the United Kingdom Gay Man's Sex Survey 
2005. Available: www.sigmaresearch.org.uk/downloads/report07c.pdf [accessed 
03.09.07] 
 
HM (Her Majesty’s) Government (2007a). Drugs: Our Community, Your Say. A 
Consultation Paper. Home Office, London. Available:  
http://drugs.homeoffice.gov.uk/publication-search/drug-strategy/drug-strategy-
consultation.pdf?view=Binary [accessed 15.10.07] 
 
HM (Her Majesty’s) Government (2007b). PSA Delivery Agreement 25: Reduce the 
harm caused by Alcohol and Drugs. Her Majesty’s Government. 
HM (Her Majesty’s) Prison Service (2004) Addressing alcohol misuse, a Prison 
Service alcohol strategy for prisoners. Her Majesty’s Prison Service, London. 
Available:  
http://www.hmprisonservice.gov.uk/assets/documents/1000082AAddressing_Alcohol_
Misuse.doc   [Accessed 23.02.07] 
 
HM (Her Majesty’s) Prison Service (2007). Annual Report and Accounts 2006-07. The 
Stationery Office Limited, London. Available:  
http://www.hmprisonservice.gov.uk/resourcecentre/publicationsdocuments/index.asp?
cat=38 [accessed 11.10.07] 
 
HM (Her Majesty’s) Treasury (2004). 2004 Spending Review Public Service 
Agreements 2005 – 2008. Her Majesty’s Treasury, London. Available: http://www.hm-
treasury.gov.uk/media/F/2/sr04_psa_ch21.pdf  [accessed 23.09.07] 
HM (Her Majesty’s) Treasury (2007a). Public Expenditure Statistical Analyses 2007.  
UNITED KINGDOM FOCAL POINT REPORT 2007 
 212
Available at:  http://www.hm-
treasury.gov.uk/economic_data_and_tools/finance_spending_statistics/pes_publicatio
ns/pespub_pesa07.cfm [accessed 17.10.07] 
 
HM (Her Majesty’s) Treasury (2007b). Aiming High for Young People: A Ten Year 
Strategy for Positive Activities concludes the Government’s Policy Review undertaken 
to inform the 2007 Comprehensive Spending Review (CSR). Her Majesty’s Treasury, 
London.  
Available: http://www.hm-treasury.gov.uk/media/2/6/cyp_tenyearstrategy_260707.pdf 
[accessed 23.09.07] 
 
HMSO (Her Majesty’s Stationery Office) (2007). The Misuse of Drugs Act 1971 
(Amendment) Order 2006 Statutory Instrument 2006 No. 3331. Her Majesty’s 
Stationary Office, London. Available:  
http://www.opsi.gov.uk/si/si2006/20063331.htm [accessed 22.01.07] 
 
Home Office (1999). The cost of criminal justice. Research Findings 103. Home 
Office, London. 
 
Home Office (2002). Updated Drug Strategy. Home Office, London. Available: 
http://drugs.homeoffice.gov.uk/publication-search/drug-strategy/updated-drug-
strategy-2002.pdf  [accessed 23.09.07] 
 
Home Office (2003). Cul-de-sacs and gateways: Understanding the Positive Futures 
Approach. Home Office, London. 
 
Home Office (2004). Assessing the level of expected drug related need for supported 
housing. London: Home Office. Available: 
www.nta.nhs.uk/areas/treatment_planning/docs/needs_assessment_ho_04.pdf  
[accessed 17.10.07] 
 
Home Office (2005). FRANK Action Update - 'Vulnerable Young People - Making the 
Difference'. Home Office, London. Available:  
http://www.homeoffice.gov.uk/materials/VYP_Main_pages.pdf [accessed 23.09.07] 
 
Home Office (2006a). Licensee letter. Letter to the Trade. Home Office, London. 
http://drugs.homeoffice.gov.uk/324026/461229/Letter_to_trade.pdf  [accessed 
05.10.07] 
 
Home Office (2006b) Peer-Led Approaches for Ex-Drug Users to Meet Diverse 
Needs: A Practice Guide.Home Office, London. Available: 
http://www.drugs.gov.uk/publication-
search/dip/AC_PLS_PracticeGuide_Final?view=Binary [accessed 17.10.07] 
 
Home Office (2006c). Crime Statistics: An independent review. Home Office London. 
Available : 
www.homeoffice.gov.uk/rds/pdfs06/crime-statistics-independent-review-06.pdf 
[accessed 02.03.07] 
 
Home Office (2006d). Population in custody: Offender management caseload 
statistics. Available: http://www.homeoffice.gov.uk/rds/omcs.html [accessed 17.10.07] 
 
Home Office (2007a). Public consultation – independent prescribing of controlled 
drugs by nurse and pharmacist independent prescribers. Home Office, London. 
Available:http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSeco
UNITED KINGDOM FOCAL POINT REPORT 2007 
 213
ndary=true&ssDocName=CON2030628&ssTargetNodeId=373 [accessed 22.01.07] 
 
Home Office (2007b). Cutting Crime - a new partnership 2008-11 - the Home Office 
crime strategy. Available: 
http://www.homeoffice.gov.uk/documents/crime-strategy-07/crime-strategy-
07?view=Binary [accessed 05.10.07] 
 
Home Office (2007c) 2004-2006 Frank review. Home Office, London. Available: 
http://www.drugs.gov.uk/324026/461229/446360?view=Standard [accessed 23.06.07] 
 
Home Office (2007d). Identifying and exploring young people’s experiences of risk, 
protective factors and resilience to drug use. Home Office Development and Practice 
Report 47. Home Office, London.  Available: 
http://www.homeoffice.gov.uk/rds/pdfs07/dpr47.pdf [accessed 02.07.07] 
 
Home Office (2007e). Around Arrest and, Beyond Release - The experiences and 
needs of families in relation to the arrest and release of drug using offenders. Home 
Office, London. Available: http://drugs.homeoffice.gov.uk/publication-
search/dip/AC_DIP_FAMILIES_around_arrest [accessed 17.10.07] 
 
Home Office (2007f). Evaluation of Drug Interventions Programme pilots for children 
and young people: arrest referral, drug testing and Drug Treatment and Testing 
Requirements. Home Office, London.  Available: 
http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0707.pdf [accessed 23.09.07] 
 
Home Office, DfES (Department for Education and Skills) and TDA (Training and 
Development Agency (2007). Toolkit: Drug use among vulnerable young people - 
developing local profiles. Online. Available: 
http://www.everychildmatters.gov.uk/resources-and-practice/search/IG00237/  
[accessed 11.09.07] 
Hope, V.D., Ncube, F., Hickman, M., Judd, A. and Parry, J. V. (2007). Hepatitis B 
vaccine uptake among injecting drug users in England 1998 to 2004: Is the prison 
vaccination programme driving recent improvements? Journal of Viral Hepatitis online 
early access. 
 
HPA (Health Protection Agency) (2006). Hepatitis C in England: An update 2006. 
Health Protection Agency Centre for Infections, London. 
 
HPA (Health Protection Agency), Health Protection Scotland, National Public Health 
Service for Wales, CDSC (Northern Ireland, and CRDHB (Centre for Drugs and 
Health Behaviour) (2007). Shooting Up: Infections among injecting drug users in the 
United Kingdom 2006.  London: Health Protection Agency, October 2007. 
 
Hucklesby, A., Eastwood, C., Seddon, T. and Spriggs, A. (2007) The evaluation of the 
Restriction on Bail Pilot Final report. Home Office Online Report 06/07. Home Office, 
London. Available: http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0607.pdf [accessed 
25.07.07]  
 
Hughes, L. (2007). Closing the gap: A capability framework for working effectively with 
people with combined mental health and substance use problems (dual diagnosis). 
Centre for Clinical and Academic Workforce Innovation, University of Lincoln. 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 214
Hughes, R., Lart, R. and Higate, P. (eds.) (2006). Drugs: policy and politics. Open 
University Press, Maidenhead. 
 
Human Factors Analysts Ltd. (2007). Evaluation of the Incite Project a Pilot 
Psychostimulant Project in Aberdeen: Summary. (Web only publication) Scottish 
Executive Social Research. Scottish Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Publications/2007/03/13150044/9 [accessed 21.03.07] 
 
Hunt, C. and Strang, J. (2007). GP prescribing of opioids to opiate-dependent patients 
Secondary analyses of data collected during a national survey of general practitioners 
in England and Wales in mid-2001. National Treatment Agency for Substance Misuse 
Research briefing: 28. National Treatment Agency for Substance Misuse, London. 
 
ISD (Information Services Division) Scotland (2006). Drug misuse statistics Scotland 
2006. ISD Publications, Edinburgh. 
http://www.drugmisuse.isdscotland.org/publications/06dmss/06dmss-110.htm 
[accessed 11.09.07] 
 
ISD (Information Services Division)  Scotland. (2007). Scottish Schools Adolescent 
Lifestyle and Substance Use Survey 2006 National Report. Available: 
http://www.drugmisuse.isdscotland.org/publications/abstracts/salsus_national06.htm 
[accessed 03.09.07] 
 
Jacobs, M., Tinsley, J. (2006). Ethnicity and deprivation: a regional perspective An 
analysis of ethnicity and levels of deprivation in different local areas, within English 
regions. Available: 
http://www.statistics.gov.uk/articles/RegionalTrends/Article3RT39.pdf  [accessed 
23.09.07] 
 
Jayakody, A.A., Viner, R.M., Haines, M.M, Bhui, K.S., Head, J.A., Taylor, S.J.C., 
Booy, R., Klineberg, E., Clark, C. and Stansfeld, S.A. (2006). Illicit and traditional drug 
use among ethnic minority adolescents in East London. Public Health 120: 329-338. 
 
Jeal, N. and Salisbury, C. (2004). A health needs assessment of street-based 
prostitutes: a cross-sectional survey. Journal of Public Health 26: 147-151. 
 
Jeal, N. and Salisbury, C. (2007). Health needs and service use of parlour-based 
prostitutes compared with street-based prostitutes: a cross-sectional survey. British 
Journal of Obstetrics and Gynaecology 114 (7): 847-881. 
 
Jones L., Sumnall H., Burrell K., McVeigh J., Bellis, M. A. (2006). Universal drug 
prevention. John Moores University.  Centre for Public Health, Liverpool. Available 
http://www.drugpreventionevidence.info/documentbank/Universal.pdf [accessed  
23.06.07] 
 
Jones, L., James, M., Jefferson, T., Lushey, C., Morleo, M. et al. (2007). A review of 
the effectiveness and cost-effectiveness of interventions delivered in primary and 
secondary schools to prevent and/or reduce alcohol use by young people under 18 
years old. National Collaborating Centre for Drug Prevention, Liverpool John Moores 
University. 
 
Judd, A., Hickman, M., Hope, V.D., Sutton, A.J., Stimson, G.V. et al. (2007). Twenty 
years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug 
users in England and Wales? Journal of Viral Hepatitis online early access 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 215
Kenrick, J. (2007). Locked out: The prevalence and impact of housing & 
homelessness problems amongst young people, and the impact of good advice. 
Youth Access, London. Available: 
http://www.youthaccess.org.uk/news/upload/locked%20out%20article.pdf [accessed 
26.10.07] 
 
Khundakar, A., Duffy, P., Marr, A., McVeigh, J. and Bellis, M.A. (2007). NDTMS 
Themed Report Referrals into structured drug treatment in the North West of England 
from the Criminal Justice System 2005/06. Centre for Public Health, John Moores 
University. Available: http://www.cph.org.uk/cph_pubs/reports/SM/referrals_apr.pdf  
[accessed 23.09.07] 
 
Kilfoyle, M. and Bellis, M. A. (1997). Club Health: The health of the clubbing nation 
Conference proceedings from Club Health 1997. Centre for Public Health, Liverpool. 
 
LDPF (London Drug Policy Forum) (2007). The Goodenough Drug Strategy Project. 
London Drug Policy Forum, London. Available:  
http://213.86.34.248/NR/rdonlyres/55CB957E-B9E2-40A4-A65A-
A2D37B417656/0/SS_LDPF_GoodenghDSMay.pdf [accessed 13.09.07] 
 
LGDUW (Local Government Data Unit Wales) (2007). Social services expenditure 
and service volume 2005/06. Available: 
http://dissemination.dataunitwales.gov.uk/webview/index.jsp [accessed 10.10.07] 
 
Lloyd, C. (1998). Risk factors for problem drug use: identifying vulnerable groups. 
Drugs: Education, Prevention and Policy, 5: 217-232. 
 
Lloyds/TSB foundation for Scotland (2006) Substance Misuse Research Programme: 
Evaluation and Description of Drug Projects working with Young People and Families 
funded by Lloyds TSB Foundation Partnership Drugs Initiative: Summary. Available: 
http://www.scotland.gov.uk/Publications/2006/06/22170722/0  [accessed 23.09.07] 
 
Lorna Gordon, L., Tinsley, L. Godfrey, C. and Parrott, S. (2006). The economic and 
social costs of Class A drug use in England and Wales, 2003/04 in Singleton, N., 
Murray, R. and Tinsley L.(2006). Measuring different aspects of problem drug use: 
methodological developments. Home Office Online Report 16/06. Home Office, 
London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs06/rdsolr1606.pdf [accessed 12.12.06] 
 
MacGregor, S. (2000). Drugs research funded by central government departments: A 
review. London: Department of Health. Available: 
http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Substancemis
use/Substancemisusegeneralinformation/DH_4064426  [accessed 04.07.07] 
 
MacGregor, S. (2006). Tackling drugs together and the establishment of the principle 
that 'treatment works'. Drugs: education, prevention and policy. 13 (5) 399-408. 
 
Matrix Research and Consultancy and Institute for Criminal Policy Research (2007). 
Evaluation of Drug Interventions Programme pilots for children and young people: 
arrest referral, drug testing and Drug Treatment and Testing Requirements. Home 
Office Online Report 07/07. Available:  
http://www.homeoffice.gov.uk/rds/pdfs07/rdsolr0707.pdf [accessed 06.03.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 216
May et al (2002) Times they are a-changing: Policing of cannabis. Joseph Rowntree 
Foundation, York. 
 
May, T., Duffy, M., Warburton, H. and Hough, M. (2007). Policing cannabis as a Class 
C drug: an arresting change? Joseph Rowntree Foundation, York.  
 
McAra, L. and McVie, S. (2007) Criminal Justice Transitions, Number 14. The 
Edinburgh Study of Youth Transitions and Crime. Centre for Law and Society. The 
University of Edinburgh, Edinburgh. Available: 
http://www.law.ed.ac.uk/cls/esytc/findings/digest14.pdf [accessed 21.09.07] 
 
McCambridge, J., Mitcheson, L., Winstock, A. and  Hunt, N. (2005) Five-year trends in 
patterns of drug use among people who use stimulants in dance contexts in the 
United Kingdom Addiction,100, 1140–1149 
 
McCrystal, P., Percy, A. and Higgins, K. (2007a). Frequent cannabis use among 
14/15 year olds in Northern Ireland.  Drug and Alcohol Dependence. 88(1): 19-27. 
 
McCrystal, P., Percy, A. and Higgins, K. (2007b). The cost of drug use in 
adolescence: Young people, money and substance abuse. Drugs: Education, 
Prevention & Policy 14 (1): 19-28. 
 
McCrystal, P., Percy, A. and Higgins, K. (2007c). Substance use behaviours of young 
people with a moderate leaning disability: A longitudinal analysis. The American 
Journal of Drug and Alcohol Abuse 33(1): 155-161. 
 
McElrath, K. (2002). Prevalence of problem heroin use in Northern Ireland. 
Department of Health, Social Services and Public Safety Northern Ireland, Belfast. 
Available: www.dhsspsni.gov.uk/heroin_use_ni.pdf [accessed 18.10.07] 
 
McElrath, K. (2003). Review of research on substitute prescribing for opiate 
dependence and implications for Northern Ireland. Department of Health, Social 
Services and Public Safety Northern Ireland, Belfast. Available: 
www.dhsspsni.gov.uk/substitute_prescribing_report.pdf [accessed 18.10.07] 
 
McGrath, Y., Sumnall, H., McVeigh,J. and  Bellis, M. (2006). Drug use prevention 
among young people: a review of reviews. Evidence briefing update.  NICE, London. 
Available: http://www.nice.org.uk/page.aspx?o=529850 [accessed 21.09.07] 
 
McIntosh, J., MacAskill, S., Eadie, D., Curtice, J., McKeganey, N., Hastings, G., Hay, 
G. and Gannon, M. (2006). Substance misuse research: evaluation and description of 
drug projects working with young people and families funded by Lloyds TSB 
Foundation Partnership drugs initiative. Scottish Executive, Edinburgh. 
 
McIntosh, J., O'Brien, T., McKeganey, N. (2007). Drug driving and the management of 
risk: The perspectives and practices of a sample of problem drug users. International 
Journal of Drug Policy online early access. 
 
McKeganey, N. and McIntosh, J. (2000). Drug misuse research in Scotland: The 
contribution of research to Scotland’s Drug Misuse Strategy. Scottish Executive, 
Edinburgh. 
 
McKeganey, N.P., Bloor, M.J., Robertson, M., Neale, J., and MacDougall, J. (2006). 
Abstinence and Drug Abuse Treatment: Results from the Drug Outcome Research in 
Scotland Study. Drugs: Education, Prevention and Policy 13 (6) 537-550. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 217
 
McLaughlin, D., McKenna, H., Leslie, J., Moore, K. and Robinson, J. (2006). Illicit drug 
users in Northern Ireland: perceptions and experiences of health and social care 
professionals. Journal of Psychiatric and Mental Health Nursing 13 (6) 682-686. 
 
McMullan, S. and Ruddy, D. (2006). Experience of Drug Misuse: Findings from the 
2005 Northern Ireland Crime Survey. Northern Ireland Office, Belfast. 
McSweeney, T., Stevens, A., Hunt, N. and Turnbull, P. (2006). Twisting arms or a 
helping hand? Assessing the impact of 'coerced' and comparable 'voluntary' drug 
treatment options. British Journal of Criminology advance access published online Oct 
30, 2006. 
 
McVie, S. and Bradshaw, P. (2005). Adolescent smoking, drinking and drug use 
Number 7. The Edinburgh Study of Youth Transitions and Crime. Centre for Law and 
Society. The University of Edinburgh, Edinburgh. 
 
McVie, S. and Holmes, L. (2005). Family functioning and substance use at ages 12 to 
17. Number 9. The Edinburgh Study of Youth Transitions and Crime. Centre for Law 
and Society. The University of Edinburgh, Edinburgh. Available: 
http://www.law.ed.ac.uk/cls/esytc/findings/digest9.pdf  [accessed 21.09.07] 
 
McVie, S. and Norris, P.. (2006). Neighbourhood effects on youth delinquency and 
drug use. Edinburgh Study of Youth Transitions and Crime Number 10. Centre for 
Law and Society. The University of Edinburgh, Edinburgh. Available: 
http://www.law.ed.ac.uk/cls/esytc/findings/digest10.pdf [accessed 21.09.07] 
 
Measham, F., Aldridge, J. and Parker, H. (2001) Dancing on drugs: risk, health and 
hedonism in the British club scene. Free Association Books, London. 
Mentor UK (2007). Coastal and Ex-mining Areas Project, Final Report September. 
Mentor. Available: http://www.mentorfoundation.org/uploads/UK_CEMA_Report.pdf 
[accessed 23.06.07] 
Menzies, J. and Myant, K. (2006). Review of Choices for Life. Scottish Executive 
Social Research, Scottish Executive, Edinburgh. Available:  
http://www.scotland.gov.uk/Resource/Doc/153498/0041297.pdf [accessed 30.11.06] 
 
Millar, T., Gemmell, I., Hay, G., Heller, R. and Donmall, M. (2006). How well do trends 
in incidence of heroin use reflect hypothesised trends in prevalence of problem drug 
use in the North West of England. Addiction Research and Theory 14 (5) 537-549.  
 
Mintel (2006). Nightclubs United Kingdom report December 2006. Available: 
http://academic.mintel.com/sinatra/reports/display/id=173638/display/id=250065#head
ing4_1 [accessed 23.09.07] 
 
Mitcheson, L., McCambridge, J. Byrne, S. (2007). Pilot Cluster-Randomised Trial of 
Adjunctive Motivational Interviewing to Reduce Crack Cocaine Use in Clients on 
Methadone Maintenance. European Addiction Research 13 6-10. 
 
MOD (Ministry of Defence) (2006) Drugs in the Armed Forces (FOI). Ministry of 
Defence, London. Available: www.mod.uk/NR/rdonlyres/FE15F1E4-4C6B-4CD2-
9803-A2D612B81506/0/drugs_armedforces.pdf [accessed 03.09.07] 
 
Moore, T., Zammit, S., Lingford-Hughes, A., Barnes, T., Jones, P. et al. (2007). 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 218
Cannabis use and risk of psychotic or affective mental health outcomes: A systematic 
review. The Lancet 370 319-328. 
 
Morgan, O., Griffiths, C. and Hickman, M. (2006a). Association between availability of 
heroin and methadone and fatal poisoning in England and Wales 1993-2004. 
International Journal of Epidemiology 35 (6) 1579-85. 
 
Morgan, O.W., Johnson, H., Rooney, C., Seagroatt, V. and Griffiths, C. (2006b). 
Changes to the daily pattern of methadone-related deaths in England and Wales, 
1993-2003. Journal of Public Health 28 (4) 318-23.  
 
MORI (2004) MORI Youth Survey 2004. Youth Justice Board for England and Wales, 
London. 
 
Morrison, T. (2007). The Essential Drug and Alcohol Worker. DrugScope, London.  
 
Murphy, R. and Roe, S. (2007). Drug misuse declared: Findings from the 2006/07 
British Crime Survey. Home Office Statistical Bulletin 18/07. Home Office, London. 
Available: 
http://uk.sitestat.com/homeoffice/homeoffice/s?rds.hosb1807pdf&ns_type=pdf&ns_url
=%5Bhttp://www.homeoffice.gov.uk/rds/pdfs07/hosb1807.pdf%5D [accessed 
30.10.07] 
 
NACD (National Advisory Committee on Drugs) and DAIRU (Drug and Alcohol 
Information and Research Unit). (2007a). Drug use in Ireland and Northern Ireland. 
2002/03 Drug Prevalence Survey: Poly drug use. Bulletin 5. Available: 
http://www.dhsspsni.gov.uk/index/stats_research/public_health/statistics_and_researc
h-drugs_alcohol-2.htm#dacurpubs [accessed 03.09.07] 
 
NACD (National Advisory Committee on Drugs) and DAIRU (Drug and Alcohol 
Information and Research Unit). (2007b). Drug use in Ireland and Northern Ireland. 
2002/03 Drug Prevalence Survey: Sedatives, tranquilisers or anti-depressants. 
Bulletin 6. Available: http://www.dhsspsni.gov.uk/bulletin_6_stad.pdf [accessed 
03.09.07] 
 
NatCen and NFER (National Centre for Social Research/National Foundation for 
Educational Research) (2006). Research and drug use, smoking and drinking among 
young people in England in 2005: headline figures. NHS Health and Social Care 
Information Centre, Leeds and Home Office, London.  
 
National Assembly for Wales (2000). Tackling substance misuse in Wales: a 
partnership approach. National Assembly for Wales. Cardiff.  Available: 
http://wales.gov.uk/about/strategy/strategypublications/strategypubs/935796/?lang=en 
[accessed 21.09.07] 
 
Neale, J., Robertson, M. and Bloor, M. (2007a). ‘Treatment experienced’ and 
‘treatment naive’ drug agency clients compared. International Journal of Drug Policy 
online advance access. 
 
Neale, J., Bloor, M.J. and McKeganey, N. (2007b). How do heroin users spend their 
spare time? Drugs: education, prevention and policy 14 (3) 231–246. 
 
Newbery, N., McCambridge, J., and Strang, J. (2006). “Let’s Talk About Drugs” pilot 
study of a community-level drug prevention intervention based on motivational 
interviewing principles. National Addiction Centre, Institute of Psychiatry, King’s 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 219
College London, London, UK 
 
Newcombe, R. (2006). A review of the UK Drug Strategy PSA Targets and Drug Harm 
Index. Lifeline, Manchester. 
Newham, R. and Davies, J. B. (2007). Attributions given by drug users from three 
different settings. Addiction Research and Theory 15 (3) 299-308. 
 
NICE (National Institute for Health and Clinical Excellence) (2006). Review of grey 
literature on drug prevention among young people: Review Summary. National 
Institute for Health and Clinical Excellence, London. Available: 
http://www.drugpreventionevidence.info/documentbank/grey_lit_summary_v3FINAL[1]
.pdf  [accessed 21.09.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007a). Community-
based interventions to reduce substance misuse among vulnerable and 
disadvantaged children and young people. National Institute for Health and Clinical 
Excellence, London. Available: 
http://guidance.nice.org.uk/PHI4/guidance/pdf/English/download.dspx [accessed 
21.09.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007b). Methadone and 
buprenorphine for the management of opioid dependence. NICE technology appraisal 
guidance 114. National Institute for Health and Clinical Excellence, London. Available: 
http://www.nice.org.uk/guidance/TA114 [accessed 01.06.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007c) Naltrexone for the 
management of opioid dependence. NICE technology appraisal guidance 115. 
National Institute for Health and Clinical Excellence, London. Available: 
http://www.nice.org.uk/guidance/TA115/niceguidance/pdf/English [accessed 01.06.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007d). Drug misuse. 
psychosocial interventions. NICE clinical guideline 51. National Institute for Health and 
Clinical Excellence, London. Available:  
http://guidance.nice.org.uk/CG51/niceguidance/pdf/English [accessed 26.07.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007e). Drug misuse: 
opioid detoxification: NICE guideline. National Institute for Health and Clinical 
Excellence, London. Available: 
http://guidance.nice.org.uk/CG52/niceguidance/pdf/English [accessed 27.07.07] 
 
NICE (National Institute for Health and Clinical Excellence) (2007f). NICE 
implementation uptake report: Drugs used to treat hepatitis C. 
www.nice.org.uk/download.aspx?o=442053 [accessed 12.10.07] 
 
Nicholas, S., Kershaw, C., and Walker, A. (2007). Crime in England and Wales 
2006/2007. Home Office, London. Available:  
http://www.homeoffice.gov.uk/rds/pdfs07/hosb1107.pdf [accessed 20.07.07] 
 
NIO (Northern Ireland Office) (1999). Drug strategy for Northern Ireland. Northern 
Ireland Office, Belfast. 
NIO (Northern Ireland Office) (2006a) Digest of Information on the Northern Ireland 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 220
Criminal Justice System: 5 http://www.nio.gov.uk/media-detail.htm?newsID=13263 
 
NIO (Northern Ireland Office). (2006b). The Northern Ireland Prison Population in 
2005 
http://www.nio.gov.uk/media-detail.htm?newsID=13246 [accessed 5/9/07] 
 
NISRA (Northern Ireland Statistics and Research Agency) (2007). Statistics from the 
Northern Ireland Substitute Prescribing Database: 31st March 2006. Department of 
Health, Social Services and Public Safety, Belfast. Available:  
http://www.dhsspsni.gov.uk/index/stats_research/stats-pubs.htm [accessed 02.03.07] 
 
NTA (National Treatment Agency for Substance Misuse) (2003). Models of care for 
the treatment of adult drug misusers. National Treatment Agency for Substance 
Misuse, London. Available:  
http://www.nta.nhs.uk/publications/Models_of_care.pdf [accessed 23.02.07] 
 
NTA (National Treatment Agency) (2005). Young people’s substance misuse 
treatment services – essential elements. London: National Treatment Agency. 
 
NTA (National Treatment Agency for Substance Misuse) (2006). Models of residential 
rehabilitation for drug and alcohol misusers National Treatment Agency for Substance 
Misuse, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_models_of_residential_rehab_drg_
and_alc.pdf [accessed 08.10.07]   
 
NTA (National Treatment Agency for Substance Misuse) (2007a). Treatment Outcome 
Profile Form. National Treatment Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/areas/outcomes_monitoring/docs/TOP_form_may_2007.pdf 
[accessed 01.06.07]   
 
NTA (National Treatment Agency for Substance Misuse) (2007b). The Treatment 
Outcomes Profile (TOP). An implementation guide for managers. National Treatment 
Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/areas/outcomes_monitoring/docs/TOP_manager%27s_implem
entation_guide_160507.pdf [accessed 01.06.07] 
 
NTA (National Treatment Agency for Substance Misuse) (2007c). The Treatment 
Outcomes Profile (TOP) A guide for keyworkers. National Treatment Agency for 
Substance Misuse, London. Available: 
http://www.nta.nhs.uk/areas/outcomes_monitoring/docs/TOP_keyworker_guide_2709
07.pdf  [accessed 09.10.07] 
 
NTA (National Treatment Agency for Substance Misuse) (2007d). Treatment 
Outcomes Profile (TOP). Making your drug treatment better. National Treatment 
Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/areas/outcomes_monitoring/docs/TOP_service_users_guide_1
60507.pdf [accessed 01.06.07] 
 
NTA (National Treatment Agency for Substance Misuse) (2007e). Good practice in 
care planning National Treatment Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_good_practice_in_care_planning_g
pcp1.pdf [accessed 31.10.07] 
 
NTA (National Treatment Agency for Substance Misuse) (2007f). National evaluation 
of crack cocaine treatment and outcome study (NECTOS). A multi-centre evaluation 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 221
of dedicated crack cocaine treatment services. National Treatment Agency for 
Substance Misuse, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_nectos_national_evaluation_crack_
cocaine_treatment_and_outcome_study.pdf [accessed 09.10.07] 
 
NTA (National Treatment Agency for Substance Abuse) (2007g). The NTA’s 2005 
survey of needle exchanges in England. National Treatment Agency, London. 
Available: 
http://www.nta.nhs.uk/publications/documents/nta_nus1_user_satisfaction_survey.pdf 
[accessed 17.10.07] 
 
NTA (National Treatment Agency for Substance Abuse) (2007h). Business plan 
2007/08. National Treatment Agency for Substance Misuse, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_business_plan_2007_08.pdf 
[accessed 28.09.07] 
 
NTA (National Treatment Agency) (2007i). Assessing young people for substance 
misuse. National Treatment Agency, London. Available: 
http://www.nta.nhs.uk/publications/documents/nta_assessing_young__people__for__
substance__misuse_yp1.pdf [accessed 24.09.07] 
 
Nutt, D., King, L.A. Saulsbury, W. and Blakemore, C. (2007). Development of a 
rational scale to assess the harm of drugs of potential misuse. Lancet  369 1047–53. 
 
Ofsted (Office for Standards in Education) (2002). Drug education in schools: An 
update – 2002. Available: 
http://www.ofsted.gov.uk/portal/site/Internet/menuitem.eace3f09a603f6d9c3172a8a08
c08a0c/?vgnextoid=94871e7a681eb010VgnVCM2000003607640aRCRD [accessed 
01.10.07] 
 
O’Hagan, C. (1999). British dance culture: Sub-genres and associated drug use. 
Release, London. 
 
Oliver, P., Forrest, R. and Keen, J. (2007a). Benzodiazepines and cocaine as risk 
factors in fatal opioid overdoses. Research briefing 31. April 2007. National Treatment 
Agency for Substance Misuse, London. 
 
Oliver, P., Forrest, R. and Keen, J. (2007b). Does the combined use of heroin and 
methadone and other substances increase the risk of overdose. Research briefing 27. 
National Treatment Agency for Substance Misuse, London. 
 
Oliver, P., Horspool, H., Rowse, G., Parry, M., Keen, J. and Mathers, N. (2007c). A 
psychological autopsy study of non-deliberate fatal opiate-related overdose. Research 
briefing 24. National Treatment Agency for Substance Misuse, London: 
 
ONS (Office for National Statistics) (2003) The mental health of young people looked 
after by local authorities. Office for National Statistics, London. Available: 
http://www.statistics.gov.uk/pdfdir/hel0603.pdf [accessed 24.09.07] 
 
ONS (Office for National Statistics) (2004a) Mental health of young people looked 
after by local authorities in Scotland. Office for National Statistics, London. Available: 
http://www.statistics.gov.uk/pdfdir/mhs0504.pdf [accessed 24.09.07] 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 222
ONS (Office for National Statistics) (2004b). Mental health of young people looked after by 
local authorities in Wales. Office for National Statistics, London. Available:  
http://www.statistics.gov.uk/pdfdir/mhw0504.pdf [accessed 24.09.07] 
 
ONS (Office for National Statistics) (2004c). Focus on Ethnicity and Identity. Office for 
National Statistics, London. Available: http://www.statistics.gov.uk/focuson/ethnicity/ 
[accessed 24.09.07] 
 
Perry, A., Coulton, S., Glanville, J., Godfrey, C., Lunn, J., McDougall, C. and Neale, Z 
(2006). Interventions for drug-using offenders in the courts, secure establishments 
and the community. Cochrane Database of Systematic Reviews 2006 Issue 3. Art No: 
CD005193, DOI: 10.1002/14651858.CD005193.pub2. 
 
Petrie, J., Bunn, F. and Byrne, G. (2007). Parenting programmes for preventing 
tobacco, alcohol or drugs misuse in children under 18: a systematic review. Health 
Education Research 22 (2): 177-191 
 
Pleace, N., and Fitzpatrick, S. (2004). Centrepoint Youth Homelessness Index: An 
estimate of youth homelessness for England. Centre for Housing Policy, University of 
York, York. Available:  
http://www.centrepoint.org.uk/documents/Centrepoint_YorkResearch-report.pdf 
[accessed 24.09.07] 
 
Powis, B., Griffith, P., Gossop, M., Lloyd ,C. and Strang, J. (1998). Drug use and 
offending behaviour among young people excluded from school. Drugs: Education, 
prevention and policy 5 245-256. 
 
The Prostitution (Public Places) (Scotland) Act 2007.   
PSNI (Police Service Northern Ireland) (2006). Chief Constable’s Annual Report 
2005-06. http://www.psni.police.uk/psni_cc_report_2006.pdf [accessed 11.10.07] 
 
PSNI (Police Service of Northern Ireland) (2007). Recorded Crime In Northern Ireland 
2006/07. Police Service of Northern Ireland, Belfast.  Available:  
http://www.psni.police.uk/1._recorded_crime.pdf [accessed 20.07.07] 
 
Pudney, S., Badillo, C., Bryan, M., Burton, J., Conti, G. and Iacovou, M. (2006). 
Estimating the size of the UK illicit drug market in Singleton, N., Murray, R. and 
Tinsley, L. (Eds.) Measuring different aspects of problem drug use: methodological 
developments. Home Office Online Report 16/06. Available: 
http://www.drugs.gov.uk/news-events/latest-news/compendium [accessed 31.08.07] 
 
RCGP (Royal College of General Practitioners) (2007) Guidance for the prevention, 
testing, treatment and management of hepatitis C in primary care. Royal College of 
General Practitioners, London. 
 
Reuter, P. (2006). What drug policies cost.  Estimating government drug policy 
expenditures. Addiction 101: 315-322. 
 
Reuter, P. and Stevens, A. (2007). An Analysis of UK Drug Policy. UK Drug Policy 
Commission, London. 
http://www.ukdrugpolicycommission.org.uk/docs/UKDPC%20drug%20policy%20revie
w.pdf [accessed 05.10.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 223
Rhodes, T. and Lyons, M. (2006). Access to clean injecting equipment among 
injecting drug users in South Wales: A qualitative study. Cardiff: National Public 
Health Service for Wales. 
 
RNID (Royal National Institute for the Deaf )(2007). Like it Loud - Young people, loud 
music and hearing damage. Available: 
http://www.dontlosethemusic.com/Content.aspx?ciid=302610 [accessed 24.09.07] 
 
Roberts, M., Bewley -Taylor, D.R. and Trace, M. (2006). Monitoring drug policy 
outcomes: The measurement of drug-related harm. Report nine. Beckley Foundation, 
Oxford 
 
Robertson, J.R., Raab, G.M., Bruce, M., McKenzie, J.S., Storkey, H.R. and Salter, A. 
(2006). Addressing the efficacy of dihydrocodeine versus methadone as an alternative 
maintenance treatment for opiate dependence: a randomised controlled trial. 
Research Report. Addiction 101 1752 – 1759. 
 
Robinson, I. (2007). The Essential Drug Service Manager. DrugScope, London.  
 
Roe, S., and Man, L. (2006). Drug misuse declared: findings from the 2006/06 British 
crime survey. Home Office, London. Available:  
http://www.homeoffice.gov.uk/rds/pdfs06/hosb1506.pdf [accessed 24.09.07] 
 
Roy, A., Davies, K., Mir, Y., Fountain, J., Anitha, S., Bashford, J. and Patel. K. (2007). 
Helping prisons to meet the drug service needs of Black and minority ethnic prisoners: 
a practice guide. Centre for Ethnicity and Health Faculty of Health, University of 
Central Lancashire. 
 
Royal College of Psychiatrists (2002). Co-existing Problems of Mental Disorder and 
Substance Misuse (dual diagnosis): An Information Manual. Royal College of 
Psychiatrists Research Unit, London.  
 
RSA (The Royal Society for the Encouragement of Arts, Manufactures and 
Commerce) (2007). Drugs – facing facts. The report of the RSA Commission on Illegal 
Drugs, Communities and Public Policy. The Royal Society for the Encouragement of 
Arts, Manufactures and Commerce. Available: 
http://www.rsa.org.uk/projects/drugs.asp  [accessed 15.03.07] 
 
SACDM (Scottish Advisory Committee On Drug Misuse) (2007a). Reducing harm and 
promoting recovery: A report on methadone treatment for substance misuse in 
Scotland. SACDM Methadone Project Group. Scottish Advisory Committee On Drug 
Misuse, Edinburgh.  Available:  
http://www.scotland.gov.uk/Publications/2007/06/22094730/0 [accessed 29.07.07] 
 
Scaife, V. H. (2007).  Maternal and Paternal Drug Misuse and Outcomes for Children: 
Identifying Risk and Protective Factors. School of Social Work and Psychosocial 
Sciences, University of East Anglia, Norfolk, United Kingdom, Children and Society. 
Available: 
http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1099-0860.2007.00093.x 
[accessed 24.09.07] 
 
Schifano, F., Corkery, J.M. and Cuffolo, G. (2007). Smokable ("ice"; "crystal meth") 
and non smokable amphetamine-type stimulants; clinical pharmacological and 
epidemiological issues, with special reference to the UK. Ann Ist Super Sanita 43 
(1)110-115. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 224
 
Scott-Ham, M. and Burton, F.C. (2006). Toxicological findings in cases of alleged drug 
facilitated sexual assault in the United Kingdom over a 3-year period. Journal of 
Clinical Forensic Medicine 12 175-186 
Scottish Executive (2000). Review of Executive expenditure on tackling drug misuse. 
Scottish Executive, Edinburgh. Available: 
http://www.drugmisuse.isdscotland.org/publications/abstracts/PUDrugExpenRev.htm 
[accessed 10.10.07] 
 
Scottish Executive (2001). Getting our priorities right: Policy and practice guidelines 
for working with children and families affected by problem drug use. Scottish 
Executive, Edinburgh. 
 
Scottish Executive (2002). Homelessness: an action plan for prevention and effective 
response report from the Homelessness Task Force to Scottish Ministers. Available: 
http://www.scotland.gov.uk/Topics/Housing/homeless/htf  [accessed 26.10.07] 
 
Scottish Executive (2003a). Mind the Gaps – Meeting the Needs of People with Co-
occurring Substance Misuse and Mental Health Problems. Scottish Executive, 
Edinburgh. 
 
Scottish Executive (2003b). Getting our priorities right: good practice guidance for 
working with children and families affected by substance misuse. Scottish Executive. 
Edinburgh.  
 
Scottish Executive (2004). Protecting Children and Young People - The Charter 
Scottish Executive, Edinburgh. Available:   
http://www.scotland.gov.uk/Publications/2004/04/19082/34410 [accessed 31.10.2007] 
 
Scottish Executive (2006a). Hepatitis C Action Plan for Scotland Phase 1: September 
2006 – August 2008. Edinburgh: Scottish Executive. 
 
Scottish Executive (2006b). Neonatal Abstinence Syndrome. A new intervention: A 
community based, structured health visitor assessment. Scottish Executive, 
Edinburgh.  
 
Scottish Executive (2006c). Recorded Crime in Scotland 2005/06. Statistical Bulletin. 
Criminal Justice Series Scottish Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Publications/2006/08/30140700/26 [accessed 20.07.07] 
 
Scottish Executive (2006d). Annual Report of HM Chief Inspector of Constabulary for 
Scotland 2005/06. Scottish Executive, Edinburgh.  Available:  
http://www.scotland.gov.uk/Publications/2006/11/29160835/0 [accessed 10.10.07] 
 
Scottish Executive (2006e). Prison Statistics Scotland 2005/06 Statistical Bulletin 
CrJ/2006/5.  Available: http://www.scotland.gov.uk/Publications/2006/08/18103613/87 
[accessed 4/9/07] 
 
Scottish Executive (2006f). School level pupil numbers by stage, as at September 
2005 Scottish Executive, Edinburgh. Available:  
http://www.scotland.gov.uk/Topics/Statistics/Browse/School-
Education/pupilsbystagesep05 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 225
 
Scottish Executive (2006g). Evaluation of the effectiveness of drug education in 
Scottish Schools. Scottish Executive, Edinburgh. 
 
Scottish Executive (2006h) Primary school class sizes as at September 2005 Scottish 
Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Topics/Statistics/16412/PrimClassSizesSep05  
 
Scottish Executive (2006i). Looked After Children 2005-06 Publication. Available: 
http://www.scotland.gov.uk/Resource/Doc/159750/0043434.pdf [accessed 23.09.07] 
 
Scottish Executive (2006j). Index of Multiple Deprivation 2006: General Report. 
Available: http://www.scotland.gov.uk/Publications/2006/10/13142739/1 [accessed 
24.09.07] 
 
Scottish Executive (2007a). Know the Score: Anti-Heroin 2006/07 Campaign 
Evaluation. Scottish Executive Social Research, Scottish Executive. Edinburgh. 
Available:  
http://www.scotland.gov.uk/Publications/2007/02/15132059/10 [accessed 23.06.07] 
 
Scottish Executive (2007b). Know The Score: Cocaine Wave 4 - 2006/07: Post-
Campaign Evaluation Scottish Executive Social Research, Scottish Executive. 
Edinburgh. Available: http://www.scotland.gov.uk/Resource/Doc/194320/0052167.pdf 
[accessed 09.10.07] 
 
Scottish Executive (2007c). Looked After Children and Young People: We Can and 
Must Do Better. Scottish Executive, Edinburgh. Available:  
http://www.scotland.gov.uk/Publications/2007/01/15084446/0 [accessed 13. 09.07] 
 
Scottish Executive (2007d). National Quality Standards for Substance Misuse 
Services. Scottish Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Publications/2006/09/25092710/0 [accessed 01.06.07] 
 
Scottish Executive (2007e). A Stocktake Alcohol and Drug Action Teams (ADATs) in 
Scotland. Scottish Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Publications/2007/06/22094551/15 [accessed 26.07.07] 
 
Scottish Executive (2007f). A report on the review of residential drug detoxification 
and rehabilitation services in Scotland. Scottish Executive Online publication: 
Available:  
http://www.scotland.gov.uk/Publications/2007/06/22094802/0 [accessed 02.08.07] 
 
Scottish Executive (2007g). Review of Methadone in Drug Treatment: Prescribing 
Information and Practice. Scottish Executive, Edinburgh. Available: 
http://www.drugmisuse.isdscotland.org/publications/abstracts/review_presc_info_prac
_0707.htm [accessed 26.07.07]  
 
Scottish Executive (2007h). Scottish Local Government Financial Statistics 2005-06. 
Scottish Executive, Edinburgh. Available:  
http://www.scotland.gov.uk/Publications/2007/01/09093510/9  
 
Scottish Executive (2007i). SQA attainment and school leaver qualifications in 
Scotland: 2005/06. Available: 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 226
http://www.scotland.gov.uk/Resource/Doc/171047/0047888.pdf [accessed 24.09.07] 
 
Scottish Executive (2007j). Exclusions From Schools, 2005/06, Scottish Executive 
National Statistics Publication. Available: 
http://www.scotland.gov.uk/Publications/2007/01/30100624/1 [accessed 24.09.07] 
 
Scottish Executive (2007k). Prison Statistics Scotland, 2006/07. Available: 
http://www.scotland.gov.uk/Resource/Doc/196743/0052707.pdf [accessed 24.09.07] 
 
Scottish Executive (2007l). Scottish Households Below Average Income 2005/06 
Scottish Executive National Statistics Publication. Available: 
http://www.scotland.gov.uk/Publications/2007/05/30085716/15 [accessed 24.09.07] 
 
Scottish Executive (2007m). Delivering a Healthy Future An Action Framework for 
Children and Young People’s Health in Scotland. Scottish Executive, Edinburgh.  
 
Scottish Government (2007). Guidance for local authorities and their community 
planning partners on street prostitution. Scottish Government, Edinburgh. 
Available: 
http://www.scotland.gov.uk/Topics/Justice/criminal/17543/Response/streetprostguidec
ons/LAguidance/LAguidance  [accessed 11.09.07] 
 
Scottish Office (1998). Scottish Drug Misuse Information Strategy. Scottish Office, 
Edinburgh. Available: http://www.scotland.gov.uk/library/documents4/drugmis.htm 
[accessed 04.07.07] 
 
Scottish Office (1999). Tackling drugs in Scotland: Action in partnership. The Scottish 
Office, Edinburgh. http://www.scotland.gov.uk/library/documents-w7/tdis-00.htm 
[accessed 05.10.07] 
 
Scottish Prison Service (2006). Annual Report & Accounts 2005/06. Available: 
www.sps.gov.uk/MultimediaGallery/03d01d53-de6e-430d-b735-d20cc4191574.pdf  
 
SDF (Scottish Drugs Forum) (2007): Review of the role of methadone in the treatment 
of drug problems. Scottish Executive, Edinbugh. Available:  
http://www.drugmisuse.isdscotland.org/publications/abstracts/sdf_review_of_meth_07
07.htm [accessed 03.08.07] 
 
Seddon, T. (2006). Drugs, crime and social exclusion: Social context and social theory 
in British drugs-crime research.  British Journal of Criminology 46 (4): 680-703 
 
Sharp, C., Aldridge, J. and Medina, J. (2006). Delinquent youth groups and offending 
behaviour: findings from the 2004 Offending, Crime and Justice Survey. Home Office 
Online Report 14/06. Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs06/rdsolr1406.pdf [accessed 23.02.07] 
 
Shaw, C., Salmon, J. and McVeigh, J. (2007a). Evaluation of the Peer to Peer Project. 
Available: http://www.cph.org.uk/publications.asp [accessed 01.08.07] 
 
Shaw, A., Egan, J. and Gillespie, M. (2007b). Drugs and poverty: A literature review. 
Scottish Drugs Forum (SDF), Edinburgh. Available: 
http://www.drugmisuse.isdscotland.org/publications/abstracts/sdf_poverty.htm 
[accessed 21.03.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 227
Sheard, L., Adams, C.E., Wright N.M.J. El-Sayeh, H., Dalton, R. and Tompkins, 
C.N.E. (2007). The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) 
prisons project pilot study: protocol for a randomised controlled trial comparing 
dihydrocodeine and buprenorphine for opiate detoxification. Trials 8 1-5. Available: 
http://www.trialsjournal.com/content/8/1/1 [accessed 01.06.07] 
 
Shelter (2005). Young people and homelessness. Available:  
http://england.shelter.org.uk/files/docs/14542/ypandhomelessness.pdf [accessed 
24.09.07] 
 
SMMGP (Substance Misuse Management in General Practice) (2007). Modern 
Maintenance Therapy: Prescribe Imperative or Patient Choice? Report of a Socratic 
Dialogue. 
 
SOCA (Serious Organised Crime Agency) (2006). United Kingdom Threat 
Assessment of Serious Organised Crime 2006/07. Available: 
http://www.soca.gov.uk/assessPublications/index.html [accessed 31.07.07] 
 
Staffordshire Police Authority (2006). Reform and Performance Management 
Committee. 28 April 2006. Available: 
http://www2.staffordshire.gov.uk/policeauthority/reform/2006/280406/Item%20No.%2
010.pdf [accessed 10.10.07]   
 
Stead, M., MacKintosh, A.M., McDermott, L., Eadie, D., Macneil, M. et al. (2007). 
Evaluation of the Effectiveness of Drug Education in Scottish Schools. Scottish 
Executive, Edinburgh. Available: 
http://www.scotland.gov.uk/Resource/Doc/96353/0023319.pdf [accessed 23.06.07] 
 
Stevens, A. (2007). When two dark figures collide: Evidence and discourse on drug-
related crime. Critical Social Policy 27 (1) 77-99. 
 
Strang, J., Sheridan, J., Hunt, C., Kerr, B., Gerada, C. and Pringle, M. (2005). The 
Prescribing of Methadone and Other Opioids to Addicts: National Survey of GPs in 
England and Wales. British Journal of General Practice 55 444–451. 
 
Strang, J., Robson, P. and Solomons, N. (2006). Beyond the end of the line: Case 
reports of conversion from dextromoramide to other opiates within addiction 
maintenance treatment. Drugs: education, prevention and policy 13 (5) 473-480.  
 
Strang, J., Manning, V., Mayet, S., Ridge, G., Best, D. and Sheridan, J. (2007a). Does 
prescribing for opiate addiction change after national guidelines? Methadone and 
buprenorphine prescribing to opiate addicts by general practitioners and hospital 
doctors in England, 1995-2005. Addiction 102 761-770. 
 
Strang, J., Hunt, C., Gerada, C. and Marsden, J. (2007b). What difference does 
training make? A randomised trial with waiting list control of general practitioners 
seeking advanced training in drug misuse. Addiction online early access. 
 
Sumnall, H., Jones, L., Burrell, K., Witty, K., McVeigh, J. and Bellis, M. (2006a). 
Annual Review of Drug Prevention National Collaborating Centre for Drug Prevention, 
Liverpool. Available: 
http://www.drugpreventionevidence.info/documentbank/ANNUAL%20REPORT[final].p
df [accessed 24.09.07] 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 228
Sumnall, H., McGrath, Y., McVeigh, J., Burrell, K., Wilkinson, L. and Bellis, M.  
(2006b). Drug use prevention among young people: Evidence into practice briefing. 
National Institute for Health and Clinical Excellence, London. Available:  
www.nice.org.uk/page.aspx?o=529843 [accessed 24.09.07] 
 
Taylor, H. (2006). Why a `roof' is not enough: The characteristics of young homeless 
people referred to a designated Mental Health Service. Journal of Mental Health, 
Volume 15 491-501  
 
Taylor, P., Budd, S. and Thorpe, K. (2007). Crime in England and Wales: Quarterly 
Update to September 2006. Home Office Statistical Bulletin 01/07. Home Office, 
London. 
 
Terrence Higgins Trust.  (2006). Terrence Higgins Trust report investigates the health 
needs of female sex workers in Coventry. Press Release 16 November 2006. 
Available : 
http://www.tht.org.uk/mediacentre/pressreleases/2006/november/swishreport.htm 
[accessed 03.09.07] 
 
The Information Centre (2007a). Hospital Episode Statistics. Primary diagnosis: 4 
character 2005-06. Available  at: 
http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=21
4 [accessed 11.09.07] 
 
The Information Centre (2007b). Personal Social Services Expenditure and Unit Costs 
(PSS EX1) 2005/06. London: Department of Health. Available at 
http://www.ic.nhs.uk/statistics-and-data-collections/social-care/adult-social-care-
information/personal-social-services-expenditure-and-unit-costs-england:-2005-06 
[accessed 10.10.07] 
 
The Social Justice Policy Group (2007). Breakthrough Britain. Ending the costs of 
social breakdown. Policy recommendations to the Conservative Party. The Social 
Justice Policy Group, London. Available:  
http://www.centreforsocialjustice.org.uk/default.asp?pageRef=182  [accessed 
16.07.07] 
 
TNS System Three (2007). Young Pre-Driver Qualitative Research Report. Road 
Safety Scotland, Edinburgh. Available: http://www.road-
safety.org.uk/research/completed/predriver_qualitative_research.asp 
[accessed 11.09.07] 
 
Trathen, B., O' Gara, C., Sarkhel, A., Sessay, M., Rao, H. and Luty, J. (2007). Co-
morbidity and cannabis use in a mental health trust in South East England. Addictive 
Behaviours online early access. 
 
The Treatment of Drug Users (Scotland) Bill. Her Majesty’s Stationary Office, 
Norwich. 
 
Tregidga, J., Williamson, H. and Noaks, L. (2005) Realism, Relevance and Respect? 
A Formative Evaluation of the All Wales Police Schools Liaison Programme. (2005) 
http://wales.gov.uk/dsjr/research/realismrespect/report?lang=en 
 
Turnbull, P.J. and Webster, R. (2007). Supervising crack-using offenders on Drug 
Treatment and Testing Orders. National Treatment Agency for Substance Misuse. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 229
Research briefing: 22. National Treatment Agency for Substance Misuse, London. 
 
Turning Point (2006). Bottling it up: The effects of alcohol misuse on children, parents 
and families. Available: http://www.turning-point.co.uk/NR/rdonlyres/33C57B5C-
BB5E-49A2-8232-B77B081BDC41/0/Bottlingitup06report.pdf [accessed 24.09.07] 
 
Turning Point (2007). At the sharp end: A snapshot of 21st century injecting drug use. 
Available: http://www.turning-
point.co.uk/Campaigns+and+Policy/at+the+sharp+end/at+the+sharp+end.htm 
[accessed 01.08.07] 
 
UKADCU (United Kingdom Anti-Drugs Co-ordination Unit) (1998). Tackling drugs to 
build a better Britain. The Stationery Office, London. http://www.archive.official-
documents.co.uk/document/cm39/3945/3945.htm [accessed 05.10.07] 
 
WAG (Welsh Assembly Government) (2004a). SJR-17-04 (p.1) Annex A 
http://www.assemblywales.org/bus-home/bus-committees/bus-committees-
second/bus-committees-second-sjr-home/bus-committees-second-sjr-
agendas.htm?act=dis&id=15384&ds=12/2004  
 
WAG (Welsh Assembly Government) (2004b). SJR-17-04 (p.1) 
http://www.assemblywales.org/bus-home/bus-committees/bus-committees-
second/bus-committees-second-sjr-home/bus-committees-second-sjr-
agendas.htm?act=dis&id=15386&ds=12/2004 
 
WAG (Welsh Assembly Government) (2004c). Children and Young People: Rights to 
Action. Stronger Partnerships for Better Outcomes. Welsh Assembly Government, 
Cardiff. Available: 
http://www.learning.wales.gov.uk/scripts/fe/news_details.asp?NewsID=1909 
[accessed 24.09.07] 
 
WAG (Welsh Assembly Government) (2005). A Fair Future for Our Children:The 
Strategy of the Welsh Assembly Government for Tackling Child Poverty. Welsh 
Assembly Government, Cardiff. Available: 
http://new.wales.gov.uk/dsjr/publications/childrenyoung/fairfuture/strategye?lang=en 
[accessed 24.09.07] 
 
WAG (Welsh Assembly Government) (2006a). The Welsh National Database for 
Substance Misuse – First Annual Report. Welsh Assembly Government, Cardiff. 
Available: 
http://new.wales.gov.uk/topics/housingandcommunity/safety/publications/submisusew
ndreport1?lang=en  
 
WAG (Welsh Assembly Government) (2006b). Key Performance Indicators for 
substance misuse treatment in Wales. Welsh Assembly Government, Cardiff. 
Available: 
http://new.wales.gov.uk/topics/housingandcommunity/safety/substancemisuse/pmf/kpi
?lang=en  [accessed 08.10.07] 
 
WAG (Welsh Assembly Government) (2007a) Exclusions from Schools in Wales 
2005/06. Statistical Release 32/2007 Welsh Assembly Government, Cardiff. 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 230
WAG (Welsh Assembly Government) (2007b). Homelessness (April to June 2007) 
Statistical Release 142/2007. Available: 
http://new.wales.gov.uk/topics/statistics/headlines/housing-
2007/hdw20071003/?lang=en  [accessed 29.10.07] 
 
Ward, J., Henderson, Z., Pearson, G (2003). One Problem Among Many: Drug Use 
Among Care Leavers in Transition to Independent Living. Home Office Research 
Study 260. Home Office, London. 
 
Warfa, N., Klein, A., Bhui, K., Leavey, G., Craig, T. and Stansfield, S.A. (2007). Khat 
use and mental illness: A critical review. Social Science and Medicine online early 
access. 
 
Weaver, T., Hart, J., Fehler, J., Metrebian, N., D’Agostino, T. and Benn. P. (2007). Are 
contingency management principles being implemented in drug treatment in England? 
National Treatment Agency for Substance Misuse. Research briefing: 33. National 
Treatment Agency for Substance Misuse, London. 
 
Whiting, E. and Cuppleditch, L. (2006) Home Office Statistical Bulletin Re-offending of 
juveniles: results from the 2004 cohort 10/06. Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs06/hosb1006.pdf [accessed 24.09.07] 
 
Williams, J., Jackson, S., Maddocks, A., Cheung, W-Y., Love, A. and Hutchings, H. 
(2001). Case-control study of the health of those looked after by local authorities. 
Archives of Disease in Children 85 280-285 
 
Wilson, D., Sharp, C. and Patterson, A.  (2006) Young People and Crime: Findings 
from the 2005 Offending, Crime and Justice Survey. Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs06/hosb1706.pdf [accessed 24.09.07] 
 
Wincup, E. Buckland, G. and Bayless, R. (2003) Youth homelessness and substance 
use: report to the drugs and alcohol research unit, Home Office Research Study 258 
February 2003 Home Office, London. Available: 
http://www.homeoffice.gov.uk/rds/pdfs2/hors258.pdf [accessed 24.09.07] 
 
Wright, N. and Tompkins, C. (2006). A review of the evidence for the effectiveness of 
primary prevention interventions for Hepatitis C among injecting drug users. Harm 
Reduction Journal 3 27. 
 
Youth Justice Board (YJB) (2003) Asset. A summary of the evaluation of the validity 
and reliability of the Youth Justice Board’s assessment for young offenders. Available: 
http://www.yjb.gov.uk/Publications/Scripts/prodView.asp?idProduct=84&eP=PPYJB 
[accessed 24.09.07] 
 
YJB Youth Justice Board (2006a). Youth Justice Annual Statistics 2005/06. Available: 
http://www.yjb.gov.uk/Publications/Scripts/prodView.asp?idproduct=325&eP 
[accessed 24.09.07] 
 
YJB (Youth Justice Board) (2006b). A health needs assessment for young women in 
young offender institutions. Available: 
 http://www.yjb.gov.uk/Publications/Scripts/prodView.asp?idproduct=321&eP  
[accessed 24.09.07] 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 231
 
 
 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 232
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 233
 
List of tables used in text 
Table Page 
Table 2.1: Percentage of 16-59 year olds reporting having used drugs in lifetime, 
last year and last month, England and Wales, 20006/07 
 
27
Table 2.2: Percentage of 16-59 year olds reporting having used drugs in lifetime, 
last year and last month, Scotland, 2006 
 
28
Table 2.3: Percentage of 16 to 59 year olds reporting having used drugs in the 
last year,  Northern Ireland, 2001 to 2005 
 
29
Table 2.4: Percentage of 16-24 year olds reporting having used drugs in lifetime, 
last year and last month, England and Wales, 2006/07 
 
30
Table 2.5: Frequent use: percentage of 16 to 24 year olds (all respondents) who 
have used any drug more than once a month in the past year, England and 
Wales, 2002/03 to 2006/07 
 
31
Table 2.6: Percentage of respondents reporting last year use of drugs by age and 
gender, Scotland, 2006 
 
32
Table 2.7: Percentage of pupils reporting use of individual drugs in the last month, 
in the last year and in lifetime, by gender, England, 2006  
 
33
Table 2.8: Percentage of pupils reporting use of individual drugs in the last year, 
England, 2001 to 2006 
 
34
Table 2.9: Frequency of use: Percentage of pupils who usually take drugs at least 
once a month by age, England, 2003 to 2006 
 
34
Table 2.10: Percentage of pupils reporting lifetime use of individual drugs 
individual drugs by age and gender, Scotland, 2006.  
 
35
Table 2.11: Frequency of use by school children in Scotland, 2006, as a 
percentage 
 
35
Table 2.12: Drug tests and outcomes amongst Armed Forces personnel, 2000-
2006 
 
37
Table 2.13: Last year use of individual drugs amongst gay men in the United 
Kingdom, 2005 
 
38
Table 2.14: Percentage of year 9 pupils (aged 13 to 14) reporting lifetime use of 
cannabis and volatile substances, by ethnicity and sex 
 
39
Table 4.1: Problem drug users estimates and rates per 1,000 population aged 15 
to 64 for the United Kingdom 
 
54
Table 4.2: Estimate of problem drug users aged 15 to 64 by Region in England 
2004/05: rate per 1,000 population and number 
 
54
Table 4.3: Estimate of opiate users aged 15 to 64 by Region in England, 2004/05: 
rate per 1,000 population and number 
 
54
Table 4.4: Estimate of crack users aged 15 to 64 by Region in England, 2004/05: 
rate per 1,000 population and number 
 
55
UNITED KINGDOM FOCAL POINT REPORT 2007 
 234
Table 4.5: Estimate of drug injectors aged 15 to 64 by Region in England, 
2004/05. rate per 1,000 population and number 
 
55
Table 4.6: Estimate of problem drug users and problem opiate users by age in 
England, 2004/05 
 
55
Table 4.7: Estimate of problem drug users and problem opiate users by gender in 
England, 2004/05 
 
55
Table 4.8: Estimate of problem drug use in the United Kingdom: number and rate 
per 1,000 population  
 
56
Table 4.9: Estimate of injecting drug use in the United Kingdom: number and rate 
per 1,000 population  
 
56
Table 4.10: Presentations by centre type in the United Kingdom, 2003/04 to 
2005/06 
 
58
Table 4.11: Number and percentage of drug treatment presentations by primary 
drug of use  in the United Kingdom, 2005/06  
 
58
Table 4.12: Number and percentage of first drug treatment demands by primary 
drug of use  in the United Kingdom, 2005/06  
 
59
Table 4.13: Age of drug users identified through TDI in the United Kingdom, 
2005/06  
 
59
Table 4.14: Injecting status by gender in the United Kingdom, 2005/06; all 
treatment  
 
60
Table 4.15: Injecting status by gender in the United Kingdom 2005/06; first 
treatment  
 
60
Table 4.16: Number and percentage of drug treatment presentations by primary 
drug in the United Kingdom, 2003/04, 2004/05 and, 2005/06  
 
61
Table 4.17: Number and percentage of first drug treatment presentations by 
primary drug, in the United Kingdom, 2003/04, 2004/05 and, 2005/06 
 
61
Table 4.18: Proportion of arrested users of heroin, crack or cocaine identified as 
dependent (Severity of Dependence Scale) in England and Wales, 2003-04 by 
age  
 
62
Table 4.19: Frequency of use of heroin, crack and cocaine by arrestees in 
England and Wales, 2003-04 as a percentage of all arrestees 
 
63
Table 4.20: Proportion of arrestees who had ever injected drugs among those 
who had taken drugs that could be injected in England and Wales, 2003-04, by 
age 
 
63
Table 4.21: Polydrug use in the last month by age amongst arrestees using 
heroin, crack and/or  cocaine in the last month in England and Wales, 2003-04 as 
a percentage 
 
63
Table 4.22: Proportion of arrestees who had used drugs in the last month, by 
ethnicity in England and Wales, 2003/04 
 
64
Table: 4.23: Lifetime use of heroin, crack and cocaine amongst arrestees who 
have been in contact with treatment services in England and Wales, 2003-04 as a 
percentage 
65
UNITED KINGDOM FOCAL POINT REPORT 2007 
 235
Table 4.24: Primary and secondary opiate users, crack users and opiate and/or 
crack users identified in TDI (England), 2005/06 
 
66
Table 4.25: PDU estimates, PDUs identified in TDI and PDUs identified through 
English treatment monitoring system (NDTMS) 
 
66
Table 6.1 Drug mentions on death certificates in the United Kingdom, 2002 to 
2005 
 
90
Table 6.2: Effect of maternal use of drugs of addiction in England 2003/04 to 
2005/06 
 
100
Table 6.3: Maternity services diagnosis in Scotland, 2000/01 to 2004/05 
 
101
Table 10.1: Number of seizures of drugs by law enforcement agencies in the 
United Kingdom 2003 to 2005 and percentage change 
 
133
Table 10.2: Quantity of seizures of drugs by law enforcement agencies in the 
United Kingdom 2003 to 2005 and percentage change 
 
133
Table 10.3: Law enforcement agencies: Mean price of illegal drugs in the United 
Kingdom, 2003 to 2006 
 
134
Table 10.4: Independent Drug Monitoring Unit: Mean price of drugs at street level 
in the United Kingdom, 2004 to 2006 
 
135
Table 10.5: Street level mean percentage purity of drug in the United Kingdom 
2003 to 2005 
 
136
Table 11.1: Labelled drug-related expenditure classified by COFOG and Reuter in 
the United Kingdom, 2005-06 
 
139
Table 11.2: Total government expenditure in the United Kingdom, 2005/06 by 
COFOG Functions 3: Public Order and Safety and 7: Health 
 
143
Table 11.3: Estimates of the proportion of criminal activity that is drug-related in 
England and Wales 
 
144
Table 11.4: Receptions to prison attributable to drugs in the United Kingdom, 
2005-06 
 
145
Table 11.5: Expenditure on accommodating adult drug offenders in prison in the 
United Kingdom, 2005-06  
 
145
Table 11.6: Finished hospital episodes with a primary diagnosis of drug misuse in 
England 2005/06 
 
147
Table 11.7: General acute inpatient discharges with a diagnosis of drug misuse by 
type of admission in Scotland, 2005/06 
 
148
Table 11.8 Calculation of teacher time spent on drug education in England, 
2005/06 
 
150
Table 11.9: Estimated expenditure on unemployment benefits for problem drug 
users in the United Kingdom, 2005/06 
 
151
Table 11.10: Overall estimated unlabelled government expenditure attributable to 
drugs in the United Kingdom, 2005/06 
 
 
154
UNITED KINGDOM FOCAL POINT REPORT 2007 
 236
Table 12.1: Percentage of 15 year olds who have used drugs in the last year by 
parental drinking and drug use in Scotland 
 
166
Table 12.2 Proportion of 10 to 25 year olds who committed an offence in the last 
12 months by drug status in England, 2005  
 
175
Table 13.1: University research groups and institutes currently undertaking drug-
related research 
 
189
Table 13.2: Drug-related articles published in scientific journals by UK based 
researchers in 2006 
 
192
Table 13.3: National disciplinary scientific journals publishing drug-related 
research since Autumn 2005 
 
198
Table 13.4: National drug conferences with an element of research dissemination 
 
199
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 237
List of figures in the text 
Figure Page 
Figure 2.1: Percentage of 16 to 59 year olds reporting having used drugs in the 
last year in England and Wales, 1996 to 2006/07 
 
28
Figure 2.2: Percentage of 16 to 24 year olds reporting having used drugs in the 
last year, England and Wales, 1996 to 2006/07 
 
31
Figure 2.3: Drug use amongst school children in England, 2001 to 2006 
 
33
Figure 6.1: Number of deaths using EMCDDA DRD standard definition by 
country, United Kingdom, 1996-2004 
 
88
Figure 6.2: Comparison of total number of deaths using three definitions, United 
Kingdom 1996 – 2005 
 
89
Figure 6.3: Deaths by age and gender in the United Kingdom, 2004: EMCDDA 
definition  
 
89
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 238
List of abbreviations used in the text  
 
A&E Accident and Emergency 
ABC Activity Based Costing 
ACMD  Advisory Council on the Misuse of Drugs 
ACORN A Classification of Residential Neighbourhood 
ACPO  Association of Chief Police Officers 
ACPOS  Association of Chief Police Officers Scotland 
ADATs  Alcohol and Drug Action Teams  
AD(H)D Attention Deficit (Hyperactivity) Disorder 
ADPB Alcohol and Drugs Policy Branch 
AIDS  Acquired Immunodeficiency Syndrome  
Anti-HBC  Antibodies to hepatitis B virus 
Anti-HCV  Antibodies to hepatitis C virus 
BCS  British Crime Survey  
BHIVA British HIV Association 
BME Black and Minority Ethnic 
BNF British National Formulary 
BYDS Belfast Youth Development Study 
BZP Benzylpiperazine 
CAF Common Assessment Framework 
CAPI Computer Assisted Personal Interviewing 
CARATS  Counselling, Assessment, Referral, Advice and Through-care Services 
CCTV  Closed Circuit Television  
CDR Weekly Communicable Disease Report Weekly 
CDRPs Crime and Disorder Reduction Partnerships 
CDSC (NI) Communicable Disease Surveillance Centre Northern Ireland  
CDT Community Drugs Team 
CDTD The Central Drugs Trafficking Database  
CI  Confidence Interval 
CJA Criminal Justice Act 
COFOG Classification of the Functions of Government 
CSPs Community Safety Partnerships 
D(A)ATs Drug (and Alcohol) Action Teams  
DACTs Drug and Alcohol Coordination Teams  
DAIRU  Drug and Alcohol Information and Research Unit 
DASA Drug Assisted Sexual Assault 
DATs Drug Action Teams  
DCSF Department for Children, Schools and Families 
DCLG Department for Communities and Local Government 
DfES  Department for Education and Skills 
DFSA Drug Facilitated Sexual Assault 
DH  Department of Health 
DHSSPSNI  Department of Health, Social Services and Public Safety Northern Ireland 
DIP Drug Interventions Programme 
DIR Drug Interventions Record 
DMRI  Drug Misuse Research Initative 
DORIS  Drug Outcome Research in Scotland  
DRD Drug Related Deaths 
DRR  Drug Rehabilitation Requirement 
DSD  Drug Strategy Directorate 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition 
DTORS Drug Treatment Outcomes Research Study 
DTTO Drug Treatment and Testing Order 
DVLA Driver and Vehicle Licensing Agency 
EDDRA Exchange on Drug Demand Reduction Action 
EIU  Effective Interventions Unit 
EMCDDA  European Monitoring Centre for Drugs and Drug Addiction 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 239
ESPAD European School Survey Project on Alcohol and Other Drugs 
ESRC Economic and Social Research Council 
EU European Union 
EYTC Edinburgh Youth Transitions Survey 
FSS  Forensic Science Service 
GAE Grant Aided Expenditure 
GCSE General Certificate of Education 
GDP Gross Domestic Product 
GHB  Gamma hydroxybutyrate  
GLADA Greater London Alcohol and Drug Alliance 
GMR  General Mortality Register  
GP  General Practitioner 
GRO  General Register Offices for England and Wales 
GRONI  General Register Office for Northern Ireland 
GROS  General Register Office for Scotland 
HAS  Health Advisory Service  
HBSC  Health Behaviour in School Aged Children 
HBV  Hepatitis B Virus 
HCC Heroin, Crack and Cocaine 
HCV  Hepatitis C Virus 
HES Hospital Episode Statistics 
HFA High Focus Area 
HIV  Human Immunodeficiency Virus  
HMPS Her Majesty’s Prison Service for England and Wales 
HMRC HM Revenue and Customs  
HMSO Her Majesty’s Stationery Office 
HPA  Health Protection Agency 
HPS Health Protection Scotland 
HSSB Health and Social Service Boards 
HSSD The Housing Strategy and Support Directorate 
ICD-10 International Statistical Classification of Diseases and Related Health 
Problems – tenth edition 
IDMU Independent Drug Monitoring Unit 
IDTS  Integrated Drug Treatment System 
IDUs Injecting Drug Users 
ISD Information Services Division 
ITMDF Integrated Team Monitoring Data Form 
KPI Key Performance Indicator 
LDPF  London Drug Policy Forum 
LGDUW Local Government Data Unit Wales 
LHB Local Health Board 
LSCB Local Safeguarding Children Boards 
LSD  Lysergic Dyethylamide acid  
MDA  Methylenedioxymethamphetamine  
MDMA  3,4-Methylenedioxy-n-methylamphetamine 
MDT  Mandatory Drug Tests  
MHRA  Medicines and Health Care Products Regulation Agency  
MMT Methadone Maintenance Therapy 
MoJ Ministry of Justice 
MRSA Methicillin resistant Staphylococcus aureus 
NACD National Advisory Committee on Drugs 
NatCen  National Centre for Social Research 
NCB National Children’s Bureau 
NCCDP National Collaborating Centre for Drug Prevention 
NCH National Children’s Home 
NCIS  National Criminal Intelligence Service 
NDEC  National Drug Evidence Centre 
NDTMS National Drug Treatment Monitoring System 
NET Neuro-Electric Therapy  
NFER  National Foundation for Educational Research  
UNITED KINGDOM FOCAL POINT REPORT 2007 
 240
NHS  National Health Service 
NICE  National Institute for Clinical and Health Excellence 
NIO Northern Ireland Office 
NOMS  National Offender Management Service 
NPHSW National Public Health Service for Wales p 88 
np-SAD  National Programme on Substance Abuse Deaths 
NSD New Strategic Direction  
NSPCC National Society for the Prevention of Cruelty to Children 
NTA  National Treatment Agency 
NTORS  National Treatment Outcome Research Study 
OASys Offender Assessment System p120 
OCJS Offending Crime and Justice Survey 
ODPM Office of the Deputy Prime Minister 
Ofsted  Office for Standards in Education 
ONS  Office for National Statistics  
OST Office for Science and Technology 
p2w  Progress2Work 
PCC Primary Care Clinic 
PCTs  Primary Care Trusts 
PDI Partnership Drugs Initiative 
PDU Problem Drug Users 
PF Positive Futures 
PPO  Prolific and other Priority Offender 
PSA  Public Service Agreement  
PSHE Personal, Social, Health and Economic Education 
PSM Propensity Score Matching 
PSNI Prison Service Northern Ireland 
RCGP  Royal College of General Practitioners 
RCT Randomised Controlled Trial 
RDS  Research Development and Statistics 
RIOTT Randomised Injectable Opiates Treatment Trial 
RIWG Research Information Working Group 
RoB  Restriction on Bail 
ROUTES Research On Understanding Treatment Experiences and Services 
RSA Royal Society for the encouragement of Arts, manufactures and commerce 
SACDM Scottish Advisory Committee on Drugs Misuse 
SALSUS  Scottish Schools Adolescent Lifestyle and Substance Use Survey 
SARCS Sexual Assault Referral Centres 
SCDEA Scottish Crime and Drug Enforcement Agency 
SCIEH  Scottish Centre for Infection and Environmental Health  
SCVS Scottish Crime and Victimisation Survey 
SD Standard Deviation 
SDS Severity of Dependence Scale 
SLO Schools Liaison Officer 
SMATs Substance Misuse Action Teams 
SMMGP Substance Misuse Management in General Practice 
SMR  Special Mortality Register  
SMRT Substance Misuse Research Team 
SOCA Serious Organised Crime Agency 
SOCRATES Stages Of Change Readiness And Treatment Eagerness Scale 
SOPHID Survey of Prevalent HIV Infections Diagnosed 
SPD Substitute Prescribing Database 
SPS  Scottish Prison Service 
STI  Sexually Transmitted Infection 
TDI Treatment Demand Indicator 
TOP Treatment Outcomes Profile 
UAPMP  Unlinked Anonymous Prevalence Monitoring Programme 
UK United Kingdom 
UKADCU United Kingdom Anti Drugs Co ordination Unit 
UKDPC United Kingdom Drug Policy Commission 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 241
VDT  Voluntary Drug Testing 
VSA  Volatile Substance Abuse 
WAG Welsh Assembly Government 
YOT Youth Offending Team 
YPSMG  Young People’s Substance Misuse Partnership Grant 
 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 242
List of websites used in the text 
 
10 Downing Street 
http://www.number-
10.gov.uk/output/Page1.asp 
 
Aberlour 
www.abelour.com    
 
Association of Chief Police Officers 
www.acpo.police.uk 
 
Bank of England 
www.bankofengland.co.uk 
 
Barnardos 
www.barnardos.org.uk 
 
British Broadcasting Corporation 
www.bbc.co.uk 
 
Cabinet Office 
http://www.cabinetoffice.gov.uk/ 
 
CACI 
http://www.caci.co.uk/  
 
Centre for Drug Misuse Research, 
University of Glasgow 
www.gla.ac.uk/centres/drugmisuse 
 
Centrepoint 
www.centrepoint.org.uk 
 
Children and Young People’s Unit 
Northern Ireland 
http://www.allchildrenni.gov.uk/  
 
Children in Scotland’s Policy Information 
Network 
http://childpolicyinfo.childreninscotland.org
.uk/ 
 
Children’s hearings 
www.childrens-hearings.co.uk  
 
Communicable Disease Surveillance 
Centre, Northern Ireland 
www.cdscni.org.uk 
 
Communities and Local Government 
http://www.communities.gov.uk/corporate/  
 
Community Care 
www.communitycare.co.uk/  
 
Crime Reduction 
www.crimereduction.gov.uk  
 
Criminal Justice System Northern Ireland 
www.cjsni.gov.uk/  
 
Dan 
http://www.askdan.org.uk/ 
 
Department for Education and Skills  
www.dfes.gov.uk 
 
Department for Transport 
www.dft.gov.uk 
 
Department for Transport, Local 
Government 
and the Regions 
www.dltr.gov.uk 
 
Department for Environment, Food and 
Rural 
Affairs 
http://www.defra.gov.uk 
 
Department for Work and Pensions 
www.dwp.gov.uk 
 
Department of Health 
www.dh.gov.uk 
 
Department of Health, Social Services and 
Public Safety, Northern Ireland 
www.dhsspsni.gov.uk 
 
Drug Misuse Research Initiative 
http://www.mdx.ac.uk/www/drugsmisuse/   
 
Drug Misuse Research Initative: Routes 
http://www.lshtm.ac.uk/research/dmri/  
 
Drugs Misuse Information Scotland 
www.drugmisuse.isd.scotland.org 
 
Drugs Strategy Directorate, Home Office 
www.drugs.gov.uk 
 
DrugScope 
www.drugscope.org.uk 
 
Drug Treatment Outcomes Research 
Study 
http://www.dtors.org.uk 
 
Every Child Matters 
www.everychildmatters.gov.uk 
 
Foresight 
UNITED KINGDOM FOCAL POINT REPORT 2007 
 243
http://www.foresight.gov.uk/  
 
FRANK 
www.talktofrank.com 
 
General Register Office 
www.gro.gov.uk 
 
General Register Office for Scotland 
www.gro-scotland.gov 
 
General Register Office Northern Ireland 
www.groni.gov.uk 
 
Health Promotion Agency 
http://www.healthpromotionagency.org.uk/ 
 
Health Protection Agency 
www.hpa.org.uk 
 
Her Majesty’s Inspectorate of Education 
http://www.hmie.gov.uk/  
 
Her Majesty’s Prison Service for England 
and Wales 
www.hmprison.gov.uk 
 
Her Majesty’s Treasury 
www.hm-treasury.gov.uk 
 
Home Office 
www.homeoffice.gov.uk 
 
Hospital Episode Statistics Online 
www.hesonline.org.uk 
 
International Review of Curriculum and 
Assessment Frameworks Internet Archive 
http://www.inca.org.uk/index.html  
 
Know the Score 
www.knowthescore.info 
 
Medicines and Healthcare products 
Regulatory Agency 
www.mhra.gov.uk  
 
Mind (National Association for Mental 
Health) 
http://www.mind.org.uk/  
 
Ministry of Justice 
http://www.justice.gov.uk/ 
 
National Children’s Bureau 
www.ncb.org.uk 
 
National Children’s Homes 
http://www.nch.org.uk/  
 
National Collaborating Centre for Drug 
Prevention 
http://www.drugpreventionevidence.info/  
 
National Drug Treatment Monitoring 
System 
www.ndtms.net  
 
National Institute for Health and Clinical 
Excellence 
www.nice.org.uk 
 
National Society for the Prevention of 
Cruelty to Children 
www.nspcc.org.uk 
 
National Statistics 
http://www.statistics.gov.uk/ 
 
National Treatment Agency for Substance 
Misuse 
www.nta.nhs.uk 
 
Northern Ireland Prison Service 
www.niprisonservice.gov.uk 
 
Office of Public Sector Information 
http://www.uk-legislation.hmso.gov.uk/ 
 
Politics.co.uk 
http://www.politics.co.uk/ 
 
Re-solv 
www.re-solv.org 
 
Respect 
www.respect.gov.uk  
 
Scottish Drug Forum 
www.sdf.org.uk 
 
Serious Organised Crime Agency 
www.soca.gov.uk 
 
Substance Misuse Management in 
General 
Practice 
www.smmgp.demon.co.uk 
 
Sure Start 
www.surestart.gov.uk 
 
The Children’s Society 
http://www.childrenssociety.org.uk/  
 
The Herald 
http://www.theherald.co.uk/ 
 
The Mentor Foundation  
http://www.mentorfoundation.org/  
UNITED KINGDOM FOCAL POINT REPORT 2007 
 244
 
The National Electronic Library for 
Medicines 
http://www.nelm.nhs.uk 
 
The National Youth Agency’s Youth 
Information website 
www.youthinformation.com  
 
The Royal College of Psychiatrists 
http://www.rcpsych.ac.uk/  
 
The Shipman Inquiry 
http://www.the-shipman-
inquiry.org.uk/home.asp 
 
The Stationary Office 
www.official-documents 
 
The United Kingdom Parliament 
www.parliament.uk 
 
UK Drug Policy Commission 
http://www.ukdpc.org.uk/index.shtml  
 
Welsh Assembly Government 
www.wales.gov.uk 
 
Welsh Local Government Data Unit  
www.lgdu-wales.gov.uk  
 
World Health Organisation 
www.who.int  
  
 
  
